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A. SUMMARY 
 
Sinorhizobium meliloti is a model organism for studies of plant-microbe interactions. This Gram-
negative soil bacterium can enter an endosymbiosis with alfalfa plants through the formation of nitrogen-
fixing nodules. S. meliloti genome sequence determination has provided a basis for different approaches of 
functional genomics to this bacterium. One of these approaches is gene disruption with subsequent 
analysis of mutant phenotypes.  
Usually, the selection of mutants that can survive under a certain condition is simple and efficient, and 
can be performed using a mixture of different mutants. However, the selection of mutants that have an 
attenuated phenotype in a tested condition is problematic, because all mutants have to be checked 
separately one by one. A microarray-based signature-tagged mutagenesis (STM) strategy can overcome this 
problem. 
Signature-tagged mutagenesis is based on a collection of mutants split into sets, where each mutant is 
modified by one or more different signature tags. The tags are short DNA segments that are unique for 
each mutant in a set and can be amplified using invariant or specific priming sites. Tagged mutants from 
the same set are pooled prior to an experiment, and each mutant in the mixture can be identified based on 
the unique tag in its genome. The presence of a particular tag in the mixture can be detected through a 
hybridization of amplified products to a microarray containing tag-specific probes. In order to integrate 
the signature tags into the genome, a strategy based on libraries of tag-carrying transposons can be used. 
In the transposon-based STM, the number of mutants that can be pooled together in one experiment 
depends on the quantity of transposons containing different tags. In this study, the construction of a novel 
set of 412 mTn5-based signature-tagged transposons was performed, which is the largest tagged 
transposon set reported so far, and this set was applied to the mutagenesis of S. meliloti. To achieve a high 
specificity of tag detection, each transposon was bar coded by two signature tags. In order to generate 
defined, non-redundant sets of signature-tagged S. meliloti mutants for subsequent experiments, 12000 
mutants were constructed and insertion sites for more than 5000 mutants were determined. 
One set consisting of 378 mutants was used in a validation experiment to identify mutants showing 
altered growth patterns. This and one additional mutant set, which also contained 378 mutants, were used 
in the experiment for identification of genes in S. meliloti relevant to symbiosis and competitiveness. From 
all the tested mutants, 69 were found to be attenuated. For 25 mutants, attenuated phenotypes were 
checked by a different method. As a result, the attenuated competitiveness phenotype could be confirmed 
for 22 from 25 tested mutants. Four mutants were found to have additional symbiotic defects: Fix- 
phenotype (ccmC mutant), low efficiency of nodulation (asnO mutant) and delayed nodulation (cysG and 
metA mutants).  
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B. INTRODUCTION 
B.1 NITROGEN FIXATION 
 
Nitrogen is one of the most abundant elements on Earth and, next to hydrogen, oxygen and 
carbon, one of the most important components of the living cells. All of the nutritional nitrogen 
is obtained by humans and animals directly or indirectly from plants. Plants, in turn, acquire 
nitrogen from two principal sources: the soil, through commercial fertilizer and/or mineralization 
of organic material, and the atmosphere, through nitrogen fixation by symbiotic bacteria (Vance, 
2001).  
The process of biological nitrogen fixation is limited to prokaryotes. The group of 
prokaryotes that can fix nitrogen due to an evolutionarily conserved nitrogenase protein complex 
is diverse and contains both eubacteria and archaea (Zehr et al., 2003). Limiting factors in 
maintaining a high rate of nitrogen fixation are the large quantity of energy needed to break the N 
– N triple bond, and the high sensitivity of nitrogenase to oxygen. Different mechanisms have 
evolved to overcome this limitation. For the anaerobic microorganisms (Clostridium) that 
predominate in waterlogged soils, where organic substrates are available but oxygen supply to the 
micro-environment of the bacteria is severely restricted, this is not problematic (Chen and 
Johnson, 1993). In cyanobacteria, nitrogen fixation occurs in special cells known as heterocysts 
which do not photosynthesize but are devoted solely to N2 fixation (Golden and Yoon, 2003). 
The obligate aerobe Azotobacter protects the nitrogenase in two ways: producing special auxiliary 
proteins which cause nitrogenase to aggregate when exposed to oxygen and by very high 
respiratory rate that creates a nearly anoxygenic environment in the cytoplasm of the cells (Poole 
and Hill, 1997). The most efficient way of nitrogen fixation, however, is the symbiosis between 
bacteria and plants, where the plant supplies the carbon source for the reduction of nitrogen and 
at the same time, creates microaerobic environment to protect the nitrogenase. Bacteria, in turn, 
provide the plant with the nitrogen in form of ammonia. This process is mostly restricted to a 
limited number of bacterial groups, including the genera Rhizobium, Mesorhizobium, Sinorhizobium 
(Ensifer), and Bradyrhizobium (collectively referred to as rhizobia), and Frankia. All these genera 
except Frankia belong to the Rhizobiacae family in the alpha-proteobacteria, and enter symbiosis 
with plants from family Leguminosae. Frankia is an actinomycete that enters symbiosis with 
plants from the families Rosaceae, Casuarinaceae, Betulaceae, Myricaceae, Rhamnaceae, 
Datisticaceae, Eleganaceae and Coriariaceae (Gage, 2004).  
The subject of this study is Sinorhizobium meliloti, an organism from the genera Sinorhizobium 
that is able to establish nitrogen fixing symbiosis with plants of genera Medicago, Melilotus and 
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Trigonella. The S. meliloti genome sequence was determined and consists of one chromosome (3.65 
Mb) and two megaplasmids, pSymA (1.36 Mb) and pSymB (1.68 Mb) (Galibert et al., 2001).  
 
B.2 SYMBIOSIS BETWEEN RHIZOBIA AND THE LEGUMINOUS 
PLANTS 
 
B.2.1 Determinate and indeterminate nodules 
 
The symbiosis between Rhizobia and their host plants results in the formation of specialized 
symbiotic organs called nodules. Nodules are formed by the plant tissue and occupied by the 
nitrogen-fixing bacteria. Mature nodules are either of determinate or indeterminate type.  
Determinate nodules are formed on tropical and subtropical legumes (Glycine max, Phaseolus 
vulgaris). They are characterized by meristemic activity that disappears early after nodulation that 
causes globose shape of nodules. Nodule primordia initiate in the outer cortex (Fig. B1) (Brewin, 
1991). 
 
 
 
 
 
 
 
 
 
Fig. B1. Scheme of the determinate globose nodule. CS, central stele; VB, vascular bundle; PT, peripheral tissue; 
BTs, bacteroids; SBs, symbiosomes; SG, starch grain; IC, invaded cell; UC, uninvaded cell (Patriarca et al., 2002).  
 
Indeterminate nodules are usually formed on temperate legumes (e.g., from Medicago sativa, 
Pisum sativum, and Vicia hirsuta) and are characterized by persistent meristematic activity, that 
causes elongated shape of nodules. The central tissue of such nodules consists of a number of 
distinct zones containing invaded cells at different stages of differentiation, in which 
symbiosomes also show a progressive differentiation (Fig. B2). Nodule primordia initiate in inner 
cortex (Patriarca et al., 2002; Pawlowski and Bisseling, 1996).  
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Fig. B2. Scheme of the indeterminate elongated nodule. BA, bacteria; BTs, bacteroids; SBs, symbiosomes; SG, 
starch grain; CS, central stele; VB, vascular bundle. The nodule zones (Z) are indicated (Patriarca et al., 2002). 
 
 
B.2.2 Formation of  indeterminate nodules 
 
Formation of nodule is a complicated and selective process, characterized by the exchange of 
molecular signals between the symbiontes. At the first step of the interaction, bacteria sense the 
specific compounds of plant root exudates. Amino acids, dicarboxylic acids and flavonoids 
present in the root exudates induce positive chemotaxis of rhizobia (van Rhijn and Vanderleyden, 
1995). Furthermore, bacteria respond to the flavonoids by production of the 
lipochitooligosaccharide signalling molecules known as Nod factors. 
At the second step of nodule formation, the rhizobia attach to the plant root surface. For 
many rhizobia, primary target sites for infection are young growing root hairs but there are no 
exclusive loci for rhizobial attachment. In some conditions, host plant lectins specifically bind 
polysaccharides structures present on the bacterial cell surface at the stage of attachment (Brencic 
and Winans, 2005; van Rhijn and Vanderleyden, 1995). At the same time, the root hair deforms 
by reinitiating tip growth with a changed growth direction in response to the Nod factors (Fig. 
B3). On Vicia sativa the first root hair deformation can be observed only 1 h after the application 
of Nod factors, while the maximal deformation is established in 3 h. A period of Nod factor-root 
contact as short as 10 min is sufficient to induce root hair deformation (Heidstra et al., 1994). The 
morphological changes of root hair are caused by rearrangements of the actin filaments (Allen et 
al., 1994) and increased cytoplasmic streaming (Heidstra et al., 1994). 
Root hairs curl in the way that the bacterial cells become entrapped in a pocket of host cell 
wall. After the entrapment, a local lesion of the root hair cell wall is formed by hydrolysis of the 
cell wall, so that infection can be initiated. The plasma membrane invaginates, and a tube-like 
structure, called an infection thread, is formed. The infection thread grows down the inside of the 
B.  INTRODUCTION 
 5
root hair and into the body of the epidermal cell. Rhizobia inside the infection thread grow and 
divide, thereby keeping the tubule filled with bacteria (Gage, 2004). Even before the infection 
thread has crossed the epidermis, cells of cortex and pericycle respond in a local manner to the 
presence of rhizobia. Cells in the inner cortex dedifferentiate by entering the cell cycle; later these 
cells will form the nodule tissue. The group of dividing cortical cells is called the nodule 
primordium (Geurts and Bisseling, 2002; Timmers et al., 1999).  
 
Fig. B3. Overview of the nodulation process in 
plants that form indeterminate nodules (Gage, 
2004). (A) One form of Nod factor synthesized 
by S. meliloti. (B) Diagrammatic cross section of a 
root, showing gradients of an activating factor at 
protoxylem poles (blue) and an inhibitor at 
protophloem poles (red). Nodules are formed 
next to the protoxylem poles, which are at the 
ends of the Y-shaped structure depicted in the 
center the diagram, rather than above the 
protophloem poles, depicted as ovals. (C)–(K) 
Steps of the infection thread formation. (L) 
Enlarged view of the root hair shown in panel I. 
 
At the next step, the infection thread branches in the nodule primordium, thereby increasing 
the number of sites from which bacteria can exit the thread and enter nodule cells. At this point, 
cells at the base of primordium establish a radial pattern consisting of a central tissue surrounded 
by peripheral tissues, and the cells at the apex of primordium form the meristem tissue, thus 
creating a young nodule (Pawlowski and Bisseling, 1996). Eventually, bacteria exit the infection 
thread, and the symbiosomes – compartments containing nitrogen-fixing rhizobia surrounded by 
the plant-derived peribacteroid membrane (Becker et al., 2005) – are formed. 
 
B.2.3 Structure of  mature indeterminate nodules 
 
Once inside nodule cells, the bacteria continue to differentiate and synthesize proteins 
required for nitrogen fixation. Ultrastructural studies of wild type nodules distinguish 5 steps in 
bacteroid differentiation (types 1 to 5), each of them being restricted to a defined histological 
region of the nodule (Zones I to IV) (Fig. B2) (Luyten and Vanderleyden, 2000; Vasse et al., 
1990).  
Zone I contains meristematic tissue, situated at the apex of the nodule. This is a region of 
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actively dividing plant cells devoid of bacteria.  
Zone II is called the infection zone. Here the bacteria enter the root cells via infection 
threads. Bacteria, released from the infection threads, are called type 1 bacteroids. These 
bacteroids divide and resemble free-living bacteria by size and cytoplasm content. They have a 
large periplasmic space, and the peribacteroid membrane (membrane of the plant origin that 
surrounds invading bacteria) appears irregular in shape due to local fusions with plant 
cytoplasmic vesicles. In the proximal part of Zone II, type 2 bacteroids are the most abundant. 
These bacteroids are elongated; their periplasmic and peribacteroid spaces are reduced, and the 
peribacteroid membrane is more regular in shape. The cell division stops once the type 2 
bacteroid stage is reached. DNA replication stops several rounds after the cell division has 
stopped. Therefore, bacteroids have an increased DNA content comparing to the free-living 
cells. Nitrogen fixation does not take place in the Zone II.  
Interzone II-III is a very restricted zone that contains only 3-4 layers of cells, separating the 
prefixation zone II and nitrogen-fixing Zone III. The Interzone II-III is easily identified by the 
abundance of amyloplasts (plastids involved in the synthesis and storage of starch). It contains 
bacteroids of type 3 which have stopped elongating and are about seven times longer than the 
free-living bacteria. The membranes surrounding each bacteroid, including the peribacteroid 
membrane, are smooth, often in contact with each other, with small periplasmic and 
peribacteroid spaces. Bacteroids do not fix nitrogen in the Interzone II-III, but the expression of 
the nitrogen fixation genes (nif and fix) already takes place. 
Zone III is filled with the fully differentiated, nitrogen-fixing bacteroids of type 4. In mature 
nodules, this zone is spread over eight to twelve cell layers. In this zone, the leghaemoglobin is 
produced that gives a nodule its pink or red color. Leghaemoglobins are essential for symbiotic 
nitrogen fixation in legume nodules, since they bind oxygen molecules, protecting the 
nitrogenase.  
In the proximal Zone III, the bacteroids stop fixing nitrogen and show a dispersion of the 
ribosome-enriched areas, thus becoming the bacteroids of type 5. 
Zone IV is the senescence zone, located proximal to the point of attachment to the plant 
root. Here, both symbiotics partners degrade and the number of bacteroids gradually decreases. 
Ghost membranes of plant and bacteroid origin are the ultimate result of the senescing process.  
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B.2.4 Bacterial genes involved in competitiveness, efficient nodule formation 
and nitrogen fixation 
 
B.2.4.1 Genes important for survival and competitiveness in the rhizosphere 
 
Survival of bacteria in the rhizosphere is an important factor of competitiveness, especially in 
field conditions. Plant root exudates contain a great variety of different compounds, and nearly 
5% to 21% of all photosynthetically fixed carbon can be transferred to the rhizosphere through 
the root exudates (Walker et al., 2003). Therefore, the ability to transport and catabolize the 
compounds represented in the root exudates is crucial for the survival and competitiveness of 
bacteria in the plant rhizosphere. This is reflected by the content of rhizobial genomes: rhizobia 
have approximately 170 ABC transporters, compared to 47 in E. coli, so that they can access a far 
greater range of nutrients present at low concentrations in the soil and in the rhizosphere (Prell 
and Poole, 2006). Abiotic factors, such as temperature, osmotic pressure, UV light, and pH also 
play role in the selection and activity of microbes in soils and at the plant surface (Savka et al., 
2002). 
Bacteria in the rhizosphere compete furthermore via production of and resistance to 
antibacterial compounds that can originate both from plant root system and from other soil 
organisms (Savka et al., 2002). An example of such interaction is a mimosine system. The toxin 
mimosine is produced by the tree legume Leucaena and provides a nodulation competition 
advantage to mimosine-degrading Rhizobium strains (Soedarjo et al., 1994). Another example is the 
production of an antirhizobial peptide trifolitoxin (TFX) by Rhizobium leguminozarum bv. trifolii 
T24. The TFX-producing, TFX-resistant rhizobial strains exhibited at least 20% higher greater 
nodule occupancy than the non-producing strains in field grown plants 2 years after inoculation 
(Robleto et al., 1998).  
Bacteria can also produce some selective growth-promoting factors, or stimulate the 
production of such factors by the plant. The best studied system of this type is the Agrobacterium 
tumefaciens-plant interaction. These pathogenic bacteria genetically engineer the host plant to 
synthesize carbon- and nitrogen-containing molecules (opines) that favour their growth and 
dissemination of pathogenicity (Savka et al., 2002). Several Rhizobium strains and related legume-
associated species have evolved the ability to synthesize carbon compounds called opine-like 
molecules due to the similarity of their action to the agrobacterial opines. Rhizopine, which is one 
of such molecules, is synthesized in the bacteroids during symbiosis in the plant nodules 
(Heinrich et al., 2001). The ability to catabolize rhizopine provides a growth advantage to the 
rhizopine-degrading rhizobial strains.  
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B.2.4.2. Genes important for the formation of nodules and infection 
 
At the stage of initiation and growth of infection threads, the genes encoding for the 
synthesis of signal molecules are especially important. The efficiency of the infection process 
depends also on the ability of bacteria to adapt to the conditions inside the infection thread and 
the plant cells. The following genes are crucial for the infection of the host plant by rhizobia.  
nod genes  
Nod factors initiate many of the developmental changes seen in the host plant early in the 
nodulation process, including root hair deformation, membrane depolarization, intracellular 
calcium oscillations, and the initiation of cell division in the root cortex, which establishes a 
meristem and nodule primordium (Ehrhardt et al., 1992; Gage, 2004). Nod factors consist of an 
oligomeric backbone of β-1,4-linked N-acetyl-D-glucosaminyl residues, N-acetylated at the 
nonreducing-terminal residue (Kamst et al., 1998). Qualitative and quantitative aspects of the Nod 
factor populations are strain-specific. In different strains, 2 to 60 different individual Nod factors 
can be synthesized (D'Haeze and Holsters, 2002).  
Bacterial genes involved in Nod factor synthesis and export are the nod (nodulation) genes. 
They are not expressed in free-living bacteria, with the exception of nodD, which is expressed 
constitutively (Mylona et al., 1995). NodD protein is activated by the binding of the flavonoids 
and, in turn, activates the transcription of other nod genes (Goethals et al., 1992), which encode 
enzymes involved in the synthesis of Nod factors. S. meliloti has three nodD genes. NodD1 
activates expression of nod genes in presence of the plant flavonoids luteolin and 
methoxychalcone. NodD2 is activated by methoxychalcone and two betaines, trigonelline and 
stachydrine. NodD3 does not need a plant inducer, but the nodD3 gene is regulated by NodD1 
and another regulator, SyrM (Luyten and Vanderleyden, 2000). The complex regulation of the nod 
gene expression is necessary since the concentration and composition of Nod factors need to be 
optimal for the efficient nodulation of the host.  
Mutations in the nod genes result either in the complete abolishment of nodulation, or in a 
delayed nodulation phenotype. Essential for the nodulation are the nodABC genes that encode for 
the enzymes involved in the synthesis of the chitin oligomer backbone (John et al., 1993; Rohrig et 
al., 1994), and nodHPQ, responsible for the formation of the sulphate group on the reducing 
sugar (Roche et al., 1991). In addition, S. meliloti mutants of ilvC gene, which are auxotrophs for 
isoleucine and valine, have a not-nodulating (Nod-) phenotype, because nodABC genes are not 
activated by the inducer luteolin in these mutants. This could be caused by the high concentration 
of the valine and isoleucine precursors that probably inhibit the expression of nod genes, or 
antagonize the inducing effect of luteolin (Aguilar and Grasso, 1991). Other nod genes involved in 
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efficient nodulation, are: 
nodEF – products of these genes are involved in the synthesis of C16 polyunsaturated acyl 
chains (Fig B3). nodEF mutants have a delayed nodulation phenotype and show low number of 
infection threads (Demont et al., 1993)  
nodG – encodes, putatively, for a 3-oxoacyl-acyl carrier protein reductase (Lopez-Lara and 
Geiger, 2001). nodG mutants have a minor defect in the infection. 
nodL – the product of this gene attaches the O-acetyl decoration at the non-reducing end. 
nodL mutants have a delayed nodulation phenotype, and the overall production of Nod factors is 
reduced 5- to 10-fold. Depending on the host, the symbiotic defects of nodL mutants range from 
a reduced quantity of infection threads (M. truncatula and M. alba) to the complete loss of 
nodulation (M. lupine or M. littoralis) (Luyten and Vanderleyden, 2000).  
Genes of polysaccharides synthesis  
Another group of rhizobial genes that play an important role in the infection process and in 
the survival of rhizobia inside the infection threads are the genes involved in the synthesis of the 
surface polysaccharides, such as exopolysaccharides (EPS), lipopolysaccharides (LPS), capsular 
polysaccharides (K antigens) and cyclic β-(1, 2)-glucans.  
Exopolysaccharides are extracellular polysaccharides that accumulate on the surface with little 
or no cell association. S. meliloti produces two types of EPS. Succinoglycan (EPS I) is composed 
of octasaccharide repeating units containing one galactose and seven glucose residues (in molar 
ratio 1:7), joined by β-1,3, β-1,4 and β-1,6 glycosidic linkages. The single repeating unit is 
decorated by acetyl, pyruvyl and succinyl groups (Reinhold et al., 1994). Galactoglucan (EPS II) is 
a polymer of disaccharide repeating unit composed of an acetylated glucose and one pyruvylated 
galactose coupled by α-1,3 and β-1,3 glycosidic bonds (Skorupska et al., 2006).  
Both EPS I and II are secreted in two major fractions of different molecular weight: HMW 
(High Molecular Weight), consisting of hundreds to thousands of repeating units (polymers of 
106 – 107 Da) and LMW (Low Molecular Weight) that represent monomers, dimers and trimers in 
case of EPS I and oligomers (15–20) in case of EPS II (Skorupska et al., 2006). 
The gene groups responsible for EPS I synthesis are exo and exs (Fig. B4). Mutations in genes, 
responsible for the synthesis of nucleotide sugar precursors, exoB and exoC not only result in the 
lack of EPS I production, but also affect the synthesis of EPS II, LPS and β-glucans (Leigh and 
Lee, 1988). Mutants of the exoN gene, which encodes for a UDP-glucose pyrophosphorylase, 
results in a decreased production of EPS I (Becker et al., 1993b).  
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Fig. B4. Biosynthesis of exopolysaccharides. Modified from (Fraysse et al., 2003) 
 
In S. meliloti strain Rm1021, mutations in exoB, exoC and in other exo genes such as exoA, 
exoF, exoL, exoM, exoY, exoO, exoP, exoQ, exoT, exoU, exoV, exoW or exoY that abolish the EPS I 
production, cause severe defects in symbiosis. S. meliloti clones that have a mutation in any of 
these genes are able to initiate root hair curling and infection thread formation, but the infection 
threads abort within the peripheral cells of developing nodules, resulting in a formation of empty 
nodules that do not fix nitrogen (Becker et al., 1993b; Becker et al., 1993c; Fraysse et al., 2003; 
Reuber and Walker, 1993). exoH mutants that produce symbiotically nonfunctional high-
molecular-weight EPS I lacking the succinyl modification, also induce formation of ineffective 
nodules that do not contain intracellular bacteria or bacteroids (Leigh et al., 1987; Skorupska et al., 
2006). An exoZ mutant, which produces EPS I without the acetyl modification, exhibited a 
reduced efficiency in the initiation and elongation of infection threads, but produces nitrogen-
fixing nodules (Cheng and Walker, 1998). exoG and exoJ mutants form a mixture of white and 
pink nodules (Long et al., 1988). 
Genes responsible for the synthesis of EPS II form the exp gene cluster. EPS II can 
functionally replace the EPS I in nodule invasion (Zhan et al., 1989). In S. meliloti Rm2011 and 
Rm1021 EPS II is synthesized only under phosphate starvation (Zhan et al., 1991) or when 
mutation in the regulatory gene mucR (Keller et al., 1995) occurs. The restoration of the reading 
frame of the regulator gene expR by the excision of an insertion sequence also leads to the 
production of EPS II (Pellock et al., 2002). An additional gene, expG (mucS) positively regulates 
the expression of the exp genes (Baumgarth et al., 2005; Rüberg et al., 1999).  
The role of EPSs in symbiosis is still not well understood. Their possible biological functions 
include protection of bacteria against environmental stresses, attachment of bacteria to the roots, 
structural role in the infection thread formation, release of bacteria from infection threads, 
suppression of plant defence responses, and protection against plant antimicrobial compounds. It 
+
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was also assumed that EPSs might serve as signalling molecules that trigger plant developmental 
response and as determinants of host-specificity (Skorupska et al., 2006). 
Rhizobial K polysaccharides (capsular polysaccharides) show structural analogies to group II 
K-antigens found in Escherichia coli. In S. meliloti, the synthesis of K-polysaccharides is performed 
by the products of rkp genes. In enteric bacteria, capsular polysaccharides form an adherent 
cohesive layer that contributes to the protection against abiotic factors (Roberts, 1996). K 
polysaccharides may have a similar function in rhizobia, protecting the bacteria also against 
legume defence products during the infection process (Becker et al., 2005; Roberts, 1996). 
Furthermore, it was shown that S. meliloti Rm41 exoB mutant, unable to synthesize EPS I and II, 
successfully infects the host plant due to its symbiotically active K polysaccharide. A mutation in 
the rkpZ gene that affected the size distribution of K-polysaccharide led to the loss of its 
symbiotic activity. The introduction of rkpZ from Rm41 into the exoB mutant of strain Rm1021 
partially restored the symbiotic efficiency (Becker et al., 2005; Reuhs et al., 1995).  
Lipopolysaccharides (LPS) are anchored in the outer membrane of bacteria. They consist of a 
lipid A anchor, associated with a core polysaccharide or an O-antigen polysaccharide moiety 
(Becker et al., 2005). The main gene clusters encoding for the lipopolysaccharide synthesis are lpx, 
lps and acp clusters. Lipopolysaccharides may be involved in symbiosis not only at the infection 
stage, but also during release of bacteria into plant cells and formation of symbiosomes. 
Characteristically for rhizobia, their lipid As are acylated with a very long fatty acid chain, 27-
hydroxyoctacosanoic acid. Biosynthesis of this substitution requires a special acyl carrier protein, 
AcpXL, which serves as a donor of C28 (ω-1)-hydroxylated fatty acid (Brozek et al., 1996). The 
acpXL mutant of S. meliloti Rm1021 displayed delayed nodulation of Medicago sativa and a reduced 
competitive ability (Sharypova et al., 2003). It was hypothesized that very long-chain fatty acid 
could stabilize the bacterial membrane, therefore supporting the adaptation of rhizobia to the 
conditions inside the nodule (Becker et al., 2005). It has been also demonstrated that LPSs of S. 
meliloti suppress the defence response to the yeast elicitor in a Medicago sativa cell suspension 
culture. Addition of either LPS or lipid A, or lipid A lacking the very long acyl chain, inhibited the 
defence reactions in a concentration-dependent manner (Scheidle et al., 2005).  
Cyclic β-(1,2)-glucans are found almost exclusively in rhizobia; their synthesis is directed by 
the products of exo and ndv genes. Cyclic β-glucans reach levels from 5% to 20% of cellular dry 
weight and are predominantly localized within the periplasmic compartment (Luyten and 
Vanderleyden, 2000). S. meliloti ndv mutants, affected in the biosynthesis of cyclic β-glucans, 
induce small white pseudonodules, devoid of bacteroids and containing no infection threads 
(Dylan et al., 1986). Accumulation of cyclic β-glucans may allow bacteria to adapt to changing 
osmotic conditions during plant infection. Their role as signalling molecules has also been 
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suggested (Dylan et al., 1990; Luyten and Vanderleyden, 2000). 
Synthesis of amino acids and nucleotides  
The fast-growing cells in the infection thread require supply of nitrogen and carbon from the 
plant. Indeed, plant provides these bacteria with most of the amino acids at the early stages of 
symbiosis. R. etli strains defective in the biosynthesis of amino acids, such as aromatics, aspartate, 
cysteine, glutamate, glycine, histidine, isoleucine/valine, leucine, lysine, phenylalanine, and 
tryptophan, with the exception of arginine and methionine auxotrophs, are able to induce 
nodules. Analogous observations have been reported in the case of S. meliloti (Kerppola and 
Kahn, 1988; Patriarca et al., 2002). In the case of the isoleucine/valine auxotrophs which have a 
Nod- phenotype, the symbiotic defect is not caused by the inaccessibility of the respective amino 
acids (Chapter B.2.4.2). 
In contrast, nucleotide compounds are not provided by the plant in the infection threads. 
The strains of B. japonicum, R. etli, Rhizobium fredii, and R. leguminosarum that are auxotrophic for 
the synthesis of purines or pirimidines, induce only empty pseudonodules (Patriarca et al., 2002). 
phoCDET genes 
A S. meliloti phoCDET mutant shows a delayed infection, blocked at an early stage, and the 
bacteria are not released from the infection threads. The phoCDET cluster encodes for an ABC-
type transport system, responsible for the uptake of phosphate and phosphonates. It was 
suggested that the symbiotic defect of the phoCDET mutant results from the failure to obtain 
sufficient phosphorus for growth during the infection process (Bardin et al., 1996).  
pha genes 
A S. meliloti mutant carrying a Tn5 inserion in the pha gene cluster induced empty nodules 
with aborted infection threads. The pha gene cluster encodes for a K+/H+ antiporter that 
regulates internal pH and is required for the adaptation to the alkaline pH in the presence of K+. 
It was suggested that the propagation of pha mutants in the infection thread may be inhibited by 
the alkaline pH and/or by the presence of K+ ions (Luyten and Vanderleyden, 2000).  
bacA gene 
A  S. meliloti bacA mutant is blocked in the bacteroid development. Mutant bacteria are able to 
enter the root and form infection threads and are released into the plant cytoplasm. However, in 
the plant cytoplasm bacteria degrade at the stage of type 1 bacteroids. bacA encodes for an inner 
membrane protein with seven membrane spanning domains. The exact function of the BacA 
protein is still not identified. bacA mutants are sensitive to the detergent deoxycholate and 
resistant to the antibiotic bleomycin. It was also shown that BacA is involved in the modification 
of LPS by the very-long-chain fatty acid (Ferguson et al., 2004; Ichige and Walker, 1997).   
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B.2.4.3. Genes important for the efficient nitrogen fixation 
 
Nitrogen fixation is a highly energy-dependent process. Therefore, it is not surprising that not 
only the genes encoding for nitrogenase components are crucial for the nitrogen fixation, but also 
the genes encoding for electron transport chain proteins, for proteins of metabolic pathways and 
for the dicarboxilic acid transporter protein. Disruption of the genes responsible for the nitrogen 
fixation might influence the composition of bacteria inside the nodule. It has been proposed that 
the symbiosome has properties of the lytic compartment continuously being neutralized by 
ammonia which is exported by the bacteroids (Kannenberg and Brewin, 1989). According to this 
hypothesis, the lack of bacterial nitrogen fixation would lead to the degradation of bacteroids 
(Mylona et al., 1995).  
The following genes were shown to be important for nitrogen fixation: 
nif genes 
All the nif genes are essential for nitrogen fixation. nifA gene encodes a regulatory protein, 
nifHDK genes encode the structural proteins of the nitrogenase enzyme, nifENB encode enzymes 
involved in biosynthesis of the nitrogenase Fe-Mo cofactor, and nifSWX genes encode proteins 
of unknown functions that are required for full nitrogenase activity (Brencic and Winans, 2005). 
Downstream of the nifB gene in S. meliloti, a small gene fdxN, encoding ferredoxin-like electron 
transfer protein, is situated. This gene is cotranscribed with nifENB and is also absolutely 
necessary for nitrogen fixation (Klipp et al., 1989). 
fix genes 
The fixL, fixJ, and fixK genes encode regulatory proteins. In S. meliloti, the FixL-FixJ two-
component system is the master regulator of all nif and fix genes. FixL is a membrane-bound 
histidine kinase, which autoactivates by phosphorylation in response to low levels of oxygen, and 
then phosphorylates the FixJ protein. Phosphorylated FixJ in turn activates transcription of the 
regulatory fixK and nifA genes, whose products regulate transcription of the rest of the nitrogen 
fixation genes (Brencic and Winans, 2005). Null mutations in fixL or fixJ genes of S. meliloti result 
in the formation of symbiotically inefficient nodules (Fischer, 1994). 
The fixABCX genes might code for an electron transport chain to nitrogenase. Mutations in 
any one of the fixABCX genes of S. meliloti, B. japonicum, and A. caulinodans completely abolish 
nitrogen fixation (Earl et al., 1987; Fischer, 1994).  
All four fixGHIS gene products are predicted to be transmembrane proteins. FixG is may be 
involved in a redox process, since its sequence shows similarity to bacterial ferredoxins. FixI is 
homologous to the catalytic subunit of bacterial and eukaryotic ATPases involved in cation 
pumping; it is probably a symbiosis-specific cation pump whose function is coupled to the redox 
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reaction catalyzed by the FixG subunit. S. meliloti mutant strains carrying a transposon insertion in 
fixG, fixH, or fixI are unable to fix nitrogen (Kahn et al., 1989). 
fixNOQP encode the membrane-bound cytochrome oxidase required for respiration of the 
rhizobia in low-oxygen environments. In S. meliloti, fixNOQP is a duplicated region linked to the 
regulatory genes fixLJ and fixK. S. meliloti mutant strains deleted for both fixNOQP regions are 
defective in symbiotic nitrogen fixation (Fischer, 1994).  
cycHJKL cluster 
The cycHJKL gene cluster encodes for a multisubunit cytochrome c lyase that is essential for 
the biogenesis of all cellular c-type cytochromes. Particularly, it is involved in the attachment of 
the heme to fixO-encoded cytochrome c (Kereszt et al., 1995). 
dctA gene 
In S. meliloti, dctA gene encodes for a high affinity transporter (permease) of C4-dicarboxylic 
acids malate, fumarate succinate and oxaloacetate, the amino acid aspartate, and the cyclic 
monocarboxylate orotate. Dicarboxylate transport plays an important role in the operation of an 
effective, nitrogen-fixing symbiosis.  Dicarboxylates were shown to be the major energy and 
carbon source for the nitrogen-fixing rhizobia. Expression of the dctA gene is controlled by a two 
component kinase regulatory system, DctB/DctD. dctA mutants exhibit a clear non-fixing (Fix-) 
phenotype (Yurgel and Kahn, 2004).  
dme and genes encoding for TCA cycle enzymes 
dme gene encodes for NAD+- dependent malic enzyme which converts malate to pyruvate 
and simultaneously reduces NAD+ to NADH. The dme gene is expressed constitutively in free-
living cells and in the bacteroids (Driscoll and Finan, 1997). DME activity is very important in 
bacteroids (the dme mutants have a Fix- phenotype), since the nitrogen-fixing bacteria use C4-
dicarboxylic acids as the main energy source for the nitrogen fixation, and feed them directly into 
the TCA cycle. To use a C4-dicarboxylic acid such as malate, one molecule is oxidized to 
oxaloacetate by malate dehydrogenase, and the second one is oxidatively decarboxylated by the 
malic enzyme to pyruvate. The pyruvate is then oxidized to acetyl-CoA and it condensed with 
oxaloacetate to citrate, enabling the TCA cycle to proceed (Prell and Poole, 2006). According to 
this, the S. meliloti mutants for other TCA cycle proteins as citrate synthase (Mortimer et al., 1999), 
isocitrate dehydrogenase (McDermott and Kahn, 1992), succinate dehydrogenase (Gardiol et al., 
1982) and α-ketoglutarate dehydrogenase (Duncan and Fraenkel, 1979) also have a Fix- 
phenotype. However, α-ketoglutarate dehydrogenase mutant of Bradyrhizobium japonicum has a 
delayed Fix+ phenotype (Green and Emerich, 1997), and an aconitase mutant of B. japonicum can 
fix nitrogen normally (Thöny-Meyer and Künzler, 1996). 
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The symbiosis-related genes, listed in this chapter, represent the real picture only partially. 
Many genes, whose disruption has a more subtle effect on symbiosis, have still not been 
identified. Moreover, among the 6,204 possible open reading frames of S. meliloti, only 59% have 
been assigned a possible function (Galibert et al., 2001). The methods for identification of 
unknown gene functions are described in the next chapter.  
 
B.3 SYSTEMATIC APPROACHES TO STUDY THE GENES 
IMPORTANT FOR THE SYMBIOSIS AND COMPETITIVENESS 
 
The classical approaches to study the function of genes are based on investigation of 
particular genes and their functions. Gene disruption with subsequent analysis of mutant 
phenotype, and promoter-reporter fusions are usual tools for such type of studies. However, 
these methods are laborious and require much time for analysis of every single mutant. The 
availability of the 6.7 Mb S. meliloti genome sequence has enabled (or eased) the application of 
several large-scale genomic methods to study the function of this organism’s genes. 
 
B.3.1 Proteomics 
 
Proteomics is the large-scale study of proteins, particularly their structures and functions. It 
comprises protein separation and identification, protein sequence analysis, determination of 
protein structures in three-dimensional space, studies of interactions of proteins on the atomic, 
molecular and cellular levels, post-translational modifications of proteins, and mapping of the 
location of proteins and protein-protein interactions in whole cells during key cell events.  
The key technologies used in proteomics include (Twyman, 2004; Wilkins et al., 1997): 
⋅ gel electrophoresis (one- and two-dimensional), used to identify the relative mass of a 
protein and its isoelectric point;  
⋅ tandem mass spectrometry combined with 2-D electrophoresis, used to identify and 
quantify proteins; 
⋅ affinity chromatography, yeast two hybrid techniques, fluorescence resonance energy 
transfer (FRET), and Surface Plasmon Resonance (SPR); used to identify protein-
protein and protein-DNA binding reactions; 
⋅ X-ray crystallography and nuclear magnetic resonance, used to characterize the three-
dimensional structure of peptides and proteins; 
⋅ X-ray tomography, used to determine the location of labeled proteins or protein 
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complexes in an intact cell. 
A proteomic examination of S. meliloti strain Rm1021 was undertaken using a combination of 
two-dimensional gel electrophoresis and peptide mass fingerprinting by Matrix-assisted laser 
adsorption ionization time of flight (MALDI-TOF) to analyze the protein expression in the 
symbiotic state and during carbon or phosphate starvation (Djordjevic et al., 2003). As a result, a 
total of 27 putative nodule-specific proteins and 35 nutrient-stress-specific proteins were 
identified. These proteins were related to nitrogen fixation, heme synthesis, protection from 
oxidative stress, iron uptake, EPS/KPS synthesis and secretion, regulation as well as to other 
unclassified functions.  
Recently, a proteomic approach was also used to analyze identify salt tolerance-related 
proteins in Rhizobium etli and Sinorhizobium meliloti (Shamseldin et al., 2006). Using two-dimensional 
gel electrophoresis and MALDI-TOF, six proteins were found to be induced by 4% NaCl in R. 
etli, but they could not be identified due to the absence of R. etli genome sequence. In a second 
approach used in this work, soluble proteins from salt-induced or non-salt-induced cultures from 
R. etli strain EBRI 26 were separately labeled with different fluorescent cyano-dyes prior to 2D 
difference in gel electrophoresis. Results revealed that 49 proteins were differentially expressed 
after the addition of sodium chloride, 14 of them overexpressed and 35 - downregulated. In a 
similar experiment using S. meliloti strain Rm2011, four overexpressed and six downregulated 
proteins were identified. Particularly, carboxynospermidin decarboxylase, which plays an 
important role in the biosynthesis of spermidin, was identified as overexpressed, and the enzyme 
catalase was identified as downregulated.  
 
B.3.2 DNA macro- and microarrays in the analysis of  gene expression 
 
DNA macro- and microarrays are used to measure the levels of abundance of defined 
mRNAs in the experimental conditions. In these methods, the known DNAs (probe) 
corresponding to the mRNAs of the studied organism, are affixed to a support at the pre-defined 
spots. The mRNAs, isolated from the sample, are reverse transcribed, labeled in a specific way 
and these molecules, called targets, are then hybridized to the array. After washing steps, the spots 
to which the targets have been hybridized are visualized.  
DNA arrays can be classified as macro- or microarrays, depending on the format of the 
support. In the DNA macroarray method, nylon membranes are used, on which the array of 
gene-specific DNA fragments is spotted. The targets from the control and test samples are 
labeled with radioactive phosphate and hybridized to the separate membranes carrying the same 
array. The hybridization signals are detected by a phosphorimaging instrument. Log-transformed 
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ratios between signal intensities for each spot reflect the relative quantities of particular mRNAs 
in the control and experiment samples.  
A DNA microarray is a collection of microscopic DNA spots attached to a solid surface, 
such as glass, plastic or silicon chip forming an array. Due to the small format of the microarray, 
a much smaller amount of the target has to be used. There are two main types of microarrays. In 
spotted microarrays (or two-channel microarrays), the probes are oligonucleotides, cDNA or 
PCR products, corresponding to mRNAs. Spotted microarray is hybridized with cDNA from 
two samples that have to be compared (experiment and control) that are labeled with two 
different fluorofores (in most cases, Cyanine 5 and Cyanine 3). The samples are mixed and 
hybridized to one single microarray that is then scanned, allowing the visualization of up- and 
down-regulated genes at once (Cummings and Relman, 2000). In single-channel microarrays, 
the short oligonucleotide probes, synthesized in photolithographic process, are designed to match 
several parts of single mRNAs. These microarrays give estimations of the absolute value of gene 
expression and therefore the comparison of two conditions requires the use of two separate 
microarrays (Lipshutz et al., 1999). 
A macroarray (Ampe et al., 2003), a whole-genome spotted microarray (Rüberg et al., 2003) 
and a whole-genome (including intergenic regions) single-channel microarray (Barnett et al., 2004) 
have been developed and successfully used to determine the gene expression patterns in different 
conditions in S. meliloti. 
 
B.3.3 Metabolomics 
 
Metabolomics is the study of global metabolite profiles in a system (cell, tissue, or organism) 
under a given set of conditions. The analysis of the metabolome is particularly challenging due to 
the diverse chemical nature of metabolites. Metabolites are the result of the interaction of the 
organism’s genome with its environment and are not merely the end product of gene expression 
but also form part of the regulatory system in an integrated manner (Rochfort, 2005). Recently, 
metabolite analysis was established for Sinorhizobium meliloti (Barsch et al., 2004) The hydrophilic 
compounds of bacteria grown on minimal medium were analysed via GC-MS, and from about 
200 peaks in each chromatogram, 65 compounds could be identified.  
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B.3.4 Promoter-reporter gene fusion mutant libraries and in vivo expression 
technology 
 
To create a random library of promoter-reporter fusion mutants, a transposon carrying a 
reporter gene is used to perform the mutagenesis. In the case of the reporter gene having the 
same direction as the gene interrupted by the transposon, the expression of the interrupted gene 
can be studied based on the expression of the reporter gene. This method was successfully 
applied to the analysis of S. meliloti genes induced under nutrient deprived conditions and oxygen 
limitation. The collection of 5000 Rm2011 derivatives carrying Tn5-1063, a Tn5-based reporter 
transposon containing the luxAB genes of Vibrio harveyii, was used to identify genes induced by 
nitrogen and carbon deprivation (Milcamps et al., 1998) and by oxygen limitation (Trzebiatowski 
et al., 2001). As a result, 21 genes were found to be induced by nitrogen deprivation, 12 genes – 
by carbon deprivation, and 11 genes – by oxygen limitation. In a similar approach, transposon 
Tn5-1062, also carrying luxAB reporter genes, was used for mutagenesis, and four cold shock 
induced loci were identified in S. meliloti (O'Connell et al., 2000).  
For the identification of genes expressed in bacteroids under symbiotic conditions, a method 
called in vivo expression technology (IVET) can be used. This method was originally developed 
for the identification of genes expressed in parasitic bacteria in the animal host. Here, a library of 
plasmids is constructed that carry random genomic fragments fused to the promoterless gene, 
necessary for the survival in the host (reporter gene). This library is transferred into a strain, in 
which the reporter gene is deleted from the genome. The plasmids integrate into the genome by 
homologous recombination, and the resulting library of clones is used to infect the host. In the 
case that genomic fragment in front of reporter gene carries a promoter that functions in the 
host, the mutant survives and can be isolated from the model (reviewed in Angelichio and 
Camilli, 2002). IVET was successfully applied to study symbiotically induced genes in S. meliloti, 
using bacA (Oke and Long, 1999) and exoY (Zhang and Cheng, 2006) as reporter genes.  
 
B.3.5 Signature-tagged mutagenesis 
 
Usually, the selection of mutants that can survive under a certain condition is simple and 
efficient, and can be performed using a mixture of different mutants. However, the selection of 
mutants that have an attenuated phenotype in a tested condition is laborious and time 
consuming, because all mutants have to be checked separately one by one. The signature-tagged 
mutagenesis (STM) strategy (Hensel et al., 1995) (Fig. B5) can overcome this problem. 
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Fig. B5. Scheme of the signature-tagged mutagenesis. Mutants, carrying different signature tags, are mixed 
together prior to the experiment (in this case, an infection model). The input pool of tags is than compared to the 
output pool. Mutants, whose tags are not represented in the output pool, are impaired in growth under the 
experimental condition. Scheme from http://pollux.mpk.med.uni-muenchen.de/alpha1/forschung/haas/dia-
stm.jpg. 
 
Signature-tagged mutagenesis, similarly to IVET, was originally created to study the genes in 
parasitic bacteria relevant to infection and pathogenicity. STM strategy is based on a collection of 
mutants split in sets, where each mutant is modified by one or more different signature tags. The 
tags are short DNA segments that are unique for each mutant in a set and can be amplified using 
invariant (Chiang et al., 1999) or specific (Lehoux et al., 1999) priming sites.  
Tagged mutants from the same set are pooled prior to an experiment, and each mutant in the 
mixture can be identified based on the unique tag in its genome. The presence of a particular tag 
in the mixture can be detected through hybridization of amplified products to dot blots (Chiang 
et al., 1999), to a macroarray (Shea et al., 2000) or to a microarray (Groh et al., 2005; Karlyshev et 
al., 2001; Winzeler et al., 1999) containing tag-specific probes. In the case of variable priming sites 
being used, individual PCR reactions are performed using individual pairs of primers, and the 
presence of a tag in the mixture is detected through the presence of the amplification product in 
the respective PCR reaction (Lehoux et al., 1999).   
Two main strategies are used for the integration of the signature tags into the genome: the 
PCR targeting deletion strategy and the strategy based on libraries of signature tag carrying 
transposons. The PCR targeting strategy was used in the Saccharomyces Genome Deletion Project 
(Shoemaker et al., 1996; Winzeler et al., 1999) for gene disruption. Application of the targeted 
disruption protocol resulted in replacement of each gene with a KanMX marker cassette, where 
the cassette for each replacement was marked by an individual pair of 20-bp long tags.  
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In the transposon-based signature tagged mutagenesis, a library of transposons carrying 
signature tags is created, and these transposons are then used to perform the mutagenesis. This 
strategy, unlike the PCR targeted deletion, results in a library of random mutants. The production 
of transposon mutants is less labor and cost intensive than the production of deletion mutants 
and can also be performed in the organism whose genome is not sequenced. Moreover, one 
transposon library can be used for mutagenesis in all the organisms in which the chosen 
transposon can insert into the genome. The quantity of mutants generated by the transposon-
based STM is not limited; however, the size of mutant pools depends on the quantity of 
differently tagged transposons. The largest tagged transposon library reported so far contains 192 
transposons (Karlyshev et al., 2001).  
Most STM studies to date have applied the miniTn5 transposon system (de Lorenzo et al., 
1990), which was used in the original STM screen (Hensel et al., 1995). The mTn5 transposons 
can transpose in a large spectrum of bacteria. However, some bacteria are nearly refractory to 
Tn5-derived transposons. Several recent studies in Streptococcus pneumoniae (Hava and Camilli, 
2002), Neisseria meningitidis (Geoffroy et al., 2003) and Campylobacter jejuni (Hendrixson and DiRita, 
2004) have solved this problem by in vitro mutagenesis using transposons from the mariner family 
(Saenz and Dehio, 2005).  
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B.4 OBJECTIVES OF THIS WORK 
 
Signature tagged mutagenesis approach is a powerful and easy-to-use method to identify 
bacterial genes important for competitiveness and survival in the host. This method can also be 
used to study symbiotic interactions (Hendrixson and DiRita, 2004), but it has never been applied 
to study rhizobia-legume symbiosis before. The application of signature-tagged transposon 
mutagenesis in S. meliloti was the main objective of this work. This objective can be split in several 
smaller tasks. At the first step, a novel, large library of double-tagged transposons had to be 
constructed. This library had to be used to obtain tagged S. meliloti mutants, and the transposon 
insertion sites had to be determined for a significant part of the mutant library. The tag detection 
system had to be created and verified in controlled conditions, and finally, the mutant library had 
to be screened in experiments in planta in order to identify genes important for competitiveness 
and survival in symbiotic conditions. The candidate mutants had also to be checked individually  
in order to verify the attenuated symbiotic phenotype.  
Some crucial steps of this project (design of tags, analysis of transposon insertion sites and of 
tag - detection data) were performed in cooperation with Faculty of Technology (Technische 
Fakultät) and Bioinformatics Resource Facility at the Center of Biotechnology (Centrum für 
Biotechnologie) at Bielefeld University. 
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C. RESULTS 
 
At the beginning of this PhD project, signature tagged mutagenesis had already been applied 
to a large spectrum of organisms. The most interesting published works that used this system 
were the Saccharomices Genome Deletion Project (Winzeler et al., 1999) and signature tagged 
transposon mutagenesis of Yersinia (Karlyshev et al., 2001). Both of these projects used two short 
signature tags to mark each mutant, and a single-channel oligonucleotide microarray to detect the 
tags in the input and output pools. It was therefore decided to apply a similar approach to S. 
meliloti: double-tagged mutants in a combination with a two-channel microarray for the detection 
of tags. The design of tags was performed by Ulf Schiller and Stefan Kurtz (Praktische 
Informatik, Technische Fakultät, Universität Bielefeld). They designed 1498 signature tags, 24 
nucleotides in length, with melting temperatures between 69.5°C and 70.5°C using the programs 
DNASequenceGenerator and vmatch. Less than 8 contiguous nucleotides of sequence identity were 
allowed for the tags. Half of the tags were equipped with sticky ends for the HindIII restriction 
site, and the other half with sticky ends for the KpnI restriction site (H-tags and K-tags, 
respectively).  
My contribution to the project started with design of the plasmid vector, that would carry the 
suitable mTn5 transposon, and continued with cloning of the tags in this transposon. 
 
C.1 CONSTRUCTION OF THE mTn5-STM TRANSPOSON AND THE 
CARRIER PLASMID pG18-STM 
 
Plasmid pG18-STM (Fig. C2) carrying the transposase gene tnpA** and a modified mTn5-
GNm transposon was constructed based on the vector pG18Mob2 (Kirchner and Tauch, 2003). 
The mini transposon mTn5-GNm, used in this study, contains the nptII resistance and a 
promotorless gusA reporter gene (Reeve et al., 1999). The gusA gene is particularly suited for use 
as a reporter gene in rhizobia, because these bacteria, as well as their legume hosts, have no β-
glucuronidase activity (Reeve et al., 1999; Wilson et al., 1995). The mTn5-GNm contains also a 
terminator sequence, situated after nptII gene. The mini Tn5 contains no transposase gene; 
therefore, it has to be provided externally (on the plasmid). The plasmid pG18Mob2 already 
contained the RP4 mob region necessary for the transfer into S. meliloti from E. coli S17-1 cells, 
which have a chromosomally integrated copy of RP4 able to supply the transfer functions in trans. 
Furthermore, pG18Mob2 replicates in E. coli, but not in S.meliloti (suicide vector).  
Since the tags were equipped with sticky ends for the HindIII and KpnI restriction sites, these 
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restriction sites also had to be used for the cloning of tags into the mini transposon. 
Consequently, the plasmid that carries the mini transposon had to be devoid of HindIII and KpnI 
restriction sites, and the mini transposon had to be modified in order to carry the restriction sites 
for the cloning, and the priming sites for the amplification of the signature tags.  
At the first step, the HindIII restriction site situated 1105 bp downstream of the start codon 
of the tnpA* gene from pCRS530 (Reeve et al., 1999) was mutated according to the standard 
procedure (Carter, 1991). For this single-site mutagenesis, four primers were used: two primers, 
complementary to the ends of the gene with overhangs containing sites for cloning into 
pG18Mob2 (Xba_polym_begin and Sph_polym_end), and two primers for the nucleotide 
replacement in HindIII restriction site (Hind_mut_1 and Hind_mut_2). The primers for 
nucleotide replacement are complementary to each other and to the part of the sequence 
containing the HindIII restriction site, except for one nucleotide that is exchanged (the same 
nucleotide in both primers). In the first round of PCR, primers Xba_polym_begin and 
Hind_mut_2 were used to amplify one part of the gene, whereas primers Sph_polym_end and 
Hind_mut_1 were used to amplify another part of the gene. In the second round of PCR the two 
first-round PCR amplification products were used as megaprimers to create the whole gene 
product containing the replaced nucleotide (Fig. C1). The nucleotide was replaced in the way that 
the HindIII restriction site was abolished, but the amino-acid content of the transposase protein 
was not changed. 
 
 
Fig. C1. Single-nucleotide replacement in the tnpA* gene. (A) The primers used for amplification and nucleotide 
replacement (the mismatched nucleotide is marked as a green circle). (B) The amplification products from the first-
round PCR containing the replaced nucleotide. (C) The products from the first PCR round are used as megaprimers 
in the second round of PCR together with the primer annealing at the ends of the tnpA* gene. (D) The product of 
the second round of PCR containing the replaced nucleotide abolishing the HindIII restriction site (tnpA**). 
 
 
B 
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The tnpA** gene containing the mutated HindIII restriction site (GAGCTT) was inserted 
into the SphI and XbaI restriction sites of pG18Mob2. The cloning of the correct insert with 
mutated HindIII site was demonstrated by restriction analysis and sequencing. 
The mini transposon mTn5-GNm was recovered from pCRS530 using the flanking XbaI and 
EcoRI restriction sites and inserted into pG18mob2. Subsequently, the HindIII restriction site in 
the polylinker of pG18Mob2 was inactivated by treatment of the HindIII sticky ends with 
Klenow enzyme and blunt-end ligation.  
An artificial linker 
(AATTCGGCCGCCTAGGCCAAAGGACGTGGTTTACGGGGCACGTAGTTTAAGGAA
GTACGGTAAGGTACCGGGGGTGGCGGCATTCATATAGCTGCGTGATTTCATTTTA
ACTCCCCTCCGCCGCAAGCTTAGGTGGACCGTCGTAGAGCTAGTAGGGCTCAATG
CACCAGGACTAGGCCGCCTAGGCCGAATTC) containing four priming sites (underlined) 
flanking KpnI and HindIII restriction sites (printed in bold italic) for insertion of variable tag 
sequences was generated and inserted into the SfiI restriction site of the mTn5-GNm transposon 
resulting in the transposon mTn5-STM (Fig. C2 B). 
 
 
Fig. C2. Vector constructed for sequence-tagged mutagenesis of S. meliloti, based on pG18Mob2 containing a 
modified mTn5-GNm transposon and a transposase gene tnpA** devoid of the HindIII restriction site (A) and a 
detailed representation of the mTn5-STM transposon (B). The artificial linker denoted AL was inserted into the SfiI 
restriction site of mTn5-GNm. HindIII and KpnI restriction sites of the artificial linker were used to clone the 
signature tags (H-tag and K-tag). P1, P2, P3 and P4 denote the annealing sites for primers P1_Kpn, P2_Kpn, 
P3_Hind and P4_Hind respectively; Qseq1 denotes the annealing site for the sequencing primer. IE and OE indicate 
the inside and outside end required for transposition. 
A 
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The computational design of the artificial linker was performed by Ulf Schiller and Stefan 
Kurtz (Praktische Informatik, Technische Fakultät, Universität Bielefeld). Candidate sequences 
for priming sites were designed using the program DNASequenceGenerator (Feldkamp et al., 2001). 
For primer design, 87 candidate sequences were generated that fulfilled the requirements of 
having less than 7 identical contiguous nucleotides, of length (21bp) and melting temperature (65 
to 70°C) and contained no KpnI, HindIII, EcoRI or SfiI restriction sites. To construct the linker 
sequence, 4 of these primer sequences were chosen. The primer and linker sequences were 
checked for similarity to the S. meliloti genome using the program vmatch (http://www.vmatch.de) 
(Abouelhoda et al., 2004). Sequences with the lowest degree of similarity to the S. meliloti genome 
were chosen. The linker was synthesized as six separate oligonucleotides that were annealed and 
ligated using the sticky ends of the restriction sites KpnI and HindIII. The plasmid sequence was 
submitted to GenBank under the accession Nr. DQ408591 
 
C.2 CLONING OF TAGS INTO THE mTn5-STM TRANSPOSON 
 
The H- and K-tags were inserted into the linker cassette of transposon mTn5-STM. Tags 
were synthesized as complementary single-stranded oligonucleotides and were annealed prior to 
insertion into the linker. First, the H-tags were inserted into the HindIII restriction site of pG18-
STM. Subsequently, K-tags were cloned into the KpnI restriction site of each individual plasmid 
that contained an H-tag from the first tag cloning step.  
The main complication in the cloning of the tags was the inability to screen for the positive 
clones by blue-white selection or other instant selection methods. Moreover, the ends of tags 
were not phosphorylated in order to avoid their concatemerization; consequently, the ends of the 
digested plasmid could not be dephosphorylated and could easily ligate together without the 
insert. To make the cloning procedure maximally efficient, very low quantity of the digested 
plasmid was used in the ligation together with high quantity of the insert. Ligation mixtures were 
then transformed in highly competent E. coli cells (Inoue et al., 1990). The tag-containing clones 
were verified by PCR using primer pairs for amplification of the tags (P1_Kpn, P2_Kpn in the 
case of K-tags and P3_Hind, P4_Hind in the case of H-tags) and subsequent separation of the 
amplification products in agarose gels. Since the amplification products from the clones 
containing tags were only 24 bp longer than the amplification products from the empty clones, 
the high-percentage agarose gel (2.3 – 2.5%) was used to separate the products. 
To check if the tags were cloned correctly, the linker region of each plasmid was sequenced. 
As a result, a collection of 412 transposons was generated, where each transposon is individually 
marked by two unique signature tags. 
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C.3 TRANSPOSON MUTAGENESIS OF S. MELILOTI 
 
The tagged transposon library was used for random mutagenesis of S. meliloti Rm2011. E. coli 
S17-1 mediated conjugation was used to transfer the plasmids carrying the tagged transposons 
into S. meliloti cells (Fig. C3). The RP4 mobilizable region of pG18-STM enabled the conjugal 
transfer of plasmids from the E. coli donor strain S17-1 into the S. meliloti recipient cells through a 
procedure of biparental mating. Mutants were selected based on resistance to neomycin due to 
the nptII gene of the transposon. From each conjugation, 24 to 30 clones were picked, resulting in 
a library of 12000 tagged mutants. The mutant clones were re-arrayed into sets, each containing 
mutants that differ by their signature tags. Since the mTn5-STM transposons used for 
mutagenesis contain a terminator sequence, the generated mutations can influence the 
transcription of the whole gene operone (polar mutations). 
Fig. C3. Construction of the transposon mutant library 
 
C.4 MAPPING OF THE TRANSPOSON INSERTION SITES  
 
The transposon insertion sites of 5089 mutants were determined by sequencing the 
transposon-genome junction using a primer Qseq1 that binds 64 bp upstream of the linker with 
the cloned tags (Fig. C2 B). It was therefore possible not only to determine the insertion sites of 
the transposons, but also to check the tags in the mutants. Sequencing was performed by Qiagen 
(Hilden, Germany) using genomic DNA as template. No amplification or cloning steps were 
carried out. The computational analysis of insertion sites was performed by Danijel Wetter 
(International Graduate School in Bioinformatics and Genome Research, Bielefeld University).  
For transposon insertion site mapping, the GenDB annotation system was used (Meyer et al., 
2003). A GenDB extension was implemented for automated transposon position identification, 
where the sequences of transposon-genome junction regions were compared to the S. meliloti 
genome using the BLAST algorithm (Altschul et al., 1997). The transitions from transposon 
sequence to genome sequence were identified as “jump-in” positions and mapped onto the S. 
meliloti genome. Fig. C4 summarizes the results from transposon mapping. The complete list of 
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mapped mutations is available on the website of the public S. meliloti GenDB genome project 
(http://www.cebitec.uni-bielefeld.de/groups/nwt/sinogate). 
 
Fig. C4. Distribution of the mTn5-STM transposon insertions throughout the S. meliloti genome: genes with 
transposon insertions. 
 
C.5 STATISTICAL ANALYSIS OF THE MUTANT LIBRARY  
 
Statistical verification of the insertion sites was performed in cooperation with Danijel 
Wetter. Several statistical tests were performed to ensure that the distribution of transposon 
insertions was random, and that the mTn5-STM transposons have no hot spots in the S. meliloti 
genome. An important parameter that shows the randomness of transposon insertions is the 
quantity of genes that carry a transposon insertion. A low quantity of genes hit by the transposon 
indicates a bias in the pattern of transposition. In order to determine the theoretical quantity of 
genes that has to be hit by at least one transposon, the neutral-base pair model (Jacobs et al., 
2003) was applied. This model allows the estimation of the number of gene hits based on 
genome length, number of transposon insertions and gene sizes. Applying this model to the 
library of 5089 S. meliloti transposon mutants, it was predicted that 2890 genes with a standard 
deviation of ± 378 had to be mutated. The actual number of genes that were hit by at least one 
transposon was 2711 (43.68 % of the predicted in S. meliloti 6207 protein-coding genes), 
complying with the expectations based on the neutral-base pair model.  
Furthermore, a genome wide analysis of all transposon insertion sites in relation to the GC 
(AT) content was performed. Using a 100 bp window centered at the transposon insertion 
position, the mean GC (AT) content values were calculated. The difference between the mean 
GC (AT) content within all of these windows and the mean GC (AT) content of the whole 
genome is 0.2 % for GC, and 0.1 % for AT. A χ2 test was also made, to exclude balancing effects 
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in deviations to the GC (AT) mean. The result was a very low χ2 score of 12.8 for GC and 14.2 
for AT distribution with 2710 degrees of freedom, implying that there was no preference of the 
mTn5-STM transposons to jump into GC or AT rich regions. 
In order to test for uniform distribution of all transposon insertions we performed a χ2 test. 
Given a p-value of 0.01 and 29 degrees of freedom per replicon, we found a uniform distribution 
to be highly improbable. This could be explained by the existence of essential genes that are not 
represented in the mutant library. Moreover, mutations causing slow growth of bacteria under the 
conditions used for selection of the transconjugants in this study result in underrepresentation of 
such mutants in the library. The χ2 test was therefore repeated, assuming that the S. meliloti 
genome contains essential genes. There is not enough information available about quantity and 
position of essential genes in the S. meliloti genome that would allow excluding defined groups of 
genes from the χ2 test. To cope with this problem, sets of randomly chosen genes were created, 
and the χ2 test was performed many times, leaving out one of the gene sets each time. The 
number of genes per set ranged from 1 to 100 % of all genes that were localized on a certain 
replicon and did not have transposon insertions. 
Such a modified χ2 test showed that the distribution of transposon insertions in the genome 
is likely to be random. The best χ2 test result for pSymB was a likelihood of 90 % for a random 
distribution of transposons over this replicon. This result was obtained when a set containing 6 
% of genes with no transposon insertion was excluded from the test. For pSymA, an 87 % 
likelihood of randomness was observed when 10 % of genes with no hit were left out. In 
contrast, when all genes that do not have a transposon insertion were excluded from the χ2 test, 
the probability for the distribution to be random was lower than 11 % for both megaplasmids.  
Though the modified χ2 test worked well for the megaplasmids, it failed in the analysis of the 
transposon insertion distribution throughout the S. meliloti chromosome. A set of genes whose 
exclusion from the χ2 test increased the likelihood of randomness to more than 15 % could not 
be found. The reason for this might be a high proportion of essential genes on the chromosome 
(Capela et al., 2001) and the great size of the replicon, that leads to the large fraction of genes not 
hit by a transposon. Therefore, a random search to detect essential genes seems to be unsuitable 
if the number of transposon insertions is not saturating. Nevertheless, based on the data for 
pSymA and pSymB and the results from the analysis of transposon insertion sites in relation to 
the GC (AT) content, a genome wide random distribution of transposon insertion sites can be 
assumed.  
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C.6 CREATION OF TWO SETS OF MUTANTS FOR THE 
SUBSEQUENT EXPERIMENTS.  
 
After the transposon insertion sites were determined for the mutants, this information could 
be used to create non-redundant sets, containing mutants of interest. These sets could be than 
used in experiments in free-living and symbiotic conditions. Each set has to contain mutants with 
different tags; therefore, one set can maximally include 412 mutants. 
Two sets of mutants were created: set 1 and set 2, each one containing 378 mutants. The sets 
were for the biggest part non-redundant, so that just one mutant for each gene was present in the 
sets. For several genes, two or three mutants were included in the sets in order to test if the 
results for these mutants will be similar. Particularly, three fixL, two fixN1 and two ilvC mutants 
were included in the sets. Since both of the sets were planned to be screened in symbiotic 
conditions, I tried to combine the mutants in the way that many potentially attenuated mutants 
would have been included in the sets. For example, many mutants with a transposon insertion in 
genes with known symbiotic phenotype were included, as well as in genes that potentially could 
have a symbiotic phenotype. Also, many mutants with transposon insertion in hypothetical genes 
were included in the sets.  
 
C.7 PILOT COMPETITION EXPERIMENTS IN FREE-LIVING 
CONDITIONS 
 
In order to validate the STM approach used here, two pilot experiments were carried out 
using the mutant set 1. In all cases, the input pool (inoculate) was used as the reference. Each 
experiment was repeated three times using independent cultures. 
As test conditions for the first experiment, growth in rich (TY) medium and minimal medium 
(VMM) was chosen. The goal of this experiment was not only to compare the differences in the 
survival of the mutants between rich and minimal medium, but also to study the kinetics of 
changes in the content of mutants during the growth of culture. Rich and minimal medium were 
inoculated by the glycerol culture of the mixture of mutants to o.D.600=0.003.  
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Fig. C5. Growth of S. meliloti mutant set in rich (TY) and minimal (VMM) medium 
 
Bacteria were then cultured for 3 days; points at which the cultures were collected are 
indicated on the Fig. C5. In the second experiment, the same set of mutants was grown in high 
osmolarity medium and in medium containing SDS as detergent. The cells were collected in the 
exponential growth phase.  
The genome DNA was isolated from the collected cells and the tags were amplified using 
fluorescently labeled primers (5´-modified by Cy3 in case of the experiment and by Cy5 in case of 
the input pool) (Fig. C6). 
 
 
Fig. C6. Schematic representation of a competition experiment using signature-tagged mutants 
 
C.8 TWO-CHANNEL TAG MICROARRAY FOR THE DETECTION OF 
THE TAGS 
 
In this project, a two-channel microarray was for the first time used in the signature tagged 
mutagenesis screen. The mTn5-STM-1 microarray was created, that contains 24mer 
oligonucleotides with 5´ C12-amino modifications, directed against the variable sequences of 
timepoints at 
which the 
cultures were 
collected 
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signature tags in 412 created mTn5-STM transposons. Since the signature tags are quite short 
oligonucleotides, the hybridization and subsequent washing protocols for the similar Sm6kOligo 
70-mer microarray (Becker and Rüberg, 2003) were modified in order to optimize the output. 
The hybridization time was set to only 45 minutes, in comparison to the usual 14 – 18 hours, and 
the hybridization temperature of 36 °C was used instead of 42 °C. The washing conditions for 
the tag-microarray were also milder than conditions for the 70-mer oligonucleotide microarray 
(see chapter E.2.12 for further details). 
 
C.9 ANALYSIS OF TAG-MICROARRAY DATA 
 
A comparison of the STM approach to the standard microarray experiments shows several 
important differences. First, instead of measuring expression levels of genes, the absence or 
presence of mutants in a complex pool is analyzed. Second, the PCR fluorescently labeled 
amplified products are used for hybridization instead of cDNA. Third, the utilization of two tags 
to barcode each transposon requires modified normalization procedure. Therefore, the specific 
properties of this kind of data sets have to be taken into account if data from high throughput 
STM experiments have to be analyzed employing bioinformatics. A framework for appropriate 
analysis of tag-microarray data was developed based on a carefully designed combination of 
existing methods for analysis of microarray data as well as selection of suitable parameters. This 
analysis was performed in cooperation with Silke Szymczak (Angewandte Neuroinformatik, 
Technische Fakultät, Universität Bielefeld). 
 
C.9.1 Normalization and filtering 
 
The pre-processing of the tag-microarray data was performed similarly to the usual 
microarray analysis approach. At the next step, LOWESS normalization based on local regression 
that accounts for intensity and spatial dependence in dye biases was performed for data of the 
two tags separately. The separate normalization for the two kinds of tags was the most suitable, 
because the targets for H- and K-tags originate from the separate PCR reactions (Fig. C7). 
Then, the ct distances between H- and K-tag for each mutant were calculated and 10 % of the 
mutants with the largest ct values and therefore with the largest discrepancy between H- and K-
tag, were removed. The weighted mean of the medians of the m-values was calculated for each 
mutant combining values of H-tags and K-tags, and used for subsequent analysis. 
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Fig. C7. Reduction of differences in data between the two types of tags by separate normalization. MA plots of 
data from a single slide before (A) and after (B) normalization (red: H-tag, blue: K-tag, dashed line: LOWESS 
smoother for H-tag, dotted line: LOWESS smoother for K-tag). 
 
C.9.2 Clustering 
 
The clustering approach was developed using the data from the time course TY-VMM pilot 
experiment. In order to make the analysis as efficient as possible, different ways of calculating 
distances and linkage methods for agglomerative clustering were tested. In addition, the results of 
agglomerative clustering were compared to the results produced by the k-means clustering 
approach. The results were validated based on the similarity of grouped patterns. For a review on 
clustering methods, see (Heyer et al, 1999) and (Zhao and Karypis, 2005). 
The first comparison examined the effect of the following distance calculation methods on 
the result of clustering: Euclidean, centered correlation and uncentered correlation (E.2.13.3), 
while average linkage method was applied every time. The second comparison was performed to 
explore the effect of the different linkage methods on clustering (single, complete, average and 
centroid) while the uncentered correlation distance calculation was used in each of the cases. The 
results of the different distance calculations are shown in Fig. C8, whereas Fig. C9 presents the 
dendrograms created using different linkage methods. At all the clustering images, green colour 
represents attenuated, red color represents fast growing mutants in a respective condition. 
Choice of a distance calculation method seems to have a greater influence on the output than 
the choice of a linkage method. Using centered correlation as distance calculation method, no 
separation between mutants with increased and attenuated growth can be observed (Fig. C8 A). 
This is due to the fact that this distance calculation method is based on shape, i. e. global 
behaviour of each mutant is taken into account. Euclidean distance calculation method makes a 
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separation of attenuated and increased mutants possible (Fig. C8 B). However, mutants with 
attenuated growth only in minimal medium are not separated from mutants showing attenuated 
growth behaviour in both minimal and rich medium. The uncentered correlation coefficient 
calculation (Fig. C8 C) which combines the advantages of the centered Pearson coefficient (shape 
relevant) with the advantages of the Euclidean distance (separation based on negative and 
positive values) allowed the generation of clusters containing mutants with similar behaviour. 
 
 
Fig. C8. Effects of different distance calculation methods on clustering. Dendrograms generated with 
agglomerative clustering (average linkage) on the same data set using centered correlation (A), Euclidean (B) and 
uncentered correlation (C) distance. 
 
When comparing the effects of various linkage methods on the output of clustering, only 
small differences in the inner structure of several clusters can be observed. The application of 
A B
C
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single linkage, however, generates a dendrogram where the chaining effect of this linkage method 
is visible. In many joining steps single mutants are merged with other clusters (e. g. mutants 3-5A, 
3-6D, 3-11B, 3-10H and 3-5B in Fig. C9 A). Complete, average and centroid linkage show very 
similar results (see Fig. C9 B, C and D). Complete linkage, however, is sensitive to outliers since 
only the distance between the two data points that are furthest apart are used for calculation. 
Centroid linkage sometimes suffers from inversion problems (Morgan and Ray, 1995). Therefore, 
if the agglomerative clustering is used, the best suitable linkage for this STM system is the average 
linkage method. 
 
 
 
Fig. C9. Effects of different linkage methods on clustering. Dendrograms generated with agglomerative 
clustering (uncentered correlation distance) on the same data set using single (A), complete (B), average (C) and 
centroid (D) linkage. 
C 
A B
D
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Fig. C10. Comparison of the best results from agglomerative (A) and k-means clustering (B) in the TY-VMM 
timecourse experiment. Cutting of the dendrogram in (A) at the depth indicated by the dotted line leads to a 
comparable partition of clusters 
 
 
After selecting the appropriate distance calculation method, 
agglomerative and k-means (MacQueen, 1967) clustering approaches 
were compared (Fig. C10). To obtain clusters from the agglomerative 
clustering approach, the dendrogram was cut at the depth indicated by 
the dotted line in Fig. C10 A, which results in seven clusters. The 
number of clusters k in k-means clustering was set to 6. The resulting 
separation into clusters is very similar using the two methods, with the 
difference that in using the k-means clustering approach it was possible 
to unite the mutants, which grew faster early after inoculation and in 
the stationary phase, in one cluster (cluster 4). 
The adjucsted k-means clustering approach was applied to analyze 
the data from the second pilot experiment, using the number of 
clusters k=8.  
 
Fig. C11. K-means cluster analysis of tag microarray data from the stress conditions experiment. 
 
A B
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The data from the stress conditions were clustered together with the time point 3 
(exponential phase) data for VMM and TY cultures (Fig. C11). The clustering pattern of the 
stress conditions experiment is similar in part to the clustering pattern of the time course 
experiment. Particularly, the mutants 3-11D and 3-12D are grouped in one cluster in both 
experiments. Furthermore, all the mutants that belong to cluster 4 in the time course experiment 
and are characterized by a faster growth in the stationary phase compared to other mutants, grew 
faster than other mutants also in SDS- and salt induced stress conditions (cluster 4 in the stress 
conditions experiment).  
The characterized mutants in the respective clusters from the time course data and from the 
stress conditions/VMM/TY comparison are listed in the Tables C1 and C2, respectively. In the 
Appendix Table G2, the complete list of m-values and p-values is given for the stress conditions 
experiment and for the time point 3 in VMM and TY cultures.  
 
 
C. RESULTS 
 38
TABLE C1. Characteristics of mutants that have a changed phenotype in the time course experiment 
 
meanw-values 
mutant ID 
mutated 
genea 
gene product 
TY1 TY2 TY3 TY4 TY5 TY6 VMM1 VMM2 VMM3 VMM4 VMM5 VMM6 
Cluster 1 impaired in growth in VMM             
1-9A  SMb20616    thiamine biosynthesis oxidoreductase protein 
ThiO   
-0.064 -0.014 0.29 0.336 -0.05 -0.09 -0.283 -0.702 -0.399 -0.918 -0.807 -0.603 
4-12C   SMc01053    CysG siroheme synthase protein   0.0595 -0.264 -0.265 -0.04 0.406 0.26 -1.168 -1.154 -1.119 -1.121 -1.07 -1.018 
4-3E   SMc02117    MetC cystationine beta-lyase protein   -0.04 -0.207 0.157 0.267 0.138 0.1 -0.51 -0.534 -0.49 -0.826 -0.683 -0.649 
 Cluster 2   impaired in growth in TY medium and partially in VMM             
2-1H   SMc01219    lipopolysaccharide core biosynthesis 
mannosyltransferase LpsB E3 component of 2-
oxoglutarate   
-0.534 -0.805 -0.526 -0.7 -1.01 -1.07 -0.113 -0.258 -0.289 -0.285 -0.375 -0.084 
3-7B  SMc02487    dehyrogenase complex transmembrane protein 
LpdA2   
-0.793 -1.219 -0.957 -0.98 -1.19 -1.21 -1.023 -0.754 -0.841 -0.933 -1.067 -1.092 
4-12B  SMc02144    PstC phosphate transport system permease 
ABC transporter protein   
-0.797 -0.854 -0.964 -1.08 -0.96 -0.98 -0.409 -0.543 -0.542 -0.647 -0.473 -0.491 
 Cluster 3   impaired in growth under all conditions, strongly impaired in 
VMM 
            
1-11C   SMc04346    IlvC ketol-acid reductoisomerase protein   -0.267 -0.563 -0.266 -0.2 -0.42 -0.5 -1.221 -0.886 -0.899 -1.027 -1.138 -0.87 
2-9A   SMc02899    PheA prephenate dehydratase protein   -0.372 -0.155 0.086 -0.06 -0.51 -0.35 -1.296 -0.692 -0.693 -0.946 -1.134 -1.458 
2-9E   SMc03782    hypothetical signal peptide protein   -0.747 -0.695 -0.329 -0.59 -0.79 -0.76 -1.015 -1.034 -0.836 -0.74 -1.023 -0.827 
3-1C   SMc01842    putative methyltransferase transcription 
regulator protein   
-0.38 -0.294 -0.167 -0.19 -0.5 -0.78 -1.011 -0.88 -0.825 -0.882 -1.136 -0.404 
3-6A  SMc03777    gamma-glutamil phosphate reductase protein 
ProA   
-0.567 -0.422 0.043 -0.2 -0.42 -0.33 -0.663 -0.53 -0.38 -0.6 -0.59 -0.939 
3-7D   SMc01174    CysK2 cysteine synthase A protein   -0.229 -0.304 -0.476 -0.36 -0.14 -0.24 -0.605 -0.777 -0.636 -0.439 -0.509 -0.447 
4-1A  SMc00917    ATP phosphoribosyltransferase protein HisG  -0.128 -0.356 0.018 -0.12 -0.91 -0.77 -0.961 -0.441 -0.266 -0.94 -1.18 -0.319 
4-1H   SMc03776    ProB1 glutamate 5-kinase protein   -0.585 -0.546 -0.535 -0.55 -0.96 -0.77 -0.986 -0.843 -1.021 -1.284 -1.089 -0.747 
4-9A   SMc00825    glutamate-cysteine ligase GshA   -0.571 -0.686 -0.263 -0.65 -0.84 -0.6 -0.924 -0.329 -0.557 -0.931 -0.825 -0.717 
 Cluster 4    highly competitive at early growth stages and in the stationary 
phase 
            
2-11B  SMc01881   PanB 3-methyl-2-oxobutanoate 
hydromethyltransferase protein   
1.6331 -0.516 -0.409 -0.38 -0.05 -0.11 0.569 -0.378 -0.39 -0.308 -0.202 0.899 
3-10H   SMb20360    hypothetical protein. putative protease subunit 
of ATP-dependent Clp protease   
1.1341 0.227 -0.294 -0.35 0.059 -0.03 0.583 -0.07 -0.187 0.147 0.233 1.106 
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3-11B   pSymB, pos. 
1003846  
 intergenic   1.8135 0.315 0.158 0.203 0.467 0.46 0.718 0.134 0.358 0.425 0.445 1.583 
3-5B  SMb20931    sugar uptake ABC transporter periplasmic 
solute-binding protein  precursor  
0.8503 -0.145 0.106 0.166 0.072 0.04 0.436 0.157 0.175 0.09 0.058 0.192 
 Cluster 5    highly competitive under all conditions             
1-3G   pSymB, pos. 
543971   
 intergenic   0.5552 0.883 1.211 1.002 0.472 0.89 0.295 0.749 0.636 0.523 0.459 0.4 
1-5G   SMa0621    FixI2 E1-E2 type cation ATPase   0.5542 0.824 0.848 0.812 0.797 1.03 0.32 0.518 0.66 0.638 0.567 0.427 
2-10B   SMa0564    hypothetical protein   0.88 1.361 0.863 0.786 1.174 1 0.643 0.774 0.679 0.918 0.859 0.853 
3-12B   SMb20476     putative ABC transporter periplasmic 
dipeptide-binding protein   
0.6717 0.846 0.762 0.782 1.065 0.95 0.481 0.57 0.507 0.474 0.611 0.499 
3-5A SMb20037 AroE2 shikimate 5-dehydrogenase protein 0.3029 0.254 0.748 0.801 0.397 0.24 0.435 0.549 0.657 0.33 0.315 0.312 
3-6D SMc03032 FlgI flagellar P-ring precursor transmembrane 
protein   
0.777 0.428 0.428 0.418 0.451 0.33 0.635 0.291 0.238 0.589 0.321 0.745 
 Cluster 6   clones with low competitiveness under normal conditions and 
normal competitiveness at early growth stages and in the 
stationary phase  
            
 3-11D   SMb20377    putative translation initiation inhibitor protein  0.2047 -0.175 -0.552 -0.6 -0.09 -0.13 0.098 -0.101 -0.744 -0.043 -0.06 0.26 
 3-12D   SMc00334    Cmk cytidilate kinase protein   0.3993 -0.375 -1.036 -0.83 -0.63 -0.7 0.051 -0.745 -0.817 -0.495 -0.811 0.245 
 
aFor the mutants that have a transposon insertion in intergenic regions, an exact position of insertion in the respective replicon is given. 
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TABLE C2. Characteristics of mutants showing an altered phenotype in TY, VMM and/or stress conditions 
a For mutants carrying a transposon insertion in an intergenic region the exact position of insertion in the respective 
replicon is given. 
meanw-values mutant 
ID 
mutated genea 
TY VMM
TY-
SDS 
TY-
NaCl 
gene product 
Cluster 1 
highly competitive under most of the tested 
conditions 
 
2-2E SMb21633 0.39 0.55 0.67 0.88 PaaG enoyl-CoA hydratase protein 
3-5A SMb20037 0.90 0.79 0.65 0.71 AroE2 shikimate 5-dehydrogenase protein 
3-6D SMc03032 0.51 0.29 0.83 0.81 FlgI flagellar P-ring precursor transmembrane protein 
Cluster 2 
highly competitive in TY and VMM under non-
stress conditions 
 
1-3G pSymB, 543971 1.46 0.77 -0.01 0.12 intergenic 
1-5G SMa0621 1.02 0.79 0.07 0.12 FixI2 E1-E2 type cation ATPase 
3-12B SMb20476 0.92 0.61 -0.09 0.14 putative ABC transporter periplasmic dipeptide-binding protein 
Cluster 3 impaired in growth in VMM  
1-11C SMc04346 -0.33 -1.08 -0.11 -0.04 IlvC ketol-acid reductoisomerase protein 
2-9A SMc02899 0.10 -0.83 0.26 0.04 PheA prephenate dehydratase protein 
3-1C SMc01842 -0.20 -0.99 -0.15 0.08 putative methyltransferase transcription regulator protein 
4-12C SMc01053 -0.32 -1.35 -0.08 -0.01 CysG siroheme synthase protein 
4-1H SMc03776 -0.65 -1.23 0.21 0.01 ProB1 glutamate 5-kinase protein 
Cluster 4 highly  competitive in stress conditions  
2-11B SMc01881 -0.50 -0.47 2.09 2.03 PanB 3-methyl-2-oxobutanoate hydromethyltransferase protein 
2-5H SMc03164 -0.18 -0.08 0.77 0.43 XylB xylulose kinase protein. putative 
2-7H pSymB, 96435 0.28 0.11 0.82 0.43 intergenic 
3-10H SMb20360 -0.36 -0.22 1.67 1.50 hypothetical protein. putative protease subunit of ATP-dependent Clp protease 
3-11B pSymB, 1003846 0.19 0.43 1.95 1.85 intergenic 
3-5B SMb20931 0.12 0.21 0.94 0.76 putative sugar uptake ABC transporter periplasmic solute-binding protein precursor 
Cluster 5 
impaired in growth under all conditions, strongly 
impaired in VMM 
 
2-9E SMc03782 -0.40 -1.01 -0.37 -0.52 hypothetical signal peptide protein 
3-7D SMc01174 -0.58 -0.77 -0.40 -0.37 CysK2 cysteine synthase A protein 
Cluster 6 
clones with low competitiveness under normal 
conditions and slightly increased competitiveness 
under stress conditions 
 
3-11D SMb20377 -0.67 -0.90 0.46 0.46 putative translation initiation inhibitor protein 
3-12D SMc00334 -1.26 -0.98 0.79 0.51 Cmk cytidilate kinase protein 
Cluster 7 
clones with low competitiveness under normal 
conditions but not disadvantaged in stress 
conditions 
 
3-12C SMc00808 -0.76 -0.35 0.21 0.15 ChrA chromate transport protein 
4-10C SMa0091 -0.75 -0.42 0.13 0.13 conserved hypothetical 
4-11C SMc02597 -0.72 -0.50 -0.03 -0.13 SodC superoxide dismutase Cu-Zn precursor transmembrane protein 
4-12D SMa0070 -0.75 -0.46 0.13 0.08 ABC transporter permease 
Cluster 8 
impaired in growth in TY medium and partially 
under other conditions 
 
2-1H SMc01219 -0.64 -0.35 -0.74 -0.19 lipopolysaccharide core biosynthesis mannosyltransferase LpsB 
3-11H SMc01700 -0.72 -0.31 -0.26 -0.24 peptidyl-prolyl cis-trans isomerase A (PpiA) 
3-8C SMc02050 -0.74 -0.70 -0.54 -0.49 trigger factor protein Tig. probable 
4-12B SMc02144 -1.17 -0.65 -0.70 -0.62 PstC phosphate transport system permease ABC transporter protein 
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C.9.3 Confirmation of  biological significance of  the applied statistical 
analysis 
 
The applied k-means clustering provides not only a clear visualization of the STM data, but 
also a basis for the detailed analysis of mutants. To confirm that the analysis of STM data is 
biologically significant, it is important to support the observed patterns by other studies. 
Moreover, mutants which have similar defects should belong to the same cluster. Here, the 
clustering pattern from the stress conditions/VMM/TY clustering (Table C2) is analyzed in 
detail.  
Cluster 1 contains clones that are highly competitive under most of the tested conditions. It 
includes, particularly, the flgI mutant, which is impaired in the synthesis of flagella. The fast-
growing phenotype of this mutant supports the observation that the synthesis of flagella is 
energetically disadvantageous (Macnab, 1996). Two other mutants in this cluster are paaG 
(SMb21633) and aroE2 (SMb20037) mutants. paaG encodes a putative enoyl-CoA 
hydratase/isomerase involved in phenylacetate catabolism, and aroE2 codes for a putative 
shikimate 5-dehydrogenase protein involved in chorismate metabolism. Both genes have paralogs 
in the S. meliloti genome.  
Cluster 2 represents clones that are highly competitive in TY medium and VMM under non-
stress conditions. This cluster consists of three mutants bearing a transposon insertion in fixI2 
(encoding an E1-E2 type cation ATPase), in SMb20476 (coding for a putative ABC transporter 
periplasmic dipeptide-binding protein) and in the intergenic region between SMb20518 (encoding 
a putative endohitinase) and SMb20519 (encoding a conserved hypothetical protein), probably 
influencing transcription of SMb20519.  
Mutants that belong to cluster 3 are strongly impaired in growth in VMM. Characteristically, 
all mutants in this cluster have a transposon insertion in genes involved in the synthesis of amino 
acids or cofactors, not present in VMM: isoleucine/valine (ilvC), phenylalanine (pheA), 
ubiquinone/menaquinone (SMc01842), cysteine (cysG), and proline (proB1). It was previously 
shown that ilvC mutants of S. meliloti are isoleucine/valine auxotrophs (Aguilar and Grasso, 1991) 
and that CysG mutants of R. etli are cysteine auxotrophs (Tate et al., 1997).  
Cluster 4 contains six mutants that show high competitiveness in stress conditions but not in 
non-stress conditions. Two of these mutants carry a transposon insertion in the intergenic 
regions of pSymB: preceding SMb20088 (encoding a conserved hypothetical protein) and 
upstream of SMb21337 (coding for a putative iron-sulfur-binding protein, probably a subunit of 
an oxidoreductase-like aldehyde oxidase or xanthine dehydrogenase). This cluster also contains a 
C. RESULTS 
 42
panB (SMc01881) mutant. In Salmonella enterica, a panB mutation causes auxotrophy for 
pantothenate (Rubio and Downs, 2002). It can be suggested that in S. meliloti the function of 
PanB can also be performed by another protein, probably by the product of SMb20821 that at 
the amino acid level shares 31% identity with SMc01881 and contains a conserved PanB domain. 
Three other clones in cluster 4 have mutations in xylB (coding for a putative xylulose kinase 
protein that participates in degradation of D-xylose), SMb20360 (encoding a putative protease 
subunit of an ATP-dependent Clp protease) and SMb20931 (coding for a putative sugar uptake 
ABC transporter periplasmic solute-binding protein precursor). 
Cluster 5 contains two clones, cysK2 and SMc03782 mutants, impaired in growth under all 
conditions tested and more impaired in growth in VMM. cysK2 encodes a probable cysteine 
synthase A (O-acetylserine sulfhydrylase A) whereas the gene product of SMc03782 shows 
similarities to membrane-bound metallopeptidases involved in cell division and chromosome 
partitioning.  
Cluster 6 and 7 contain mutants which are more impaired in competitiveness under normal 
conditions than in stress conditions. Such a pattern occurs, probably, due to the fast growth of 
non-stressed cultures in the exponential phase in comparison to growth of SDS- and salt-stressed 
cultures. In the fast-growing cultures, mutants that grow and divide slower than others may be 
less competitive than in stressed slow-growing cultures, if the slow-growing phenotypes are not 
caused by the stress condition itself. Cluster 6 contains mutants in the cmk gene encoding a 
putative cytidilate kinase and in SMb20377 encoding a putative translation initiation inhibitor 
protein. Cluster 7 contains two clones with mutations in transporter genes (chrA and SMa0070), a 
sodC (coding for a superoxide-dismutase) mutant and a SMa0091 (encoding a hypothetical 
protein) mutant.  
Cluster 8 contains mutants that are impaired in growth in TY medium, and partially under 
other conditions. This cluster includes an lpsB (encoding a lipopolysaccharide core biosynthesis 
mannosyltransferase) mutant that was weakened in competitiveness in the fast-growing TY 
culture and the TY-SDS culture. Since it was previously shown (Clover et al., 1989) that lpsB 
mutants are sensitive to sodium deoxycholate (DOC), this mutant was expected to be attenuated 
in SDS-containing medium as well. The second mutant in the cluster has a transposon insertion 
in the ppiA gene that encodes a peptidyl-prolyl isomerase (PPIase). This enzyme has a chaperone-
like activity and facilitates the cis-trans isomerisation of peptide bonds N-terminal to proline 
residues within polypeptide chains (Shaw, 2002). Interestingly, another mutant in this cluster 
carries a transposon insertion in the tig gene that encodes a PPIase as well. Trigger factor (TF) 
encoded by tig is a ribosome-bound protein that combines both functions – peptidyl-prolyl 
isomerization and chaperone-like activities (Genevaux et al., 2004), similarly to the ppiA gene 
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product. Cluster 8 further contains a pstC mutant, whose slow-growing phenotype is especially 
noticeable in the fast-growing TY culture, and is less obvious in VMM and in the stressed 
cultures. pstC encodes a permease protein of a high affinity, high velocity Pi-specific ABC 
transporter (Yuan et al., 2006a). A comparatively high concentration of inorganic phosphate in 
VMM might be the reason for the faster growth of the pstC mutant in this medium compared to 
TY medium. 
Three mutants that showed an altered growth behavior in cultivation of the mutant pool in 
VMM compared to TY medium were analyzed individually in competition with the wild type. In 
these competition experiments the proB mutant (cluster 3) was analyzed in VMM, whereas the 
chrA mutant (cluster 7) and the tig mutant (cluster 8) were tested in TY. In accordance with the 
competition experiment analyzing the mutant pool by quantification of the signature tags in 
microarray hybridizations, the three individually tested mutants showed a reduced 
competitiveness compared to the wild type. 
 
 
C.10 STUDY OF SURVIVAL AND COMPETITIVENESS OF MUTANTS 
IN PLANTA 
 
C.10.1 Screening procedure 
 
The most important task in this PhD thesis was the application of the STM approach to 
identify the rhizobial genes important for the survival and competitiveness in symbiosis. For this, 
a system had to be used that would allow screening of about 400 mutants (one set of tagged 
mutants) in one experiment. The quantity of mutants that can be tested simultaneously in planta 
depends on the quantity of nodules that can be obtained in one experiment. In order to produce 
statistically reasonable results, a quantity of harvested nodules is required that exceeds the 
quantity of tested mutants in at least 4 – 5 fold and reaches, in this case, 1.5 to 2 thousands 
nodules. To obtain such a high quantity of nodules in one experiment, the aeroponic system was 
used. The plant roots grow especially well in this system, so that 150 – 200 nodules can be 
formed per plant, whereas up to 80 plants are cultivated in one aeroponic tank (Fig. C12). 
Furthermore, the aeroponics allows spreading of the mixture of mutants equally to all the roots 
and, since no solid substrate is used, provides an easy access to the roots. 
In the experiment in planta, both sets of mutants were screened: set 1, used in a validation 
experiments and set 2. For each set, a separate aeroponic tank with approximately 60 M. sativa 
plants was run. Mature nodules were collected 4 weeks after inoculation. For the first set, 18 ml 
C. RESULTS 
 44
of nodules were collected, and for the second set, 16 ml of nodules were collected. Nodules were 
stored in 9 aliquots at -80 °C (5 aliquots for set 1 and 4 aliquots for set 2).  
 
Fig. C12. Aeroponic tank used in this study 
 
Total plant and bacterial DNA was isolated from the nodules. DNA isolations were 
performed for each aliquot of nodules (1.5 - 2.5 g) separately and the tags were amplified from 
this DNA using Cy3-labeled primers. DNA was also isolated from the cultures by which the 
aeroponic tanks were inoculated. The tags were amplified by Cy5-labeled primers from this DNA 
and used as reference in the tag-microarray hybridizations.  
Four microarray hybridizations were made for each set. Three of these hybridizations were 
made with Cy3-labeled targets synthesized from the separate DNA isolations from different 
aliquots of nodules. The fourth hybridization for each set was made using targets synthesized 
from a mixture of DNA from all three aliquots.  
Hybridization, scanning, microarray image processing and data preprocessing were 
performed in the same way as in the pilot verification experiments. The normalization method 
used in this experiment was a modification of the global median normalization. Here, 15% of the 
smallest m-values were excluded from the pool of data used to calculate the median. This was 
made because a bias toward low m-values was expected. The two mutant sets tested here, 
contained approximately 5% of mutants that were expected to be attenuated in symbiosis 
(internal positive controls). Moreover, the chance of finding more attenuated mutants was much 
higher than the chance of finding mutants that survives especially well in the plant. The 
calculation of the median excluding 15% of the small m-values resulted in a reasonable number 
of attenuated and of well-growing mutants. Furthermore, in this way most of internal positive 
controls could be detected as attenuated. 
At the next step of statistical analysis, the mean weighted values were calculated for each 
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mutant grouping the data from three slides that represent three aliquots of nodules. Based on 
these meanw values, 83 mutants were found to be attenuated (37 in the set 1 and 46 in set 2) and 
50 mutants were found to be highly represented in the sets under symbiotic conditions (30 in set 
1 and 20 in set 2). In order to filter possible false positive clones out, meanw values from three 
grouped slides were compared to the data from the fourth slide. The mutants whose absolute m-
values in the fourth hybridization were lower than 0.7 were filtered out. Mutants whose 
respective tags were not detected on the fourth slide were not filtered out from the list of 
attenuated mutants, since low a-values could originate from very low signals in the Cy3 
(experiment) channel (in case of highly represented mutants such cases were not observed). As a 
result of this filtering, 67 attenuated mutants (30 from the set 1 and 37 from the set 2) and 29 
highly represented mutants (22 from set 1 and 7 from set 2) were considered as mutants showing 
an altered phenotype under symbiotic conditions. The resulting attenuated mutants are listed in 
the Table C3, and the highly represented mutants are listed in the table C4. All the tested mutants 
with corresponding m-values and p-values are listed in Appendix (Tables G3 and G4) 
 
TABLE C3. Characteristics of mutants showing an attenuated phenotype under symbiotic conditions 
 
set 
mutant 
ID in 
the set 
mutantID complete 
mutated 
gene 
function 
m-value 
slide 4 
meanw 
value, 3 
slides 
combined
1 1-9C 2011mTn5STM.1.10.C09 SMa0244 hypothetical protein NA -0.82 
1 2-2D 2011mTn5STM.2.09.D02 SMa0322 hypothetical protein -0.87 -0.80 
2 4-6E 2011mTn5STM.4.09.E06 SMa0414 hypothetical protein NA -0.80 
1 1-11D 2011mTn5STM.1.05.D11 SMa0814 NifB FeMo cofactor biosynthesis protein -1.06 -1.09 
1 3-1A 2011mTn5STM.3.12.A01 SMa0819 FixB electron transfer flavoprotein alpha chain NA -0.87 
2 2-6E 2011mTn5STM.2.07.E06 SMa0829 NifK nitrogenase Fe-Mo beta chain -1.10 -0.96 
1 1-9D 2011mTn5STM.1.05.D09 SMa0840 NodD3 transcriptional regulator NA -0.93 
1 2-5D 2011mTn5STM.2.08.D05 SMa0849 SyrM transcriptional regulator -0.96 -0.78 
2 3-6G 2011mTn5STM.3.06.G06 SMa0863 NodJ membrane transport protein -1.03 -0.82 
2 1-4H 2011mTn5STM.1.10.H04 SMa0873 NifN Nitrogenase Fe-Mo cofactor biosynthesis protein NA -0.97 
1 1-4A 2011mTn5STM.1.11.A04 SMa1004 hypothetical protein -0.83 -0.86 
1 1-4C 2011mTn5STM.1.01.C04 SMa1229 FixL oxygen regulated histidine kinase -1.11 -1.11 
2 1-8C 2011mTn5STM.1.13.C08 SMa1229 FixL oxygen regulated histidine kinase -1.08 -0.96 
2 3-7H 2011mTn5STM.3.05.H07 SMa1229 FixL oxygen regulated histidine kinase -1.09 -0.91 
2 4-8B 2011mTn5STM.4.10.B08 SMa1742 putative iron uptake protein -0.72 -0.73 
1 1-6G 2011mTn5STM.1.08.G06 SMa1798 Kup2 Potassium uptake protein -1.05 -0.94 
1 4-3F 2011mTn5STM.4.08.F03 SMa1913 putative transport protein -0.76 -0.86 
1 4-6D 2011mTn5STM.4.04.D06 SMb20227 nutrient deprivation-induced protein A (NdiA1) -0.77 -0.75 
1 4-4D 2011mTn5STM.4.04.D04 SMb20481 AsnO asparagine synthase, glutamine-hydrolyzing -1.05 -1.10 
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2 3-3H 2011mTn5STM.3.06.H03 SMb20509 putative transcriptional regulator -0.74 -0.92 
2 2-9H 2011mTn5STM.2.06.H09 SMb20612 C4-dicarboxylate transport sensor protein DctB -0.83 -0.76 
2 2-11D 2011mTn5STM.2.05.D11 SMb20615 putative thiamine biosynthesis protein ThiC -1.06 -0.92 
1 1-9A 2011mTn5STM.1.04.A09 SMb20616 ThiO putative thiamine biosynthesis oxidoreductase protein -0.98 -0.88 
1 2-8E 2011mTn5STM.2.08.E08 SMb20757 methylmalonyl-CoA mutase protein BhbA -0.84 -0.87 
1 4-11E 2011mTn5STM.4.04.E11 SMb20942 UDP glucose 4-epimerase protein ExoB -1.14 -1.07 
1 2-6G 2011mTn5STM.2.05.G06 SMb20943 acetyltransferase protein ExoZ -1.12 -1.05 
1 1-8G 2011mTn5STM.1.12.G08 SMb20948 ExoU glucosyltransferase -1.05 -1.06 
1 3-9B 2011mTn5STM.3.10.B09 SMb20957 exopolysaccharide biosynthesis protein ExoA -1.15 -1.18 
1 1-9B 2011mTn5STM.1.01.B09 SMb20958 exopolysaccharide biosynthesis protein ExoM -1.08 -1.02 
1 2-9C 2011mTn5STM.2.09.C09 SMb20959 probable exopolysaccharide biosynthesis protein ExoO -1.05 -1.08 
2 1-9B 2011mTn5STM.1.07.B09 SMb20962 probable phoshomethylpyrimidine kinase protein ThiD -1.13 -1.05 
1 4-12E 2011mTn5STM.4.08.E12 SMb21158 putative transcriptional regulator, probably of sugar phosphate metabolism protein -1.13 -0.96 
2 2-10A 2011mTn5STM.2.12.A10 SMc00129 sensor histidine kinase protein FeuQ -0.99 -0.96 
2 1-1A 2011mTn5STM.1.11.A01 SMc00169 NAD-malic enzyme oxidoreductase protein Dme -0.94 -0.99 
2 2-7C 2011mTn5STM.2.05.C07 SMc00236 probable indole-3-glycerol phosphate synthase TrpC -0.99 -0.82 
1 1-10E 2011mTn5STM.1.12.E10 SMc00349 GTP-binding membrane protein LepA -0.97 -0.94 
2 4-3C 2011mTn5STM.4.02.C03 SMc00644 hypothetical protein -1.13 -1.08 
1 4-6B 2011mTn5STM.4.03.B06 SMc00781 methylmalonate-semialdehyde dehydrogenase MmsA (IolA) -1.09 -1.03 
1 4-3G 2011mTn5STM.4.02.G03 SMc00828 hypothetical protein -0.87 -0.86 
2 3-2B 2011mTn5STM.3.07.B02 SMc00963 biotin ABC transporter, permease component BioN -1.09 -1.07 
1 4-12C 2011mTn5STM.4.04.C12 SMc01053 siroheme synthase protein CysG  -1.06 -1.06 
2 4-11D 2011mTn5STM.4.02.D11 SMc01139 RNA polymerase sigma-54 factor -1.17 -1.03 
2 4-2E 2011mTn5STM.4.05.E02 SMc01183 Putative LexA repressor regulator -0.89 -0.86 
1 2-1H 2011mTn5STM.2.12.H01 SMc01219 lipopolysaccharide core biosynthesis mannosyltransferase LpsB -0.91 -0.84 
2 3-5F 2011mTn5STM.3.10.F05 SMc01431 probable acetolactate synthase isozyme III large subunit protein IlvI -0.99 -0.83 
2 1-7G 2011mTn5STM.1.02.G07 SMc01877 probable DNA repair protein RecN -0.77 -0.73 
2 3-3C 2011mTn5STM.3.10.C03 SMc01929 hypothetical protein -0.70 -0.79 
1 2-1D 2011mTn5STM.2.10.D01 SMc01950 high-affinity branched-chain amino acid ABC transporter, permease protein LivM -0.86 -0.81 
2 2-2A 2011mTn5STM.2.09.A02 SMc02109 probable ATP-dependent CLP protease ATP-binding subunit protein ClpA -0.96 -1.03 
2 4-7A 2011mTn5STM.4.10.A07 SMc02123 hypothetical protein -0.81 -0.77 
2 1-6C 2011mTn5STM.1.13.C06 SMc02143 putative phosphate transport system permease ABC transporter protein PstA -0.95 -0.95 
1 4-12B 2011mTn5STM.4.09.B12 SMc02144 phosphate transport system permease ABC transporter protein PstC -0.76 -0.93 
2 2-4D 2011mTn5STM.2.01.D04 SMc02165 probable orotate phosphoribosyltransferase protein PyrE -0.96 -0.84 
1 4-6E 2011mTn5STM.4.02.E06 SMc02226 hypothetical protein -1.05 -0.97 
2 4-1A 2011mTn5STM.4.08.A01 SMc02274 putative capsule polysaccharide export protein precursor RkpU -0.75 -0.74 
2 1-6H 2011mTn5STM.1.10.H06 SMc02361 cytochrome C-type biogenesis transmembrane protein CycH -0.85 -0.90 
2 3-10F 2011mTn5STM.3.06.F10 SMc02562 phosphoenolpyruvate carboxykinase protein PckA -1.04 -0.85 
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2 1-12H 2011mTn5STM.1.09.H12 SMc02767 N-5'-phosphoribosylanthranilate isomerase TrpF -0.95 -0.94 
2 2-6A 2011mTn5STM.2.10.A06 SMc03181 pH adaptation potassium efflux system transmembrane protein PhaD1 -1.03 -0.92 
2 3-9G 2011mTn5STM.3.08.G09 SMc03277 MFS-type transport protein -0.93 -0.88 
2 4-3F 2011mTn5STM.4.09.F03 SMc03797 homoserine O-succinyltransferase MetA -1.20 -1.20 
2 3-12G 2011mTn5STM.3.08.G12 SMc03849 cytochrome c-type biogenesis protein CcmC -1.06 -0.98 
2 4-5B 2011mTn5STM.4.08.B05 SMc03900 beta-glucan export ATP-binding protein NdvA -1.06 -1.02 
2 3-5A 2011mTn5STM.3.05.A05 SMc04045 probable dihydroxy-acid dehydratase protein IlvD2 -0.99 -0.85 
1 1-11C 2011mTn5STM.1.08.C11 SMc04346 IlvC ketol-acid reductoisomerase protein -0.83 -0.78 
2 1-11D 2011mTn5STM.1.03.D11 SMc04346 IlvC ketol-acid reductoisomerase protein NA -0.88 
2 2-7E 2011mTn5STM.2.02.E07 SMc04405 3-isopropylmalate dehydrogenase LeuB -1.12 -0.94 
 
 
TABLE C4. Characteristics of mutants highly represented under symbiotic conditions 
 
set 
mutant 
ID in 
the set 
mutantID complete 
mutated 
genea 
function 
m-
value 
slide 4 
meanw 
value, 3 
slides 
combined
1 2-7H 2011mTn5STM.2.09.H07 pSymB, 96435 intergenic 1.20 1.69 
1 3-11B 2011mTn5STM.3.12.B11 pSymB, 1003846 intergenic 1.53 1.25 
1 4-7F 2011mTn5STM.4.03.F07 
S. meliloti 
chromosome, 
2051945 
intergenic 0.90 0.86 
1 2-12B 2011mTn5STM.2.09.B12 
S. meliloti 
chromosome, 
2862221 
intergenic 1.11 1.32 
1 2-10B 2011mTn5STM.2.04.B10 SMa0565 hypothetical protein 1.20 1.29 
1 1-5G 2011mTn5STM.1.12.G05 SMa0621 FixI2 E1-E2 type cation ATPase 0.79 0.86 
1 3-5A 2011mTn5STM.3.11.A05 SMb20037 shikimate 5-dehydrogenase protein AroE2 1.20 1.12 
1 3-10H 2011mTn5STM.3.08.H10 SMb20360 hypothetical protein 1.21 1.21 
2 3-9D 2011mTn5STM.3.05.D09 SMb20426 hypothetical transcriptional regulator protein 1.06 1.38 
1 3-9D 2011mTn5STM.3.10.D09 SMb20582 putative transcriptional regulator, LysR family protein 1.06 1.10 
2 3-11B 2011mTn5STM.3.10.B11 SMb20607 hypothetical protein 0.72 0.88 
1 2-10D 2011mTn5STM.2.03.D10 SMb20748 glycosyltransferase protein PssF 0.87 0.75 
2 1-10E 2011mTn5STM.1.03.E10 SMb21630 hypothetical protein 1.58 1.70 
1 2-2E 2011mTn5STM.2.04.E02 SMb21633 PaaG enoyl-CoA hydratase protein 1.00 0.74 
1 3-12D 2011mTn5STM.3.07.D12 SMc00334 Cmk cytidilate kinase protein 1.09 0.80 
1 1-1C 2011mTn5STM.1.09.C01 SMc00513 putative amino-acid binding periplasmic protein 0.91 1.10 
2 1-3A 2011mTn5STM.1.06.A03 SMc00790 probable dipeptide transport ATP-binding ABC transporter protein DppF 0.78 0.71 
2 1-1E 2011mTn5STM.1.02.E01 SMc00898 
probable glutathione-regulated 
potassium-efflux system transmembrane 
protein KefB 
0.91 1.23 
2 3-9C 2011mTn5STM.3.07.C09 SMc01127 OlsB protein required for ornithine-containing lipid biosynthesis 1.17 0.75 
1 3-5D 2011mTn5STM.3.07.D05 SMc01406 putative transcription regulator protein 0.80 0.76 
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1 2-11B 2011mTn5STM.2.06.B11 SMc01881 PanB 3-methyl-2-oxobutanoate hydromethyltransferase protein 2.84 2.01 
1 3-8H 2011mTn5STM.3.09.H08 SMc01965 
putative spermidine/putrescine 
transport ATP-binding ABC transporter 
protein 
0.94 0.84 
1 1-9F 2011mTn5STM.1.02.F09 SMc02612 glutamate synthase family protein GlxD 0.98 0.82 
1 3-6D 2011mTn5STM.3.11.D06 SMc03032 flagellar P-ring precursor transmembrane protein 1.23 1.08 
2 4-12A 2011mTn5STM.4.05.A12 SMc03112 methionine synthase MetH 0.85 0.84 
1 2-5H 2011mTn5STM.2.05.H05 SMc03164 xylulose kinase protein XylB 0.78 1.10 
1 4-11D 2011mTn5STM.4.09.D11 SMc03873 RNA polymerase sigma factor protein SigC 1.23 1.15 
1 3-1B 2011mTn5STM.3.08.B01 SMc04217 hypothetical protein 0.71 0.79 
1 2-11D 2011mTn5STM.2.01.D11 SMc04452 NADH dehydrogenase transmembrane protein Ndh 1.17 1.02 
 
a For mutants carrying a transposon insertion in an intergenic region the exact position of insertion in the respective 
replicon is given. 
 
 
C.10.2 Determination of  quantity of  mutants in single nodules 
 
An additional experiment was performed in order to determine how many mutants enter one 
nodule in aeroponics. To answer this question, 9 nodules from each aeroponic tank were tested. 
The DNA from each of these nodules was used to perform separate target preparations and 
microarray hybridizations. The presence of a specific mutant in a nodule was detected based on 
high average spot intensity values for both tags. An example of the results from such 
hybridization is presented on Fig. C13. As a result of this experiment, it could be determined that 
most of nodules (15 from 18 nodules) were occupied by a single mutant clone. Two nodules 
contained two different mutant clones, and one nodule contained three different mutant clones. 
Two of the nodules (set 1, nodules 7 and 9) contained the same mutant clone; all other nodules 
contained different mutant clones (Table C5). It can be therefore concluded that most of the 
nodules in aeroponic conditions were occupied by a single mutant clone. 
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Fig. C13. Determination of quantity of different mutant clones in a single nodule from the aeroponic tank. Results 
of hybridization for the nodule 2 from set 1. Here, mutants with IDs 1-1G, 2-3H and 3-2B were detected. The 
average H-tag and K-tag intensity values for the clone 3-2B lay so close that they overlap on the diagram. 
 
 
TABLE C5. Quantity of different mutant clones in single  
nodules from the aeroponic tanks 
 
set 
nodule 
Nr 
quantity of 
mutants in the 
nodule 
Short mutant 
IDs 
1 1 2 1-5G, 2-7G  
1 2 3 1-1G, 2-3H, 3-2B
1 3 1 3-9D 
1 4 1 3-12A 
1 5 1 1-7H 
1 6 1 2-2B 
1 7 1 2-10B 
1 8 1 2-11F 
1 9 1 2-10B 
2 1 1 1-4F 
2 2 1 2-6D 
2 3 1 2-3A 
2 4 2 1-8A, 4-7D 
2 5 1 3-8F 
2 6 1 2-11C 
2 7 1 1-10A 
2 8 1 1-9F 
2 9 1 2-2B 
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C.10.3 Phenotype confirmation for attenuated mutants 
 
Since the signature tagged mutagenesis is a screening strategy, some of the attenuated 
mutants were tested individually for their competitiveness phenotype in order to confirm or to 
reject the phenotype observed in the STM experiment. From 67 attenuated mutants, 25 mutants 
with no previously known fixation or nodulation defect were chosen for the testing procedure. 
M. sativa plants, growing on agar plates, were inoculated by a 1 : 1 mixture of wild type Rm2011 
and a checked mutant, and after 4-5 weeks the nodules were harvested. Since the mTn5 
transposon carries a neomycin resistance gene, the presence of a mTn5 mutant in a nodule can be 
revealed by plating the nodule content on an agar plate with neomycin-containing medium. In 
order to identify the wild type/mutant ratio of dividing bacteria in the nodules, the equal quantity 
of diluted nodule content is plated on neomycin plates and on plates without neomycin, and the 
number of clones grown on these plates is compared. For each mutant, 25 to 30 nodules from 
15-18 plants were analyzed, and the average value from the percentage of mutant in each nodule 
was calculated. The attenuated competitiveness phenotype could be confirmed for 22 mutants 
from 25 (Table C6).  
 
TABLE C6. Competition phenotypes of 25 clones in individual tests  
 
mutantID complete 
mutated 
gene 
function 
meanw 
value, 3 
slides 
combined 
number 
of 
analyzed 
nodules 
average 
percentage 
of mutant 
in nodules 
2011mTn5STM.4.09.F03 SMc03797 homoserine O-succinyltransferase MetA -1.20 26 0.04 
2011mTn5STM.4.04.C12 SMc01053 siroheme synthase protein CysG  -1.06 30 0.45 
2011mTn5STM.1.04.A09 SMb20616 ThiO putative thiamine biosynthesis oxidoreductase protein -0.88 30 1.89 
2011mTn5STM.1.12.E10 SMc00349 GTP-binding membrane protein LepA -0.94 30 3.97 
2011mTn5STM.4.09.B12 SMc02144 phosphate transport system permease ABC transporter protein PstC -0.93 29 4.06 
2011mTn5STM.2.12.A10 SMc00129 sensor histidine kinase protein FeuQ -0.96 29 4.54 
2011mTn5STM.1.07.B09 SMb20962 probable phoshomethylpyrimidine kinase protein ThiD -1.05 25 4.96 
2011mTn5STM.3.08.G12 SMc03849 cytochrome c-type biogenesis protein CcmC -0.98 27 7.93 
2011mTn5STM.4.02.E06 SMc02226 hypothetical protein -0.97 33 1.24 
2011mTn5STM.1.13.C06 SMc02143 
putative phosphate transport system 
permease ABC transporter protein 
PstA 
-0.95 30 11.45 
2011mTn5STM.2.09.A02 SMc02109 
probable ATP-dependent CLP 
protease ATP-binding subunit protein 
clpA 
-1.03 28 13.31 
2011mTn5STM.2.10.D01 SMc01950 
high-affinity branched-chain amino 
acid ABC transporter, permease 
protein LivM 
-0.81 31 15.31 
2011mTn5STM.4.05.E02 SMc01183 Putative LexA repressor regulator -0.86 30 16.67 
2011mTn5STM.4.04.D04 SMb20481 AsnO asparagine synthase, glutamine-hydrolyzing -1.10 25 18.04 
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2011mTn5STM.4.02.C03 SMc00644 hypothetical protein -1.08 30 18.98 
2011mTn5STM.1.02.G07 SMc01877 probable DNA repair protein RecN -0.73 30 21.70 
2011mTn5STM.4.04.D06 SMb20227 nutrient deprivation-induced protein A (NdiA1) -0.75 27 25.46 
2011mTn5STM.4.10.A07 SMc02123 hypothetical protein -0.77 25 27.16 
2011mTn5STM.3.06.H03 SMb20509 putative transcriptional regulator -0.92 25 28.25 
2011mTn5STM.4.02.G03 SMc00828 hypothetical protein -0.86 31 31.61 
2011mTn5STM.4.09.E06 SMa0414 hypothetical protein -0.80 29 32.03 
2011mTn5STM.3.10.C03 SMc01929 hypothetical protein -0.79 28 34.24 
2011mTn5STM.3.08.G09 SMc03277 MFS-type transport protein -0.88 28 49.43 
2011mTn5STM.2.09.D02 SMa0322 hypothetical protein -0.80 28 53.15 
2011mTn5STM.4.08.F03 SMa1913 putative transport protein -0.86 27 77.73 
 
 
C.10.4 Symbiotic phenotypes other than reduced symbiotis competitiveness 
 
Each of 25 mutants whose competition phenotypes were tested individually was also tested 
to see if any defect in symbiosis can be observed if the plants are inoculated only by the mutant 
culture. Only severe symbiotic defects, like Fix- phenotype or strong delay in nodulation were 
considered. Mutants in four genes were found to have such symbiotic defects. 
Clone 2011mTn5STM.3.08.G1 that has a transposon insertion in the ccmC (SMc03849) gene 
showed a Fix- phenotype: the induced nodules were white (Fig. C14 B) and the plant shoots 
started to turn yellow 2.5 – 3 weeks after inoculation.  
Clone 2011mTn5STM.4.04.D04 that has a mutation in asnO (SMb20481) gene could induce 
only very few nodules. On one plant, the nodules formed by this mutant had a strongly abnormal 
morphology (Fig. C14 C), but all nodules formed on other plants looked normal and had a Fix+ 
phenotype (Fig. C14 D). Most of nodules, induced by asnO mutant, were bifurcated.  
Clones 2011mTn5STM.4.04.C12 and 2011mTn5STM.4.09.F03 carrying mTn5 insertion in 
cysG (SMc01053) gene and in metA (SMc03797) respectively, showed a delayed nodulation 
phenotype, and the nodules formed by these mutants turned pink 6-8 days later than the wild 
type induced nodules. While the metA mutant formed pink effective nodules three weeks after 
inoculation (Fig C14 E) on all plants, cysG mutant induced different kinds of nodules: on some 
plants, small white nodules were formed, and on other plants nodules were pink and large. Fig 
C14 F shows three plants, inoculated by the cysG mutant and growing in the same plate, that 
formed nodules of different morphology.  
To analyze these phenotypes more closely, the kinetics of nodule formation was observed. 
Additionally, acetylene reduction assay and histochemical GUS staining of nodules were 
performed. 
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Fig. C14. Phenotype of nodules at 21 dpi induced by: (A) wild type S. meliloti, (B) ccmC mutant, (C) and (D) asnO 
mutant, (E) metA mutant, and (F) cysG mutant. In (D), the arrows indicate the nodules. 
 
 
C.10.4.1 Kinetics of nodule formation 
 
In case of asnO, cysG and metA mutants and wild type Rm2011, formation of nodules on 110 
plants were analyzed. In case of ccmC, 27 plants were observed. Plants were inoculated by a 
respective bacterial culture (o.D.600=0.02) and nodules were counted at 9, 12, 17 and 21 days post 
inoculation (dpi). M. sativa plants were grown on agar plates, with 3 plants per plate. The results 
of this experiment are depicted on Fig. C15. 
As expected, the ccmC mutant that showed a Fix- phenotype, induced more nodules than the wild 
type (Paau et al., 1985). Plants inoculated by cysG mutant and plants inoculated by the metA 
mutant started to form nodules later than plants inoculated by the wild type S. meliloti, but formed 
A B C D
E F 
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the same, or even higher, quantity of nodules at 17-21 dpi. The asnO mutant induced strikingly 
few nodules: even at 21 dpi only 21 nodules were formed on 110 plants in generally.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. C15. Kinetics of nodule formation by the asnO, cysG, ccmC and metA  mutants comparing to the wild type 
Rm2011 
 
 
C.10.4.2 Acetylene reduction assay 
 
In order to investigate the nitrogen fixation rate in nodules induced by cysG, ccmC and metA 
mutants, acetylene reduction assay was performed. The asnO mutant was not included in this 
experiment because the quantity of nodules produced by this mutant was not sufficient.  
The whole plants were incubated with acetylene in order to reduce the stress factor in the 
measurements. Three plants were placed in each tube. In case of plants inoculated by wild type S. 
meliloti and cysG, and metA mutants, 10 tubes were analyzed. In case of ccmC mutant, 5 tubes were 
analyzed. The results of the assay (Fig. C16) correlate with the observed phenotype of mutants. 
Particularly, the nodules induced by ccmC mutant did not show any acetylene assimilation higher 
than the background. Nodules induced by the metA mutant reduced the same quantity of 
acetylene as nodules induced by the wild type S. meliloti (Fig. C16 B). However, since the quantity 
of nodules formed on plants inoculated by metA mutant was higher than on the plants inoculated 
by the wild type Rm2011 (Fig. C15), the metA-inoculated plants generally reduced more acetylene 
(Fig. C16 A).  
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Fig. C16. Percentage of assimilated acetylene per tube (3 plants) (A) and per nodule (B).  
 
The results of acetylene reduction measures for the cysG mutant reflect the heterogeneity in 
the phenotypes of nodules induced by this mutant (fig. C14 F). While in some tubes low levels of 
acetylene were reduced (1.2-1.4 %), in other tubes the percentage of reduced acetylene was much 
higher than expected (4.5% or even 9.5% reduced acetylene per tube in comparison to the 
average of 2.4% in the case of the wild type inoculated plants). Generally, nodules induced by the 
cysG mutant reduced more acetylene than the wild type induced nodules. 
 
C.10.4.3 Histochemical GUS staining 
 
In the tested ccmC, asnO, metA and cysG mutants, the mTn5 transposon was inserted in a way 
that the promotorless gusA gene had the same direction as the interrupted gene. It was therefore 
possible to visualize the promoter activity of the mutated gene in the nodules based on the 
expression of the gusA gene. Nodules were collected at 22 dpi, sectioned, stained for GUS activity 
and observed by microscopy. Additionally, nodule sections were stained by 0.1 M potassium 
iodide in order to visualize the starch granules.  
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ccmC mutant 
 
Nodules induced by the ccmC mutant contain bacteria only in the apical infection zone, 
where expression of the reporter gusA gene is especially strong (Fig. C17, C18). This corresponds 
with the non-fixing phenotype observed in the acetylene reduction assay and indicates the 
possible role of the ccmC gene in the infection process.  
Another interesting feature of the nodules induced by the ccmC mutant is the high 
concentration of starch in the apex part and in the periphery of the nodule (Fig. C18 B) 
 
                         
Fig. C17. GUS staining (blue) of a longitudinal section of a nodule induced by the ccmC mutant. 
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Fig. C18. Longitudinal sections of a nodule induced by the ccmC mutant. (A) GUS staining; (B) GUS and K-iodide 
staining. Starch is stained dark brown. 
 
 
asnO mutant 
 
One of the pink nodules, induced by this mutant, was analyzed. The nodule is filled with 
bacteria and the expression of the reporter gene take place in bacteroids of all developmental 
stages (Fig. C19). Starch granules are observed in the interzone, like in the wild type induced 
nodules. Nevertheless, the structure of the nodule is quite unusual: it does not have the typical 
prolonged form with a clear definition of zones throughout all longitudinal sections. In Fig. C19 
A C and D, three longitudinal sections of the same nodule are shown. Whereas in section A the 
meristematic zone I and infection zone II occupy a large part of the nodule, in sections C and D 
these zones are almost not observed; most of the plant cells on these sections are swollen and 
filled with bacteroids. Furthermore, the proximal part of the nodule is unusually broad, which 
probably originates from difficulties in infection. 
 
 
A B
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Fig. C19. Longitudinal sections of a nodule induced by the asnO mutant. (A), (C), (D) GUS staining; (B) GUS and 
K-iodide staining. Starch accumulation in the interzone is indicated by arrows.  
 
 
metA mutant 
Longitudinal sections of a nodule induced by the metA mutant are shown on Fig. C20. 
Expression of the reporter gene was detected only in the middle and in the proximal part of the 
nodule. In addition, some plant cells, filled with starch, could be detected in the middle part of 
the nodule. Since the nodules induced by metA can fix nitrogen at the same rate as the wild type 
induced nodules, it can be suggested that the metA gene is expressed only at a low level in the 
Zone III nitrogen-fixing bacteroids, and at a higher level in the Zone IV bacteroids.  
 
 cysG mutant 
Longitudinal sections of a cysG mutant-induced pink nodule are shown on the Fig. C21. The 
general morphology of the nodule appears normal, except for a high quantity of non-infected 
Zone III cells, located mostly in the center of the nodule. Expression of the reporter gene takes 
place in the Zone III and Zone IV of the nodule.  
A B
C D
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Fig. C20. Longitudinal sections of a nodule induced by the metA mutant. (A), GUS staining; (B), GUS and K-iodide 
staining. Arrows indicate the cells in the middle part of the nodule, filled with starch.  
 
 
 
 
                         
Fig. C21. Longitudinal sections of a nodule induced by the cysG mutant. (A), GUS staining; (B), GUS and K-iodide 
staining. Starch accumulation in the interzone is indicated by arrows. 
A B
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D. DISCUSSION 
D.1 SIGNATURE TAGGED TRANSPOSON MUTAGENESIS IS AN 
EFFICIENT APPROACH TO STUDY GENES INVOLVED IN 
SURVIVAL OF RHIZOBIA IN SYMBIOTIC AND FREE-LIVING 
CONDITIONS 
 
Symbiosis between rhizobia and their legume hosts is a complicated and fragile process that 
requires participation of many gene products from both symbionts. At present, most of rhizobial 
genes and many legume genes that are crucial for the establishment of successful symbiosis 
and/or nitrogen fixation have been discovered. However, many of the genes that influence 
symbiosis in a more subtle way are still not identified. In order to discover genes which are 
specifically expressed in symbiosis, novel high-throughput methods such as transcriptomics 
(Ampe et al., 2003; Becker et al., 2004; Capela et al., 2006; Long et al., 1988), proteomics 
(Djordjevic et al., 2003), and in vivo expression technology (Oke and Long, 1999; Zhang and 
Cheng, 2006) were successfully applied to Sinorhizobium meliloti. Data from these experiments, 
however, provides no information about the involvement of the identified genes in survival and 
competitiveness of rhizobia in the host. Usually, to study the function of genes in symbiosis and 
competitiveness, gene disruption or deletion with subsequent analysis of symbiotic phenotypes is 
applied. This method is efficient when one or several few genes have to be tested. However, it is 
very laborious and time consuming when used for the screening of hundreds or thousands of 
mutants. A pre-selection of mutants in defined free-living conditions is often performed in order 
to reduce the number of mutants that have to be tested in planta (Milcamps et al., 1998; Summers 
et al., 1998; Trzebiatowski et al., 2001; Uhde et al., 1997). At the same time, such a pre-selection 
reduces the chances to find unknown genes involved in symbiosis, if this genes are not expressed 
in the tested free-living conditions. The method of signature tagged mutagenesis, in contrast, 
enables the screening of hundreds of mutants in one passage through the host, so that the whole 
library of mutants can be screened quite easily.  
Originally developed to identify genes involved in the pathogen-host interactions, signature-
tagged transposon mutagenesis was used in this project for the first time to study the rhizobia-
legume symbiosis. Furthermore, the efficiency of the STM approach was improved here through 
the creation of a novel, largest to date, library of tagged transposons, and through the 
combination of the STM approach with two-channel microarrays. The utilization of two 
signature tags per transposon together with an appropriate data normalization and filtering 
technique allowed high specificity of the tag-microarray data. The determination of the 
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transposon insertion sites for more than 5000 mutants provided the possibility to influence the 
composition of the tested mutant sets and to immediately evaluate the results of the STM 
experiments. The pilot validation experiments performed using one set of transposon tagged 
mutants showed biologically reasonable results.  
 
D.2 S. MELILOTI MUTANTS, KNOWN TO BE IMPAIRED IN 
SYMBIOSIS, WERE DETECTED AS ATTENUATED IN STM 
EXPERIMENT 
 
The two sets of mutants, tested in planta, were generated in a way that a number of mutants 
in genes with known role in symbiosis were included in order to ensure the reliability of the 
obtained results. For some of these genes, two or three mutants were included in the sets. In fact, 
27 from 67 mutants that were detected as attenuated were expected to be impaired in 
competitiveness in S. meliloti. These include mutants containing a transposon insertion in the 
following genes: 
exo (exopolysaccharide synthesis) genes  
6 from generally 9 exo mutants included in the test sets were detected as attenuated. The 
attenuated mutants included those with a transposon insertion in exoA, exoB, exoM, exoO, exoU 
and exoZ genes. The meanw values of exoK, exoN2 and exoP2 mutants were -0.33, -0.55 and -0.15 
respectively by a threshold of -0.7 and were therefore filtered out. exoA, exoB, exoO exoM and 
exoU mutants do not produce succinoglycan and were shown to form empty Fix- nodules (Becker 
et al., 1993b; Becker et al., 1993c; Skorupska et al., 2006). exoZ mutant was shown to have a 
reduced efficiency in the initiation and elongation of infection threads (Cheng and Walker, 1998), 
which can lead to the impaired competitiveness. In contrast, exoK mutant could induce pink 
nodules normally (Becker et al., 1993a). Symbiotic phenotypes of exoP2 and exoN2 S. meliloti 
mutants have not been reported till now.  
nod (nod factor synthesis and transport) genes 
Two nod mutants were included in the test sets. Both nodD3 and nodJ mutants were 
attenuated in the STM experiment. NodD3 protein is involved in the regulation of the nod factor 
production, whereas NodJ is responsible for the transport of nod factors. Both S. meliloti nodD3 
(Barran et al., 2002; Honma and Ausubel, 1987) and nodJ (Barran et al., 2002) mutants exhibit 
delayed nodulation on alfalfa.  
fix (nitrogen fixation) genes 
From 13 fix mutants in the sets, 4 could be identified as attenuated: all three fixL mutants 
present in the sets (one fixL mutant in the set 1 and 2 fixL mutants in the set 2) and a fixB 
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mutant. Attenuated phenotype of these mutants was expected since fixL (Batut et al., 1985; Vasse 
et al., 1990) and fixB (Hirsch and Smith, 1987) S. meliloti mutants have a Fix- phenotype, that can 
lead to the degradation of the symbiosomes containing these mutants (Mylona et al., 1995). 
Two fixN1mutants and mutants with a transposon insertion in fixM, fixN2, fixO3, fixP1, 
fixP2 and in fixT3 genes were not attenuated. A fixI2 mutant was detected as highly represented 
under symbiotic conditions. For fixN1, fixN2, fixO3, fixP1, fixP2 mutants, the non-attenuated 
phenotype originates from the duplication of the fixNOQP region in the S. meliloti genome, so 
that a single mutation in one of these regions does not influence symbiotic efficiency. The 
disruption of fixM was reported not to affect nodulation or nitrogen fixation efficiency (Cosseau 
et al., 2002). Symbiotic phenotypes of fixT3 and fixI2 S. meliloti mutants have not been reported 
till now.  
nif (nitrogen fixation) genes 
All three nif mutants (with transposon insertion in nifB, nifK and nifN genes), included in the 
sets, were attenuated. nifN mutants were shown to induce nodule formation that was similar to 
that induced by the wild type strains both in time of appearance of nodules and in distribution of 
nodules. However, no acetylene reduction was detected 3, 4, and 5 weeks after inoculation. After 
4 weeks plants showed symptoms of nitrogen starvation (Aguilar et al., 1985; Aguilar et al., 1987). 
nifB (Buikema et al., 1987) and nifK (Hirsch et al., 1983; Zimmerman et al., 1983) mutants are 
unable to symbiotically fix nitrogen.  
syrM encodes a transcriptional regulator that activates expression of nod genes through 
NodD3. The syrM mutation was shown to cause a delayed nodulation phenotype (Dusha et al., 
1999). 
dctB encodes a C4-dicarboxylate transport sensor protein. The dctB mutant was shown to 
induce nodules on alfalfa with about half the nitrogen fixation activity of the wild type (Engelke et 
al., 1987). 
dme encodes NAD-malic enzyme oxidoreductase protein. The dme mutants induce non-
fixing nodules (Driscoll and Finan, 1997).  
bioN encodes the permease component of biotin ABC transporter. Mutation in bioN 
eliminated growth on alfalfa roots and reduced bacterial capacity to maintain normal intracellular 
levels of biotin (Entcheva et al., 2002). The deficiency in root colonization leads to the weak 
competitiveness of the mutant strains (Guillen-Navarro et al., 2005). 
rpoN codes for RNA polymerase sigma-54 factor. The rpoN mutant was shown to elicit Fix- 
root nodules on alfalfa (Ronson et al., 1987). The product of lpsB gene - lipopolysaccharide core 
biosynthesis mannosyltransferase – is involved in the synthesis of LPS. lpsB mutants were shown 
to be slightly compromised for infection thread formation and fixed nitrogen at reduced levels 
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(Campbell et al., 2002; Campbell et al., 2003).  
cycH encodes cytochrome C-type biogenesis transmembrane protein. The cycH mutant in S. 
meliloti strain AK631 was defective in symbiotic nitrogen fixation, "respiratory" nitrate reduction, 
and cytochrome c oxidase activity (Kereszt et al., 1995). 
The product of pckA gene – phosphoenolpyruvate carboxykinase – catalyzes the the 
decarboxylation and phosphorylation of oxaloacetate to phosphoenolpyruvate. This reaction is 
the first step in the gluconeogenic pathway. The pckA mutant was shown to elicit nodules with 
reduced nitrogen-fixing activity. It had acetylene-reducing activities of approximately 60% of 
plants inoculated with the wild type bacteria (Finan et al., 1991; Osteras et al., 1995). 
phaD1 encodes a pH adaptation potassium efflux system transmembrane protein. It was 
shown that the S. meliloti mutants defective for the Pha K+ efflux system are affected in the 
invasion of alfalfa root nodules, K+ sensitive and unable to adapt to alkaline pH in the presence 
of K+ (Putnoky et al., 1998). 
ndvA codes for beta-glucan export ATP-binding protein involved in cyclic β-(1,2)-glucan 
production. On alfalfa, the ndvA S. meliloti mutant formed a small number of early infection 
threads, roughly 3% to 15% of the level seen with the wild type. Infection threads aborted and 
were not observed in mature ndv-induced pseudonodules. The mutant delayed formation of 
numerous small white nodules that are distributed throughout the root system. These nodules 
were not invaded by the mutant bacteria and consequently did not fix nitrogen (Dickstein et al., 
1988; Stanfield et al., 1988).  
ilvC codes for ketol-acid reductoisomerase protein, involved in isoleucine / valine synthesis. 
Both ilvC mutants in two different sets were detected as attenuated. The ilvC mutant was shown 
to be strongly impaired in nodulation. It did not induce nodules or induced small ineffective 
nodules in about 10% of inoculated M. sativa plants. The mutant also induced abnormal root hair 
deformations: alfalfa plants showed abundant hypertrophied root hairs with numerous 
branchings and swellings and, only exceptionally, curled root hairs (Aguilar and Grasso, 1991). 
The fact, that many mutants that were expected to be attenuated, could be detected in the 
STM experiment, supports the reliability of the two-tag microarray detection system. Importantly, 
the mutants that had a defect on late stages of symbiosis, like some fix or nif mutants, or mutants 
with only a slight symbiotic deficiency, like lpsB or dctB mutants, could also be detected by this 
method as weakly competitive.  
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D.3 INDIVIDUAL COMPETITIVENESS TEST CONFIRMED THE 
STM EXPERIMENT RESULTS FOR THE MOST OF CHECKED 
MUTANTS. 
 
The main interest of the STM experiment in planta was the identification of the genes whose 
attenuated competitiveness phenotype was not observed before. It was important to prove the 
attenuated phenotypes of such mutants by another method. Therefore, individual 
competitiveness test was performed for 25 signature tagged mutants with no previously known 
fixation or nodulation defect. For 22 mutants, the attenuated phenotype could be confirmed 
(Table C6). The mutants that had a defect in competitiveness, but no other obvious nodulation 
or nitrogen fixation defect, had a transposon insertion the following genes: 
thiD gene encodes probable phoshomethylpyrimidine kinase, involved in thiamine synthesis 
and thiO encodes putative thiamine biosynthesis oxidoreductase protein, probably involved in 
thiamine synthesis. Both genes are situated on pSymB, but belong to different clusters. S. meliloti 
is able to synthesize thiamine, but still depends on external supply of this vitamin. It was shown 
that colonization of roots can be limited by availability of thiamine (Streit et al., 1996). On the 
other hand, it was shown that in R. etli mutant strain, constitutively expressing thiCOGE gene 
cluster, the fixNOQP operon was constitutively expressed  (Miranda-Rios et al., 1997). This 
mutant strain also showed an increased capacity to fix nitrogen during symbiosis (Soberon et al., 
1990). It was suggested that a metabolite related to the purine-thiamine biosynthetic pathway, 
probably AICAR (5-amino-4-imidazolecarboxamide), is a negative effector for the fixNOQP 
expression. The constitutive expression of thiC could lower the concentration of several 
metabolites of the purine biosynthetic pathway, particularly AICAR, and, as a result, block the 
negative regulation of fixNOQP (Miranda-Rios et al., 1997). Mutations in thiamine-synthesis genes 
could therefore have an effect on symbiotic competitiveness through a slight deficit in the 
thiamine, and/or through the down-regulation of nitrogen fixation genes. 
ndiA1 was shown to be induced by carbon and nitrogen deprivation, osmotic stress, oxygen 
limitation and during entry into stationary phase. Its expression is also positively regulated by the 
products of tspO and fixL genes (Davey and de Bruijn, 2000). Mutation in ndiB gene, situated 
downstream of ndiA1 and ndiA2, did not cause any defect in nodulation efficiency and nitrogen 
fixation (symbiotic competitiveness was not tested) (Davey and de Bruijn, 2000). Here, ndiA1 
mutant was weakly impaired in competitiveness in STM experiment as well as in the individual 
test (25.46% nodule occupation when co-inoculated with wild type). Since the function of ndiA1, 
and of the downstream genes ndiA2 and ndiB is still unknown, it is difficult to speculate on the 
nature of attenuated competitiveness phenotype of the ndiA1 mutant. The putative explanation 
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for this phenotype could be the impaired ability of the ndiA1 mutant to adapt to the stress 
conditions faced by rhizobial cells during infection and nodule formation.  
feuQ gene codes for sensor histidine kinase. In R. leguminosarum, a mutation in feuQ led to the 
loss of the high affinity iron uptake system, although siderophores were still produced (Yeoman 
et al., 1997). Iron is particularly important in symbiosis, since many enzymes and proteins 
involved in nitrogen fixation, including nitrogenase, ferredoxin, cytochromes and leghaemoglobin 
are iron-containing. Interestingly, feuPQ operon is situated closely upstream of the cytochrome 
maturation operon cycHJKL in both R. leguminosarum (Yeoman et al., 1997) and S. meliloti. 
However, a mutation in feuQ did not affect cytochrome c function or expression of the cycHJKL 
operon in R. leguminosarum (Yeoman et al., 1997). Still, the expression of the feuPQ and cycHJKL 
clusters could be in some way connected, since the cycK mutant, similarly to feuQ mutant, had a 
defect in high affinity iron acquisition (Nadler et al., 1990; Yeoman et al., 1997). The defect of 
feuQ transposon mutant in symbiotic competitiveness, observed here, could be probably 
explained by the internal deficit of this mutant in iron that could lead to slower growth and 
reduced rates of nitrogen fixation.  
pstA and pstC encode for the parts of the high-affinity phosphate transporter system 
PstSCAB (Yuan et al., 2006a). pstA and pstC belong to the same gene cluster, where pstC is 
situated downstream of pstS gene and upstream of pstA. Downstream of pstA gene, genes pstB, 
phoU and phoB are situated. It was recently shown that pstSCAB genes and the phoUB genes are 
transcribed from a single promoter (Yuan et al., 2006a). Since the signature tagged mutants 
generated by the mTn5-STM transposon contain a transcription terminator, the transcription of 
all the downstream genes in the operon is disrupted. It is especially important in the case of phoB 
that encodes a transcriptional regulator. PhoB protein, which is activated by the sensor kinase 
PhoR in conditions of low external phosphate concentration, regulates the transcription of a large 
spectrum of genes (Pho regulon). In S. meliloti, PhoB was shown to induce the expression of 
pstSCAB and phoCDET operons which encode ABC-type high affinity phosphate transport 
systems (Bardin et al., 1996; Bardin and Finan, 1998), exp operons which encode enzymes for 
EPS II biosynthesis (Rüberg et al., 1999), operon phnGHIJK that codes for phophonate 
degradation enzymes (Parker et al., 1999) and pta-ackA operon involved in acetyl phosphate 
metabolism (Summers et al., 1999), and to repress the espression of orfA-pit operon that encodes 
a low affinity phosphate transport system (Bardin et al., 1998). In recent studies (Krol, 2004; Yuan 
et al., 2006b), many more putative Pho regulon members were identified, that led to a suggestion 
that the Pho regulon overlaps and interacts with several other control circuits, such as the 
oxidative stress response and iron homeostasis (Yuan et al., 2006b).  
Furthermore, PstSCAB transporter system can have an influence on the PhoB activity 
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through the inactivation of PhoR in presence of high external phosphate. In S. meliloti Rm1021 
(but not in Rm2011) a single nucleotide deletion led to a frameshift in the pstC gene, and as a 
result, to the truncation of the PctC protein. This resulted in the deregulation of the phosphate 
starvation response in Rm1021 (Krol, 2004).  
The attenuated symbiotic competitiveness phenotype of the pstA and pstC transposon 
mutants originates, probably, from a combinational effect of PstSCAB- and PhoB- phenotypes. In 
order to identify the impact of single mutations on the symbiotic competitiveness, a comparison 
between non-polar pstA, pstC and phoB mutants needs to be performed.  
livM encodes a permease protein of high-affinity branched-chain amino acid ABC 
transporter that belongs to hydrophobic amino acid transporter (HAAT) family. S. meliloti livM 
gene shows a 69% identity to braE from Rhizobium leguminosarum bv. trifolii. In R. leguminosarum, 
amino acid uptake is dominated by two ABC transporters, the general amino acid permease (Aap) 
and the branched-chain amino acid transporter permease (BraRl) (Hosie et al., 2002). The double 
aap-bra mutant was shown to retain a nitrogenase activity at rates per bacteroid that were equal or 
exceeded the wild type rates, but the plants, nodulated by this mutant, were severely nitrogen 
starved (Lodwig et al., 2003). To explain these results, it was suggested that in R. leguminosarum an 
amino acid cycle operates where an amino acid such as glutamate, or a derivative of it, is supplied 
by the plant to the bacteroid. The bacteroid uses the amino acid to transaminate oxaloacetate or 
pyruvate to produce aspartate or alanine, respectively, and either or both of these amino acids are 
secreted (Lodwig et al., 2003; Prell and Poole, 2006). The mutation on both of the amino-acid 
transporters would disrupt this cycle and result in nitrogen starvation of the nodulated plant. 
S. meliloti genome, in contrast to R. leguminosarum genome, contains several branched-chain 
amino acid transporters. Particularly, gene SMa0677, encoding a periplasmic solute-binding 
protein of such a transporter, showed induced expression in bacteroids (Becker et al., 2004). The 
expression of another branched-chain amino acid transporter operon, that includes genes 
SMb20602 to SMb20605 and SMb21707, was induced during nitrogen deprivation (Milcamps et 
al., 1998). The livM gene, in contrary, was repressed in bacteroids in comparison to growth in 
free-living conditions (Becker et al., 2004). The possible explanation for the attenuated 
competitiveness phenotype of the livM mutant could be that this gene is active during root 
colonization. The rhizobial ABC transporters are very important for the survival in the 
rhizosphere, since the plant exudates contain many different compounds that can be catabolised 
by rhizobia. Inability to transport some of these compounds can negatively influence 
competitiveness of S. meliloti cells carrying the livM mutation.   
lexA codes for a repressor transcription regulator. LexA negatively regulates the SOS genes 
under normal growth conditions by binding to a 20-bp consensus sequence (the SOS box) in the 
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operator region of these genes. Activation of the SOS genes occurs after DNA damage by the 
accumulation of single-stranded DNA regions. The RecA protein, stimulated by single-stranded 
DNA, interacts with LexA causing an autocatalytic cleavage which disrupts the DNA-binding 
part of LexA, leading to derepression of the SOS regulon and eventually DNA repair (Brent and 
Ptashne, 1980). In rhizobia, the effect of lexA mutation has not been studied yet.  
recN codes for a DNA repair protein. RecN participates in SOS response and is involved in 
recombination and double strand repair (Picksley et al., 1984) recN is a part of SOS regulon 
(Rostas et al., 1987) and is controlled by multiple SOS boxes (Schnarr et al., 1991). Since the 
transposon insertion is situated only 131 nucleotides before the end of the gene, it could be 
possible that the truncated RecN is partly functional.  
Downstream of recN, ligA gene is situated that encodes a DNA ligase protein. In view of the 
fact that the ligA mutation is lethal for the most of bacteria (Lavesa-Curto et al., 2004), its 
transcription is probably not disrupted by the transposon insertion in recN.  
It was shown that the recN mutation, similarly to lexA mutation, causes constitutive 
activation of the SOS regulon (Chua et al., 1993; Dunman et al., 2000). Since the lexA and recN 
mutants have similar symbiotic phenotypes, it could be possible that the constitutively active SOS 
regulon causes a disadvantage in the establishment of symbiosis. It is known that the SOS-
response is error-prone and that in the cells expressing SOS genes, the rate of mutagenesis is 
enhanced (Smith and Walker, 1998). These high mutagenesis rates, particularly, could be 
detrimental for rhizobia in symbiosis.  
lepA encodes GTP-binding membrane protein that belongs to the GTP-binding elongation 
factor family. This family includes three factors involved in the translation process (EF-G, EF-Tu 
and IF2) two GTPases of the FtsY family (FtsY and Ffh), Era, ThdF/TrmE, EngA, YchF, Obg 
and LepA (Caldon et al., 2001). Similarity of LepA to protein synthesis elongation-factor GTPases 
indicates its involvement in transcription. It was suggested that LepA can regulate ribosome 
function (Caldon et al., 2001; March, 1992). With a help of two-hybrid screens in Bacillus subtilis, 
an interaction between HolA (delta subunit of DNA polymerase III holoenzyme) and LepA 
protein was detected, suggesting that LepA might act to coordinate DNA replication and protein 
synthesis (Noirot-Gros et al., 2002). The defect of the lepA mutant in symbiotic competitiveness 
indicates that an unknown symbiosis-relevant intracellular signaling mechanism might exist that 
involves the LepA GTPase protein.  
clpA encodes a the regulatory subunit of ATP-dependent Clp protease. ClpA is a member of 
the Hsp100/Clp family of molecular chaperones. It associates with the ClpP serine-type protease 
protein, forming the active holoenzyme. Usually, Clp proteases are present at low levels during 
normal growth, but are inducible during many types of stress. Their functions include 
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degradation of damaged proteins that occur in stress conditions and control of diverse cell 
activities. In Bacillus subtilis, ClpP is involved in sporulation, cell competence, stress tolerance and 
regulation of gene expression (Porankiewicz et al., 1999). 
Interestingly, in Bradyrhizobium japonicum USDA 110, a mutation in the clpA gene caused 
changes in EPS synthesis. The mutant strain produced approximately twofold higher levels of 
low-molecular-weight EPS when compared to the wild type USDA 110 strain (Louch and Miller, 
2001). An effect of clpA mutation on EPS synthesis might occur in S. meliloti as well.  In this case, 
changes in EPS could influence the symbiotic competitiveness of the clpA mutant.   
SMb20509 codes for a putative transcriptional regulator from a helix-turn-helix (HTH) -type 
GntR family. This family was named after the Bacillus subtilis repressor of the gluconate operon 
(Haydon and Guest, 1991). The members of this regulator family contain a well-conserved DNA-
binding HTH domain at the N terminus, and a variable effector-binding or oligomerisation 
domain at the C terminus.  (Rigali et al., 2002).  
Genes SMa0414, SMc00644, SMc01929, SMc02123, SMc00828 and SMc02226 encode 
hypothetical proteins. SMa0414 has an ATP dependent DNA ligase domain and shows similarity 
to the thermostable DNA ligases. SMc01929 shows similarity to metallo-beta-lactamases, and 
SMc00828 has a similarity to the diadenosine and diphosphoinositol polyphosphate 
phosphohydrolases. Genes SMc00644 and SMc02226 do not show significant homologies to 
known genes. In the gene SMc02123, which also shows no homologies to the known genes, the 
transposon insertion is situated nearly at the end of the gene. The downstream gene fpr, which is 
probably co-transcribed with SMc02123, codes for a probable ferredoxin--NADP reductase.   
 
D.4 FOUR MUTANTS, IMPAIRED IN SYMBIOTIC 
COMPETITIVENESS, EXHIBIT ALSO OTHER SYMBIOTIC 
PHENOTYPES 
 
While the main goal of the signature tagged mutagenesis experiment in planta was to identify 
genes important for symbiotic competitiveness, it was also interesting to test if the attenuated 
mutants exhibit other symbiotic phenotypes. Four mutants were identified that showed a strong 
defect in symbiosis. These mutants were studied in more detail using GUS-staining of nodules, 
monitoring of nodulation dynamics, and acetylene reduction assay. In this chapter, the 
phenotypes of these four mutants will be discussed.  
ccmC mutant was the only mutant in the sets which showed a Fix- phenotype. ccmC (cycZ) 
gene codes for cytochrome c-type biogenesis protein. This gene belongs to the cluster 
ccmABCDG, where ccmA, ccmB, ccmC and ccmD encode parts of the heme transporter, and ccmG 
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encodes periplasmic thiol:disulfide oxidoreductase. Cytochrome biogenesis is very important in 
symbiosis since the respiratory pathways that involve cytochromes are required for normal 
nitrogen fixation. Moreover, the ccmC mutant, studied here, has even more severe symbiotic 
defect than the fix mutants (Hirsch and Smith, 1987), since it induces empty nodules devoid of 
bacteroids. In a recent work (Capela et al., 2006) ccmA gene was detected as induced during early 
stages of the S. meliloti-alfalfa symbiosis. The ccmA mutant, constructed by Capela et al., showed a 
Fix- phenotype.  
The symbiotic phenotypes of ccm mutants are similar to those of cyc mutants. It was shown 
that the cycHJKL gene cluster is necessary for the biogenesis of all cellular c-type cytochromes in 
S. meliloti and respiratory nitrate reduction ex planta (Kereszt et al., 1995). In Rhizobium phaseoli, 
cytochrome c – deficient mutant induced empty nodules on Phaseolus vulgaris (Soberon et al., 1993). 
A polar cycH mutant of Rhizobium etli, in which expression of downstream cycJKL genes was 
disrupted, also induced empty nodules on Phaseolus vulgaris (Tabche et al., 1998).  
 
 
Fig. D1. Representation of the different proteins involved in the type I system for the maturation of c-type 
cytochromes (Cianciotto et al., 2005). CcmA (A) and CcmB (B) form an ABC transporter for the transport of yet-to-
be-discovered molecule. In the cytoplasm, but associated with membrane, the enzyme ferrochelatase (HemH) 
performs the last step of haem biosynthesis by converting protoporphyrin IX (white star) to haem (red star). Once 
haem reaches the periplasm, perhaps via CcmC (C), it is transferred to the haem chaperone CcmE (E). The protein 
CcmD (D) has been shown to facilitate the interaction between CcmC and CcmE. Haem is passed from CcmE to 
CcmF (F), which, in association with CcmG (G) and CcmH (H), forms a haem-lyase complex. CcmG and CcmH 
maintain the apocytochrome (apo-c) in a reduced state.  
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TABLE D1. Homology between ccm and cyc genes.  
 
 genesa 
ccm ccmA ccmB ccmC ccmD ccmE ccmF ccmG ccmH ccmI 
cyc cycV cycW cycZ cycX cycJ cycK cycY cycL cycH 
aGenes, annotated in S. meliloti, are written in red font.  
 
The explanation for the similarity in phenotypes of ccm and cyc mutants could be that both 
gene clusters encode different parts of one cytochrome maturation system, but were annotated 
differently (Table D1). Fig. D1 illustrates the known structure of the Ccm cytochrome c 
maturation system that could be also true for S. meliloti. 
The severe symbiostic defect of ccm and cyc mutants, together with the fact that the 
expression of ccmA gene was induced at the early stage of symbiosis, allows suggestion that ccm 
and cys genes are important not only for nitrogen fixation, but also for the successful infection.  
asnO mutant displayed a severe defect in nodulation efficiency. Nodules, formed by this 
mutant, could fix nitrogen, but their morphology differed from those of wild type induced 
nodules. The broad proximal part of the nodules and bifurcated morphology indicate the 
difficulties in the infection. When the plants were inoculated with asnO mutant only, it could 
form nodules at less than 5% of the wild type nodulation rate. Interestingly, when the plants were 
inoculated with the mixture of wild type Rm2011 and asnO mutant, the average percentage of 
asnO mutant in nodules reached 18%. This indicates that the presence of the wild type Rm2011 
might facilitate infection of plants by the asnO mutant.  
asnO gene codes for a protein homologous to glutamine-dependent asparagine synthetases, 
but it is not absolutely required for the asparagine synthesis in S. meliloti GMI211 background 
(Berges et al., 2001). Here, the signature tagged asnO mutant did not show an attenuated growth 
in Vincent minimal medium; it can be therefore suggested that asnO mutation does not cause 
auxotrophy in Rm2011 background as well.  
In the S. meliloti, constitutive expression of fixT gene inhibits expression of FixLJ dependent 
genes. Berges et al. (2001) have shown that a Tn5 insertion in the asnO gene impairs this 
inhibition. Moreover, they demonstrated that asnO gene expression was induced in microoxic 
conditions. This data indicates that asnO gene has a regulatory function in symbiosis. However, it 
is not clear how the phenotype observed by Berges et al. is connected to the impaired infection 
phenotype of the signature tagged asnO mutant, since the activation of the fix genes does not take 
place at the infection step, but later in symbiosis.  
CysG mutant showed a delayed nodulation phenotype and low occupation of plant cells by 
bacteroids, but high rates of nitrogenase activity. This mutant induced pink and white nodules on 
different plants. Moreover, cysG mutant was impaired in growth in Vincent minimal medium, 
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probably, due to cysteine auxotrophy.  
cysG gene encodes for siroheme synthase (uroporphyrinogen III methylase), which is 
necessary for siroheme synthesis. Siroheme is the prosthetic group of many nitrite and sulfite 
reductases that function in the conversion of the highly oxidized forms of nitrogen and sulfur to 
the fully reduced forms (NH4+ and S2-). Unlike other cys genes, cysG is transcribed together with 
nitrite reductase gene, and not with genes for cysteine synthesis. A cysG mutant was obtained in 
R. etli by Tn5 mutagenesis (Tate et al., 1997). This mutant was identified as a cysteine auxotroph 
based on its inability to utilize sulfate as the sole sulfur source. Also, cysG mutant could not grow 
with nitrate as the sole nitrogen source, because cysG gene product is required for the activity of 
the nitrite reductase complex. Furthermore, this mutant had a Nod+ Fix+ phenotype, but was 
impaired in competitiveness 5-fold. Poor competitiveness phenotype could be restored by 
addition of an organic sulfur source. Acetylene reduction activity of the R. etli cysG mutant-
induced nodules was the same as of the wild type-induced nodules (Tate et al., 1997), whereas the 
S. meliloti cysG mutant studied here showed higher acetylene reduction rates than the wild type. It 
should be noted, however, that the difference between the S. meliloti and R. etli acetylene 
reduction data could originate from the utilization of different approaches in acetylene reduction 
measurements: in R. etli, the quantity of reduced acetylene per gram of nodules was estimated, 
whereas here, the quantity of reduced acetylene per plant/nodule was estimated. 
In S. meliloti, the symbiotic defect of the cysG mutant seems to be generally more acute than 
in case of R. etli cysG mutant. Particularly, S. meliloti cysG mutant is stronger impaired in the 
symbiotic competitiveness. Here, in 30 analyzed nodules from the plants inoculated by the 1:1 
mixture of wild type Rm2011 and cysG mutant, only trace amounts of the mutant was detected, 
indicating that all of the tested nodules were occupied by the wild type. Furthermore, shape and 
histological organization of nodules induced by R. etli cysG mutant were the same as of wild type-
induced nodules. In case of S. meliloti cysG mutant, both of these characteristics were changed in 
comparison to the wild type Rm2011. The symbiotic defect of the cysG mutant is probably caused 
by the pleyotropic character of the cysG mutation, which influences several important biochemical 
pathways. 
metA mutant had a delay in nodulation, but formed pink nodules that could fix nitrogen at 
the same rate as the wild type. Besides, metA mutant was very strongly impaired in symbiotic 
competitiveness: when co-inoculated with the wild type Rm2011, the mutant practically did not 
enter the nodules at all. GUS-staining of the nodules induced by the metA mutants has shown 
that metA gene is mainly expressed in the proximal part of the nodules.  
metA gene codes for homoserine O-succinyltransferase which catalyses the first step in 
methionine biosynthesis in gram-negative bacteria. E. coli metA mutant was shown to be a 
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methionine auxotroph (Michaeli et al., 1981). Interestingly, S. meliloti metA gene contains a 
riboswitch. Riboswitches are structured elements typically found in the 5´ untranslated regions of 
mRNAs. Riboswitches can directly bind a ligand, and in this bound state they induce or repress 
the gene they are encoded in. Thus, an mRNA that contains a riboswitch is directly involved in 
regulating its own activity, depending on the presence or absence of its target molecule. 
Riboswitches regulate several metabolic pathways including the biosynthesis of vitamins (e.g. 
riboflavin, thiamin and cobalamin) and the metabolism of methionine, lysine and purines (Tucker 
and Breaker, 2005; Vitreschak et al., 2004). 
Mutation that cause methionine auxotrophy were shown to result in a Fix- phenotype in S. 
meliloti 104A14 (Kerppola and Kahn, 1988) and in Rhizobium fredii HH303 (Kim et al., 1988). 
Unfortunately, in these studies the genes, which were disrupted in the auxotrophic mutants, were 
not deduced. Since the metA mutant studied here, does not have a Fix- phenotype, it is probably 
not strictly auxotrophic for methionine. On the other side, the impaired competitiveness 
phenotype indicates that the metA mutant might suffer from the methionine unavailability during 
growth in the infection threads.  
It is surprising that the expression of the gusA reporter gene in the metA mutant was detected 
mainly in mature and senescing bacteroids, since it was shown that the protein synthesis declines 
in the mature nodules (Bisseling et al., 1979). This could indicate an unknown function of the 
metA gene in the senescing bacteroids. 
 
D.5 CONCLUSIONS AND OUTLOOK 
 
In this study, signature-tagged mutagenesis (STM) strategy is presented which for the first 
time was applied to study rhizobium-legume symbiosis. The STM approach was modified in 
order to enhance the efficiency of screening. A library of 412 different double-tagged 
transposons was created using a novel set of signature tags. Also, a new two-channel microarray 
hybridization approach was designed and used to identify and quantify individual mutants in the 
pool.  
A number of studies demonstrated a broad host range for transposition of the mTn5 
transposon (Saenz and Dehio, 2005) including, e.g. S. typhimurium, E. coli, K. pneumoniae, V. cholerae, 
P. mirabilis, B. melitensis, Y. pestis, and C. rodentium. This broad application spectrum in combination 
with the large number of signature tags and the tag-specific microarray makes the mTn5-STM 
transposon set a powerful and easy-to-use tool that can be applied to a large spectrum of bacteria. 
An extensive library of transposon mutants containing more than 12000 clones was created 
applying the set of tagged transposons. The transposon insertion sites were determined for 42 % 
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of the mutants in this library. As a result, 44 % coverage of all predicted protein-coding genes by 
mapped transposon insertions was achieved. Analysis of the transposon library suggests that 
insertion sites of the mTn5-STM transposons are random and show no hotspots.  
Pilot experiments were performed to verify the modified STM approach. The statistical 
processing of the tag microarray data comprising normalization and clustering allowed 
identification of clusters of mutants that showed a similar growth pattern throughout different 
growth conditions. As expected, clones, carrying a similar kind of mutation, were grouped into 
the same cluster. 
Two sets of mutants, each one containing 378 mutants, were screened in planta in order to 
identify mutants impaired in symbiotic competitiveness. 67 mutants were detected as attenuated 
in symbiotic conditions. Many of these mutants were already known to have a Nod-, Fix-, or low 
competitiveness phenotype. For 25 mutants, whose symbiotic defect was not observed in S. 
meliloti before, the symbiotic competitiveness was checked by another method, and for 22 
mutants the attenuated competitiveness phenotype could be confirmed. Furthermore, four of the 
checked mutants showed additional symbiotic defects: Fix- phenotype (ccmC mutant), low 
efficiency of nodulation (asnO mutant) and delayed nodulation (cysG and metA mutants). These 
phenotypes were verified by histochemical GUS-staining of nodules, acetylene reduction assay 
and by monitoring the dynamics of nodule formation.  
The signature tagged mutagenesis system, applied in this work, offers many possibilities for 
the following research. In this study, only a small part of the library of signature tagged mutants 
has been screened. The screening of the rest of the library can reveal many new mutants with 
reduced competitiveness. Furthermore, the genes, identified in this study as important for 
symbiotic competitiveness, need a closer inspection. This is especially important in case of genes 
annotated as hypothetical proteins. At last, the mutants, which were identified as highly 
competitive in the STM experiment, also have to be studied in detail.  
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E. METHODS AND MATERIALS  
 
E.1 MATERIALS 
 
E.1.1 Sources for chemicals and kits 
 
Amersham  dNTPs 
DUCHEFA X-Gluc (5-Bromo-4-chloro-3-indolyl-ß-D-glucuronide) 
Fermentas Restriction enzymes, Shrimp alkaline phosphatase 
Fluka NaFe-EDTA 
Invitrogen Select Agar 
Macherey-Nagel NucleoSpin Plasmid kit, NucleoSpin Tissue kit, NucleoSpin Extract II PCR 
clean-up kit 
Merck CaCl2, CaCl2 × 2 H2O, CoCl2 × 6 H2O, CuSO4 × 5 H2O, EDTA, FeCl3 × 6 
H2O, Fe-Citrate × 3 H2O, H3BO3, HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), K-Acetate, K2HPO4, KH2PO4, KI, KOH, 
K2SO4, Mg-Acetate, MgCl2 × 6 H2O, MgSO4 × 7 H2O, MnSO4 × 4 H2O, Na-
Acetate, Na2-citrate × 2 H2O, Na3-Citrate, NaCl, NaOH, Na2-succinate, NH4Cl, 
NH4NO3, (NH4)2SO4, NaMoO4 × 2 H2O, ZnSO4 × 7 H2O  
Oxoid Yeast extract, Agar Nr. 1, Tryptone 
Peqlab Taq-polymerase, agarose 
Qiagen DNeasy Plant Mini kit 
QMT 4 × Blocking solution 
Roche T4 DNA ligase, exo- Klenow fragment, DNA marker X, DNA marker IX, DIG 
EasyHyb solution 
Roth Ethanol, acetic acid, sulfuric acid, orthophosphoric acid, hydrochloric acid 
SERVA All antibiotics, bromphenol blue, ethidium bromide, Triton-X-100, polyethylene 
glycol (PEG), RNase A, glucose, glycerol, sodium dodecyl sulfate (SDS) 
Sigma-Aldrich Biotin, Bovine serum albumin (BSA), K3Fe(CN)6, K4Fe(CN)6 × 3H2O, Tris-HCl, 
Dithiothreitol (DTT) 
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E.1.2 Bacterial strains and plasmids 
 
Strain or plasmid Relevant characteristicsa Source or reference 
S. meliloti   
Rm2011 wild type, Smr J. Dénarié, France  
E. coli   
DH5α 
F-supE44 ΔlacU169 (φ80lacZΔM15) hsdR17 recA1 endA17 gyrA96 
thi-1 relA1 
(Sambrook et al., 1989) 
S17-1 MM294, RP4-2-Tc::Mu-Km::Tn7 chromosomally integrated (Simon et al., 1983) 
Plasmids   
pBC KS (-) Cloning vector; Camr; 3.4kb Stratagene 
pG18Mob2 pK18Mob derivative, Gmr, 2.8kb 
(Kirchner and Tauch, 
2003) 
pCRS530 Contains mTn5GNm, Kmr, Apr (Reeve et al., 1999) 
pG18-STM 
pG18Mob2 derivative containing modified mTn5GNm, Kmr, 
Gmr 
This study 
 
a Camr, chloramphenicol resistance, Smr, streptomycin resistance, Kmr, kanamycin resistance, Gmr, gentamicin 
resistance, Apr, ampicillin resistance 
 
E.1.3 Plant material 
 
In this study, Medicago sativa cv Europe was used (KWS, Einbeck, Germany). 
 
E.1.4 Primers and other oligonucleotides 
 
All the oligonucleotides listed here were synthesized by Qiagen Operon. Primers P1_Kpn, 
P2_Kpn, P3_Hind and P4_Hind were also synthezised with a Cy3 or Cy5 5´ modification. The 
list of cloned tags is given in the Appendix (Table G1) 
 
Name Sequence Comment 
Primers   
P1_Kpn AAAGGACGTGGTTTACGGGGC Amplification of K-tag 
P2_Kpn TATATGAATGCCGCCACCCCC Amplification of K-tag 
P3_Hind ATTTTAACTCCCCTCCGCCGC Amplification of H-tag 
P4_Hind TAGTCCTGGTGCATTGAGCCC Amplification of H-tag 
Qseq1 ATCTAGCCCGCCTAATGAGC 
Sequencing of the transposon-genome 
junction site 
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M13 universal 
forward 
TGTAAAACGACGGCCAGT 
Amplification and sequencing at some steps 
of the construction of pG18-STM 
M13 universal 
reverse 
CAGGAAACAGCTATGACC 
Amplification and sequencing at some steps 
of the construction of pG18-STM 
Hind_mut_1 GCTCAGAGAGAGCTTCACGCT Mutagenesis of HindIII site in tnpA* gene 
Hind_mut_2 AGCGTGAAGCTCTCTCTGAGC Mutagenesis of HindIII site in tnpA* gene 
Sph_polym_end ACATGCATGCGATCAGATCTTGATCCC Mutagenesis of HindIII site in tnpA* gene 
Xba_polym_begin ATAGTCTAGACACAAGTAGCGTCCTGAACG Mutagenesis of HindIII site in tnpA* gene 
4-30_long GATGCAGCCAAGCTAGCTTGCGG Sequencing of the tags in transposon 
Other oligonucleotides  
L1 up 
AATTCGGCCGCCTAGGCCAAAGGACGTGGTT 
TACGGGGCACGTAGTTTAAGGAAGTACGGTA 
AGGTAC  
Used for the construction of L123 
L1 down 
CTTACCGTACTTCCTTAAACTACGTGCCCCGTA 
AACCACGTCCTTTGGCCTAGGCGGCCG 
Used for the construction of L123 
L2 up 
CGGGGGTGGCGGCATTCATATAGCTGCGTG 
ATTTCATTTTAACTCCCCTCCGCCGCA 
Used for the construction of L123 
L2 down 
AGCTTGCGGCGGAGGGGAGTTAAAATGAAAT 
CACGCAGCTATATGAATGCCGCCACCCCCGGT 
AC 
Used for the construction of L123 
L3 up 
AGCTTAGGTGGACCGTCGTAGAGCTAGTAGGG 
CTCAATGCACCAGGACTAGGCCGCCTAGGCCG 
Used for the construction of L123 
L3 down 
AATTCGGCCTAGGCGGCCTAGTCCTGGTGCAT 
TGAGCCCTACTAGCTCTACGACGGTCCACCTA 
Used for the construction of L123 
 
E.1.5 Growth media and supplements 
 
E.1.5.1 Media 
 
All the media, if not indicated other, were dissolved by distilled water and autoclaved.  
 
LB-medium (Luria-Bertrani Broth, (Sambrook et al., 1989) ) 
   10 g/l  Tryptone 
   5 g/l  Yeast Extract 
   5 g/l  NaCl 
 
LBG-medium (Luria-Bertrani Broth containing glucose)  
   10 g/l  Tryptone 
   5 g/l  Yeast extract  
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   5 g/l  NaCl 
   1 g/l  Glucose 
 
TY-medium  (Beringer, 1974) 
   5 g/l  Tryptone 
   3 g/l  Yeast extract 
   0.4 g/l  CaCl2 
 
2 × TY-medium 
   10 g/l  Tryptone 
   6 g/l  Yeast extract 
   0.4 g/l  CaCl2 
 
Modified Vincent minimal medium (Becker et al., 2004; Vincent, 1970) 
 Stock 1: 2.56 g/l K2HPO4 
   1.56 g/l KH2PO4 
   0.246 g/l MgSO4 × 7 H2O 
   1 g/l  NH4Cl 
   1.62 g/l Na2-succinate 
Ingredients were dissolved in 800 ml Millipore and pH value was set to 7.0 
by KOH or H3PO4. Than, Millipore water was added to fill 1 liter and the 
stock was autoclaved. 
 
 Stock 2: 67 g/l  CaCl2 
Autoclaved 
 
 Stock 3: 1 mg/ml Biotine 
Dissolved by 0.1 N NaOH and sterile filtered 
 
 Stock 4: 10 g/l  FeCl3 × 6 H2O 
Sterile filtered 
 
 Stock 5: 3 g/l  H3BO3 
   2.23 g/l MnSO4 × 4 H2O 
   0.287 g/l ZnSO4 × 7 H2O 
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   0.125 g/l CuSO4 × 5 H2O 
0.065 g/l CoCl2 × 6 H2O 
0.12 g/l NaMoO4 × 2 H2O 
Sterile filtered 
For full strength medium, 1 ml of each solution 2, 3, 4 and 5 were added one by one to 1 l of 
solution 1. 
 
SOB Medium (Sambrook et al., 1989), used for preparation of the competent E. coli cells 
Stock A: 20 g  Tryptone 
   5 g  Yeast extract 
   0.5 g  NaCl 
 dissolved in 980 ml H2O  
Stock B: 18.65 g/l  KCl 
Stock C: 406.6 g/l MgCl2 × 6 H2O 
Stock D: 493 g/l  MgSO4 × 7 H2O 
10ml of the stock solution B were added to the stock solution A prior to autoclaving. Solutions C 
and D were autoclaved separately, and 5 ml of each were added to the autoclaved and cooled 
mixture of A and B solutions. 
  
SOC medium 
SOB medium supplemented with 20 ml 180 g/l solution of glucose 
  
10 × Hogness Freezing Medium (Werner et al., 1997) 
 Stock 1: 520 ml   Glycerol (87%) 
   4.99 g   Na2-citrate × 2 H2O  
   9 g   (NH4)2SO4 
   0.99 g   MgSO4 × 7 H2O 
Filled-up with water till 800ml and autoclaved 
 Stock 2: 6.2 g   K2HPO4 
   1.796 g   KH2PO4 
Filled-up with water till 200ml and autoclaved 
After autoclaving solutions were cooled down and mixed together. 
E. METHODS AND MATERIALS 
 78
Plant agar medium (Broughton and Dilworth, 1971) 
 Stock A: 294 g/l  CaCl2 × 2 H2O 
 Stock B 136.1 g/l KH2PO4 
 Stock C: 6.7 g/l  Fe-Citrate × 3 H2O 
   123 g/l  MgSO4 × 7 H2O 
   87 g/l  K2SO4 
   0.338 g/l MnSO4 × H2O 
 Stock D:  0.247 g/l H3BO3 
   0.288 g/l ZnSO4 × 7 H2O 
   0.1 g/l  CuSO4 × 5 H2O 
   0.056 g/l CoSO4 × 7 H2O 
   0.048 g/l Na2MoO4 × 2 H2O 
The stock solutions A, B, C and D were dissolved and autoclaved. 15g of agar (Agar Nr. 1, 
Oxoid) were autoclaved in 1 l of Millipore water. For the final medium, 0.5 ml of each stock 
solution A, B, C and D were added to the liquid agar. The plates were poured using an inclined 
support.  
 
Plant medium for aeroponics (Journet et al., 2001) 
Stock 1 (0.5 ml/l): 294 g/l  CaCl2 x 2 H2O 
Stock 2 (0.5 ml/l): 123 g/l  MgSO4 x 7 H2O 
Stock 3 (1.5 ml/l): 60.9 g/l  K2SO4  
Stock 4 (2.5 ml/l): 7.35 g/l NaFe-EDTA 
Stock 5 (5 ml/l): 131.9 g/l  K2HPO4 
    46.7 g/l  KH2PO4 
Stock 6 (1 ml/l):  2 g/l  H3BO3 
   1.8 g/l  MnSO4 x H2O 
    0.2 g/l   ZnSO4 x 7 H2O 
    0.08 g/l CuSO4 x 5 H2O 
    0.25 g/l Na2MoO4 x 2 H2O 
    0.02 g/l CoCl2 x 6 H2O 
 Stock 7 (5 ml/l): 80 g/l  NH4NO3 
The stock solutions were added to the sterile Millipore water one by one, stirring (solutions 1 and 
4 were added at the end). Stock solution 7 was left out in the nitrogen-free variant of the medium 
(E.2.2.3). After 15 min of stirring pH value was measured and set to pH 6.5 – 7.0 using 20 % 
H2SO4 or 10 % KOH. 17 – 21 liter of this medium was prepared for one aeroponic tank. 
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E.1.5.2 Supplements 
 
Supplements for solid media 
Select Agar (Invitrogen) 
For the solid bacterial media, 16 g/l were added. 
Agar Nr. 1 (Oxoid) 
Nitrogen-depleted agar. For the solid plant medium, 15 g/l were added. 
 
Antibiotics 
 Chloramphenicol (Cam) 
For the selection of Chloramphenicol -resistant E. coli clones, 12.5 mg/l of antibiotic were added 
to solid media.  
 Gentamycin (Gm) 
For the selection of Gentamycin-resistant E. coli clones, 8 – 10 mg/l of antibiotic were added to 
solid media.  
 Kanamycin (Km) 
For the selection of Kanamycin-resistant E. coli clones 50 mg/l of antibiotic were added to solid 
media; 25 mg/l were of antibiotic added to liquid media to prevent the loss of plasmids. 
Nalidixic acid (Nx) 
For the selection of S. meliloti strains Rm2011 and Rm1021, 8 - 10 mg/l of antibiotic were added 
to solid media; 2.5 – 5 mg/l were added to liquid media.  
Neomicin (Nm) 
For the selection of S. meliloti carrying mTn5 transposon, 120 mg/l of antibiotic were added to 
solid media.  
Streptomycin (Sm) 
For the selection of S. meliloti strains Rm2011 and Rm1021, 600 mg/l of antibiotic were added to 
solid media.  
 
Other  
X-Gluc  
For the detection of gusA expression in S. meliloti, 20 mg/l of X-Gluc (5-bromo-4-chloro-3-
indolyl-beta-D-glucuronic acid) were added to solid media.  
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E.1.6 Buffers and solutions 
 
E.1.6.1 DNA- and enzyme buffers 
 
 TE-buffer   10 mM  Tris-HCl 
     1 mM  EDTA 
     pH 7.5 
 
 10 × TA- restriction buffer 660 mM K-Acetate  
     330 mM Tris-HCl 
     100 mM Mg-Acetate 
     5 mM  Dithiothreitol (DTT) 
     1 mg/ml Bovine serum albumin (BSA) 
     pH 7.5  (adjust with acetic acid) 
  
 10 mM dNTP-mix  10 mM  dATP 
     10 mM  dCTP 
     10 mM  dGTP 
     10 mM  dTTP 
 RNase A   20 mg/ml 
 
E.1.6.2 DNA electrophoresis buffers 
 
 1 × TA-buffer   40 mM  Tris-HCl 
     10 mM  Na-Acetate 
     1 mM  EDTA 
     pH 7.8  (adjust with acetic acid) 
 
 BPB loading buffer  80 ml  Glycerol 
     10 ml  TA-buffer 
     2.5 g  Bromphenol blue 
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E.1.6.3 Solutions for microarray-hybridizations 
 
 20 × SSC   3 M  NaCl 
     0.3 M  Na3-Citrate 
     pH 7.4 
  
 Rinsing solution 1  250 ml   H2O 
     250 µl   Triton X100 
Dissolved at 80 °C for 5 min; cooled down to the room temperature 
 
 Rinsing solution 2  500 ml  H2O 
50 µl   32 % HCl 
 
 Rinsing solution 3  225 ml  H2O 
     25 ml   1 M KCl 
 
Blocking solution  150 ml  H2O 
  40 µl  32 % HCl  
     50 ml   4 × QMT Blocking solution 
MilliQ/HCL mix is pre-warmed to 50°C. The 4 × QMT Blocking solution was added 5 min 
before use and the complete Blocking solution was pre-warmed to 50°C for at least 5 min.  
 
 Washing buffer 1  2 × SSC 
     0.2 % SDS 
     30 °C 
 
 Washing buffer 2  0.5 × SSC 
     20 °C 
 
E.1.6.4 Buffer for the preparation of competent E. coli cells 
 
TB buffer   10 mM   HEPES 
15 mM  CaCl2 × 2 H2O 
55 mM  MnCl2 × 2 H2O 
250 mM  KCl 
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All components, except MnCl2, were mixed and the pH was adjusted to 6.7 with KOH. Then the 
MnCl2 was added and the mixture was filter sterilized. 
 
E.1.6.5 GUS staining buffer 
 
X-Gluc stock solution: 
25 mg X-Gluc (5-Bromo-4-chloro-3-indolyl-ß-D-glucuronide)  
dissolved in 500 µl N,N-Dimethylformamid (N,N-DMF) 
Use immediately 
Potassium-Ferri/Ferrocyanide stock solution 
100 mM  Potassium Ferricyanide K3Fe(CN)6 
100 mM Potassium Ferrocyanide K4Fe(CN)6 × 3H2O 
Store at -20° C 
Tris-HCl/NaCl-Buffer 
100 mM  Tris-HCl 
50 mM  NaCl 
pH 7.0 
For 1 ml of GUS-Buffer, add 20 µl of Potassium-Ferri/Ferrocyanide stock solution and 20 µl of 
X-Gluc stock solution to 960 µl of Tris-HCl/NaCl-buffer. The resulting buffer can be stored at 
4° C for maximally 1 – 2 days. 
 
E.1.7 Software and databases 
 
Program/ 
resource URL Reference 
BioEdit 7.00 http://www.mbio.ncsu.edu/BioEdit/bioedit.html (Hall, 1999) 
Primer3 http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi (Rozen and Skaletsky, 2000) 
GenDB http://www.cebitec.uni-bielefeld.de/groups/brf/software/gendb_info/index.html (Meyer et al., 2003) 
Java TreeView http://genetics.stanford.edu/_alok/TreeView/ (Saldanha, 2004) 
Cluster 3.0 2http://bonsai.ims.u-tokyo.ac.jp/_mdehoon/software/cluster/software.htm#ctv (Yang et al., 2002) 
S. meliloti genome 
project 
http://bioinfo.genopole-
toulouse.prd.fr/annotation/iANT/bacteria/rhime/ (Galibert et al., 2001) 
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E.1.8 Contents and layout of  the tag microarray 
 
The mTn5-STM-1 microarray contains 23mer oligonucleotides carrying 5´ C12-amino 
modifications. The probes are directed against the variable sequences of signature tags of the 412 
mTn5-STM transposons. A microarray slide contains two arrays each with 4608 spots in 16 grids 
of 18 rows and 16 columns. The 16 grids were arrayed in a 4x4 pattern. Each oligonucleotide is 
present in at least four replicates per array. Besides, 3 23-mer genomic control sequences were 
printed in 192 replicates. Spotting was performed as described by Rüberg et al. (2003). Tag 
sequences and the layout of the mTn5-STM-1 microarray are described at  
http://www.cebitec.uni-bielefeld.de/groups/nwt/transcriptomics_facility/services_and_printed_arrays/. 
 
E.2 METHODS 
 
E.2.1. Cultivation of  bacteria 
 
E.2.1.1 Growth conditions 
 
Bacteria were grown on using solid media, as well as liquid media. In special cases, the media 
were supplemented with additives listed above (E.1.5.2). E. coli cells were cultivated at 37 °C in 
LB, LBG, SOB or SOC medium. For the preparation of competent E. coli cells, they were 
cultivated at the room temperature (18 – 22 °C). S. meliloti cells were cultivated at 28 – 30 °C in 
TY, 2 × TY, or in Vincent minimal medium.  
 
E.2.1.2 Determination of bacterial cell number 
 
Baterial cell numbers were determined using photometrical measures of cell density at 600 
nm. Optical density of 0.1 corresponds to 2 × 107 cells/ml if E. coli culture is measured, and to 
108 cells/ml if S. meliloti culture is measured. The number of living cells was determined by the 
quantity of colonies grown on solid medium from the diluted culture.  
 
E.2.1.3 Storage of bacterial strains 
 
Mutant library was stored in standard flat well 96-well plates (Greiner). Other strains were 
stored in eppendorf tubes. 
Storage in glycerol solution  
Bacteria were grown in the liquid medium overnight (E. coli) or for 2 – 3 days (S. meliloti); 100 
μl of bacterial culture were mixed with 120 μl of 87 % (v/v) glycerol and stored at -20 °C. 
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HFM culture  
Bacteria were grown as above. 180 μl of bacterial culture were mixed with 20 μl of Hogness 
Freezing Medium (E.1.5.1) and stored at -80 °C.  
 
E.2.2 Cultivation of  plants and harvesting of  nodules 
 
E.2.2.1 Sterilization of M. sativa seeds 
 
The seeds of M. sativa are treated by the concentrated sulfuric acid in order decontaminate 
seeds from bacteria and fungi, and to stimulate the germination. This method also helps to 
increase the fraction of germinating seeds to over 90 %. 
 
• Place 20 seeds in an eppendorf tube (in case large quantities of seeds have to be sterilized, use 
blue caps and multiply all volumes by 40).  
• Add 0. 5 ml of concentrated (95 – 97 %) sulfuric acid. Incubate for 12 min agitating.  
• Pipet the acid away. It is important to remove as much acid as possible.  
• Add 1 ml of sterile Millipore water, invert 2 – 3 times, and remove the water.  
• Add 1 ml of fresh Millipore water. Incubate for 2 – 3 min, agitating.  
• Repeat the washing 2 more times.  
• Let the seeds covered with water (150 – 200 μl) stand in light for 30 – 40 min. 
• Place the seeds on the plant agar plates using sterile glass pipette, seal the plates with Parafilm 
and wrap them in aluminum foil.  
• Incubate for 24 hours at 4 °C and subsequently for 24 hours at 28 °C.  
 
E.2.2.2 Cultivation of plants on Petri dishes and inoculation by S. meliloti 
 
• Culture the S. meliloti strains overnight on TY agar plates. Resuspend the bacteria in 0.85 % 
NaCl solution, and dilute the cell suspensions so that they contain 2 × 107 cells/ml 
(o.D.600=0.02).  
• Using tweezers, put the prepared germ buds on the upper 1/3 of plant agar plates in the way 
that the roots are directed to the thick side of the agar. Three germ buds are put on one agar 
plate.  
• Use 150 μl of bacterial cell suspension to inoculate each plate. Apply the bacterial suspension 
on the lower part of the plate and along the roots.  
• Let the plates dry and place them in the plant incubator roots down. Incubate for 3 weeks or 
more so that the nodules can form.  
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E.2.2.3 Cultivation of plants in aeroponic system  
(Journet et al., 2001) 
 
The aeroponic system is used when big quantity of plant root material is needed. In this 
work, this system was used in order to obtain several thousands of nodules from one experiment.  
In the aeroponics, plants are cultivated without any solid substrate, and the roots are kept moist 
by the plant medium aerosol.  
Seeds of M. sativa cv Europe were sterilized and cultivated for 6 – 8 days on the plates with 
plant medium. During this time, the aeroponic tank was sterilized using 0.1 % H2O2 for 2 days 
and subsequently dried for 3 days. The tank was partly filled with 17 – 21 l of aeroponics plant 
medium supplemented with 5 mM ammonium nitrate. The defensor was switched on for 1 day 
before the planting to reach the correct humidity inside the tank. The plants were picked from 
the agar plates and their roots were carefully inserted in the holes of the aeroponic tank lid. After 
10 days of cultivation in the presence of nitrogen, the medium containing nitrogen was changed 
to the nitrogen-free medium. After two more days of cultivation plants were inoculated with 17 
ml of S. meliloti culture (o.D.600=1.0, washed twice in plant medium) to promote nodulation. The 
nodules were harvested 4 weeks after inoculation.  
 
E.2.2.4 Harvesting and sterilization of nodules from the agar plates 
 
The surface of the nodules must be sterilized and washed to avoid the contamination by 
bacteria that stick to the surface of the nodules.  
• Harvest nodules using tweezers and put each one into an eppendorf tube.  
• Add 1ml of sterile Millipore water and vortex. Remove the water. 
• Add 500 μl of 70 % ethanol and vortex. Incubate for 1 min. Remove the ethanol.  
• Wash the nodules three times with 1 ml Millipore, vortex each time. 
 
E.2.2.5 Harvesting and sterilization of nodules from the aeroponic tank 
 
The roots of plants that were grown in the aeroponics are more than 1 m long and carry 
about 150 - 200 nodules. Nodules were harvested using tweezers and immediately frozen in liquid 
nitrogen in aliquots of 1.5 – 2.5 g wet weight (3 – 4 ml) in 50 ml blue caps. Before the DNA 
isolation, nodules had to be washed in order to remove bacteria that stick to their surface.  
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Protocol:  
• Thaw the nodules 
• Add 45 ml of sterile Millipore water and invert several times. Remove the water with a glass 
pipette. 
• Add 10 ml of 70% ethanol and invert several times. Incubate for 1 min. Remove the ethanol.  
• Wash the nodules three times with 45 ml sterile Millipore. 
• Remove as much water as possible. Transfer the nodules into a mortar and immediately cover 
with liquid nitrogen. Continue with the protocol for DNA isolation (E.2.4.3).  
 
E.2.2.6 Exogenous climatic factors for plant growth 
 
 Plant incubator (agar plates) Climatic chamber (aeroponics) 
Temperature 19 °C 22 °C 
Light hours  17 h 18 h 
 
E.2.3 DNA transfer 
 
E.2.3.1. Transformation of E. coli  
 
Bacterial transformation is the process by which bacterial cells take up naked DNA molecules.  
In the transformation procedure, the cell walls of bacteria are treated in a way that the DNA can 
pass into the cytoplasm. Such treated E. coli are called competent cells. In this work, a highly 
efficient chemical method of competent cells preparation was used (Inoue et al., 1990), resulting 
in 1 x 107 to 1 x 108 transformants per microgram of plasmid DNA.  
 
Preparation of competent cells  
• Pick 7 – 10 large E.coli colonies from the LB-agar plate and resuspend them in 3 ml of SOB. 
Use approximately 1 ml of the cell suspension to inoculate 150 ml of SOB. Incubate the 
flask in a shaker (150 rpm) overnight at the room temperature (18 – 22 °C). Harvest the 
culture at the o.D.600 of 0.5 – 0.6. Pre-cool the TB buffer and prepare liquid nitrogen. 
After this point, all the procedures are made on ice. 
• Transfer the culture to blue caps and cool them 10 min on ice.  
• Centrifuged for 10 min, at 3000 rpm, 4 °C, discard the supernatant. 
• 50 ml ice-cold TB buffer (E.1.6.4) and incubate for 10 min on ice. 
• Centrifugation step as above. 
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• Gently resuspend the pellets in 10 ml of ice-cold TB buffer. Add 0.7 ml of DMSO and 
incubate on ice for 10 min more. 
• Aliquot the cells using in pre-cooled eppendorf tubes and plastic tips. Glass pipettes should 
not be used for aliquoting. 
• Freeze the aliquots in liquid nitrogen and store at -80 °C. 
 
Transformation of competent cells by DNA  
• Thaw 150 μl of competent cells at room temperature. Add DNA in the volume of 10 μl or 
less. Incubate the cells together with DNA on ice for 25 – 40 min. 
• Heat-shock the cells by placing in 43 °C water bath for 30 sec and subsequently cooling them 
on ice for 5 min. 
• Add 750 μl of SOC to the cells and incubate at 36 °C for 45 min. 
• Plate the transformed cells (10 – 100 μl) on LB plates containing the antibiotic for selection.  
 
E.2.3.2 Conjugation  
(Simon et al., 1983) 
 
The E.coli S17-1 cells were grown overnight in liquid LB medium supplemented with 
kanamycin to o.D.600 = 0.5 - 0.6. S. meliloti cells were grown in liquid TY to o.D.600=0.8 - 1.0. The 
two cultures were mixed together so that quantity of S. meliloti cells was equal to the quantity of 
E.coli cells, e.g 700 μl of rhizobial culture of o.D. 600=0.8 would have been mixed with 190 μl of 
E.coli culture that of o.D.600 = 0.6.  
The mixture was centrifuged and the supernatant was discarded (poured away, not pipetted 
out). The sells were resuspended in the rest of medium (about 40 μl) and applied on the cellulose 
acetate filter (Sartorius) placed on TY plate without antibiotic. After growth overnight at 30 °C 
the filter was taken from the plate and cells were washed from it using 700 μl of 0.85 % NaCl. 
100 μl of the suspension were then plated on plates with antibiotic. 
 
E.2.4. Isolation and purification of  DNA 
 
E.2.4.1. Isolation of plasmid DNA from bacteria (E. coli) 
 
Plasmid DNA was isolated using NucleoSpin® Plasmid kit from Macherey-Nagel. In this 
method, the plasmid DNA is liberated from the E. coli host cells by SDS/alkaline lysis and 
purified by binding to the NucleoSpin®Plasmid column with subsequent washing end elution 
steps.  
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Protocol (Columns, and all the components marked by the sign ◘ are a part of the kit): 
• Plate plasmid containing cells on the medium containing antibiotic. Incubate overnight. 
• Using a glass pipette, scrape some cells from the plate and resuspend them in 250 μl buffer 
A1◘ by vigorous vortexing.  
• Add 250 μl of buffer A2◘ and mix gently with the cell suspension by inverting the tube 6 – 8 
times, than incubate at room temperature for 5 min. 
• Add 300 μl of buffer A3◘ and mix gently by inverting the tube 6 – 8 times.  
• Centrifuge for 5 - 10 min at 11,000 × g at room temperature. 
• Place a NucleoSpin® Plasmid column in a 2 ml collecting tube and load the supernatant from 
step 3 onto the column. Centrifuge for 1 min at 11,000 × g. Discard flow-through. 
• Place the NucleoSpin® Plasmid column back into the 2 ml collecting tube and add 600 μl of 
buffer A4◘ mixed with ethanol as indicated on the bottle. Centrifuge for 1 min at 11,000 × g. 
Discard flow-through. 
• To dry the silica membrane completely, reinsert the NucleoSpin® Plasmid column into the 2 
ml collecting tube. Centrifuge for 2 min at 11,000 x g. 
• Place the NucleoSpin® Plasmid column in a 1.5 ml microcentrifuge tube and add 50 μl buffer 
AE◘. Incubate 1 min at room temperature. Centrifuge for 1 min at 11,000 × g. 
• Store the DNA at -20 °C 
 
E.2.4.2 Isolation of genomic DNA from bacteria (S. meliloti) 
 
The whole genomic DNA was isolated from S. meliloti cells using NucleoSpin® Tissue kit from 
Macherey-Nagel. With the NucleoSpin Tissue method, lysis is achieved by incubation of the 
samples in a solution containing SDS and proteinase K at 56 °C. Appropriate conditions for 
binding of DNA to the silica membrane of the NucleoSpin® Tissue columns are created by 
addition of large amounts of chaotropic ions and ethanol to the lysate. Contaminations are 
removed by efficient washing with buffer. Pure genomic DNA is finally eluted under low ionic 
strength conditions in a slightly alkaline elution buffer. 
 
Protocol (Columns, and all the components marked by the sign ◘ are a part of the kit): 
• Centrifuge up to 1 ml culture with o.D.600 = 0.8 for 5 min at 8,000 × g. Remove supernatant 
(for more dense cultures, less culture was used; for less dense cultures, several centrifugation 
steps were performed adding more culture to the same tube). 
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• Resuspend the pellet in 180 μl buffer T1◘ by pipeting up and down. Add 25 μl proteinase K◘. 
Vortex vigorously and incubate at 56 °C until complete lysis is obtained (at least 1 – 3 h). 
Vortex occasionally during incubation or use a shaking incubator. 
• Add 20 μl RNase A solution and incubate for an additional 5 min at room temperature. 
• Vortex the samples. Add 200 μl of buffer B3◘, vortex vigorously and incubate at 70 °C for 10 
min. Vortex briefly. 
• Add 210 μl of ethanol (96 – 100 %) to the sample and vortex vigorously. 
• For each sample, place one NucleoSpin® Tissue column into a 2 ml collecting tube. Apply the 
sample to the column. Centrifuge for 1 min at 11,000 × g. Discard the flow-through and 
place the column back into the collecting tube. 
• Add 500 μl buffer BW◘. Centrifuge for 1 min at 11,000 × g. Discard flow-through and place 
the column back into the collecting tube. 
• Add 600 μl buffer B5◘ to the column and centrifuge for 1 min at 11,000 × g. Discard flow-
through and place the column back into the collecting tube. 
• Centrifuge the column for 1 min at 11,000 × g. 
• Place the NucleoSpin® Tissue column into a 1.5 ml microcentrifuge tube and add 100 μl 
prewarmed elution buffer BE◘ (70 °C). Incubate at room temperature for 1 min. Centrifuge 
1 min at 11,000 × g 
 
E.2.4.3. Isolation of pure DNA from M. sativa nodules  
 
The mixed bacterial and plant DNA was isolated from M. sativa nodules using DNeasy® Plant 
Mini kit from Qiagen. In the DNeasy Plant procedure, plant material is first mechanically 
disrupted and then lysed by addition of lysis buffer and incubation at 65 °C. RNase A in the lysis 
buffer digests the RNA in the sample. After lysis, proteins and polysaccharides are salt 
precipitated. Cell debris and precipitates are removed in a single step by a spin through the 
QIAshredder Column that serves as filtration and homogenization unit. The cleared lysate is 
transferred to a new tube and binding buffer and ethanol are added to promote binding of the 
DNA to the DNeasy membrane. Contaminants such as proteins and polysaccharides are 
removed by two wash steps. Pure DNA is eluted in a low-salt buffer.  
 
Protocol (Columns, and all the components marked by the sign ◘ are a part of the kit): 
• Grind the washed nodule tissue (E.2.2.5) under liquid nitrogen to a fine powder using a 
mortar and pestle. Transfer tissue powder to eppendorf tubes (approximately 50 mg of tissue 
powder per tube). 
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• Add 400 μl of Buffer AP1◘ and 4 μl of RNase A◘ stock solution (100 mg/ml) to each tube 
and vortex vigorously (from here all the steps are described for one tube).  
• Incubate the mixture for 10 min at 65 °C. Mix 2 – 3 times during incubation by inverting tube. 
• Add 130 μl of Buffer AP2◘ to the lysate, mix, and incubate for 5 min on ice. 
• Centrifuge the lysate for 5 min at 20,000 × g. 
• Apply the lysate to the QIAshredder Mini Spin Column (lilac) placed in a 2 ml collection tube 
and centrifuge for 2 min at 20,000 × g. 
• Transfer flow-through fraction from step 4 to a new tube without disturbing the cell-debris 
pellet. 
• Add 1.5 volumes of Buffer AP3/E◘ to the cleared lysate and mix by pipetting. 
• Apply 650 μl of the mixture from step 6, including any precipitate which may have formed, to 
the DNeasy Mini Spin Column sitting in a 2 ml collection tube. Centrifuge for 1 min at 
≥6000 × g and discard flow-through. 
• Repeat the previous step with remaining sample. Discard flow-through and collection tube. 
• Place DNeasy Mini Spin Column in a new 2 ml collection tube, add 500 μl Buffer AW◘ to the 
DNeasy Mini Spin Column and centrifuge for 1 min at ≥6000 × g. Discard flow-through 
and reuse the collection tube in the next step. 
• Add 500 μl Buffer AW◘ to the DNeasy Mini Spin Column and centrifuge for 2 min at 20,000 
× g to dry the membrane. 
• Transfer the DNeasy Mini Spin Column to a 1.5 ml or 2 ml microcentrifuge tube and pipet 
100 μl of Buffer AE◘ directly onto the DNeasy membrane. Incubate for 5 min at room 
temperature (15 – 25°C) and then centrifuge for 1 min at ≥6000 × g to elute. 
 
E.2.4.4. Isolation of DNA from M. sativa nodules by boiling 
 
This method was used to isolate DNA from single nodules.  
Protocol:  
• Place the washed nodule (E.2.2.4) in an eppendorf tube together with 100 μl of sterile 
Millipore water.  
• Grind the nodule using a sterile micropestle.  
• Place the tube in a boiling water bath for 5 min.  
• Centrifuge 1 min at 6000 × g 
• Use 5 μl of supernatant for the PCR. 
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E.2.4.5. Purification of PCR products 
 
Purification of PCR products was performed using a NucleoSpin® Extract II PCR clean-up kit 
from from Macherey-Nagel. With this method, DNA binds to a silica membrane in the presence 
of chaotropic salt added by binding buffer NT. The binding mixture is loaded directly onto 
NucleoSpin® Extract II columns. Contaminations like salts and soluble macromolecular 
components are removed by a washing step with ethanolic buffer NT3. Pure DNA is finally 
eluted under low ionic strength conditions with slightly alkaline buffer NE (5 mM Tris/HCl, pH 
8.5). 
Protocol (Columns, and all the components marked by the sign ◘ are a part of the kit): 
• Mix 1 volume of sample with 2 volumes of buffer NT◘ (e.g. mix 100 μl PCR reaction and 200 
μl NT). 
• Place a NucleoSpin® Extract II column into a 2 ml collecting tube and load the sample. 
• Add 600 μl buffer NT3◘. Centrifuge for 1 min at 11,000 x g. Discard flow-through and place 
the NucleoSpin® Extract II column back into the collecting tube. 
• Centrifuge for 2 min at 11,000 x g to remove buffer NT3◘ quantitatively. Make sure the spin 
column doesn’t come in contact with the flow-through while removing it from the 
centrifuge and the collecting tube. 
• Place the NucleoSpin® Extract II column into a clean 1.5 ml microcentrifuge tube. Add 15 – 
50 μl elution buffer NE◘ and incubate at room temperature for 1 min to increase the yield of 
eluted DNA. Centrifuge for 1 min at 11,000 × g. 
 
E.2.5 Visualization and quantification of  DNA 
 
E.2.5.1 Agarose gel electrophoresis 
 
This method is used for visualization, as well as quantification of double-stranded DNA. The 
agarose gels used in this study were prepared of 1 % or 2.3 % (m/v) strength, depending on the 
size of DNA fragments that had to be visualized.  
 
Protocol: 
• Mix the agarose with TA buffer and boil till diluted.  
• Pour the agarose-TA, cooled to 65 °C, in a horizontal chamber with a comb. 
• After the gel becomes solid, cover it with TA buffer and remove the comb. 
• Mix the DNA probes mixed with BPB loading buffer 2 : 1 Vol. Pipet them into the 
pockets of the gel.  
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• Run the gel using the voltage of 40 – 80 V dependent on the gel strength (the higher the 
strength of a gel, the lower the voltage). 
• Dye the gel using a weak Ethidium Bromide solution for 5 min and wash the gel for 7 
min with water. 
• Make a photograph on the transilluminator under UV light. 
 
E.2.5.2 Checking fluorescently labeled targets on agarose gels prior to microarray 
hybridizations  
(Becker and Rüberg, 2003) 
 
• combine 2 µl of the labeled target with appr. 4 µl of 80 % (v/v) glycerol (NO BPB or 
other dyes!) 
• run a 0.8 % (w/v) agarose gel in TA buffer for 20 min at 80 V 
• do not touch gel with gloves or hands at places where targets are loaded 
• load BPB-marker at least 2 slots away from the target as a positive control 
• switch on the Typhoon Imager at least 30 min before use 
• place the agarose gel in -90° orientation on the bottom left corner 
• start the “Typhoon Scanner Control” software 
• load the Cy5/Cy3_medium template file (click on the menu: Template, Load, 
Cy5/Cy3_medium) 
• the template file specifies the following: 
o aquisition: fluorescence 
o orientation: -90° 
o pixel size: 200 µm 
o focal plane: 3 mm 
o setup is as follows (due to bleaching, Cy5 should be scanned first, then Cy3) 
Use Emission filter  PMT  Laser  Sensitivity 
   √ Cy5 670 BP30  800  red 633  medium 
√ Cy3 555 BP20  800  green 532 medium 
 
• scan the gel at 633 and 532 nm to detect Cy5-red and Cy3-green labeled target cDNA. 
Note that BPB markers are only detected together with the Cy5 targets at 633 nm. 
• save and store the *.ds file obtained on a network drive 
• load the *.ds file into ImageQuant. Selecting laser buttons 1 and/or 2 allows to 
individually evaluate the Cy5 and Cy3 labelings for separately labeled targets or the joint 
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detection of Cy5/3 images for combined targets. Copy/paste selected regions into 
Powerpoint, print and archive the bitmap images together with the slide hybridization 
performed using these targets. 
 
E.2.5.3 Quantification of DNA 
 
The concentration and purity of DNA was determined using ND-1000 Spectrophotometer 
(NanoDrop). Analysis of dsDNA was performed using a programmed method as recommended 
by the manufacturer.  
 
E.2.6 Polymerase chain reaction (PCR) 
 
Polymerase chain reaction is a technique for enzymatic replication of DNA in vitro. PCR uses 
two primers that anneal to the sence and anti-sence strands at the ends of the DNA fragment 
which has to be amplified. The cycles of DNA denaturing - primer annealing - second strand 
DNA synthesis lead to the amplification of the chosen DNA fragment. Termostable DNA 
polymerase Taq was used in all PCR reactions in this work. The following termal cyclers were 
used: PTC-100TM (Programmable Thermal Controller, MJ Research), PTC-200TM (Programmable 
Thermal Cycler, MJ Research) and DYADTM (Programmable Thermal Cycler, MJ Research) 
 
PCR mixture: 
5 µl  DNA template (50-100 ng/µl) 
2.5 µl   primer mix (25 pmol/µl) 
1 µl  Taq-Polymerase 
2.5 µl  dNTPs (10 mM) 
10 µl  PCR buffer containing MgSO4 
79 µl  H2O 
 
PCR program: 
1) Initial denaturation 95 °C  1min 
2) Denaturation 95 °C             30 sec 
3) Annealing  50-65 °C 25 sec 
4) Elongation  72 °C  1-2 min 
5) Final elongation 72 °C  5 min 
6) Storage  4 °C  forever 
Steps 2 to 4 are cycled 25-35 times. 
 
E.2.7 Cloning 
 
E.2.7.1 DNA digestion using restriction enzymes 
 
Restriction endonucleases cleave double-stranded DNA molecules at the specific recognition 
sequences. This results in forming of DNA fragments with “blunt” or “sticky” ends, depending 
on the restriction enzyme. The restriction digestion was performed as recommended by the 
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manufacturer of the restriction endonucleases and using a suitable restriction buffer. The 
inactivation of the enzymes was performed by incubation at 65 °C for 20 min. In some cases, a 
subsequent purification was performed using a NucleoSpin® Extract II PCR clean-up kit from 
from Macherey-Nagel (E.2.4.5).  
 
E.2.7.2 DNA annealing 
 
DNA annealing is performed in case two single-stranded complementary DNA molesules 
have to be joined in a single double-stranded molecule. For this, two molecules have to be mixed 
in proportion 1 : 1, heated in order to denaturate the DNA molecules and slowly cooled down.  
 
An annealing mixture could be prepared as follows: 
7.2 μl   DNA 1, 100 mM 
7.2 μl  DNA 2, 100 mM 
1.6 μl  NaCl, 0.5 M 
The annealing mixture is heated to 95 °C and slowly colled to 4 °C (e.g. in a water bath).  
 
E.2.7.3 DNA ligation 
 
The digested DNA fragments with “blunt” ends or compatible “sticky” ends can be joined 
together using the enzyme T4-Ligase. DNA ligation involves creating a phosphodiester bond 
between the 3´ hydroxyl of one nucleotide and the 5´ phosphate of another. The concentrations 
and proportions of ligated molecules may vary depending on application. In case an insert have 
to be cloned in the plasmid DNA, the concentration of the insert DNA normally should exceed 
the concentration of the plasmid DNA 3 – 4 fold.  
 
A ligation mixture could be prepared as follows: 
3 μl   plasmid DNA  
6 μl   insert DNA  
2 μl   10 × ligation buffer  
1 μl   T4-Ligase  
8 μl   H2O  
The ligation mixture is incubated overnight at 4 °C or at a gradient from 17 °C to 4 °C.  
 
E.2.7.4 Blunting of overhangs with Klenow fragment 
 
Klenow fragment of DNA polymerase I has 5´ -> 3´ DNA polymerase and 3´ -> 5´ 
exonuclease activity. Exo- Klenow fragment, used here, lacks 3´ -> 5´ exonuclease activity. In the 
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“fill-in” blunting reaction, the 5´ overhangs, created by cleavage with many restriction enzymes, 
are blunted by the synthesis of the second strand. Klenow fragment and dNTPs can be directly 
added to the restriction mixture after the deactivation of restriction enzyme (1 µl Klenow and 1 
µl of 10 mM dNTPs / 20 µl restriction mixture). Reaction is stopped by heating the mixture for 
10 minutes at 75 °C. 
 
E.2.7.5 Dephosphorylation of DNA 5´-termini 
 
Dephosphorylation of 5´ termini is often performed for the linearized plasmid vector in order 
to prevent self-ligation of the vector. Here, the shrimp alkaline phosphatase (SAP) was used, 
which is easier to inactivate by heating than Calf Intestinal Alkaline Phosphatase. SAP can be 
added directly to the restriction mixture so that restriction and dephosphorylation steps can be 
combined. 1 unit of SAP is added per 1 picomole of DNA 5´-termini and the mixture is 
incubated at 37 °C for 30 min. The reaction is stopped by heating at 65 °C for 15 min (one 
heating step is enough to deactivate restriction enzyme and SAP). 
 
E.2.8 Large scale methods (96-well plate format) 
 
The procedures, described here, were used for cloning of the H-tags and K-tags into plasmids 
and for the transfer of these plasmids into S. meliloti. All the methods were optimized to enhance 
their efficiency and adjusted to 96-well format. Most of the pipetting was performed using 8-
channel automatic pipettes. 
 
E.2.8.1 Annealing of tags 
 
Since the tags were synthesized as single-stranded nucleotides, they had to be annealed before 
cloning into pG18-STM. Annealing was performed in low profile microtiter plates (ABgene) as 
follows.  
An annealing mixture: 
7.2 μl   Up-tag, 100 mM 
7.2 μl   Down-tag, 100 mM 
1.6 μl   NaCl, 0.5 M 
The plate was placed in thermal cycler for 3 min with heating at 95 °C. The block was let to 
cool down till the room temperature, and then the plate was taken out and cooled at +4 °C for at 
least 15 min. The mix was stored at +4 °C 
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E.2.8.2 DNA digestion with KpnI restriction enzyme 
 
In the second round of tag cloning, plasmids carrying H-tags, were digested with KpnI 
restriction enzyme in order to clone K-tags. Prior to digestion, the concentration of H-tag 
carrying plasmids was measured. The restriction was then performed in a way that the final 
restriction mixture contained 200 - 250 ng of the plasmid. Restriction enzyme, restriction buffer 
an water were pre-mixed and pipetted into the wells. The corresponding volume of each plasmid 
was added, and the missing reaction volumes were filled-up with water in the respective wells. 
Restriction was performed in low profile microtiter plates (ABgene) 
 
The restriction mixture was prepared as follows: 
     1 reaction  105 reactions  
Plasmid DNA   0.5 - 3 μl    - 
10 × restriction buffer  2.5 μl   262.5 μl 
KpnI    1 μl   105 μl 
H2O     16.5 μl    1732.5 μl 
The plate was incubated at 37 °C overnight in a termal cycler and stored at -20 °C. 
 
E.2.8.3 Ligation 
 
Ligation mixture was prepared as follows: 
1 reaction  105 reactions  
Digested plasmid   0.5 μl    52.5 μl for H-tag cloning 
Annealing mix   7.3 μl   766.5 μl 
T4 ligase buffer   1 μl    105 μl 
T4 DNA ligase    0.7 μl   73.5 μl 
PEG    0.5 μl    52.5 μl 
Ligase, PEG and ligase buffer were pre-mixed and dispensed in low profile microtiter plates 
(ABgene) (2.2 μl of mix per well). Then annealing mix and the digested plasmid were added. The 
plate was placed in thermal cycler and slowly cooled from 16 °C to 8 °C. 
 
E.2.8.4 Transformation of E. coli  
 
Transformation of competent DH5α cells by ligation mix  
150 μl of competent cells were added to each well of the low profile microtiter plate (ABgene) 
containing 10 μl of the ligation mix. The mixture was placed on ice for 25 minutes, then in the 42 
°C water bath for 30 sec, and subsequently transferred to the ice bath.  
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The transformation mix was transferred from low profile microtiter plate to the deep-well 
plate (ABgene) and 750 μl of SOC were added to each well. The plate was shaken vigorously for 
1 hour at 37 °C. After centrifugation at 3000 rpm for 6 min, 600 μl of supernatant were removed 
and discarded, and 120 μl of cells were plated on LBG plates supplemented with antibiotic.  
 
Tranformation of competent S17-1 E. coli cells by purified plasmid 
In the case of transformation by a purified plasmid DNA, 50 μl of competent cells were used, 
and 250 μl of SOC medium were added to each well instead of 750 μl. 50 μl of each 
transformation mix were then plated on Omnitray plates (Nunc) filled with LBG plates 
supplemented with antibiotic. Plating was performed using an eight-channel pipette with 4 tips 
instead of 8. In this way, 4 transformations were be plated on one Omnitray plate.  
 
E.2.8.5 Conjugation 
 
The transformed S17-1 E. coli cells were picked from LB-kanamycin plates grown overnight in 
700 μl of LB supplemented with kanamycin in deep-well plate at 37 °C with shaking. S. meliloti 
cells were scraped from a TY plate, resuspended in 100 ml of TY and grown overnight at 30 °C 
in a 500 ml flask. 150 μl of each E. coli overnight culture were added to 600 μl of fresh LB -
kanamycin and grown till o.D.600 = 0.5 - 0.6. 50 ml of overnight culture of S. meliloti 1021 were 
added to 150 ml of fresh TY and grown till o.D.600 = 0.8 - 1.0. Then, 150 μl of E. coli culture 
from each well were mixed with 700 μl of S. meliloti culture in a new deep-well plate. The plate 
was centrifuged 10 minutes at 2500 rpm, the supernatant was discarded and the cells resuspended 
in the rests of medium (20 – 30 μl).  
For better conjugation efficiency, cellulose membrane filters from Sartorius (product code 
11107--47------N) were used. The filters were placed into wells of 24-well plates (Nunc), filled 
with 2 × TY agar medium. The resuspended cells were dropped at the filters, dried and incubated 
at 30°C overnight. 
The filters with bacteria were then transferred to 700 μl of 0.85% NaCl in deep-well plate and 
vortexed. 120 μl of suspension were plated on 2 × TY agar plates supplemented with neomycin, 
streptomycin and nalidixic acid, and incubated at 30 °C for 3 - 4 days. 25 to 30 colonies were 
picked to the fresh 2 × TY plates with the same antibiotics and incubated for 2 days at 30 °C.  
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E.2.9 Growth conditions for bacteria in competition experiments in free-
living conditions 
 
378 mutants containing different tags were mixed in roughly equal quantities and the mixture 
was stored as a glycerol stock. A part of the mutant mixture was stored separately and used as a 
reference (input pool). In all experiments, 3 biological replicates were used. Rich (TY) and 
minimal (VMM) media were inoculated by the glycerol culture stock of the mixture of mutants to 
o.D.600=0.003. Cultures reached the stationary growth phase at o.D.600=14 (in TY medium), 
o.D.600=12.5 (in VMM) and o.D.600=8.5 (in stress conditions). The timepoints, at which the cells 
were collected, are denoted in the Table E1.  
For salt- and detergent-induced stress experiments, S. melioti cells were cultured in TY medium 
for 6 h after inoculation and then NaCl or sodium dodecyl sulfate (SDS) were added to a 
concentration of 400 mM or 0.87 mM, respectively.  
 
TABLE E1. Absolute time after inoculation and optical density 
 o.D.600 of the time points at which the samples were collected 
 
medium time o.D.600 
TY 20 h 0.28 
TY 28 h 2.9 
TYa 36 h 7.2 
TY 43 h 11 
TY 49 h 13.5 
TY 60 h 12.5 
VMM 24 h 0.28 
VMM 30 h 2.3 
VMMa 37 h 5.9 
VMM 43 h 10 
VMM 49 h 12.5 
VMM 60 h 11.5 
TY-NaCl 24h 4.5 
TY-SDS 24h 5 
aThese cultures were used in both experiments 
 
E.2.10 Acetylene reduction assay 
 
In the acetylene reduction assay, nodules or the whole plants are incubated with acetylene, 
and then the quantity of ethylene that has formed over time is measured. Since nitrogenase can 
reduce acetylene to ethylene, the measured ethylene/acetylene ratio reflects nitrogenase activity in 
the nodules.  
Plants were grown on the plant agar plates and harvested 22 days post inoculation. Plants were 
picked from the plates with the whole root system and placed in 12 ml screw cap glass tubes, 
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covered with rubber septa and closed with perforated screw caps. In each tube, 3 plants were 
placed. 1 ml of acetylene was injected in each tube using a 1 ml Hamilton GASTIGHT syringe. 
The tubes with plants were placed in the plant incubator. After 20 hours, the ethylene / acetylene 
ratio was determined using Hewlett Packard 5710A gas chromatograph.  
 
E.2.11 Histochemical GUS staining 
 
GUS staining was used to detect expression of the promoters in the studied genes in the nodules. 
Fresh nodules were sectioned using VT1000S vibratom (Leica) to obtain 80 μm thick sections. 
The sections were covered by GUS buffer (500 μl for 5-8 sections) and incubated at 37 °C until 
blue staining could be observed (1 to 8 hours, depending on the strength of the promotor). The 
stained sections were rinsed two times in the Tris-HCl / NaCl Buffer. Additionally, the sections 
were stained by 0.1 M potassium iodide by dropping about 20 μl of the solution at the edge of 
cover slip immediately before microscoping. Photographs were taken using a Nicon ECLIPSE 
80i microscope with 10-fold magnification and Nicon Digital Sight DS-2Mv camera. 
 
E.2.12 Microarray hybridization 
 
Sm6kOligo microarrays were spotted on Quantifoil QMT epoxy slides. These had to be 
processed prior to hybridizations to block free epoxy groups. 
 
QMT slide processing (Becker and Rüberg, 2003) 
• place the slides in a plastic rack and carry out the processing by transferring the racks 
from one container to the other, occasionally lift the rack up and down during washing 
• wash slides for 5 min at room temperature in 250 ml of rinsing solution 1 
• wash slides for 2 min at room temperature in 250 ml of rinsing solution 2, repeat this step 
• wash slides for 10 min at room temperature in 250 ml of rinsing solution 3 
• wash slides for 1 min at room temperature in 250 ml of MilliQ H2O 
• incubate slides for 15 min at 50 °C in 200 ml prewarmed blocking solution in a glass 
container, shake at least every 5 min or apply constant shaking. Use a flat bottom glass 
container to process 1-2 slides (20 ml of blocking solution) and a multiple glass container 
to process multiple slides (200 ml blocking solution) 
• wash slides for 1 min at room temperature in 250 ml of MilliQ H2O 
• place rack on an 12 × 8 cm plastic microplate cover (Genomics Solutions) containing 2 
Kim-wipes and immediately spin in the microplate centrifuge at 1200 rpm for 3 min. Use 
a stack of 3 used glass slides at every side of the plastic dish to lift up the rack with the 
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slides, this avoids precipitation artetacts at the side of the slide. Be sure to counter-
balance using an appropriate balance. 
 
Fluorescently labeled purified PCR products were were lyophilized and resuspended in 110 
μl of DIG Easy Hyb solution. Hybridization was carried out at 36 °C for 1 h in the HS4800 
Hybridization Station (Tecan). Before applying the hybridization sample to the microarray, it was 
denatured for 3 minutes at 95 °C. Following hybridization, the arrays were washed twice in 2 × 
SSC, 0.2 % SDS for 5 minutes at 30 °C and subsequently twice in 0.5 × SSC for 2 minutes at 20 
°C. 
 
E.2.13 Tag-microarray data analysis 
 
E.2.13.1 Pre-processing 
 
Image processing was performed with ImaGene (version 6.0.1). For each spot the 
background corrected spot intensities were calculated using the means of all chosen pixels for 
background and signal. Negative spots or spots that were flagged as empty or having bad quality 
were removed. Mutants for which less than half of the replicated spots (for each tag separately) 
were detected, were sorted out prior to further analysis. 
The mean intensity (a-value) was calculated for each spot using the standard formula 
ai=log2(RiGi)0.5. Ri=Ich1i-Bgch1i and Gi= Ich2i-Bgch2i, where Ich1i or Ich2i is the intensity of a 
spot in channel 1 or channel 2 and Bgch1i or Bgch2i is the background intensity of a spot in 
channel 1 or channel 2, respectively. The logarithm to the base 2 of the ratio of intensities (the m-
value) was calculated for each spot using the formula mi=log2(Ri/Gi) (Becker et al., 2004). 
 
E.2.13.2 Normalization and filtering 
 
Normalization accounts for systematic differences between the two fluorescent dyes caused 
by different labelling and detection efficiencies (Quackenbush, 2001). Due to these differences, 
the data distribution is not centered around zero although often most of the genes or mutants 
should have similar values in experiment and reference. 
In a normalization procedure, a normalization factor c is calculated and used to move the 
center of the distribution to zero: 
 
m-valuenorm(i) = m-value(i) − c for spot i 
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Several approaches for computation of the normalization factor exist. In this study, global 
median and LOWESS normalization were used. Data used for the calculation is assumed to have 
an m-value of zero.  
The two types of tags used in this STM experiment introduce additional differences. They 
may be caused by variable efficiencies of dye incorporation depending on the primers used for 
amplification of the different tags. Normalization was therefore performed for each type of tag 
separately. 
The data from the pilot verification experiments was normalized using locally weighted 
regression (LOWESS) (Cleveland, 1979). This method accounts for differences between the 
two dyes that depend on intensity (a-values) (Yang et al., 2002).  
The data from the experiment in planta was analysed using a modified global median 
normalization. This normalization method assumes that the differences between the two dyes 
can be described by a constant factor calculated as the median of the m-values (Yang et al., 2002): 
 
c = median (m-value(i)), where i=1,...,nr of spots. 
 
15% of the smallest m-values were excluded from the pool of data used to calculate the 
median.  
For the filtering, the distances between H- and K-tag for each mutant were calculated, using 
the formula 
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where meantag, stdtag and ntag denote mean, standard deviation and number of m-values for a 
single mutant, respectively. The 90%-quantiles of the distribution of each criterion for all mutants 
were determined and the mutants exceeding this threshold were removed from the data set. 
In case several technical replicates were used, the weighted mean of the medians of the m-
values derived from the biological replicates was calculated for each mutant combining values of 
H-tags and K-tags: 
∑ == repni iiw mediannnmean 1 *1 , 
Where nrep, ni and mediani denote the number of replicates, the number of spots of replicate i 
and the median of the m-values of replicate i respectively, and ∑ == repi inn 1  is the overall number 
of spots. Mutants, whose meanw-values were higher than 0.7 or lower than -0.7, were considered 
as having an induced or attenuated phenotype, respectively.  
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E.2.13.3 Cluster analysis 
 
Cluster analysis was performed using Cluster 3.0 (Yang et al., 2002), a successor of Eisen’s Cluster 
software (Eisen et al., 1998).  
The following distances between two data points x and y were applied in the clustering 
algorithms: 
1. Euclidean distance:  ∑= −= ni ii yxyxd 1 2)(),(  
2. Centered correlation: cryxd −=1),( , where 
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k-means clustering was performed in the following way. The algorithm was repeated 105 times. 
Each times a different set of k rows (= mutants) was selected as prototype vectors in the 
initialization step. The solution with the smallest sum of distances within clusters (i. e. distances 
between data points in one cluster) was chosen as the final result. 
Java Treeview (Saldanha, 2004) was used for visualization where the contrast value for all 
plots was set to 2.0. 
In the TY-VMM time course experiment, the data matrix for clustering analysis after filtering 
of absolute m-values consisted of 27 mutants in rows and 12 time points (6 per medium) in 
columns. In the k-means clustering, number of clusters k was set to 6. In the stress conditions 
experiment, the data from the stress conditions were clustered together with the timepoint 3 data 
for VMM and TY cultures. As a result, the data matrix for the clustering consisted of 29 mutants 
in rows and 4 conditions in columns. Number of clusters k was set to 8. In both experiments, the 
distance was calculated based on uncentered Pearson correlation. 
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TABLE G.1. CLONED SIGNATURE TAGS 
 
Tag ID H-tag sequence  K-tag sequence  
1-10A GCGCGATCTCTGTGAACAATGAGA GGGAGTTCTAAACGCTGGCTGACA 
1-10B TGAAAGGCCAGCGGACTGAATAGA TAAGTAATCACCAGCCAACCGGCA 
1-10C TCCGAATGCTAGAAATTCGGGTCA CTTTAGATATAGCCTGGCCGGGCC 
1-10D TCCGGTCGAGCGGTTTTTCTTACT CTCAATTCACGAGCCACAGGAACA 
1-10E GCGGGTACACTGGCTAAGAAGCCT CGGGCAGCGCTCAATAACTTTTTT 
1-10F GGCGGCTTACATGTTGGTTCAGAC CCGGGAAACCACCTACTACGAAGG 
1-10G ATGATGCAAAGCTTAAGTTGCGCG CCCCCCCCTGGAGTATACCAGTCT 
1-10H GAAGTAGGGTCCCCCGGACATTCT CGCAGGCCCTTTGCTTTTTGTACT 
1-11A ATTGACCTACTCCACCTCTGCGCA TCATTCCCCCGTCTTCTACCCAAG 
1-11B ACGCAATCTAAGCGTGCATTACGG CCCGCCGGTGCATACATAATACAA 
1-11C CCTCTCCCAATCCCACACGTTCTT GGCCAGTCGCCTCGCTGAATATAT 
1-11D AGCGCCGAACTTCGGTAACATAGG AACTGACTTGTTAATGCCGACGCG 
1-11E GAGGAGTGAGTTGAGCCGATTTCG GTACGAGATGCTGCCGAAAGGCTA 
1-11F CGCCTTACACACGCACGGGTATAT CGCATGTCTTCATTTAGTCCCCCA 
1-11G TGCGGGCGGGGAGTAACTAGTAAG TCGGTCTATGTAAATGTTGGCGG 
1-11H ATATTTTATATTGTCGCCGCCGCG ACAAGTTGGTGTGGGTCGGAAATG 
1-12A ACGGTGGAATATGACACCCACTGC ATCTTTGTTGGAAACTGAGGGCCG 
1-12B TCGCGTTCTTGGATGTCCAAATTC CCTACCAACTCGACGACGAAGTGC 
1-12C TCTACAGCGGTCACTCTGACAGCG GGCGCACCAATATCTATCGGCTTT 
1-12D CCCCCGCTCGGCGTCTTAATATAT TAGGACAGTCCAAGCATAGGCCGA 
1-12E CGCAAACTGTCTAACGGTATGGGC TCGCCCTGGGTTTCTACCGATTAG 
1-12F ATTATGACCCACGTGAACACCCCA TCTCTCTGCCAGCATGAACCGAAT 
1-12G GTCATTGTCCCATCTTCGGCCATA CGTCACTGGAGATTCTAAAGCGCG 
1-12H CGTGTCAGCTCCATGATTGTCCTC TATCGCGAGGAGATGGAAGTGGAG 
1-1A GGGCGTAGCCTCTAAGCAACCTTG CGCATCCTTTCACCAGGCCTTAGT 
1-1B CGCGCGGGGGTTTATAAGCATATA GTATTGGTCACGCATTCCTTCCGA 
1-1C GGAAAATATGGGTCCACGATCGCT TCCGGGTATTTATCACCCGTTGTG 
1-1D CGCCTATCTGTCGATCTAGCACGC TAACGCCAATAAGCAATTCGTGGG 
1-1E CACCAGATGAGTGCAATCGCTCAT TGGGAGCATCGTTCTCTTTTCTGG 
1-1F TTCCGATGGGTCACTATCGGTGAC TGGGTCCCTGTTTAGACGAAGCCT 
1-1G TTCCCGGCCTACCTTCCTACATGT CGCAGCGGCCTCCCATAGTAGTAT 
1-1H ACGCCCGCCACTATTCAATCATTT TCCAAATGGATTCACCGGAGAATG 
1-12A TCGGCGTACTTATCAGGGCCTTCT CATAAGAGGCGGGATCGGAATCTC 
1-2B AGACATCGAGATATTCCGGCAGGG CCACATTTTGTCCTTTAGCGTCGC 
1-2C CGTAGCGTTGATTGGAATAACGCG TGCCCAAGCGAAGTTAGTCACTCC 
1-2D TACTAAACCTGCGGCTGCACGGTA CCGCATGGCTTACCCATACGACTA 
1-2E ACTTTCGTCGGCTGTGAGAATCCA TCAGGTGAACATGGGAATGGACAC 
1-2F AACGATATTCGCGTTAAGGGTCCG GGGGTTCCAGCCGATCCTATAGTG 
1-2G GTGGATGGCAGGCTAAATGGGTCT GCCCGTGTGGTTGTTCCCTTTACT 
1-2H AGTACCGTCCCATTACTCCGAGCG TAATTCAATTCCGTGGTCAACCGG 
1-3A GACGCGTTAGATGCACAGGAGGAC CGATCTGGCCTCTCTTCGGTTAGC 
1-3B CCGAATCGTCGGAATTACTTTGGC GGCCATTGCTGTTCTACTGGATCG 
1-3C GTCTGGGGGCAGTAAACGCGATAT TGGCATAGACAGCAGAGCGAAGGT 
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1-3D TCAGGGAGTGCATTCGATTCACTG ACGCTGTGGAGGTTTTGCGGTAAT 
1-3E CGCGGGCCGAGATAGTATTATTGC TGGGGCCGAATAGTTTGGAGAAAG 
1-3F AGCATTAAGAGGGGTTGATCCCGA CCGCTCCAGAGGTTAAGACCTGGT 
1-3G TGGCAGTACATGGACGAAACAACG GTCCTGGCTCAGGGCGTTCTATTC 
1-3H GCGCCTAAAGCTCAAGGTGATCAA TGGGAAGAGACCCTGGTGTACTGG 
1-4A TATGTTCCCGCAGTAGGCAAGCTG ATCTCATGCATTCTAAGGCACGCG 
1-4B GGGGTTGTTGGTGCCGACCTATAC GCGCTTACCGATGACACAAATTGG 
1-4C CAACTGGACCATACCAAATGCCGT AGCTGCTGGGGTCTTGACTCCATT 
1-4D ATGTTAAGCTGATACCTCCCGGCG CAGTTTGGCTGCATGGTTAGTGCA 
1-4E GCGCCATGAGGGTGAGAACGTATA CGGCGCTGGGCAAATAATAAAATC 
1-4F TATATCCGTCACCCCACCAGTGGT CTGCCCTGTCTGCGTCTGCTATTT 
1-4G GCGGCGCTTAACCAGTGAAGACTA TGCCACATTCACAATGTGTAGCCC 
1-4H AGTGAGCCGGCCGCTTCGTATATA CGGATAAGCAGTGACTCGAGCGTC 
1-5A CGCGCATGCTGTTACTCGTACAAC TTAACGGATACCCTCACATGGCCA 
1-5B CGCACTCACCAGTAGCTGTGCAGT CGTCCCGAAAAAAGCGTCAGAATT 
1-5C GAGTCACCGTGGCAAATCGGTTAA GCTGCCTGTCTAGTCGGTCAAACG 
1-5D CGCGGCTATCTTCTGCACTTTCAT GCGCCAACAGTCCCTAATGTATCG 
1-5E ACGCAACTCGTAGCGGAAAGAGGT GAATCGGGGTCCCAGTAGGGATTT 
1-5F GTTATCCGATTATTGGAGGGGGGC GCGAGGACGTCACATCGTGTAAT 
1-5G GGTCGCCTTATACATGTCCACCCA CTTGCCGGTGGTCTGTGGTACCTA 
1-5H CTGCGGGGAAATGGAAATACTTC TGGCGGAAGTTAAACACGAAGCTG 
1-6A TGCCCTCGCATATAGTCATCACCA CGCGGCAAAAGAAGTCTCGTAACA 
1-6B GATTGGCAGTGCATCCACTGATGT AAGAGACATGGCAATTGGGCTGAG 
1-6C CTTTGTATCGTAACCGTGCCAGCG CGGTTGCGGCTTGTTACTTGGTAG 
1-6D GGTGATGTGTATCGCACGTGACCT GGGGGGGCCGTTCTTAATTAGATG 
1-6E TAATTATCCCCCGAGGATCGTCGA CTGGTCTCCCCTTCGAGCGATAAA 
1-6F ACGGAGTACCACCGCTGGATCTCT GATGCCGTACGCCCTCGACATATA 
1-6G AAGGCGCCGTAATACCTCGTGAAG TTGCTAGTACACAGGTTGCCGCCT 
1-6H CAAGAGCCAGTTGCCTGATCACAA CGGGAACTATATTCTTGGCTCGCC 
1-7A TGGGATCTTTTAGATGGTGCGAT CACCCCCCACGGACCATGTAATAT 
1-7B TCCGCAATTGAGAATAAGCGTTGG GGATAAAGTGGCCAGCCACATCCT 
1-7C AAAGAATCTGGACATTGAGGCGGC TTTAAAGAAATCAGCAGCAGCGCG 
1-7D GGGAGCAAACACGGTTCCACTATG GTGGCATATGGAATACGAGTCGCG 
1-7E CCGCCGCTACTAGACCTCGTTTGT TGTTATAAGGGCTGTACGACGCGC 
1-7F TTGACATACAGATCCGCTCCGTGA TCTAGTACCATCGTGCCACTCGCA 
1-7G TCTCCCCGATGCAGAGTCTCAACT TAACCCATCCGTAGACGGAGTCGA 
1-7H ATCCTGCCAGAAATAGTCGCTGCC CGCGCGTCGGTGTATAGAAATAA 
1-8A CGTCATGATCGTGTGTCAATGTGC GCACCGCTAGGTTACGTCTTGGTG 
1-8B TCCGCGTCCTAATATGGAGGTGAA GCCTGCACCTCAACATAGTCACCA 
1-8C AGAAGACCCAAGGGGACAAAGGTG TTAAAGCATTCAACAGACCCCCGA 
1-8D CTGGACCGCTTTACTTTTTGGCGT ACGGCGAGCAGTAGTGGATTCGTA 
1-8E GGGCGCGTCCATTATAAGTTTCGT GAGGATGGGAAACTATCCATGGGGG 
1-8F CCGCTCCTCTTGTACTGACGCAAT CCACAGTGCAAAGGCAAGGTAAGC 
1-8G GATAGCCTATCAGCAATCGGGCGT AGCGTGACAGAAAGGTTGAGGCAC 
1-8H TCTGCATGACCTTGGTCTGCCTTT CACGGCGGCTAGCGGATTAGTATC 
1-9A TAGACAAGTCTCAGGCCGAGGCAT ATTACAATGCCATGGACCCCATTG 
1-9B ATATTGCGAGGTGTATTGCCGGGT CGCGTGGGTTTGGTAGAACCTGTA 
1-9C CGTTTTATTCCGTCTCTGGTGCCA CTTGATAGACGGGCGTTAGCCATG 
1-9D TCCCAAGCCTCTGTGCTGATGAAT CGAGAAAATGCTGGTGGTGGCTTA 
1-9E TCCTTGTAAGTGTCAAAAGCCGCG TCAGATAACGTACGCGGTTGGACA 
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1-9F GCCCGTTGGCACTTACTGTTGCTA ACACAGCTGCGCTCATAGACGATG 
1-9G AAGCCATCTGCCCGTACACAAGAA AGACAGAGGGTGCAGTACGCTTGC 
1-9H AAATCCACCGCGGCCAACATATAT AATTTTGGGAGTGGCGTGGTGAAT 
2-10A CCCCCGTGAGGCGCTGTTTATATA CAACAGTCGGGCAGTTACCCTCT 
2-10B ATACTCTCGCAGGCACTTTGCGAA GCCGTTCCTCCTCGGTTTACAATC 
2-10C GCGTATTGCTCTGTTGGGGTGGTA GGATAACCACGGGGCTCGGTATAA 
2-10D AATACCTGGGGCTGACCTAGCCCT AGCGGTCTCCGAGTAATCTTTCGG 
2-10E CTGGCTTCAAGGACCACGAAAGAA AGGAGTGTTCTTCTTTGGACCCGG 
2-10F TTCTGGAAGTTTACTTCACGCGCG TGAGTAAGGCAATTACCCCGGAGC 
2-10G GCCCCTATCAATCTCTGGACGCTT GATCTGAACTCTATGGCTCCCCGG 
2-10H CGGCCACACCGTGCGAGTATATAG GCCTTTTTTAGACAAAGCCGTCGC 
2-11A GTGTTGGTACGGAATCATCTCGGG CTGTCTCGGCGAACAACGTTTCTT 
2-11B CGGATTCGATCCACTCGTCTGATT TACAGGAGTGCTCCATCCGATGTG 
2-11C TCATAATCCTCTTCAGTGGGCGGA TACTTAACGATACCGCCGAGTGCG 
2-11D CCAAAGGTCCCGTGTTGAAGTGTC CGGCTAAAGAACGAACGGGGTAGA 
2-11E TAATCGGCAAACCGATGCTTTCAC CGCAGTGAAAGAAAATCTGCTCGG 
2-11F TGCGTGAGGTGTTGTGATTTACCG TTCCGCGACTGTTCACTAGGTGCT 
2-11G CGCGGGCATATTGAGTACTACCGA ACCCGGTAGGGGCAATGGGTATAG 
2-11H AATGGATGTTGGAGAGGATCACGC CCCCCCGACCGAATATAAGTGCTT 
2-12A ATGCCGCAGTGTAGAAGTGGCATT TTCCTGCGGTAGGTGACGTTGACT 
2-12B TGTGAGACTGAAATAAGGGGGCCA GCGTGATGTCCGTAACGTTTGTCA 
2-12C TTGCCAATGCGGTCGTAGGGTATA GAGGTAGTCTCTCTTGGTCGGCGG 
2-12D TCGGGGTTACGCAAATTCCCTAAC TGGGACATTATTGTCTTGGGCGTC 
2-12E CTACTTCTATTTGATGCGCCGGCA GCCGCAGCCTCAGAGATGGTAATA 
2-12F CGGCAGAGGAACTCCGTAAAGAGC AGCGCTGGAAATCCGTACAAGGTC 
2-12G AATTGTACTAAAGATCGCCGGGCG GGTACTCAGACAACGCCTGCTTGG 
2-12H GGGTTCGGTCATTATGAACTCGGG AGGGGGGTCATGGGCATACAATAG 
2-1A CCGTCGTTAAACGACGCTTCCTTT ATTCTCGTATGTCCTCAACGCCCA 
2-1B CAACTTCAGATATCTGCGGCCC GCCTTATGCAATACCGAACGCTCA 
2-1C TGCCTTCTCAGGTAGATGCGGAAC TCGGATCCTCATAGCACCGCATAC 
2-1D CAATCGGTCCATCACCCTAATCGA TGTAAATCGACTTCATGGCAGCCA 
2-1E GGACATCTTCATGACAAGTGGCGA CGGCGTAGGCTACCAATCGATAGC 
2-1F ACACATGGAGATCAGGGACGCTGT TCCCAGCTGATTGTTCTGAGAGCA 
2-1G AGGATAGTCAGTATCGACCCGGCG GAGCTGAATTGGCCTGAAGGATGA 
2-1H ACGAACTGCACTCTTAACAGCCGG TTCTGCAGTTTCACAACGACGACC 
2-2A CTCTCTCAATACTCGGTCGTGGCG GGAGCTATGTTTCGCCCATTCCAT 
2-2B CCCTCGGTCAGAGACTTAAGGCGT CGCGGACCCAAATCTATGCTAGGT 
2-2C GCAGAATAAATAAGAGCGCCCGGA ATTAGCCCCCTCTAAATTGGGGGG 
2-2D CGTGCGCCCTTACATCTAGTTCCA CCTCATATCTTCCAGTTCACGCCG 
2-2E TCGGGCCCTATAATACCCCGACTT TTAATCCTACGGTGTCTGCAGGCG 
2-2F TACGGAGAGTGGGGTTATGCACGT GCCGCGTCAGCCTCTTTAGGTTTA 
2-2G CTAAAGTCCACGTTGCCGACAGCT GGTAGAATCGCAGATCACTCCCCA 
2-2H CCGGGTTAAGGACTCCTAACGGGT ATTAAATTTTTAGGGGCGTCGCCG 
2-3A GCGACAAGCCCGCGTCTTTAATAC AGCCCCTAGAGAAACCTTCATGCG 
2-3B TCCCTTAGTTTAGGCCCCCAAGGA CGACGCATTTTGATTTCCGTTTGT 
2-3C TAGCTTAAACCCGGTTTGGCGATC CCTCGACCCAATCATAACCGTCTG 
2-3D TCGGATAGGTAAAGATGCCGGTCC AGACCACTTCACAGGACACTCGCC 
2-3E CGCCGCGCTATAACCCTAGTATGG GACATCTACATGAAAGCGAGCCGC 
2-3F CTGGCCCCACTGGCACTATCAGGTA GTGCGCTTCTCCTAGTCGCACATT 
2-3G ATATATGGCGAGTTACCGCCCCCT TATGGTTATTCACGGAAAGCGCCC 
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2-3H AGGTATATTCCTGTACGGCGGGCA AAGGCTACAGACACACAATCGCCC 
2-4A ATTTTCAGGTGCAATTCAAGCCCC GGACGACGCAAGAAAGAGTGGTTG 
2-4B TTAGATTTTGACGGGTTTCGGCGT CAAACGTAGGACGACCGTATTCGC 
2-4C GTTTCGGTGGTGAGCTTAGACCCC ACAAATATCCACCATGGGTTGCCA 
2-4D ATCACAATAACGTTCAGCGGCGAG TCACTATTTTTCACAGCACGCCCA 
2-4E CGATTACGAGTGTGAGGTTCGCCT CCCGACCTGTAATGTAAGTCCGCA 
2-4F CGCGCGGACTCTAGAAGTTGTCAT CCGGGTGAGCCTGATAGAAAACGT 
2-4G TACAAGGCGCAAAGATCATACCGG TGAATTCCGCGTAGTGCTCTTTGG 
2-4H TGGGATATCTAGAAAAGGCCGGCA TCGGCCCACATAATTTGGGATAGG 
2-5A CGGCGGCAGGTACATTTAAGTCAG CGAAATTCCTCCCACGCTCACATA 
2-5B GGCGGGGCGAAGTCTTAGTACTTG GCGGGGGAGGCTATGGATTTTAGT 
2-5C GGCCGTTTACGTGTAGGTGTCACC GACGTCAAGAATGAAGGGCGTCTG 
2-5D CGGGGCATGATCTACAGTAACCGA CCTGTACACTTGTAGGTTGGGGCG 
2-5E CCTTTTGTAGGGTTTTATGCGGCG CGGGCTCCCATTTCATGGACTACT 
2-5F CGGGCCACAAAAAAACATGTCATT CCGGCTATGATTCTTGCTCCAGGT 
2-5G CGTTGGCCCTTAGCAGGTCATATG AGTCGGTAATACGCTAGGCTGCCG 
2-5H CGGGCTACGATGACTCAGATCCAT GACAAGCAAATATTGGGGCCTCGT 
2-6A CGTAGATTCCCAAGGTTCGTCGCT CCGAGGCGTATCAGAGTTAGCGAA 
2-6B GAGGCTTCACCGCAATCCTGCTAT ACCAAAGGGGCTCTTCAAACATGC 
2-6C CGCACCTTGTCGTATTAAGGGCAG TACGTACTGTCTGACGGGGTGCAA 
2-6D CTGGTGTGAGATCGTAGTCAGCCG GCCCGGCTGAAACCAGGTACTATG 
2-6E CGATGGGCGCGAATCCTTAATTTA TTAGCCGCTGTCTTGCTGCAAGAT 
2-6F CAAAGGAGCAACCCCGCTTCTAAA CGAGCCCGACACAGAGTGCTTACT 
2-6G CTTCACGAGGTATTACGGCGCCTT CGGGCGAGAGAAAAGCCTATGAGT 
2-6H GCGCGGATCAGTATGGTTCAAAAC CGTTATATGTGCGTAAGCAGGGCG 
2-7A ATACAGGGCGGCGCAATAACCTAA AGCGCGCAGGGCATAGGAGTATTA 
2-7B AATACACGACTCAACTGCGTGCGA ACGCCCGGTCATAGGGTTCAATAG 
2-7C GGCAAGTCAATAATTGTGAGGCCG TCTTGATCGCCTGGCGAGAAATTA 
2-7D GCGCGCTACATCTCCAATCTGGTA AAGTTCTTTTCGGAGGGTACGCGA 
2-7E TGTCGTGTGGAACGGGCTGATATA CCCCCGGCGTTTCACTACCTTAAT 
2-7F TCCCACTCGGAAGCTGTTATCCAA CCGGCACGCACCACTAAATTCTAA 
2-7G CCAAAGATATCAACACCCTGGCCA CAGATCGCTGGACCTCCTCTGTTC 
2-7H AGTAGGAGATTACGTTCGCGCGCT AAGAAGGAAGGGGGAAACGGTTTG 
2-8A TCCGATCTAAAACGGGAGCAGGAC ATCGAACCACATGTACCCCCTGTG 
2-8B CGCGCGTACAGTGTTTCGAATTTT GTAAAGCTTGTGCACGGGCAGCT 
2-8C AACGTAACGCCTCCGCATGTGATA CTATGTCATGCTTGCATTGGAGCG 
2-8D TAGCAGCTCATCCACATGCAAGGA GGCGAGGATTCAAGTGGTTTGTGT 
2-8E GATTTGAACGGTGAGAGTACCGCG CGCGAGGGTGTGATACTAGATCCG 
2-8F AATCGCGGCCCGGTTAATTCTTAC TCCAATGGATCCTGGTCCCTTTTT 
2-8G CCCGGCGGCCTAGTAATTGATTTT GCCAGCCCGATGAACTGAGATCTA 
2-8H GCGAAACGTCAATATCCGCCTTTC CCCCCCATTCTATTGGCATGAAAC 
2-9A CTATGACGTGGCGCCTACAACTCC GGCGACCGGGATTCGGTACTAATA 
2-9B CAGACCAGAGGATACATCGGCACC GCGCATTTATTGATACCAGCGCAC 
2-9C TACTTAGCACGAATCGAGGTGCGC CGGTCTGATGGCTGAGAGCATTG 
2-9D ATAGGACGGCTGCGAATCATGCTA TCGCACAGTATTACTCACGCGGAC 
2-9E CCGCGACCGATCTTGGTAACACTA TCGGGTTCGAATCGGAAGAACTCT 
2-9F ATATATCGGACGGATGCCCGTCAT CTGATAGCATGCAACCGGATCGAT 
2-9G CTCAGTACGAGCACTGTCTTCGCG CTATACAGGCACGAAGGATCGCGA 
2-9H CGCCTGTTTTAACCCAGTGATTGC GGCCTCATTCATTCACGACATCCT 
3-10A GAGTTTGACGTATAGACCCGGGGC GATGGCGCCCACCCGATTACTATA 
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3-10B TTCGAACATTCTCATACGGTGCGA CGCCGGAAGCCTGTAGACCTTAAA 
3-10C CCCGGGAGTTTAAATCCGACACTC AGTATAAGCGGATGGCTCGAACCG 
3-10D CGCGCCTGGGGGTCGTACTATATA CGCTTCACAAGGGTTTGCGATTAA 
3-10E TCTTATCGTCACAGCGAAGAGGCC TTCAACGGTGTACGTGACTGCTCC 
3-10F GACCAGACTGAGTGGAATTGCCGT CCGTATTAGTCAATGCCCTTCGCC 
3-10G ACCTACAGTGAGGCAAACGTCGGA TCCAACGTACCGGATTGGTGGTTA 
3-10H CGCGCGATCGATTGAAAGTAAGTC CCAATGAGGACGGAGCCCAGATAT 
3-11A CGCGCAATGGTAGCGGGATATAAT GCAGAGGGGAAGAATGGATAGGCA 
3-11B CTTTAACTAGAATCGCGGCGCGC GACCTCGCGTAGGGGTCAGCTAAT 
3-11C ATGGACCTTCCACCTGTTATGCC CTATCTCAAGCTGGCCCAATGGCT 
3-11D TGTCGTCGGGCGCATTCACTATAT GGCAGCCGAGTTAAGGTGGAACTT 
3-11E ACGGGATAAGTTGTTAACCCCCCG TCTGGATACGCTGCATAGCGTCAA 
3-11F CGTGGAAAGATAGTGTCGCATCGA CGCGTGCTTTTCGATTATCTAGCG 
3-11G TTGCGCTGTACTCGAACGTTGATC GGGGAGGGTGGCTAAAATACAGCC 
3-11H GGCAGAGTGGAGTTGAACAGGCAT CGTGATGAAGGCAGTGATACAGCG 
3-12A GCGAGACCCGCGAATGTGATTATA CGGGCCGTGACGGGATTATATTAG 
3-12B CTAAAACTTGATCCTTGACGCGCG TGCCGACTTGCGGTTGCTACTAAG 
3-12C GTTCATTTCAGGCAGTCAGGTCGC ATTGAGGAGCTCGGGTTTGTCGTT 
3-12D TCAGACTCTACTCTCTGTCGCGCG GCGCGAGTTGACGGTATCTACACA 
3-12E TCCCTCCCGAAGCCGACATAGTAT AAGAGACTCGAAGCGAGGGGTGTC 
3-12F CGGGACAACAACTCAATCGAGAGG GGCTCATCTCTTATCATTGCGGCA 
3-12G CAGGTTCCTCGCTACTCCTGGAGG TTAGTCGCGCTCCTTCTCCACTGT 
3-12H GAGTACGGCTTCATTACACCGCCA CACTCAGGACTGGCATTTACGGCT 
3-1A TGCCACGCAACATTACACTGACC GTGCGAGCACAGCAACGACTACAT 
3-1B CCCACAGAACAGGAAGTTGCTTGG TATCCACAATAGGCTCCACGTCGG 
3-1C AATAGATTAGCGAGCGAATCGCCG ACGGCTTAGCTGGAGGTATCCCTC 
3-1D GGCTCTATACCTGCTCGTGTGCGT GACTTCAATTTTAAGCACCCGCCG 
3-1E CGAAGTCGTCGCGAGTCTGTACAA CCGCCCCAGATGCCATTGTATATT 
3-1F CGCGGCGTCATGTGTACATTCTTA ACAGGAACGTAGTCCGGTCCAAT 
3-1G CGTCTTCCCTTGTTATCTCGTGCG AATTAGTGACGCCAGCTCGCTGC 
3-1H CTATCCGCGGTTTGATTAAACGGG GCTCCAAATAGCGCTGTCGTTCAT 
3-2A GCGAGTGATATGCATGTTGTCGGA AATCGGGAACCATCATGCAAATCA 
3-2B CGAGCGAGTCGTTACGCGAAATAG GATCAGCCACCGAGGTTGAAACAC 
3-2C TGGAACATTGCACAACAGTGACCA ACGGCCATCCGGTCAAGAGTAAG 
3-2D CGGTTAACGGCTGTAGGCTGAGTG ACTAAAGCAGGAGTCGGATGTGCG 
3-2E TGGGCGGGTAGATTTCAGAACTGA TAACCCGTTCTACATTCGAGGGGC 
3-2F AGTCTAGCAAATTAACGGGGCGCA GGCGCTGAGACGAACGAAAGGTAT 
3-2G CACCCCTTCAGCAACATCTATGGG TCCATGCCGTGCATCGTATAACTG 
3-2H CTAATAACGGCAAAGCAACGCTGC CAACGCAATGTGAGTGTATGCGTG 
3-3A GCGTCTCCAGGCATGCGATCTATA CTGAACAAACATCTCTCGGCTCGG 
3-3B ACCTGGCGTTGCATCTCAGGATAG AGTCATTAACCTGGCACAGCGGAA 
3-3C TGCAAGTCCCTGCACTGACATGAT CAACCCAGCAAACCTGAATGACC 
3-3D GGGCCCCGCACTTAATTCACTCTA ATATAACATGAACGCCGTTCGCCA 
3-3E TAAGGCAGCAACTGCAAGTGGGAT TGAACCCAATGCTGACAGGTTTCA 
3-3F TCCGGTCTACGAACGTGCCTAGAA CGGATCATGTTCCTATGGGGGATC 
3-3G GAAGCCCCTCAACTACAAACGCCT CGCTCGGGATTTCACGTATATGGA 
3-3H TCGGCCACGTGCACATAGGATAAT CCCTCTGATTTTCAAACGACTGCG 
3-4A GCACTGTTCCGTAAGCTGGAAGGA TCTTTGGTTGGAACGAATTACGCG 
3-4B TCGGTATCACCTGGGCCGTCTAAT TATTCCGAATTCCTAGCGATCCGC 
3-4C TCATGCGACGATGGACGTCTTTTA GATCGGACCTTACTGCATCAACCG 
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3-4D CGCGCAAAATGAGGTTAGAAGTCG CCGGGTGCGTTTTTTGGTTTCTTA 
3-4E TACACCGGGGTTTTTTCAAGCTCC ATTCGCCAGTGCTGTCACCAGAAT 
3-4F CGGGCGTGTAAACACATTTATCGG CGATGCAAGAGGTCTCCATTTTGG 
3-4G GATGATGCGAGAACGCAGAACATG CTGCCGATGTTTTCGACTTTGGAA 
3-4H CAGCAAATGGGCCTCCTCCAGTAT CGGTCGGAGAAGATGACTTGGAAA 
3-5A GCCCGCGGCTCATTATTTAGACTC TACCTTTGCGGCCGAAGGGATTA 
3-5B TGCGGATTCAGGAGATCTGTCTCC CTGTGTTACACGGAGTGCGAGGCTA 
3-5C TCGGGAAGATTCACGTCGAAGATC CACGCTGCTCCTAGGCAAATTGTC 
3-5D TTACTATGCGCGAAGCGTAATCCG GGGCCACCAACGAAATTAATCTGG 
3-5E TATACGCTCCCAGCGTGGTCGTAT GCTTGGAGGAAACTCACGACCTCA 
3-5F TCTCGATCGTTTGGTTAGCGCAGT GCCGGACACAGTTACATACGGGTC 
3-5G CGCAAGATGAGGTCAAATCGAGCT CCTAGCCAATGATGGAACTGGCAA 
3-5H GCCACTAACGACCTTCTCGGTGAA CTACTGCAATGGAGGGAATCGTGG 
3-6A ACCGCAACAGAAGTGCGAAGCTAG TCCCCACATTGGATGACTGAACT 
3-6B GGGTGCTGTAGTACAGGCGCTACG GGCAAGCGACTCACAGAAACATCA 
3-6C GCAGTTAGTTAACGCAACGCAGGC GGTGGCATCCATCCTGTCACACTA 
3-6D CGCGCGTTGTACCCTAGAAGAGGT GTACTAACCCTCTTTGCCAGCCGG 
3-6E GCCATGGGGTGCGGTTACACTATA TGGGGGAAGCAGTAATGAGACGTC 
3-6F CCATGGCCGGTTCTGCTTGCTATA GTCGACGCTGACCAAAGTTCATGA 
3-6G GTACATCGTTTCCACAACCAGGGG GTAGGCGGTACGCACTGTATTGGC 
3-6H AGTCGCCGAATTATGGGTGCACTA ATCTATTCGATAGGACCGCGTGCA 
3-7A CGCGCTGATCCATGGGCTACTATA CGGCACATTTGCAACATAAGGACA 
3-7B AATAAGGCTAAGGCGCGCTTGCTT GGCCGCATTTCAAGTCCTTTTACG 
3-7C GGGCGGCACAGAATTGTGTAAAAG CAGAAGAAGCGTGAATTCGCCTTG 
3-7D GTACCCTTCCGCTTTTGTGCAGGT TGCCTGCCGTGGTATGAAACAGTA 
3-7E ACTACCGCCATAAATTTGGTGGGC TGCTTAACGTCTGAGGGATGACCC 
3-7F TCCCGCAAGAGTCAGTCCTACACC TTATAGTGCAAGCGGGCTCTCTCG 
3-7G AAACCGGACAGTTATGGGACCTGC CAAGCACGTAACTTCTGAAGGCGC 
3-7H TGGACAAGACGATCGGTGGGTACT GGATCCCCTCGTCGAACTTGAAGT 
3-8A AGCCCATCTCAAATGGCCCACTAG CCGCACTGATTGACGATCTTAGCA 
3-8B TTCCTGTCTCATGGTGAGACGGGT CCTACCGTAGCTAGGTGGGGGTTG 
3-8C CGCTGCAACTAAAGGTGCTCCTGT ACTGTCGGAAGTCGCAGTCATTCC 
3-8D GAGGGCATAAACCAGCGGCACTAC GAGTGCCGTCATTGCCGAGTAGAC 
3-8E CGGTTCCGGTAAACTGATTCGACA AATTTGCAGGGCCGATGAGTTTTC 
3-8F GCCCAGTTGTAATGGCAGACGACT GGCCCCATGCGTGTTTCCTTTATA 
3-8G GCTAGGACATCGCTATGTGTGCGA GGATGCAGGCAAAATACTGCGATC 
3-8H TCCGGCCAAGTACAGAAATGCAAT CACAACTATCGTGGCCTGCAACCT 
3-9A GAAAACGACCGGTTGTTTATGGGC GCAGGTGACAAGGATTTACGCCAG 
3-9B TGGAGCGTTAATCGAGTCGGCTAA CAGAGGGACGGGTGTCTATCGTTG 
3-9C CGCTATCATATCGCTTATGGGGCA CATTAATACAGACGTGCTCCGGCC 
3-9D CGCGCACATGATATTTCCCTTACG GAAAGGGTTCGCGTGATACGATTG 
3-9E CGCCGAAGCTTGGTTATACCAAGG AGCTCCCTTAAAGGCCTACGTCGC 
3-9F GCGCGGGTTAGAGGAAGACTCATC TGGCGGCTCCGCTGATAACTTAAT 
3-9G ATATATAGGCGCGGCCTGGCTACC TGGCCCGTGACACTCATTTAAAGG 
3-9H CCGGGGCTTACGATGTTACGTAGG CTCCCTAGGTATTCCGCAAGGACG 
4-10A TATCAGTTGTTTGGTGAACGCGGA CGGTTTTACGTTACATTTGGCCCC 
4-10B CTCAGGCGCCCTAAGAGTCTTGTG AGGTCACTTAGCGATACCCCACGC 
4-10C TGCGGCACCTCTCATGTCTAATCA CGAGATCCTTAGTCGTCAGTCGGC 
4-10D GAGCATCTTACCTCGCTCAACCCA TCCCCGCGGACATAACCTTTAATG 
4-10E TTATGTCGTACCGTTGGGTCAGGC ACGTCCTAGACGACACGCAGGTGT 
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4-10F CGCGCCCGCTAACGTAGAGTAATT AGGCTGATGTTAACGAACATGCGC 
4-10G AGATTGCCTCGACTCATGCGTCTT ATGCGATAGGTTGACTGGTGTCCG 
4-10H TGGGGAATACTGGTCGTCTTCGTC GTGCCTGGGTAGCGCTTGTTGTTA 
4-11A TGGCCGCTAAATCTCAACCAGCTA CCGGAAACTTCTTATCCACGGAGG 
4-11B CCTCGGGACCGTAGATGACCAACT CTCTTAGCGGACGCTCAAGTGTCG 
4-11C TTGTCGTCCGAGCCAGCTACCTAC CGCTCTCCTTTACAACAAATCGCG 
4-11D TCTACTGAGACAATGTTGCGCCCA TGAATCAAGCTAGCGCACGACTGA 
4-11E ACTCTAAGGAGCCCTGACGAGCGT TGGGCCCTCCTTATCCTGTGTCTT 
4-11F GGACAGCTTTAACGGTTAGGCGGA AGAGTCAAATTCACCCGAAAGCGG 
4-11G TCGCGGGGCTATACCATAAGGTGT TTTGTTTTATCCTTGCCCGTGCAA 
4-11H GCAAACAGTTGCATAGGGGTGGAG ATGGGAACGCTTCAGCCTTTATGG 
4-12A TCGACTAGCTTACTGGGGCCCTTC CGGCGGGACTATCTGATTAACACG 
4-12B GTTGGTCCCCACCCCGAAGTAATA TGACTGAGGCCCGGAGATAGGAAT 
4-12C CATAAACTCGAGAGACGACGGGGA GAGCCGAAGTGATTTTTCCTGGGA 
4-12D ACCACTGACTGGGAGAAGTCAGCG CACCAAAGCGCTGACGGAGAAATA 
4-12E TGGCTCTGTGGCAGGTGGATCTAT ATTGAGTGGTAAGGCTGCTGTGGG 
4-12F ACTCATGTTGACCGCCCTCCCTAT TGCGAATTTACAAATGTCTGCCGA 
4-12G CTCGCGCACCGGATGGTTAATAAT ATGGTTGCCCGAACAAGCAGTTTT 
4-12H ATACAAGCCTGGTATGCCAAGGGC CCGGGGTGTGCCCAATAAACTTAC 
4-1A CCGCGGCAGTAGAGATGCCTTAAT ACGTCCAGGATACTGTACCGACGC 
4-1B ACCGACTGGTTTTTGGGGTCAACT CTGCTCTGAGCCGTAGTCGACCAT 
4-1C GAACACCAGCGTAGCTCAGGTTGG TATGTGTAACGGCGGTGCACAGAC 
4-1D GTTAACACCTAGAACCCGTGGGCC GTTTTGGGCTTAGGGTTGACGCAT 
4-1E CTCAGTTGCGATGCGCGGTTATAT CCTCTAGTTTGATGATGGGCACCG 
4-1F ACACGATATAAAGCGTGGCGGATG TCTGCTGAACCCCATCCCATACAT 
4-1G CGCGGCATGAGCCTACTTGAGTAA AGGCTCGCAGAGATAGATGGGTGA 
4-1H CGGTACTTCGATGAGCAGCCACTT CGGCCGAACGACTTACGAACAATA 
4-2A GCCAGCAGGCCGTTGACAATACTA GGAGCGGTCGCTGGGTAATAGCTA 
4-2B TGACACGTCCGCCCCTGAGTATAG GTTTAAGACAGGTGGCTCTCCCGG 
4-2C CGCCGCGAAAGTCTAGTGCCTATT AAGGGATGGCCAAAGCAGACAATT 
4-2D CGCTAGACAATCTCGTCCAGTCCG TCTGAGGTCTGCGGTCCGTCTTAC 
4-2E AGATTGGGCGACATGGTAGAGGGT GAGTAAGCCTGCTCTCCATCAGCG 
4-2F TATCTCGCAAGCAATGCAGCTGAA TTGCCCCAAGAAGAGAAATGAGCA 
4-2G ACAAGGAGGAGAGTTTTGGAGGCG GTAATGACAAAAGTCCCGGGTGGC 
4-2H ACGTCTGGTTACAGTACTCGGGCG ATCCTCGACGGATTGAGACATTGG 
4-3A CATAAAGCTACCGACAGGACGCCA CGCGAGCGCGTAGAGGAGTAAGTA 
4-3B AGAACTCGTTGGAGTACGTCGGA AGACTGTGAGCTAGAACACCGCGC 
4-3C CACCGCGTCGCTTAGTCCTATTGA ACCGGCGTCCGTATCTCTCCTAAG 
4-3D TGCAAGTTACTAATTTTCGCCGCG CGATTGATTAGCTTGCAGGACCCA 
4-3E CGCCCCGGAATTTTGTGATAGATT TTAATTGTCGGGAGCTGCCTCCTT 
4-3F AACACCACATATGGGGAAGGACGA TAGGATTCTAGCCGGGACGGACAC 
4-3G TAATAGAGGCGTGTCATTTGCGCA GTTAAATTATCTCCCTCGGCGCGA 
4-3H ACCAATTGTAGTTTCGGGGGCCC GCACAGTGAACGAAGAAAGGCACA 
4-4A GACGGACTATTCTCGAACTGGGGG GCCGTGCCGATCAAATCATACATC 
4-4B GATTTACTCAGCGGGGAATTGGGA TATGTGAAGAGATCTTGTGCGCCG 
4-4C TAAGCCCTTCTTCCAAGCTCTGGC ATTAGAGGTACTGGCTGGGACGCG 
4-4D TAAAGCCCACCTTTCATTGTGGCA CCACCCATGCACCTTCAGTTGAAT 
4-4E TCGGGGCCATGCAATGAGTTATAG TTTACCCAACTTGCCCCGAGAAA 
4-4F CGCGACGGTAACGAGAAGTAACCA TACGGAAGGTGTCGTAACTGGCGT 
4-4G CTCCGCACTCTCGGGCACTCTATA AGGCTCCCTCATCATGTACAAGCG 
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4-4H AACTTTACCGCGGGAGGACTTTCC TTCGTGAACCCGGAGTCCAGACTA 
4-5A CGCACTAGTCTCGAGGCGGTTAGA CCGCCGTCACTCAACAAGGTATCT 
4-5B TCCCTGGTAGCTATACTGCTGCGC CGGCCTTGTCTTTTGGGTTTTCAT 
4-5C GCCAGCAGGCCGTTGACAATACTA GGAGCGGTCGCTGGGTAATAGCTA 
4-5D GAGGGAGGTCGATGTTCCGGATAG CGTCGGGGATGTTTAGTTTTCCGT 
4-5E AATCTGCGTAATGGAGCCGGAACT TGTAAAGTCGGTGCTTGAGCACGA 
4-5F TCGGCGGGGGGAGAATATTAAAAC GGGCGAATGAGTCCTCACAGGTAA 
4-5G ACGGAGCAGAAAGATGGAGTGTGG TTGACAACCTGCATGCCGATACAG 
4-5H TAGCGTAGGTCGTAAGATCCGGCA ACTAGCAGGGAGGCAACGCGTAAG 
4-6A GTCGTTGGCTACGTACCTCGGCTT CCGGCAACAAAAATCCTATTCGCT 
4-6B TGAACGATAAAAGTGGGCTCGACG GTCAACTTAGTGAGGAAGGCCGCA 
4-6C GTTTACCTTATCTGCAAGGGCCGC AGAAACGGCAGCTGGATGTGTGTT 
4-6D CGAGGTGGTCACAGGCCTAGACAT GGAACGTCGACTTAACACAGGCGT 
4-6E CGGGGGTAAAAAGTCTCCGTTTCA TGTGCCGAGAATCACACTGAAAGG 
4-6F TAATAGACGTCGCGCAGTGGAAGC GTTCTCAAGATCACAGGGTTGGCG 
4-6G CGAGAAACTAATTGCGTATCGCGC GGCGGGAGCCGTTGCATAGATAC 
4-6H TACTACCTGGAAGCCGGCATTGGT CAGGAGGCTCCGGAAATTCTTCAG 
4-7A CGCGCGAGAAGCATACTCTAGCAG ACGCGGATGCTGTCCGAAATAAAT 
4-7B GCCGGCGAGATCAATGTAGGTCTT GGAAGTATCTGAGGAAATTGCGAA 
4-7C ATAATGGCCGAGAAGCCGCTCAT GGTGACACCGAACAGTTTTGTGTT 
4-7D AGAAATCGTTACAGGCCAGGTGCC TCGGGCGACGGAGGTAACTTTAAC 
4-7E ACGCTCTCACATCTGGCTAGACCG GATTAGCAGATAGCGTTTGGGCCG 
4-7F CAACTAGGCGTCAAAGATTTGCGG TGGGTGGCATATTCATGTGACAA 
4-7G CTCTCCGGACAACTGCCATAACCA AAACTTTGACTGCAGCACACACGG 
4-7H CTGTGCTATCCAATCGACTCGGT TTGGGTGTGGTGATAGGTGTGACG 
4-8A ATATGACGGTGCAGACTATCGCGG CGCAAAAATGTTTTAGGTGCACGC 
4-8B GTTGCACCATAGGTACAAAGCGGC ACTGTCAATACGGCTGAGGCGAAG 
4-8C GATATGAACACACGTAGCACGGCG CACACGCGATGAGAAGCTGAAAGA 
4-8D CAGTATATTGATCCAGAGCGCGGG GACGGTGGTTCTGACCCGCTTAAT 
4-8E GCGGGCGAACTCAAAATTTGATTC AGGCTTGCTCACTGACGTCGTTCT 
4-8F TCGAATCTGAGATTGGCTCCAACC GGAGCGGGTAAACGTTCTGTTCGT 
4-8G AGCGGTTGAGTATCGCCCTAGGAC GGCTTGCAATCTCCCGAGACCTAT 
4-8H TAGTAGTTAATACCGGCCCCGGCC ACTGACGGCTCGAGATGTGGTAGC 
4-9A GACAGCCCGGGGATTTAGGCTAAT CTGGTACACGAACACATGCCAGCT 
4-9B CGGATTATTCGGACTAACGGACGG CATCACGAGAGCTACCCCCATCAC 
4-9C CATGGTCGTTGATAGCCCTCTTGG ACGTCTCGGAATGATTTTGCTCGA 
4-9D CTTAGGCTGGCTATTCACACCGCA TGTGGGTAGTCCCTCGTGTCGACT 
4-9E ATTTACTAGAAGCCCGGTGACGCG CGGCGAGGCACCTTAGATACTTCC 
4-9F CCTGCGGAAACAGAAAACCTAGGC CACATTACGTACGGGAGTCCCCAA 
4-9G CTTTTGTTCGAGGAAGTCCGGGTC GCGGCCCCTGGGAAATTTTACTTA 
4-9H CGCGCCGTTTTTATAGCTTCTTGC GCAATGAACAGACATAGCCCAGGG 
5-1A ATAAGAACCAAGTGCCGGGCAAAA TCTATGATGGCCTGGGAGGTGCTA 
5-1B GGGGAACTGCCTCGTTAGAGACGT ATACCCACGACTTTTACTCGCGGG 
5-1C GCGCGCATTACCCTGAGGTTTAAC CAGAGGACCAGTTGGATGCGCTAT 
5-1D CACGTAGGTGCGGGACCATTAGTC TTGTGTCCTAAGGCTCTAGCGGCA 
5-1E CGCGAAACCTATTTGTAGCGTGGA AACGCAGCGTCTGTGTTGAGAAGA 
5-1F TCAGGAAGAAACTCTGTTTGGCCG TCGAAGCCATTCAAATACCAACGC 
5-1G CGGGAGAACGGAACTGTGAATCAG CCCGTCGCTCCGAGGAATAAGTAG 
5-1H ACGGGCTCATATTTGGTCGCTTCT CGGTGTGTTAGAGTGGCTCCGACT 
5-2A TTGCGTTCCAGATGGATCGTATGA CCCCTGAACTTAACCGCTAATGCG 
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5-2B GGGGATTCCGCTCAGTAATTAGCG GATGCCTGAGTCCGTAGGTTTGGA 
5-2C CTATATGGTCACCTTCGTCCGGGC ATGTCAATCGTTCGATTTTCCCGA 
5-2D CAGGAACCGGGAAGCGCTCTAGTA GCTAGCACCCAAGAGTTGGAAGGG 
5-2E GAGCTGCGGGTCCCGGATACTATA CGGCCCATGCTACATAGCAATCAT 
5-2F TCGGCTAGGGCTTTCTAGGAACGA CTTCGATACGTACAAACTGGCCGC 
5-2G TAGTCGGCGCCAGGATGAGACTAA GGCCGCCTTGAAACTAGGACTTCA 
5-2H TATAGACTCCCATGCCCTCACCCA AAGATTGGTCGAAGGCCACAGCTT 
5-3A CAGCAAAACTTAAAGTCACCCGCG TACGGTCTGGCATCAGGTTCAAGG 
5-3B ACATTAGCATACGTGGATTGCCCG TTCGACATGTGAATTGATGCCCAC 
5-3C AATACATCAGGCCCAAGTTGCCGT GTGCAGTGCTAGGGGGACATATGC 
5-3D TTCCCAGACTCAATGATCGAGGGA CGTGCAAACAACGCACTTGATGC 
5-3E CTCGCGCTAGGGTCTTTGGCTTAA TTCGCTTTAAACAAGAGCTGGGGC 
5-3F TATAGAGGGCAGGCGGAACAAAGC GCGCGTGGATCACATCCCTAGATA 
5-3G TCGCAGGGTTTCACGGGAATAATT TTGTTGAACTATTGATTCGGGCGG 
5-3H ACAAGCTGAGCAATTGTGCTCACG ACAAGTGCAACCCTCGAGCTCAAA 
5-4A CGAGTAGCTCGAAAGAGACGCCAA AGGTTGGATTCCCGCCATTCTCTA 
5-4B CCCCCGTAGTGTGGCTACTTAGGC CAGAACGGTCGCAACCTAGTTCGT 
5-4C CCAGCATCATACTTACCGGGCATG AGGTCGAATGACAGCCTTCCCTCT 
5-4D TGGGGGGCACAGTCAGAAAGTATG CGACCAGATCATCCGGCTAACTGT 
5-4E CAGCATACCCGAACTATGCTGGGA TGCCCACTCCAGCACCAGTTATTT 
5-4F CGATCATATTATGCTACCGCGCCA GATCGCTTGACGGCCGAGTCTTAT 
5-4G GTCGTACGTGGTCTCATATGCGCA AGGCCGATCGATATGGCAAGAACT 
5-4H TGCTGCTCTTCTGGTACTTGCGTG GCCCCGACATCTGTAACTCTCGAA 
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TABLE G.2. CHARACTERISTICS OF ALL MUTANTS IN THE EXPERIMENTAL SET 1 IN FREE-LIVING 
CONDITIONS 
 
complete mutantID mutated genea predicted function 
meanw
-value 
(TY) 
p-value 
(t) (TY) 
meanw-
value 
(VMM) 
p-value 
(t) 
(VMM) 
meanw
-value 
(SDS) 
p-value 
(t) (SDS) 
meanw-
value 
(NaCl) 
p-value (t) 
(NaCl) 
2011mTn5STM.1.10.A01 SMb21639 phenylacetic acid degradation protein PaaB 0.01 7.49E-01 0.20 1.26E-02 0.40 1.98E-20 0.48 1.95E-22 
2011mTn5STM.1.09.B01 SMa0675 cation (Ca) exchange protein, possible -0.34 4.04E-06 -0.25 8.06E-10 -0.25 1.25E-14 -0.38 6.64E-08 
2011mTn5STM.1.09.C01 SMc00513 putative amino-acid binding periplasmic protein -0.14 3.11E-02 0.16 4.10E-03 0.26 1.28E-09 0.19 2.65E-07 
2011mTn5STM.1.02.D01 SMa0259 hypothetical protein NA NA 0.26 1.15E-02 0.39 1.79E-05 0.58 1.76E-06 
2011mTn5STM.1.01.E01 SMb20834 lipopolysaccharide processing protein RkpZ1 0.14 5.50E-02 0.30 2.34E-03 -0.48 2.36E-22 -0.39 4.51E-25 
2011mTn5STM.1.13.F01 SMa0113 Sensory histidine kinase 0.14 2.24E-01 0.37 7.18E-06 NA NA 0.29 1.08E-03 
2011mTn5STM.1.02.G01 SMa1497 putative Gst12 glutathione-S-transferase -0.08 2.00E-01 0.00 3.54E-01 0.26 8.18E-02 NA NA 
2011mTn5STM.1.13.H01 SMb20167 hypothetical protein -0.01 7.69E-01 0.10 8.29E-02 0.27 3.63E-18 0.42 1.85E-18 
2011mTn5STM.1.13.B02 SMc02327 ribonuclease HI protein RnhA2 -0.11 1.55E-01 -0.11 2.21E-02 0.09 6.32E-05 0.01 7.04E-01 
2011mTn5STM.1.09.C02 SMa1903 putative protease NA NA NA NA -0.02 5.39E-01 -0.16 3.93E-02 
2011mTn5STM.1.03.D02 SMc02466 SdhB succinate dehydrogenase iron-sulfur protein -0.44 7.20E-06 -0.29 1.11E-01 0.19 1.78E-10 0.20 2.14E-08 
2011mTn5STM.1.11.E02 SMc02738 ABC cholin transporter, permease component (OpuB) -0.12 1.25E-01 0.00 9.16E-01 -0.07 2.14E-03 -0.14 1.23E-12 
2011mTn5STM.1.08.F02 SMa0525 putative ABC-type iron transport system protein -0.44 1.51E-06 -0.20 2.59E-03 -0.08 4.29E-04 -0.11 7.65E-07 
2011mTn5STM.1.07.G02 
S. meliloti 
chromosome, 
2021711 
intergenic -0.23 1.22E-03 -0.09 3.25E-01 -0.23 8.34E-17 -0.11 5.96E-07 
2011mTn5STM.1.06.H02 SMc01090 ATP-dependent RNA-helicase protein DeaD -0.45 2.19E-06 -0.34 6.30E-05 0.17 7.04E-11 0.31 1.03E-29 
2011mTn5STM.1.10.A03 SMc01046 Trk system potassium uptake protein -0.23 1.03E-02 -0.31 3.20E-07 -0.11 1.20E-04 -0.21 9.08E-05 
2011mTn5STM.1.01.B03 SMc01432 hypothetical protein -0.04 4.27E-01 0.01 8.56E-01 0.20 8.01E-10 0.23 3.22E-13 
2011mTn5STM.1.05.C03 SMb20071 putative efflux protein 0.38 7.42E-06 0.30 4.50E-06 0.30 1.84E-14 0.28 1.11E-17 
2011mTn5STM.1.03.D03 SMb20349 putative ABC transporter 0.19 7.35E-03 0.17 2.67E-08 0.04 2.47E-03 0.15 1.01E-05 
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2011mTn5STM.1.11.E03 SMa0300 ABC transporter, permease 0.31 1.61E-03 0.23 4.99E-07 -0.16 2.78E-08 -0.15 3.49E-04 
2011mTn5STM.1.06.F03 SMc00300 putative oxidoreductase protein 0.04 2.92E-01 0.11 5.20E-04 0.05 3.81E-01 0.11 7.78E-04 
2011mTn5STM.1.08.G03 pSymB, 543971 intergenic 1.17 5.59E-04 0.74 7.58E-21 0.02 8.70E-01 0.15 3.01E-07 
2011mTn5STM.1.08.H03 SMa1236 NapA periplasmic nitrate reductase 0.29 2.27E-06 0.26 9.04E-06 0.09 1.52E-06 0.12 3.92E-04 
2011mTn5STM.1.11.A04 SMa1004 hypothetical protein 0.20 8.53E-04 0.06 3.65E-01 -0.22 6.89E-09 -0.27 3.57E-07 
2011mTn5STM.1.06.B04 SMb21707 
putative short-chain amide or branched-
chain amino acid uptake ABC transporter 
ATP-binding protein 
0.17 9.31E-03 0.01 4.67E-01 0.30 3.38E-14 0.32 6.43E-19 
2011mTn5STM.1.01.C04 SMa1229 FixL Oxygen regulated histidine kinase 0.04 4.95E-01 0.17 1.94E-03 -0.28 2.67E-19 -0.26 9.49E-17 
2011mTn5STM.1.03.D04 SMa1531 NuoC2 NADH I chain C 0.21 5.84E-04 0.05 2.64E-01 0.08 1.10E-04 0.11 4.77E-06 
2011mTn5STM.1.13.E04 SMa1503 hypothetical protein 0.47 6.19E-06 0.36 2.12E-05 0.19 2.02E-08 0.22 1.56E-12 
2011mTn5STM.1.02.F04 SMa1292 hypothetical protein 0.30 8.57E-04 0.17 2.67E-02 0.00 4.64E-01 0.00 7.14E-01 
2011mTn5STM.1.01.G04 SMc01497 sorbitol/mannitol transporter SmoF 0.16 1.98E-02 0.29 1.57E-06 0.44 7.61E-18 0.38 2.46E-16 
2011mTn5STM.1.07.H04 SMb21422 putative sugar uptake ABC transporter ATP-binding protein 0.17 2.60E-05 0.07 4.75E-01 0.12 2.18E-08 0.15 4.14E-11 
2011mTn5STM.1.02.A05 SMb21645 ABC transporter, permease component 0.10 9.46E-02 0.20 4.10E-04 0.30 2.86E-13 0.40 6.33E-10 
2011mTn5STM.1.07.B05 SMb20142 putative oligopeptide ABC transporter permease protein -0.09 2.52E-01 -0.07 5.97E-01 0.19 1.00E-05 0.30 5.97E-10 
2011mTn5STM.1.03.C05 SMc02121 general L-amino acid transport ATP-binding ABC transporter protein AapP 0.05 4.75E-01 0.21 5.30E-03 0.44 1.93E-16 0.48 1.69E-18 
2011mTn5STM.1.08.D05 SMb20219 putative response regulator protein 0.13 1.37E-01 0.23 3.54E-02 0.13 1.84E-13 0.37 1.45E-22 
2011mTn5STM.1.09.E05 SMb21527 putative taurin uptake ABC transporter ATP-binding protein TauB 0.05 4.06E-01 0.20 4.02E-05 0.05 1.77E-03 0.17 7.04E-07 
2011mTn5STM.1.12.F05 SMa0803 putative ABC-transporter ATP-binding protein -0.16 3.01E-03 -0.09 2.89E-02 -0.10 2.74E-04 -0.26 3.79E-13 
2011mTn5STM.1.12.G05 SMa0621 FixI2 E1-E2 type cation ATPase 0.88 1.68E-03 0.77 3.69E-09 0.11 5.74E-05 0.16 5.19E-10 
2011mTn5STM.1.07.H05 SMa0875 NolG efflux transporter -0.12 9.63E-02 0.12 1.05E-01 0.04 8.71E-03 -0.16 2.91E-16 
2011mTn5STM.1.09.A06 SMa1507 hypothetical protein -0.20 1.64E-03 0.03 8.27E-01 0.04 1.68E-02 0.13 4.52E-10 
2011mTn5STM.1.04.B06 SMb20930 putative sugar uptake ABC transporter ATP-binding protein -0.12 3.15E-01 -0.21 7.09E-02 -0.32 9.84E-13 -0.29 1.43E-12 
2011mTn5STM.1.11.C06 SMc02507 manganese ABC transporter permease SitC 0.03 3.36E-01 0.22 1.40E-03 0.61 1.00E-12 0.72 1.63E-06 
2011mTn5STM.1.03.D06 SMa1760 hypothetical protein NA NA NA NA 0.12 1.12E-03 -0.10 2.26E-06 
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2011mTn5STM.1.06.E06 pSymA, 305100 intergenic -0.09 1.15E-01 0.10 6.25E-02 0.27 8.46E-14 0.19 7.43E-11 
2011mTn5STM.1.12.F06 SMb20390 hypothetical protein -0.11 1.18E-01 -0.07 4.77E-01 0.25 9.19E-21 0.28 1.05E-22 
2011mTn5STM.1.08.G06 SMa1798 Kup2 Potassium uptake protein -0.25 3.02E-04 -0.26 1.31E-08 -0.23 3.45E-08 NA NA 
2011mTn5STM.1.11.H06 SMa0214 putative KduI DKI isomerase -0.10 8.27E-02 -0.19 5.15E-07 0.20 9.86E-18 0.13 8.55E-08 
2011mTn5STM.1.12.B07 
S. Meliloti 
chromosome, 
1067681 
intergenic -0.06 3.68E-02 -0.02 3.69E-01 -0.06 9.26E-02 0.01 4.86E-01 
2011mTn5STM.1.12.C07 SMa0803 putative ABC-transporter ATP-binding protein 0.23 5.54E-07 0.08 3.87E-02 -0.04 7.33E-01 -0.21 8.66E-05 
2011mTn5STM.1.11.D07 SMb20819 ferredoxin, Rieske [2Fe-2S] domain MocE 0.10 6.04E-03 0.02 2.79E-01 -0.22 8.23E-16 -0.32 1.83E-30 
2011mTn5STM.1.08.E07 SMa1467 Probable inner-membrane permease 0.07 1.08E-01 0.17 4.38E-05 -0.01 1.58E-01 -0.12 1.47E-01 
2011mTn5STM.1.11.F07 SMa1115 Putative manganese transport protein -0.08 1.72E-02 -0.18 1.98E-05 -0.13 2.55E-04 -0.18 1.77E-11 
2011mTn5STM.1.04.G07 
S. meliloti 
chromosome, 
2181489 
intergenic -0.08 1.59E-01 -0.15 2.89E-01 -0.14 3.90E-05 -0.24 9.33E-16 
2011mTn5STM.1.05.H07 
S. meliloti 
chromosome, 
1621189 
intergenic -0.02 7.03E-01 0.14 1.20E-04 0.25 5.97E-16 0.23 1.02E-16 
2011mTn5STM.1.02.A08 SMc00185 putative ABC-transporter ATP-binding protein 0.07 1.32E-01 0.15 5.70E-04 0.09 6.56E-03 0.05 2.54E-02 
2011mTn5STM.1.03.B08 SMb20513 hypothetical protein -0.13 2.42E-01 -0.21 4.85E-07 -0.09 4.33E-04 -0.11 1.44E-05 
2011mTn5STM.1.05.C08 SMb21477 putative reverse transcriptase maturase protein 0.12 2.28E-02 -0.06 1.30E-01 -0.09 1.13E-05 -0.14 2.56E-05 
2011mTn5STM.1.11.D08 SMa1638 hypothetical protein -0.40 1.02E-06 -0.52 2.68E-13 -0.48 3.33E-25 -0.41 3.96E-17 
2011mTn5STM.1.03.E08 SMc02236 hypothetical protein -0.27 4.70E-05 -0.04 6.68E-01 -0.17 6.76E-08 0.13 1.69E-04 
2011mTn5STM.1.09.F08 SMa1146 hypothetical protein -0.34 1.19E-06 -0.36 8.67E-13 -0.14 6.63E-05 -0.22 6.07E-11 
2011mTn5STM.1.12.G08 SMb20948 ExoU glucosyltransferase -0.09 1.05E-01 -1.02 6.81E-15 -0.43 3.41E-19 -0.57 2.65E-29 
2011mTn5STM.1.09.H08 SMa0809 hypothetical protein -0.27 2.64E-03 -0.58 2.97E-12 0.22 2.06E-02 0.35 5.16E-02 
2011mTn5STM.1.04.A09 SMb20616 ThiO thiamine biosynthesis oxidoreductase protein 0.41 5.44E-06 -0.49 4.56E-07 0.31 4.60E-12 0.37 1.16E-14 
2011mTn5STM.1.01.B09 SMb20958 exopolysaccharide biosynthesis protein ExoM 0.25 5.29E-02 0.10 1.08E-01 -0.06 1.16E-03 -0.03 6.88E-02 
2011mTn5STM.1.10.C09 SMa0244 hypothetical protein 0.14 8.36E-03 0.19 3.76E-02 -0.05 6.07E-02 0.06 1.28E-01 
2011mTn5STM.1.05.D09 SMa0840 NodD3 transcriptional regulator 0.09 1.75E-01 -0.11 5.26E-03 -0.15 3.38E-01 -0.26 7.82E-03 
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2011mTn5STM.1.05.E09 SMc02773 sugar transport ATP-binding protein 0.28 8.85E-06 0.23 4.68E-06 0.11 2.05E-05 0.24 1.31E-08 
2011mTn5STM.1.02.F09 SMc02612 glutamate synthase family protein GlxD 0.14 4.67E-02 0.00 4.30E-01 0.30 1.19E-06 0.15 3.20E-05 
2011mTn5STM.1.03.G09 SMa1128 DegP4 protease like protein 0.33 1.89E-06 0.27 4.90E-04 -0.19 4.87E-12 -0.20 7.39E-08 
2011mTn5STM.1.12.H09 SMb21087 conjugal transfer protein TraA2 -0.12 9.37E-02 0.02 7.41E-01 -0.23 3.34E-02 -0.15 2.62E-01 
2011mTn5STM.1.13.A10 SMa0364 hypothetical protein 0.62 7.02E-06 0.34 2.56E-12 0.32 2.36E-22 0.19 5.57E-17 
2011mTn5STM.1.08.B10 SMb21578 copper-transporting P-type ATPase protein AtcU2 -0.02 6.69E-01 -0.29 5.40E-04 -0.41 2.69E-15 -0.31 1.00E-14 
2011mTn5STM.1.11.C10 SMb20070 putative sulfate permease protein 0.21 4.68E-02 0.09 3.03E-01 0.07 4.51E-03 0.18 1.40E-06 
2011mTn5STM.1.12.E10 SMc00349 GTP-binding membrane protein LepA NA NA -0.83 3.59E-03 -0.38 1.80E-22 -0.29 1.08E-18 
2011mTn5STM.1.08.F10 SMc02406 hypothetical protein -0.34 6.92E-04 0.01 2.65E-01 0.53 3.39E-16 0.09 2.74E-02 
2011mTn5STM.1.13.G10 SMa0104 ABC transporter, solute-binding protein 0.14 1.99E-02 0.03 5.65E-01 0.06 1.25E-02 0.12 9.63E-02 
2011mTn5STM.1.04.H10 SMa0252 hypothetical protein 0.14 3.55E-02 -0.07 1.91E-01 0.06 5.48E-01 0.06 3.47E-01 
2011mTn5STM.1.02.A11 SMc00413 hypothetical protein -0.09 4.84E-01 0.30 1.58E-02 NA NA 0.75 1.79E-06 
2011mTn5STM.1.07.B11 SMb20967 putative transcriptional regulator, lacI family protein 0.19 1.11E-01 0.02 5.73E-01 -0.15 2.42E-07 -0.09 9.60E-03 
2011mTn5STM.1.08.C11 SMc04346 IlvC ketol-acid reductoisomerase protein -0.20 1.95E-03 -1.09 2.20E-13 -0.08 9.33E-03 -0.02 7.34E-01 
2011mTn5STM.1.05.D11 SMa0814 NifB FeMo cofactor biosynthesis protein NA NA -0.29 1.85E-02 -0.43 7.52E-09 -0.48 6.61E-16 
2011mTn5STM.1.01.E11 SMa0765 FixN2 cytochrome c oxidase polypeptide I 0.44 1.84E-05 0.28 1.82E-01 -0.10 8.93E-05 -0.30 6.95E-17 
2011mTn5STM.1.06.F11 SMa0922 hypothetical protein -0.03 4.88E-01 0.08 4.25E-01 0.04 6.62E-02 -0.01 4.36E-01 
2011mTn5STM.1.12.G11 SMa1195 hypothetical protein 0.45 1.42E-03 0.58 5.02E-14 0.29 2.10E-17 0.25 4.08E-16 
2011mTn5STM.1.05.H11 SMa1493 putative LysR-type transcription factor 0.03 2.91E-01 0.07 1.41E-02 -0.16 1.05E-04 -0.23 2.26E-07 
2011mTn5STM.1.11.A12 SMc01664 putative transcription regulator protein -0.06 3.78E-01 -0.05 4.16E-01 -0.13 3.64E-04 -0.15 2.29E-12 
2011mTn5STM.1.11.B12 SMc00322 hypothetical protein -0.28 3.51E-04 -0.30 1.90E-04 0.03 3.89E-01 -0.06 1.68E-01 
2011mTn5STM.1.11.C12 SMa0489 putative ABC transporter, ATP-binding protein 0.21 3.84E-03 0.25 8.07E-05 0.03 1.71E-02 -0.13 7.55E-05 
2011mTn5STM.1.02.D12 SMa1288 hypothetical protein 0.02 9.07E-01 -0.25 2.20E-04 -0.20 2.62E-08 -0.21 9.20E-07 
2011mTn5STM.1.11.E12 SMc04337 hypothetical protein -0.14 3.03E-04 0.09 6.59E-02 0.10 3.51E-02 0.05 5.06E-01 
2011mTn5STM.1.04.F12 SMc04363 hypothetical protein -0.32 5.72E-04 -0.02 7.54E-01 0.32 1.13E-13 0.41 2.57E-12 
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2011mTn5STM.1.04.H12 SMb21641 regulator of phenylacetic acid degradation PaaX 0.04 8.09E-01 0.04 7.34E-01 0.25 1.87E-10 0.33 2.12E-22 
2011mTn5STM.2.05.A01 
S. meliloti 
chromosome, 
2044300 
intergenic NA NA NA NA NA NA 1.13 1.56E-05 
2011mTn5STM.2.07.B01 SMa1182 NosZ N2O reductase -0.03 8.50E-01 0.14 5.60E-04 -0.01 9.42E-01 0.05 5.13E-02 
2011mTn5STM.2.11.C01 SMa1677 hypothetical protein 0.32 6.58E-03 0.00 7.61E-01 0.23 1.42E-04 0.08 1.07E-01 
2011mTn5STM.2.10.D01 SMc01950 high-affinity branched-chain amino acid ABC transporter, permease protein LivM -0.23 1.25E-03 -0.14 1.20E-04 -0.04 8.52E-02 -0.11 5.85E-04 
2011mTn5STM.2.12.E01 SMc03249 hypothetical protein 0.49 8.91E-10 0.39 5.31E-14 0.14 3.96E-06 0.02 4.60E-02 
2011mTn5STM.2.07.F01 SMa0607 hypothetical protein 0.10 8.05E-02 0.10 8.89E-02 0.01 6.23E-01 0.06 7.59E-03 
2011mTn5STM.2.01.G01 pSymA, 854083 intergenic 0.22 2.91E-04 0.20 1.54E-08 0.03 2.40E-02 0.09 5.74E-03 
2011mTn5STM.2.12.H01 SMc01219 lipopolysaccharide core biosynthesis mannosyltransferase LpsB -0.39 4.39E-04 -0.36 3.09E-08 -0.75 2.70E-17 -0.18 1.99E-06 
2011mTn5STM.2.07.A02 SMc01607 putative permease protein 0.28 3.44E-05 0.32 1.06E-12 -0.11 6.66E-06 0.02 3.90E-02 
2011mTn5STM.2.05.B02 SMb21144 putative choline uptake ABC transporter periplasmic solute-binding protein precursor 0.11 2.21E-02 0.28 1.95E-07 0.06 2.82E-01 0.15 3.29E-04 
2011mTn5STM.2.05.C02 SMa0876 NolF secretion protein 0.21 1.03E-04 0.24 1.56E-05 -0.02 5.64E-01 -0.23 1.25E-01 
2011mTn5STM.2.09.D02 SMa0322 hypothetical protein -0.03 7.03E-01 -0.17 3.04E-07 -0.27 2.36E-16 -0.36 2.54E-17 
2011mTn5STM.2.04.E02 SMb21633 PaaG enoyl-CoA hydratase protein 0.05 9.52E-01 0.53 5.89E-05 0.75 1.38E-08 0.96 5.23E-09 
2011mTn5STM.2.05.F02 
S. meliloti 
chromosome, 
1627869 
intergenic 0.23 1.15E-03 0.54 4.13E-11 0.34 2.81E-03 0.25 7.77E-06 
2011mTn5STM.2.02.G02 SMb20273 hypothetical protein 0.03 1.28E-01 0.11 7.90E-04 0.20 1.43E-08 0.21 4.97E-07 
2011mTn5STM.2.12.H02 SMb20851 putative transcriptional regulator, sorC family protein 0.17 3.18E-02 -0.10 1.02E-01 -0.14 3.92E-09 -0.15 1.13E-06 
2011mTn5STM.2.12.A03 SMb20209 hypothetical protein 0.65 2.10E-08 0.43 2.97E-17 0.27 1.02E-09 0.35 1.30E-09 
2011mTn5STM.2.10.B03 
S. meliloti 
chromosome, 
3367064 
intergenic -0.04 3.75E-01 -0.04 1.89E-01 -0.37 1.09E-19 -0.42 1.21E-09 
2011mTn5STM.2.02.C03 SMc00556 DNA repair protein RadA 0.00 7.22E-01 0.12 6.16E-02 -0.05 5.32E-01 -0.10 1.04E-01 
2011mTn5STM.2.12.D03 SMa0485 probable ThrC2 threonine synthase -0.01 4.46E-01 -0.13 1.47E-03 -0.22 8.19E-13 -0.32 4.84E-15 
2011mTn5STM.2.01.E03 SMb20712 
rhizopine uptake ABC transporter 
periplasmic solute-binding protein precursor 
MocB 
0.39 1.33E-05 0.41 1.71E-12 0.07 1.50E-02 0.25 8.56E-08 
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2011mTn5STM.2.07.F03 SMb20168 hypothetical protein 0.29 3.42E-06 0.37 1.25E-06 NA NA 0.07 2.16E-02 
2011mTn5STM.2.06.G03 SMc03044 chemotaxis protein MotD 0.13 3.51E-02 0.19 1.22E-05 0.21 3.34E-09 0.33 9.40E-06 
2011mTn5STM.2.09.H03 SMa1833 hypothetical protein 0.07 4.91E-02 -0.12 1.02E-05 NA NA NA NA 
2011mTn5STM.2.11.A04 SMc02270 capsular polysaccharide biosynthesis transmembrane protein RkpI 0.10 1.68E-02 0.38 3.58E-06 -0.28 2.81E-13 0.04 4.29E-04 
2011mTn5STM.2.09.B04 SMb20112 hypothetical protein 0.07 6.97E-02 0.21 8.04E-09 -0.04 1.10E-01 0.13 4.27E-08 
2011mTn5STM.2.12.C04 SMc02659 GTP pyrophosphokinase protein RelA NA NA -0.34 1.13E-01 NA NA NA NA 
2011mTn5STM.2.09.D04 SMb21301 putative membrane-anchored aldehyde dehydrogenase protein -0.12 1.24E-03 0.01 9.07E-01 NA NA 0.37 1.03E-04 
2011mTn5STM.2.01.E04 SMa0306 putative histidine ammonia-lyase 0.32 5.94E-05 0.12 3.11E-05 -0.11 9.40E-07 -0.22 2.57E-11 
2011mTn5STM.2.01.F04 SMa0431 hypothetical protein 0.21 8.33E-05 0.30 1.69E-10 -0.08 4.15E-03 -0.08 3.77E-03 
2011mTn5STM.2.11.G04 SMb20472 probable carbamoyltransferase 0.11 2.77E-02 0.14 5.60E-05 -0.11 1.87E-05 -0.19 1.49E-07 
2011mTn5STM.2.10.H04 SMa0110 ABC transporter, ATP-binding protein -0.15 2.27E-03 -0.12 1.06E-02 -0.11 3.92E-04 -0.12 3.49E-03 
2011mTn5STM.2.05.A05 SMb21199 oligopeptide uptake ABC transporter ATP-binding protein OppD -0.05 9.64E-01 0.20 3.44E-05 0.03 1.50E-01 0.30 2.52E-07 
2011mTn5STM.2.10.B05 SMb21367 cytochrome c class I protein CycA 0.23 4.01E-02 0.53 4.20E-16 0.67 1.54E-16 0.49 7.96E-18 
2011mTn5STM.2.11.C05 SMa0250 hypothetical protein 0.09 2.34E-02 0.13 3.17E-02 0.11 2.65E-02 -0.03 1.69E-01 
2011mTn5STM.2.08.D05 SMa0849 SyrM transcriptional regulator 0.25 1.91E-04 0.15 4.52E-05 -0.10 1.42E-04 -0.34 1.13E-15 
2011mTn5STM.2.06.E05 SMb21177 phosphate uptake ABC transporter ATP-binding protein 0.28 1.90E-03 0.32 1.40E-04 0.09 9.38E-07 0.18 4.48E-08 
2011mTn5STM.2.06.F05 pSymB, 1225168 intergenic 0.03 3.97E-01 0.26 2.21E-06 0.52 4.71E-18 0.57 1.07E-25 
2011mTn5STM.2.06.G05 SMa1766 hypothetical protein 0.08 5.39E-02 -0.19 1.32E-07 -0.18 1.66E-04 -0.34 6.20E-18 
2011mTn5STM.2.05.H05 SMc03164 xylulose kinase protein XylB -0.32 4.18E-04 -0.10 8.61E-01 0.86 2.17E-11 0.48 1.36E-11 
2011mTn5STM.2.07.A06 SMb20866 hypothetical protein 0.37 3.60E-08 0.38 4.19E-13 -0.09 1.25E-05 -0.15 2.40E-07 
2011mTn5STM.2.11.B06 SMb20111 putative oligopeptide ABC transporter ATP-binding protein 0.23 2.59E-02 0.22 1.50E-04 -0.06 4.92E-02 0.02 9.08E-01 
2011mTn5STM.2.01.C06 SMa2163 hypothetical protein 0.36 4.56E-06 0.09 8.96E-03 -0.13 2.21E-05 -0.26 7.48E-15 
2011mTn5STM.2.06.D06 SMc00864 hypothetical protein -0.08 4.26E-01 0.05 3.60E-01 0.09 5.67E-02 0.08 1.40E-02 
2011mTn5STM.2.03.E06 SMb21174 phosphate uptake ABC transporter permease protein 0.27 1.19E-03 0.33 2.56E-07 0.11 9.75E-02 0.19 6.16E-06 
2011mTn5STM.2.10.F06 SMb21000 putative transport protein 0.30 5.20E-05 0.44 1.03E-08 0.38 6.90E-09 0.30 3.99E-05 
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2011mTn5STM.2.05.G06 SMb20943 acetyltransferase protein ExoZ -0.07 4.23E-02 0.07 1.51E-01 -0.22 5.40E-12 -0.14 2.07E-04 
2011mTn5STM.2.11.H06 SMb20114 hypothetical protein 0.01 2.41E-01 0.00 9.97E-01 0.11 2.48E-07 0.22 5.18E-16 
2011mTn5STM.2.07.A07 SMc04204 iron transport regulator transmembrane protein FecR 0.10 6.35E-02 -0.03 1.92E-01 0.03 8.94E-01 -0.10 8.52E-04 
2011mTn5STM.2.07.B07 SMb21493 putative transcriptional regulator, asnC family protein 0.11 2.15E-02 0.03 7.91E-02 0.01 5.19E-01 0.04 8.58E-03 
2011mTn5STM.2.02.C07 SMc01528 dipeptide transport ATP-binding ABC transporter protein 0.01 6.74E-01 0.18 4.23E-03 NA NA 0.26 3.71E-04 
2011mTn5STM.2.01.D07 SMa1957 hypothetical protein -0.11 1.62E-02 -0.35 2.49E-10 -0.22 9.54E-12 -0.33 1.14E-19 
2011mTn5STM.2.12.E07 SMc00383 glutatione S-transferase protein  0.44 4.37E-09 0.38 1.55E-06 0.62 2.36E-15 0.43 6.22E-13 
2011mTn5STM.2.06.F07 SMc00774 acetoacetyl-coenzyme A synthetase, additional 0.25 3.24E-04 0.33 1.84E-09 0.23 2.52E-12 0.25 9.05E-16 
2011mTn5STM.2.04.G07 SMb20123 putative transcriptional regulator protein 0.08 1.63E-02 0.00 9.84E-01 NA NA 0.80 5.08E-04 
2011mTn5STM.2.09.H07 pSymB, 96435 intergenic -0.07 4.52E-01 0.09 7.05E-01 0.91 8.13E-09 0.48 2.14E-04 
2011mTn5STM.2.04.A08 SMa0039 putative LysR-family transcriptional regulator 0.19 3.99E-05 0.24 1.04E-06 0.12 2.98E-03 0.12 7.10E-02 
2011mTn5STM.2.04.B08 
S. meliloti 
chromosome, 
3364101 
intergenic 0.32 5.35E-05 0.22 2.56E-08 0.04 5.23E-03 -0.13 2.15E-07 
2011mTn5STM.2.05.C08 SMa1956 putative LysR-family transcriptional regulator 0.03 2.92E-01 -0.15 2.77E-03 -0.13 4.34E-03 -0.30 4.53E-14 
2011mTn5STM.2.04.D08 SMc03149 hypothetical protein 0.12 2.52E-03 0.07 3.31E-02 0.06 1.04E-04 0.06 9.04E-03 
2011mTn5STM.2.08.E08 SMb20757 methylmalonyl-CoA mutase protein BhbA 0.24 3.75E-03 0.15 9.30E-04 0.24 2.44E-13 0.26 4.60E-13 
2011mTn5STM.2.12.F08 SMa1513 putative ABC transporter permease 0.23 1.39E-06 0.33 3.87E-09 -0.05 4.11E-01 0.03 6.92E-01 
2011mTn5STM.2.11.G08 SMc00527 hypothetical protein -0.26 6.00E-05 0.00 6.69E-01 0.00 8.19E-01 0.03 3.33E-01 
2011mTn5STM.2.10.H08 SMa0394 putative ABC transporter, permease -0.19 5.54E-02 -0.27 2.26E-08 -0.19 3.83E-11 -0.23 9.89E-13 
2011mTn5STM.2.11.A09 SMc02899 PheA prephenate dehydratase protein 0.12 8.98E-01 -0.85 6.20E-04 0.31 3.97E-06 0.06 4.22E-02 
2011mTn5STM.2.09.B09 SMc00148 hypothetical protein 0.06 9.21E-01 0.04 5.35E-01 -0.27 2.13E-07 -0.11 8.09E-07 
2011mTn5STM.2.09.C09 SMb20959 probable exopolysaccharide biosynthesis protein ExoO -0.11 8.75E-02 -0.12 9.20E-04 -0.39 2.99E-19 -0.21 7.94E-12 
2011mTn5STM.2.09.D09 SMc04456 chaperon protein CsaA -0.25 1.07E-03 -0.24 1.13E-07 -0.27 3.70E-13 -0.18 3.27E-14 
2011mTn5STM.2.12.E09 SMc03782 hypothetical protein -0.24 7.97E-03 -1.02 4.77E-14 -0.36 1.14E-06 -0.54 2.49E-11 
2011mTn5STM.2.07.F09 SMa0260 GabD3 succinate-semialdehyde dehdyrogenase 0.17 8.40E-02 0.47 1.91E-06 0.06 6.03E-01 0.08 7.01E-02 
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2011mTn5STM.2.10.G09 SMa1746 putative iron uptake protein -0.30 4.14E-07 -0.39 2.82E-12 -0.44 6.52E-23 -0.59 6.23E-37 
2011mTn5STM.2.03.H09 SMc02045 putative oxidoreductase protein -0.28 2.70E-06 -0.16 1.10E-03 0.22 1.66E-09 0.27 1.82E-19 
2011mTn5STM.2.10.A10 
S. meliloti 
chromosome, 
2106334 
intergenic 0.21 3.62E-04 0.10 5.85E-03 0.08 7.77E-04 0.06 5.09E-02 
2011mTn5STM.2.04.B10 SMa0565 hypothetical protein 0.82 1.69E-08 0.79 1.21E-13 NA NA 0.54 6.22E-16 
2011mTn5STM.2.04.C10 SMc00086 diheme cytochrome C-type signal peptide protein CycG -0.09 5.57E-02 -0.13 4.28E-03 -0.08 1.64E-03 0.05 4.20E-04 
2011mTn5STM.2.03.D10 SMb20748 glycosyltransferase protein PssF 0.03 5.64E-01 -0.16 2.10E-05 0.66 4.72E-16 0.51 6.21E-14 
2011mTn5STM.2.11.E10 SMb21273 spermidineputrescine ABC transporter periplasmic solute-binding protein precursor 0.23 2.49E-03 0.26 3.20E-04 0.16 3.96E-08 0.15 5.24E-08 
2011mTn5STM.2.09.F10 SMc01818 adenylate cyclase transmembrane protein CyaC -0.11 7.42E-02 -0.16 4.50E-04 -0.06 6.50E-01 NA NA 
2011mTn5STM.2.05.G10 SMb20522 hypothetical protein -0.20 1.30E-03 -0.21 1.16E-05 -0.25 4.27E-09 -0.41 2.22E-18 
2011mTn5STM.2.01.H10 SMa1017 hypothetical protein -0.35 9.02E-04 -0.57 6.02E-18 -0.47 3.74E-07 -0.26 4.25E-05 
2011mTn5STM.2.06.A11 SMc01042 nitrogen regulation protein NtrB -0.09 1.69E-02 -0.08 1.14E-02 NA NA -0.06 3.12E-01 
2011mTn5STM.2.06.B11 SMc01881 PanB 3-methyl-2-oxobutanoate hydromethyltransferase protein -0.60 3.38E-04 -0.48 1.22E-05 2.28 1.18E-21 2.20 1.38E-16 
2011mTn5STM.2.04.C11 SMb20515 putative CheR methyltransferase, SAM binding domain -0.15 6.19E-04 -0.23 8.61E-06 -0.17 7.66E-05 -0.25 1.28E-07 
2011mTn5STM.2.01.D11 SMc04452 NADH dehydrogenase transmembrane protein Ndh -0.24 7.05E-03 -0.02 5.63E-01 0.42 1.42E-04 0.68 2.40E-27 
2011mTn5STM.2.05.E11 SMa1122 hypothetical protein 0.16 9.60E-03 0.09 2.93E-02 -0.15 1.08E-01 0.06 9.72E-01 
2011mTn5STM.2.04.F11 pSymA, 510651 intergenic -0.05 6.96E-02 0.11 2.96E-03 NA NA NA NA 
2011mTn5STM.2.11.G11 SMb21345 putative sugar ABC transporter -0.11 7.17E-02 -0.05 1.73E-01 0.09 3.67E-05 0.16 1.18E-11 
2011mTn5STM.2.10.H11 SMb20549 hypothetical protein -0.40 7.99E-08 -0.52 1.37E-13 -0.20 1.07E-09 -0.41 1.71E-26 
2011mTn5STM.2.03.A12 SMc00739 hypothetical protein -0.01 6.68E-01 -0.03 9.64E-01 -0.11 8.41E-02 -0.18 7.23E-08 
2011mTn5STM.2.09.B12 
S. meliloti 
chromosome, 
2862221 
intergenic -0.32 1.03E-03 -0.18 7.44E-05 NA NA NA NA 
2011mTn5STM.2.04.C12 SMc01814 probable glutamate synthase small chain protein -0.53 5.40E-08 -0.28 2.64E-09 0.17 7.85E-05 0.11 1.40E-02 
2011mTn5STM.2.01.D12 pSymB, 610814 intergenic -0.34 2.79E-06 -0.42 1.90E-06 -0.07 1.83E-02 -0.28 4.22E-21 
2011mTn5STM.2.03.E12 SMb20548 hypothetical protein 0.17 1.52E-02 -0.19 4.30E-06 -0.37 1.70E-08 -0.41 3.48E-08 
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2011mTn5STM.2.09.F12 SMc03110 hypothetical protein -0.06 4.26E-01 0.10 3.54E-03 0.32 3.00E-10 -0.15 1.76E-04 
2011mTn5STM.2.06.G12 SMc00094 betaine aldehyde dehydrogenase protein BetB -0.15 2.11E-02 0.05 4.49E-01 0.31 6.52E-05 0.26 6.60E-08 
2011mTn5STM.2.06.H12 SMc01711 hypothetical protein -0.34 6.57E-06 -0.11 1.18E-01 0.20 6.23E-15 0.24 1.08E-21 
2011mTn5STM.3.12.A01 SMa0819 FixB electron transfer flavoprotein alpha chain 0.41 3.77E-08 0.15 3.68E-05 -0.16 1.60E-02 -0.22 5.44E-02 
2011mTn5STM.3.08.B01 SMc04217 hypothetical protein -0.04 8.65E-01 0.48 1.25E-05 0.64 2.64E-06 0.64 2.65E-10 
2011mTn5STM.3.10.C01 SMc01842 putative methyltransferase transcription regulator protein -0.12 8.01E-01 -1.00 1.62E-07 -0.13 2.89E-01 0.11 1.01E-02 
2011mTn5STM.3.10.D01 SMc00228 ATP-dependent DNA helicase protein RecG 0.08 7.07E-02 -0.15 4.08E-02 -0.14 1.65E-04 -0.13 1.01E-02 
2011mTn5STM.3.10.E01 SMc04386 aspartate aminotransferase B protein 0.01 9.02E-01 0.11 1.17E-01 0.06 7.66E-02 0.13 9.18E-05 
2011mTn5STM.3.08.F01 SMa2333 KdpA potassium-transporting ATPase A chain 0.27 9.25E-04 0.31 1.81E-06 0.03 5.84E-01 0.01 9.47E-03 
2011mTn5STM.3.05.G01 SMb20178 hypothetical protein 0.13 6.34E-03 0.07 1.89E-02 0.03 3.18E-02 0.10 1.34E-03 
2011mTn5STM.3.11.A02 pSymA, 1215937 intergenic 0.27 5.97E-06 0.11 8.98E-05 -0.19 2.67E-09 -0.31 9.97E-07 
2011mTn5STM.3.08.B02 SMc02691 putative membrane transport protein 0.28 3.47E-04 0.17 1.46E-05 0.13 1.39E-06 0.14 7.13E-05 
2011mTn5STM.3.08.C02 SMb20121 hypothetical protein 0.08 4.16E-03 0.02 5.63E-01 0.02 8.65E-02 0.02 6.68E-02 
2011mTn5STM.3.07.D02 SMc02376 putative heat shock protein -0.13 3.26E-02 -0.03 8.64E-02 0.01 2.45E-01 0.03 7.06E-01 
2011mTn5STM.3.09.E02 SMa2215 putative GntR-family transcriptional regulator 0.16 2.67E-03 0.17 5.68E-05 -0.22 2.05E-17 -0.38 2.84E-11 
2011mTn5STM.3.10.F02 SMc00420 hypothetical protein 0.00 9.34E-01 0.32 4.10E-05 0.52 3.79E-10 0.43 3.80E-09 
2011mTn5STM.3.08.G02 SMa2075 probable extracellular solute-binding protein 0.22 7.17E-05 0.01 3.10E-01 -0.11 1.02E-02 -0.15 9.94E-02 
2011mTn5STM.3.07.H02 SMc02363 cytochrome C-type biogenesis transmembrane protein CycK 0.16 3.51E-01 0.19 2.87E-01 0.01 6.31E-01 0.09 7.73E-01 
2011mTn5STM.3.09.A03 
S. meliloti 
chromosome, 
2823999 
intergenic 0.19 4.04E-03 0.09 3.54E-03 -0.16 1.35E-02 0.01 6.76E-01 
2011mTn5STM.3.11.B03 SMb20029 hypothetical protein 0.38 3.05E-05 0.29 2.49E-08 0.19 7.33E-09 0.34 5.32E-09 
2011mTn5STM.3.11.C03 SMb20067 hypothetical protein 0.11 9.58E-03 0.09 2.96E-05 0.14 6.48E-09 0.21 4.66E-06 
2011mTn5STM.3.09.D03 SMa0929 TraG conjugal transfer protein -0.04 6.01E-01 0.02 3.89E-01 0.12 1.46E-02 0.07 3.46E-02 
2011mTn5STM.3.05.E03 SMc01552 hypothetical protein 0.20 2.49E-03 0.31 2.11E-03 -0.04 3.58E-01 -0.08 6.74E-01 
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2011mTn5STM.3.08.F03 
S. meliloti 
chromosome, 
2178672 
intergenic 0.10 1.39E-01 0.34 4.93E-09 -0.20 2.84E-11 -0.19 1.06E-01 
2011mTn5STM.3.11.G03 SMa0981 NtrR2 transcription regulator 0.01 9.43E-01 0.08 3.56E-01 -0.27 3.16E-14 -0.36 1.25E-11 
2011mTn5STM.3.08.H03 SMb20436 probable nitrate transporter -0.08 6.70E-02 -0.23 3.23E-07 -0.22 1.32E-18 -0.18 8.00E-09 
2011mTn5STM.3.07.A04 SMc01131 hypothetical protein -0.26 2.30E-02 -0.19 9.80E-04 0.46 1.57E-09 0.42 8.16E-17 
2011mTn5STM.3.11.B04 SMb21431 hypothetical protein -0.01 6.43E-01 0.04 2.28E-01 -0.12 1.11E-04 -0.11 4.89E-02 
2011mTn5STM.3.06.C04 SMc01668 hypothetical protein 0.30 2.06E-01 0.26 4.91E-03 0.16 3.19E-03 0.08 1.55E-01 
2011mTn5STM.3.10.D04 SMb20672 putative sugar ABC transporter 0.02 3.76E-01 -0.05 2.34E-02 0.12 1.45E-06 0.22 5.64E-08 
2011mTn5STM.3.06.E04 SMa1179 NosR Regulatory protein for N2O reductase 0.05 2.91E-01 0.26 4.47E-07 -0.11 3.43E-03 -0.07 2.08E-01 
2011mTn5STM.3.12.F04 SMb20009 putative transcriptional regulator 0.11 4.44E-02 0.24 5.03E-08 0.19 9.48E-08 0.25 9.06E-17 
2011mTn5STM.3.06.G04 SMc00609 anaerobic dimethyl sulfoxide reductase chain A protein DmsA -0.02 6.46E-01 0.05 1.04E-01 -0.14 3.25E-03 0.01 3.32E-01 
2011mTn5STM.3.05.H04 SMb20152 hypothetical protein 0.08 2.29E-01 0.17 2.55E-05 NA NA NA NA 
2011mTn5STM.3.11.A05 SMb20037 shikimate 5-dehydrogenase protein AroE2 0.63 1.39E-04 0.76 4.76E-06 0.73 5.12E-05 0.78 3.72E-08 
2011mTn5STM.3.09.B05 SMb20931 putative sugar uptake ABC transporter periplasmic solute-binding protein precursor 0.05 2.54E-01 0.19 3.80E-04 1.04 6.40E-14 0.83 7.13E-09 
2011mTn5STM.3.08.C05 SMa2293 probable beta lactamase transcriptional activator -0.39 2.41E-07 -0.08 3.52E-02 NA NA NA NA 
2011mTn5STM.3.07.D05 SMc01406 putative transcription regulator protein -0.38 6.05E-02 -0.02 7.60E-01 0.51 2.09E-04 0.32 2.69E-02 
2011mTn5STM.3.07.E05 SMa0890 hypothetical protein 0.35 2.79E-02 0.40 3.68E-08 -0.04 1.32E-01 -0.15 1.62E-01 
2011mTn5STM.3.08.F05 SMb21527 putative taurin uptake ABC transporter ATP-binding protein 0.08 2.54E-01 0.10 1.40E-04 -0.11 1.13E-04 -0.04 2.98E-01 
2011mTn5STM.3.10.G05 SMc01717 mercuric reductase protein MerA1 -0.07 6.54E-01 0.00 3.84E-01 0.08 5.73E-01 0.14 8.70E-03 
2011mTn5STM.3.07.H05 SMa2000 Putative ABC transporter, periplasmic solute-binding protein 0.01 9.99E-01 -0.05 3.88E-02 NA NA -0.11 6.05E-04 
2011mTn5STM.3.10.A06 SMc03777 gamma-glutamyl phopsphate reductase protein ProA 0.25 2.09E-02 -0.47 5.18E-02 0.26 1.62E-05 0.29 3.12E-04 
2011mTn5STM.3.10.B06 SMc03899 hypothetical protein NA NA NA NA NA NA NA NA 
2011mTn5STM.3.10.C06 SMc02070 hypothetical protein -0.51 7.21E-03 -0.23 3.90E-03 0.06 8.45E-01 -0.29 4.52E-06 
2011mTn5STM.3.11.D06 SMc03032 flagellar P-ring precursor transmembrane protein 0.34 1.08E-05 0.27 3.25E-09 0.92 1.61E-30 0.89 1.78E-34 
2011mTn5STM.3.08.E06 SMa0953 AttA1-like ABC transporter, ATP binding protein NA NA 0.14 5.10E-02 NA NA NA NA 
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2011mTn5STM.3.11.F06 SMa2245 hypothetical protein 0.35 1.69E-07 0.36 9.77E-12 0.00 1.83E-01 -0.24 3.41E-10 
2011mTn5STM.3.10.G06 SMc02677 pyroline-5-carboxylate reductase protein ProC -0.05 7.69E-02 -0.37 4.67E-08 -0.13 2.10E-09 -0.13 1.48E-09 
2011mTn5STM.3.07.H06 SMa1052 hypothetical protein 0.01 9.62E-01 -0.04 1.76E-01 -0.20 7.25E-10 -0.28 4.29E-18 
2011mTn5STM.3.09.A07 SMb21079 putative cAMP binding protein 0.31 6.48E-06 0.11 1.45E-03 -0.11 5.02E-05 -0.22 9.73E-16 
2011mTn5STM.3.06.B07 SMc02487 dihydrolipoamide dehydrogenase LpdA2 -0.76 1.27E-02 -1.02 4.27E-05 NA NA -0.31 6.21E-02 
2011mTn5STM.3.05.C07 SMb20678 hydroxypyruvate reductase protein TtuD2 0.15 6.20E-04 0.12 7.52E-03 0.40 1.37E-14 0.41 4.48E-22 
2011mTn5STM.3.08.D07 SMc01174 cysteine synthase A  protein CysK2 -0.53 3.04E-08 -0.78 2.67E-18 -0.39 5.37E-20 -0.37 4.97E-25 
2011mTn5STM.3.05.E07 SMc01949 high-affinity branched-chain amino acid ABC transporter, ATP-binding protein LivG 0.02 7.59E-01 0.06 6.85E-01 -0.06 6.17E-03 -0.06 1.16E-01 
2011mTn5STM.3.06.F07 SMc03977 hypothetical protein -0.12 6.11E-02 -0.25 6.91E-08 -0.20 7.20E-08 -0.24 1.18E-16 
2011mTn5STM.3.07.G07 SMc01419 RNA polymerase sigma factor protein SigE1 -0.38 1.12E-06 -0.23 1.41E-07 -0.26 1.68E-22 -0.22 3.80E-18 
2011mTn5STM.3.08.H07 SMc04258 putative transport system permease ABC transporter protein -0.41 8.87E-07 -0.41 1.92E-12 -0.34 1.94E-02 -0.20 1.82E-04 
2011mTn5STM.3.06.A08 SMc01198 hypothetical protein -0.04 4.75E-01 -0.12 1.20E-03 -0.40 5.75E-20 -0.38 2.76E-24 
2011mTn5STM.3.08.B08 SMb20888 hypothetical protein 1.06 NA 0.14 3.99E-01 NA NA NA NA 
2011mTn5STM.3.10.C08 SMc02050 trigger factor protein Tig -0.67 3.66E-07 -0.71 7.20E-08 -0.55 5.97E-06 -0.50 5.52E-08 
2011mTn5STM.3.05.D08 SMc01554 hypothetical protein NA NA -1.21 6.74E-01 NA NA NA NA 
2011mTn5STM.3.10.E08 SMa2037 Putative oxidoreductase 0.04 2.85E-01 -0.12 3.43E-03 -0.22 5.65E-12 -0.26 3.68E-15 
2011mTn5STM.3.05.F08 SMc02857 heat shock protein 70 (HSP70) chaperone NA NA NA NA NA NA NA NA 
2011mTn5STM.3.08.G08 SMa0583 NrtB, Nitrate transport permease protein 0.26 1.79E-03 0.27 6.32E-07 0.01 8.64E-01 0.05 7.38E-02 
2011mTn5STM.3.09.H08 SMc01965 putative spermidine/putrescine transport ATP-binding ABC transporter protein -0.24 1.67E-02 -0.13 2.66E-05 0.27 3.10E-11 0.26 1.18E-14 
2011mTn5STM.3.11.A09 SMa0796 hypothetical protein 0.12 6.30E-03 -0.01 4.53E-01 -0.37 7.51E-21 -0.51 2.12E-32 
2011mTn5STM.3.10.B09 SMb20957 exopolysaccharide biosynthesis protein ExoA -0.06 9.67E-02 -0.29 8.26E-09 -0.19 2.64E-12 -0.20 3.67E-13 
2011mTn5STM.3.06.C09 SMb21596 hypothetical protein -0.14 3.45E-03 -0.29 1.32E-05 -0.40 7.59E-21 -0.37 1.56E-10 
2011mTn5STM.3.10.D09 SMb20582 putative transcriptional regulator, LysR family protein -0.29 3.81E-04 -0.26 4.39E-10 0.00 9.33E-01 0.03 1.44E-01 
2011mTn5STM.3.08.E09 SMb20933 putative two-component sensor histidine kinase protein 0.44 2.44E-03 -0.02 8.67E-01 NA NA -0.06 8.03E-01 
2011mTn5STM.3.12.F09 SMa1087 putative cation transport P-type ATPase -0.03 2.62E-01 0.04 5.33E-01 NA NA NA NA 
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2011mTn5STM.3.05.G09 SMa1220 FixN1 Heme b / copper cytochrome c oxidase subunit -0.05 1.90E-01 0.03 1.29E-01 -0.16 3.73E-07 -0.17 8.28E-08 
2011mTn5STM.3.07.H09 pSymB, 1322754 intergenic -0.21 3.69E-05 -0.52 3.34E-12 -0.24 1.37E-10 -0.35 1.56E-18 
2011mTn5STM.3.08.A10 SMb20860 probable non-heme chloroperoxidase 0.09 5.18E-02 -0.05 2.31E-01 -0.30 2.49E-16 -0.38 2.10E-08 
2011mTn5STM.3.07.B10 SMa0316 hypothetical protein 0.10 3.95E-02 0.00 7.22E-01 0.33 4.33E-07 0.06 3.89E-02 
2011mTn5STM.3.06.C10 SMa0615 FixO3 cytochrome-c oxidase subunit NA NA -0.58 8.19E-10 -0.16 1.68E-08 -0.30 7.22E-15 
2011mTn5STM.3.05.D10 SMa1916 hypothetical protein -0.06 1.60E-01 -0.50 3.85E-13 -0.16 2.74E-07 -0.35 1.82E-15 
2011mTn5STM.3.09.E10 SMc01000 hypothetical protein -0.30 1.48E-04 -0.37 8.24E-14 -0.53 1.56E-20 -0.51 6.80E-21 
2011mTn5STM.3.09.F10 
S. meliloti 
chromosome, 
110795 
intergenic -0.07 5.10E-02 -0.08 5.63E-03 0.10 1.15E-02 -0.05 2.05E-01 
2011mTn5STM.3.11.G10 SMc03025 flagellum-specific ATP synthase protein FliI 0.15 1.31E-03 0.11 1.90E-04 0.40 4.49E-16 0.56 1.70E-21 
2011mTn5STM.3.08.H10 SMb20360 hypothetical protein -0.22 1.42E-04 -0.24 1.02E-06 1.82 7.28E-20 1.63 2.20E-17 
2011mTn5STM.3.09.A11 SMc01968 putative transcription regulator protein 0.09 1.22E-01 0.12 3.09E-03 0.41 7.09E-18 0.37 3.65E-13 
2011mTn5STM.3.12.B11 pSymB, 1003846 intergenic 0.66 1.51E-02 0.41 2.53E-03 2.12 1.37E-16 2.01 1.43E-22 
2011mTn5STM.3.07.C11 pSymA, 291094 intergenic -0.34 3.99E-06 -0.36 8.24E-11 -0.03 5.56E-01 -0.19 6.91E-05 
2011mTn5STM.3.08.D11 SMb20377 putative translation initiation inhibitor protein -0.84 3.46E-05 -0.91 4.25E-07 0.53 3.35E-20 0.52 2.89E-09 
2011mTn5STM.3.09.E11 SMc04208 putative toxin secretion transmembrane protein -0.13 1.83E-01 -0.24 9.45E-01 NA NA NA NA 
2011mTn5STM.3.12.F11 SMc01946 leucine-specific binding protein precursor -0.24 1.35E-04 -0.16 7.97E-05 0.26 1.41E-03 0.21 3.22E-04 
2011mTn5STM.3.11.G11 
S. meliloti 
chromosome, 
2065862 
intergenic -0.65 3.46E-03 0.02 9.98E-01 NA NA NA NA 
2011mTn5STM.3.06.H11 SMc01700 peptidyl-prolyl cis-trans isomerase A -0.64 5.75E-06 -0.33 1.66E-13 -0.24 9.17E-11 -0.23 1.41E-13 
2011mTn5STM.3.08.A12 SMc00779 probable FAD-linked oxidoreductase 0.14 1.14E-01 0.09 8.90E-04 0.33 2.01E-10 0.34 8.50E-16 
2011mTn5STM.3.12.B12 SMb20476 putative ABC transporter periplasmic dipeptide-binding protein 0.77 4.42E-10 0.59 8.79E-13 -0.06 5.70E-02 0.18 2.55E-07 
2011mTn5STM.3.09.C12 SMc00808 ChrA chromate transport protein -0.63 5.48E-10 -0.37 9.55E-11 0.27 6.84E-05 0.18 2.94E-06 
2011mTn5STM.3.07.D12 SMc00334 Cmk cytidilate kinase protein -1.10 2.01E-06 -0.99 4.31E-11 0.88 4.27E-09 0.57 5.81E-05 
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2011mTn5STM.3.09.E12 
S. meliloti 
chromosome, 
2288070 
intergenic -0.31 1.62E-02 0.01 3.38E-01 0.51 1.15E-03 NA NA 
2011mTn5STM.3.08.F12 SMa0470 putative ABC transporter, ATP-binding protein -0.16 6.42E-04 -0.03 4.78E-01 0.18 2.42E-04 -0.06 2.22E-04 
2011mTn5STM.3.06.G12 SMc01340 putative aminotransferase protein -0.38 4.43E-06 -0.25 5.82E-07 0.03 4.86E-01 -0.08 6.41E-04 
2011mTn5STM.3.05.H12 SMc03198 molybdenum transport ATP-binding ABC transporter protein ModC -0.27 4.08E-05 -0.20 2.04E-06 0.33 5.01E-12 0.42 2.64E-21 
2011mTn5STM.4.01.A01 SMc00917 ATP phosphoribosyltransferase protein HisG 0.21 4.11E-01 -0.34 2.83E-02 -0.02 6.14E-01 0.48 2.93E-04 
2011mTn5STM.4.10.B01 SMa1141 putative fnr/crp family transcriptional regulator 0.12 1.59E-03 0.16 8.60E-04 -0.10 5.84E-04 -0.26 7.33E-01 
2011mTn5STM.4.02.C01 SMc02893 probable transcriptional regulator -0.09 1.66E-01 -0.08 1.69E-01 0.28 1.77E-09 0.22 6.42E-07 
2011mTn5STM.4.03.D01 SMc01549 hypothetical protein 0.06 6.21E-02 0.12 2.48E-05 NA NA -0.13 9.70E-01 
2011mTn5STM.4.10.E01 SMa1077 Nex18 Symbiotically induced conserved protein 0.35 2.19E-05 0.26 1.49E-07 -0.19 1.31E-07 -0.22 1.77E-04 
2011mTn5STM.4.07.F01 SMa0166 hypothetical protein -0.14 3.11E-02 -0.04 1.04E-01 NA NA 0.08 7.86E-01 
2011mTn5STM.4.06.G01 SMb21313 
bifunctional glycosyltransferase, forming 
alpha-glycosyl and beta-glycosyl linkages 
protein ExpE2 
0.02 9.89E-01 0.16 1.10E-04 0.19 4.94E-06 0.28 7.45E-06 
2011mTn5STM.4.01.H01 SMc03776 glutamate-5-kinase protein ProB1 -0.58 3.68E-05 -1.24 1.07E-16 0.26 2.13E-07 0.04 2.16E-01 
2011mTn5STM.4.04.B02 SMa1131 hypothetical protein 0.05 4.39E-01 0.14 6.66E-05 0.10 2.44E-01 0.07 2.75E-01 
2011mTn5STM.4.01.C02 SMa0229 hypothetical protein 0.17 7.80E-03 0.13 1.90E-04 0.07 1.39E-02 0.06 4.48E-03 
2011mTn5STM.4.04.D02 SMb21133 putative sulfate uptake ABC transporter periplasmic solute-binding protein 0.01 6.75E-01 -0.09 1.27E-02 -0.27 1.87E-16 -0.39 1.58E-19 
2011mTn5STM.4.08.E02 SMc00080 hypothetical protein -0.04 2.28E-01 0.12 1.98E-03 -0.20 8.20E-09 0.04 2.25E-02 
2011mTn5STM.4.07.F02 SMa0695 ArcB catabolic ornithine carbamoyl transferase -0.07 5.18E-01 -0.02 3.19E-01 -0.13 7.32E-04 -0.26 9.64E-01 
2011mTn5STM.4.02.G02 SMb20868 putative two-component sensor histidine kinase protein 0.14 5.43E-04 0.14 1.42E-05 -0.11 1.41E-06 -0.15 6.23E-07 
2011mTn5STM.4.08.H02 pSymB, 1408087 intergenic 0.10 8.41E-02 -0.09 5.20E-03 -0.16 3.32E-11 -0.11 3.55E-07 
2011mTn5STM.4.08.A03 SMb21536 hypothetical protein 0.24 3.66E-02 0.41 1.46E-10 0.09 1.08E-02 0.14 9.00E-05 
2011mTn5STM.4.07.B03 
S. meliloti 
chromosome, 
2005840 
intergenic 0.19 7.88E-04 0.19 5.43E-09 -0.25 3.99E-14 -0.02 9.39E-01 
2011mTn5STM.4.09.C03 SMc00606 putative ribonuclease protein -0.05 3.19E-01 -0.01 9.10E-01 -0.05 6.75E-03 -0.01 2.36E-02 
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2011mTn5STM.4.01.D03 SMc00886 hypothetical protein -0.07 5.96E-02 0.05 7.60E-01 0.10 3.21E-01 0.14 9.15E-04 
2011mTn5STM.4.09.E03 SMc02117 cystathionine beta-lyase protein MetC 0.15 5.64E-02 -0.60 1.64E-06 -0.02 7.40E-01 0.20 3.94E-04 
2011mTn5STM.4.08.F03 SMa1913 putative transport protein 0.15 1.73E-03 0.11 5.37E-01 -0.27 4.69E-09 -0.43 4.38E-04 
2011mTn5STM.4.02.G03 SMc00828 hypothetical protein -0.08 5.52E-02 -0.43 1.84E-08 -0.15 3.47E-09 -0.11 2.58E-01 
2011mTn5STM.4.01.H03 SMb20151 hypothetical protein 0.18 1.47E-02 0.23 2.43E-10 0.26 1.33E-16 0.31 1.10E-20 
2011mTn5STM.4.08.A04 SMc02139 hypothetical protein -0.16 7.68E-02 0.20 1.70E-04 0.30 3.97E-09 0.21 6.10E-08 
2011mTn5STM.4.05.B04 SMa1371 probable ABC transporter ATP-binding protein 0.17 1.92E-02 0.41 2.50E-04 0.05 8.50E-02 -0.02 1.87E-01 
2011mTn5STM.4.12.C04 SMa1465 putative ABC transporter permease -0.08 7.12E-02 -0.04 1.06E-01 -0.12 4.00E-05 0.01 9.02E-01 
2011mTn5STM.4.04.D04 SMb20481 AsnO asparagine synthase, glutamine-hydrolyzing -0.06 1.85E-01 -0.13 7.32E-03 -0.11 1.28E-07 -0.13 3.29E-11 
2011mTn5STM.4.02.E04 pSymA, 1165092 intergenic 0.42 2.37E-05 0.21 2.15E-07 -0.06 2.52E-04 -0.17 2.50E-07 
2011mTn5STM.4.09.F04 SMa2115 Gst13 glutathione S-transferase 0.08 2.45E-01 0.02 2.57E-01 -0.38 5.63E-10 -0.46 1.12E-20 
2011mTn5STM.4.03.G04 SMa0752 FAD/NAD(P)-binding oxidoreductase protein 0.01 6.15E-01 -0.07 2.87E-02 -0.27 3.71E-14 -0.39 4.87E-26 
2011mTn5STM.4.10.H04 SMc00428 hypothetical protein -0.23 6.96E-05 -0.12 2.90E-04 0.33 1.68E-10 0.45 1.11E-23 
2011mTn5STM.4.01.A05 pSymB, 376527 intergenic 0.22 2.40E-02 0.39 7.25E-09 0.16 4.34E-04 0.25 1.17E-09 
2011mTn5STM.4.06.B05 SMc00127 choline sulfatase protein BetC 0.16 1.02E-01 0.37 8.64E-07 0.16 8.56E-05 0.29 1.00E-06 
2011mTn5STM.4.03.C05 SMc00937 TRK system potassium uptake transmembrane protein TrkH -0.05 7.04E-01 -0.22 4.88E-07 -0.30 4.06E-14 -0.46 7.14E-29 
2011mTn5STM.4.05.D05 SMa0222 putative GntR-family transcriptional regulator -0.08 2.54E-01 0.07 2.97E-01 0.45 1.43E-09 0.25 1.76E-15 
2011mTn5STM.4.11.E05 SMb20534 hypothetical protein 0.21 1.03E-04 0.03 2.32E-01 NA NA -0.26 1.42E-03 
2011mTn5STM.4.11.F05 SMc02149 hypothetical protein 0.97 3.49E-05 0.77 5.33E-08 NA NA 0.42 1.25E-03 
2011mTn5STM.4.05.G05 
S. meliloti 
chromosome, 
532543 
intergenic -0.06 2.94E-01 -0.02 5.27E-01 -0.03 1.82E-01 0.01 8.95E-01 
2011mTn5STM.4.02.H05 SMc00523 hypothetical protein 0.09 2.98E-01 0.16 1.70E-04 0.09 1.38E-04 0.14 3.04E-09 
2011mTn5STM.4.09.A06 SMb20149 hypothetical protein 0.29 1.74E-05 0.19 2.34E-06 0.14 3.22E-08 0.10 5.02E-07 
2011mTn5STM.4.03.B06 SMc00781 methylmalonate-semialdehyde dehydrogenase MmsA (IolA) -0.10 1.46E-02 0.13 5.40E-04 -0.24 2.88E-11 -0.24 8.68E-16 
2011mTn5STM.4.03.C06 SMc01267 hypothetical protein -0.14 2.66E-02 -0.08 6.00E-04 -0.31 5.94E-08 -0.28 3.13E-20 
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2011mTn5STM.4.04.D06 SMb20227 nutrient deprivation-induced protein A (NdiA1) -0.13 7.63E-04 -0.23 2.86E-08 -0.14 4.25E-08 -0.05 2.18E-02 
2011mTn5STM.4.02.E06 SMc02226 hypothetical protein 0.09 2.44E-02 0.17 2.04E-03 0.25 2.69E-05 0.39 2.70E-19 
2011mTn5STM.4.05.F06 SMb20820 putative ferredoxin reductase MocF 0.10 1.10E-02 0.10 1.92E-05 -0.24 8.48E-07 -0.46 8.46E-23 
2011mTn5STM.4.07.G06 SMc00955 hypothetical protein 0.13 8.36E-02 0.26 3.72E-05 -0.11 4.06E-03 -0.08 1.58E-04 
2011mTn5STM.4.05.H06 SMa1480 probable LysR-type activator -0.15 9.57E-03 -0.13 6.50E-04 -0.19 1.67E-11 -0.07 1.95E-02 
2011mTn5STM.4.11.A07 SMa1734 hypothetical protein 0.18 9.06E-04 -0.07 5.97E-02 -0.18 3.44E-09 -0.34 3.87E-29 
2011mTn5STM.4.03.B07 SMa0417 hypothetical protein 0.19 2.37E-04 0.10 1.32E-02 -0.10 1.07E-04 -0.13 3.30E-07 
2011mTn5STM.4.07.C07 SMb20941 msbA-like saccharide exporting ABC transporter protein -0.21 4.39E-04 -0.15 1.20E-04 -0.20 3.58E-11 -0.14 1.45E-05 
2011mTn5STM.4.07.D07 SMb21592 putative sugar uptake ABC transporter ATP-binding protein -0.11 1.30E-01 -0.18 4.48E-06 NA NA NA NA 
2011mTn5STM.4.09.E07 SMc00893 hypothetical protein 0.37 3.00E-03 0.22 7.23E-06 0.05 3.54E-01 0.05 2.32E-03 
2011mTn5STM.4.03.F07 
S. meliloti 
chromosome, 
2051945 
intergenic -0.16 4.09E-03 0.04 1.49E-01 NA NA 0.22 1.72E-02 
2011mTn5STM.4.09.G07 SMa2279 hypothetical protein -0.10 9.55E-02 -0.12 7.43E-03 0.15 6.28E-08 -0.03 4.77E-01 
2011mTn5STM.4.04.H07 
S. meliloti 
chromosome, 
81040 
intergenic -0.20 6.41E-02 -0.09 1.35E-03 0.20 5.80E-10 -0.11 5.04E-04 
2011mTn5STM.4.08.A08 SMc02372 putative transport transmembrane protein 0.17 6.13E-04 0.18 1.70E-04 0.21 8.08E-03 0.15 2.33E-04 
2011mTn5STM.4.12.B08 SMa1355 hypothetical protein 0.18 1.78E-03 0.12 2.60E-04 -0.31 3.92E-18 -0.31 3.23E-17 
2011mTn5STM.4.06.C08 SMa0021 hypothetical protein -0.33 7.70E-03 -0.18 3.60E-04 0.10 1.57E-01 -0.04 5.09E-02 
2011mTn5STM.4.04.D08 SMa1782 putative LysR-family transcriptional regulator 0.31 1.78E-04 0.03 5.20E-01 -0.14 3.10E-07 -0.21 4.29E-15 
2011mTn5STM.4.01.E08 SMb20925 hypothetical protein 0.16 6.40E-03 0.06 1.80E-01 -0.23 3.00E-03 -0.16 2.68E-05 
2011mTn5STM.4.01.F08 SMc01611 ferrichrome-iron receptor precursor protein -0.03 6.72E-01 0.01 3.79E-01 -0.14 5.46E-08 -0.09 2.67E-06 
2011mTn5STM.4.10.G08 
S. meliloti 
chromosome, 
2816977 
intergenic -0.03 7.61E-01 0.03 4.74E-01 0.13 1.19E-06 0.07 2.78E-01 
2011mTn5STM.4.08.H08 SMb20007 KatC catalase protein -0.08 1.70E-01 -0.13 4.90E-04 0.36 6.53E-10 0.43 4.30E-14 
2011mTn5STM.4.03.A09 SMc00825 glutamate-cysteine ligase GshA -0.36 2.16E-02 -0.68 6.90E-04 NA NA NA NA 
2011mTn5STM.4.05.B09 SMa0574 hypothetical protein -0.04 2.62E-01 0.09 9.31E-03 -0.06 5.17E-02 -0.10 1.71E-04 
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2011mTn5STM.4.11.C09 
S. meliloti 
chromosome, 
3123223 
intergenic -0.24 7.62E-04 -0.10 4.18E-02 0.33 6.35E-10 0.34 2.81E-15 
2011mTn5STM.4.08.D09 SMa1084 hypothetical protein -0.32 4.37E-06 -0.43 2.50E-15 -0.34 9.78E-14 -0.40 3.50E-21 
2011mTn5STM.4.08.E09 SMa1163 putative cation transport P-type ATPase 0.08 2.10E-02 -0.06 7.97E-02 -0.15 2.96E-04 -0.16 2.09E-06 
2011mTn5STM.4.01.F09 SMa0734 hypothetical protein 0.07 1.46E-02 0.06 2.93E-01 -0.16 3.20E-02 -0.33 1.90E-11 
2011mTn5STM.4.07.G09 SMa1582 hypothetical protein -0.21 1.10E-04 -0.25 4.64E-08 -0.27 3.33E-15 -0.34 9.84E-27 
2011mTn5STM.4.02.H09 SMb20049 putative elongation factor G protein -0.06 1.31E-01 -0.01 2.48E-01 0.15 3.57E-05 0.14 1.74E-03 
2011mTn5STM.4.04.A10 pSymA, 248361 intergenic -0.16 5.18E-03 -0.16 4.85E-05 -0.01 7.95E-01 -0.08 6.32E-03 
2011mTn5STM.4.11.B10 SMb21300 putative deoxyribose-phosphate aldolase protein -0.10 6.51E-02 -0.01 3.01E-01 0.02 7.67E-01 -0.01 4.60E-02 
2011mTn5STM.4.11.C10 SMa0091 hypothetical protein -0.57 6.69E-08 -0.44 1.45E-13 0.18 1.86E-04 0.16 3.10E-04 
2011mTn5STM.4.02.D10 SMa1362 putative inner-membrane permease -0.36 6.49E-06 -0.37 1.10E-12 -0.18 2.48E-10 -0.25 3.89E-15 
2011mTn5STM.4.06.E10 SMb20909 hypothetical protein 0.11 4.04E-02 -0.12 2.97E-03 -0.28 1.97E-02 NA NA 
2011mTn5STM.4.12.F10 SMc02419 putative peptide transport system permease protein -0.01 7.53E-01 -0.08 1.81E-02 -0.10 7.34E-05 -0.01 3.88E-01 
2011mTn5STM.4.06.G10 SMa0769 FixP2 cytochrome c oxidase -0.21 9.62E-05 -0.36 2.80E-11 -0.32 1.05E-08 -0.56 4.65E-26 
2011mTn5STM.4.04.H10 SMc02273 RkpA fatty acid synthase protein -0.28 2.10E-06 -0.23 8.62E-06 -0.35 1.18E-23 0.05 5.25E-04 
2011mTn5STM.4.01.A11 SMa1397 hypothetical protein -0.08 1.91E-01 0.07 1.48E-01 0.01 8.11E-01 0.07 7.07E-02 
2011mTn5STM.4.05.B11 SMa0583 NrtB, Nitrate transport permease protein -0.30 2.49E-05 -0.08 7.91E-01 NA NA NA NA 
2011mTn5STM.4.01.C11 SMc02597 superoxide dismutase Cu-Zn precursor protein SodC -0.56 1.26E-09 -0.52 1.32E-10 0.00 4.02E-01 -0.11 1.69E-03 
2011mTn5STM.4.09.D11 SMc03873 RNA polymerase sigma factor protein SigC -0.57 4.38E-07 -0.49 6.43E-09 0.36 2.21E-11 0.22 4.15E-06 
2011mTn5STM.4.04.E11 SMb20942 UDP glucose 4-epimerase protein ExoB -0.08 4.51E-02 -0.17 1.90E-04 -0.34 1.01E-14 -0.36 8.65E-15 
2011mTn5STM.4.09.F11 SMa0592 hypothetical protein -0.27 1.71E-04 -0.08 1.11E-01 0.11 8.42E-02 -0.04 2.70E-03 
2011mTn5STM.4.01.G11 SMb20355 hypothetical protein -0.42 4.25E-07 -0.48 2.73E-13 -0.24 5.84E-04 -0.12 1.70E-03 
2011mTn5STM.4.08.H11 SMc00339 adenylate cyclase 1 protein CyaA -0.28 1.44E-04 -0.28 1.50E-08 0.37 1.06E-18 0.40 1.44E-26 
2011mTn5STM.4.04.A12 SMb21165 putative histidine ammonia-lyase histidase protein HutH1 -0.11 5.37E-01 -0.20 1.62E-06 -0.02 4.66E-01 0.03 6.30E-01 
2011mTn5STM.4.09.B12 SMc02144 phosphate transport system permease ABC transporter protein -0.91 1.46E-08 -0.66 1.07E-11 -0.71 4.16E-26 -0.64 4.17E-23 
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2011mTn5STM.4.04.C12 SMc01053 siroheme synthase protein CysG  -0.29 1.74E-04 -1.35 1.40E-21 -0.05 2.99E-02 0.01 5.69E-01 
2011mTn5STM.4.07.D12 SMa0070 ABC transporter permease -0.51 5.96E-05 -0.48 1.80E-13 0.17 1.51E-06 0.11 1.12E-02 
2011mTn5STM.4.08.E12 SMb21158 putative transcriptional regulator, probably of sugar phosphate metabolism protein -0.27 1.28E-04 -0.22 1.62E-07 -0.29 5.40E-24 -0.20 9.56E-18 
2011mTn5STM.4.08.F12 SMb20018 probable sugar transport ATP-binding protein -0.05 2.87E-01 0.07 1.73E-01 0.37 3.46E-12 0.44 2.15E-18 
2011mTn5STM.4.03.G12 SMc00775 FbpB ABC iron transporter, permease component -0.31 5.84E-04 -0.26 3.20E-08 0.03 3.43E-01 0.09 2.68E-03 
2011mTn5STM.4.07.H12 SMa0398 probable HisD2 histidinol dehydrogenase -0.32 3.32E-06 -0.45 4.08E-16 -0.14 1.71E-04 -0.37 5.59E-07 
 
a For mutants carrying a transposon insertion in an intergenic region the exact position of insertion in the respective replicon is given. 
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TABLE G.3. RESULTS OF IN PLANTA STM EXPERIMENT FOR SET 1 
 
Slide 4, combined DNA slides 1-3 
mutantID complete aliases function 
n m-value p-value(t) n m-value p-value(t)
2011mTn5STM.1.13.A10 SMa0364 hypothetical protein 16 -0.51 1.8E-12 40 -0.48 2.7E-15 
2011mTn5STM.1.08.B10 SMb21578 copper-transporting P-type ATPase protein AtcU2 16 -0.59 1.1E-14 39 -0.59 1.7E-17 
2011mTn5STM.1.11.C10 SMb20070 putative sulfate permease protein 16 0.35 1.1E-05 38 0.52 9.0E-13 
2011mTn5STM.1.12.E10 SMc00349 GTP-binding membrane protein LepA 16 -0.97 8.9E-16 40 -0.94 4.6E-32 
2011mTn5STM.1.08.F10 SMc02406 hypothetical protein 0 NA NA 40 0.49 4.2E-11 
2011mTn5STM.1.13.G10 SMa0104 ABC transporter. solute-binding protein 0 NA NA 40 0.22 7.3E-02 
2011mTn5STM.1.04.H10 SMa0252 hypothetical protein 16 0.60 1.2E-06 28 0.59 1.6E-07 
2011mTn5STM.1.02.A11 SMc00413 hypothetical protein 0 NA NA 24 0.32 4.7E-03 
2011mTn5STM.1.07.B11 SMb20967 putative transcriptional regulator, lacI family 
protein 
16 -0.08 2.6E-03 40 -0.22 3.6E-03 
2011mTn5STM.1.08.C11 SMc04346 IlvC ketol-acid reductoisomerase protein 11 -0.83 2.3E-05 19 -0.78 4.1E-09 
2011mTn5STM.1.05.D11 SMa0814 NifB FeMo cofactor biosynthesis protein 16 -1.06 1.2E-16 40 -1.09 3.9E-36 
2011mTn5STM.1.01.E11 SMa0765 FixN2 cytochrome c oxidase polypeptide I 16 -0.61 1.2E-12 24 -0.27 3.6E-03 
2011mTn5STM.1.06.F11 SMa0922 hypothetical protein 16 0.50 8.1E-10 40 0.12 3.1E-01 
2011mTn5STM.1.12.G11 SMa1195 hypothetical protein 16 0.32 5.2E-05 40 0.30 7.6E-10 
2011mTn5STM.1.05.H11 SMa1493 putative LysR-type transcription factor 12 -0.76 1.0E-09 12 -0.37 1.3E-03 
2011mTn5STM.1.11.A12 SMc01664 putative transcription regulator protein 16 -0.36 2.9E-09 40 -0.57 1.1E-09 
2011mTn5STM.1.11.B12 SMc00322 hypothetical protein 16 -0.42 2.4E-06 39 -0.37 3.8E-08 
2011mTn5STM.1.11.C12 SMa0489 putative ABC transporter. ATP-binding protein 16 -0.19 3.7E-05 40 -0.12 5.5E-03 
2011mTn5STM.1.02.D12 SMa1288 hypothetical protein 16 0.06 1.6E-01 39 -0.18 1.0E-01 
2011mTn5STM.1.11.E12 SMc04337 hypothetical protein 16 0.56 1.4E-05 40 0.36 1.3E-05 
2011mTn5STM.1.04.F12 SMc04363 hypothetical protein 16 0.53 3.1E-07 40 0.35 6.4E-06 
2011mTn5STM.1.04.H12 SMb21641 regulator of phenylacetic acid degradation PaaX 16 1.13 4.6E-14 40 0.67 1.1E-08 
2011mTn5STM.1.10.A01 SMb21639 phenylacetic acid degradation protein PaaB 16 0.37 2.9E-07 40 0.24 1.9E-02 
2011mTn5STM.1.09.B01 SMa0675 cation (Ca) exchange protein, possible 16 -0.70 1.5E-13 40 -0.71 1.5E-17 
2011mTn5STM.1.09.C01 SMc00513 putative amino-acid binding periplasmic protein 16 0.91 9.8E-12 16 1.10 2.8E-09 
2011mTn5STM.1.02.D01 SMa0259 hypothetical protein 16 0.17 4.4E-02 24 -0.42 2.7E-02 
2011mTn5STM.1.01.E01 SMb20834 lipopolysaccharide processing protein RkpZ1 16 -0.49 1.2E-08 40 -0.51 2.4E-15 
2011mTn5STM.1.13.F01 SMa0113 Sensory histidine kinase 13 0.45 2.3E-04 34 0.40 1.1E-06 
2011mTn5STM.1.02.G01 SMa1497 putative Gst12 glutathione-S-transferase 0 NA NA 24 0.22 3.7E-05 
2011mTn5STM.1.13.H01 SMb20167 hypothetical protein 16 -0.04 4.7E-02 40 -0.09 1.9E-01 
2011mTn5STM.1.13.B02 SMc02327 ribonuclease HI protein RnhA2 16 0.36 4.8E-09 40 0.30 5.0E-03 
2011mTn5STM.1.09.C02 SMa1903 putative protease 16 0.08 2.1E-02 28 0.27 2.4E-07 
2011mTn5STM.1.03.D02 SMc02466 SdhB succinate dehydrogenase iron-sulfur protein 12 0.63 2.6E-11 28 0.31 2.3E-03 
2011mTn5STM.1.11.E02 SMc02738 ABC cholin transporter, permease component 
(OpuB) 
16 -0.21 1.1E-05 40 -0.41 2.6E-03 
2011mTn5STM.1.08.F02 SMa0525 putative ABC-type iron transport system protein 16 -0.48 7.0E-12 40 -0.43 5.8E-10 
2011mTn5STM.1.07.G02 S. meliloti 
chromosome, 
2021711 
intergenic 16 -0.33 6.1E-08 40 -0.52 5.3E-09 
2011mTn5STM.1.06.H02 SMc01090 ATP-dependent RNA-helicase protein DeaD 0 NA NA 40 -0.09 5.9E-01 
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2011mTn5STM.1.10.A03 SMc01046 Trk system potassium uptake protein 16 0.39 9.4E-09 40 0.35 6.3E-15 
2011mTn5STM.1.01.B03 SMc01432 hypothetical protein 16 -0.03 6.2E-02 40 -0.22 6.7E-02 
2011mTn5STM.1.05.C03 SMb20071 putative efflux protein 16 -0.67 3.1E-11 23 -0.66 2.9E-09 
2011mTn5STM.1.03.D03 SMb20349 putative ABC transporter 16 -0.40 6.3E-08 40 -0.50 1.4E-07 
2011mTn5STM.1.11.E03 SMa0300 ABC transporter. permease 16 -0.47 2.7E-10 16 -0.18 7.7E-06 
2011mTn5STM.1.06.F03 SMc00300 putative oxidoreductase protein 16 0.50 4.0E-09 40 0.52 1.1E-13 
2011mTn5STM.1.08.G03 pSymB, 543971 intergenic 16 0.15 1.3E-04 24 0.11 1.5E-01 
2011mTn5STM.1.08.H03 SMa1236 NapA periplasmic nitrate reductase 16 -0.36 5.2E-09 24 -0.13 7.3E-03 
2011mTn5STM.1.11.A04 SMa1004 hypothetical protein 16 -0.83 2.0E-13 40 -0.86 3.1E-23 
2011mTn5STM.1.06.B04 SMb21707 putative ureashort-chain amide or branched-chain 
amino acid uptake ABC transporter, ATP-binding 
protein 
16 0.17 5.2E-04 40 0.11 2.2E-01 
2011mTn5STM.1.01.C04 SMa1229 FixL Oxygen regulated histidine kinase 16 -1.11 1.7E-15 39 -1.11 8.3E-29 
2011mTn5STM.1.03.D04 SMa1531 NuoC2 NADH I chain C 16 -0.10 1.5E-02 40 -0.33 4.1E-05 
2011mTn5STM.1.13.E04 SMa1503 hypothetical protein 16 0.03 1.7E-01 40 -0.12 1.3E-02 
2011mTn5STM.1.02.F04 SMa1292 hypothetical protein 0 NA NA 40 -0.30 1.5E-06 
2011mTn5STM.1.01.G04 SMc01497 sorbitol/mannitol transporter SmoF 16 0.81 3.5E-09 34 0.48 2.3E-02 
2011mTn5STM.1.07.H04 SMb21422 putative sugar uptake ABC transporter ATP-
binding protein 
16 -0.24 1.4E-05 40 -0.11 2.5E-02 
2011mTn5STM.1.02.A05 SMb21645 ABC transporter. permease component 16 -0.32 8.3E-07 40 -0.35 3.0E-11 
2011mTn5STM.1.07.B05 SMb20142 putative oligopeptide ABC transporter permease 
protein 
16 0.38 2.3E-06 40 0.43 1.3E-12 
2011mTn5STM.1.03.C05 SMc02121 general L-amino acid transport ATP-binding ABC 
transporter protein AapP 
16 0.51 4.3E-08 40 0.51 6.8E-10 
2011mTn5STM.1.08.D05 SMb20219 putative response regulator protein 16 -0.07 2.9E-03 40 -0.05 1.5E-01 
2011mTn5STM.1.09.E05 SMb21527 putative taurin uptake ABC transporter ATP-
binding protein TauB 
16 0.20 1.2E-02 40 -0.04 7.2E-01 
2011mTn5STM.1.12.F05 SMa0803 putative ABC-transporter ATP-binding protein 16 -0.26 7.3E-08 40 -0.38 1.9E-07 
2011mTn5STM.1.12.G05 SMa0621 FixI2 E1-E2 type cation ATPase 16 0.79 5.4E-13 40 0.86 4.7E-19 
2011mTn5STM.1.07.H05 SMa0875 NolG efflux transporter 0 NA NA 32 0.11 7.6E-04 
2011mTn5STM.1.09.A06 SMa1507 hypothetical protein 16 0.02 5.1E-01 40 0.09 7.9E-02 
2011mTn5STM.1.04.B06 SMb20930 putative sugar uptake ABC transporter ATP-
binding protein 
16 0.20 1.7E-03 40 0.27 2.3E-03 
2011mTn5STM.1.11.C06 SMc02507 Manganese ABC transporter permease SitC 16 -0.10 4.4E-02 40 -0.02 3.7E-01 
2011mTn5STM.1.03.D06 SMa1760 Miscellaneous; Unknown 16 -0.44 5.2E-12 40 -0.38 9.8E-05 
2011mTn5STM.1.06.E06 pSymA, 305100 intergenic 16 -0.16 5.8E-06 40 -0.30 8.5E-04 
2011mTn5STM.1.12.F06 SMb20390 hypothetical protein 16 -0.34 5.0E-07 40 -0.27 5.0E-09 
2011mTn5STM.1.08.G06 SMa1798 Kup2 Potassium uptake protein 16 -1.05 8.1E-16 24 -0.94 7.0E-19 
2011mTn5STM.1.11.H06 SMa0214 putative KduI DKI isomerase 0 NA NA 40 -0.17 1.8E-07 
2011mTn5STM.1.12.B07 S. meliloti 
chromosome, 
1067681 
intergenic 12 0.19 2.4E-03 22 0.41 4.7E-02 
2011mTn5STM.1.12.C07 SMa0803 putative ABC-transporter ATP-binding protein 0 NA NA 0 NA NA 
2011mTn5STM.1.11.D07 SMb20819 Ferredoxin, Rieske [2Fe-2S] domain MocE 0 NA NA 16 -0.34 4.0E-08 
2011mTn5STM.1.08.E07 SMa1467 Probable inner-membrane permease 16 -0.31 1.2E-10 32 -0.84 4.4E-21 
2011mTn5STM.1.11.F07 SMa1115 Putative manganese transport protein 16 0.00 6.2E-01 40 -0.01 4.3E-01 
2011mTn5STM.1.04.G07 S. meliloti 
chromosome, 
2181489 
intergenic 16 0.22 5.6E-06 40 0.24 1.9E-02 
2011mTn5STM.1.05.H07 S. meliloti 
chromosome, 
1621189 
intergenic 16 0.54 2.5E-15 40 0.48 1.8E-06 
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2011mTn5STM.1.02.A08 SMc00185 putative ABC-transporter ATP-binding protein 16 0.64 7.7E-10 40 0.49 3.2E-14 
2011mTn5STM.1.03.B08 SMb20513 hypothetical protein 16 -0.21 4.5E-08 40 -0.31 2.4E-02 
2011mTn5STM.1.05.C08 SMb21477 putative reverse transcriptase maturase protein 0 NA NA 16 0.36 6.1E-04 
2011mTn5STM.1.11.D08 SMa1638 hypothetical protein 16 -0.08 2.5E-02 40 -0.03 4.4E-01 
2011mTn5STM.1.03.E08 SMc02236 hypothetical protein 0 NA NA 40 0.20 1.1E-03 
2011mTn5STM.1.09.F08 SMa1146 hypothetical protein 16 -0.38 9.0E-10 40 -0.33 2.8E-07 
2011mTn5STM.1.12.G08 SMb20948 ExoU glucosyltransferase 15 -1.05 3.8E-14 40 -1.06 5.1E-27 
2011mTn5STM.1.09.H08 SMa0809 hypothetical protein 16 0.08 2.4E-01 38 -0.12 1.8E-01 
2011mTn5STM.1.04.A09 SMb20616 ThiO thiamine biosynthesis oxidoreductase 
protein 
14 -0.98 1.7E-09 37 -0.88 6.2E-20 
2011mTn5STM.1.01.B09 SMb20958 exopolysaccharide biosynthesis protein ExoM 13 -1.08 6.8E-14 34 -1.02 3.2E-20 
2011mTn5STM.1.10.C09 SMa0244 hypothetical protein 0 NA NA 11 -0.82 1.4E-05 
2011mTn5STM.1.05.D09 SMa0840 NodD3 transcriptional regulator 0 NA NA 16 -0.93 3.0E-11 
2011mTn5STM.1.05.E09 SMc02773 sugar transport ATP-binding protein 15 0.27 9.7E-04 32 0.17 7.6E-02 
2011mTn5STM.1.02.F09 SMc02612 glutamate synthase family protein GlxD 16 0.98 6.2E-12 40 0.82 1.2E-22 
2011mTn5STM.1.03.G09 SMa1128 DegP4 protease like protein 15 0.00 6.9E-01 40 0.01 8.8E-01 
2011mTn5STM.1.12.H09 SMb21087 conjugal transfer protein TraA2 0 NA NA 0 NA NA 
2011mTn5STM.2.10.A10 S. meliloti 
chromosome, 
2106334 
intergenic 16 0.30 1.1E-06 40 0.30 9.9E-03 
2011mTn5STM.2.04.B10 SMa0565 hypothetical protein 16 1.20 1.6E-08 40 1.29 3.3E-22 
2011mTn5STM.2.04.C10 SMc00086 diheme cytochrome C-type signal peptide protein 
CycG 
16 0.11 1.1E-02 24 0.13 8.6E-02 
2011mTn5STM.2.03.D10 SMb20748 glycosyltransferase protein PssF 16 0.87 3.8E-07 37 0.75 8.3E-13 
2011mTn5STM.2.11.E10 SMb21273 spermidineputrescine ABC transporter periplasmic 
solute-binding protein precursor 
16 0.19 7.3E-03 40 0.43 4.1E-07 
2011mTn5STM.2.09.F10 SMc01818 adenylate cyclase transmembrane protein CyaC 14 -0.02 2.4E-01 23 0.09 4.2E-02 
2011mTn5STM.2.05.G10 SMb20522 hypothetical protein 16 -0.17 5.7E-04 40 0.01 6.6E-01 
2011mTn5STM.2.01.H10 SMa1017 hypothetical protein 0 NA NA 13 0.29 3.4E-04 
2011mTn5STM.2.06.A11 SMc01042 nitrogen regulation protein NtrB 0 NA NA 0 NA NA 
2011mTn5STM.2.06.B11 SMc01881 PanB 3-methyl-2-oxobutanoate 
hydromethyltransferase protein 
10 2.84 1.6E-04 19 2.01 1.4E-08 
2011mTn5STM.2.04.C11 SMb20515 putative CheR methyltransferase, SAM binding 
domain 
13 -0.17 8.5E-02 35 -0.01 9.1E-01 
2011mTn5STM.2.01.D11 SMc04452 NADH dehydrogenase transmembrane protein 
Ndh 
16 1.17 1.8E-21 32 1.02 2.3E-19 
2011mTn5STM.2.05.E11 SMa1122 hypothetical protein 16 -0.12 3.6E-01 34 0.04 9.1E-01 
2011mTn5STM.2.04.F11 pSymA, 510651 intergenic 0 NA NA 16 0.59 3.9E-04 
2011mTn5STM.2.11.G11 SMb21345 putative sugar ABC transporter 16 0.23 2.4E-09 40 0.30 5.8E-13 
2011mTn5STM.2.10.H11 SMb20549 hypothetical protein 16 0.11 3.9E-04 40 0.04 1.1E-02 
2011mTn5STM.2.03.A12 SMc00739 hypothetical protein 16 0.74 2.6E-09 40 0.63 2.2E-07 
2011mTn5STM.2.09.B12 S. meliloti 
chromosome, 
2862221 
intergenic 16 1.11 1.4E-07 24 1.32 1.7E-13 
2011mTn5STM.2.04.C12 SMc01814 probable glutamate synthase small chain protein 16 0.49 2.2E-07 40 0.20 4.3E-02 
2011mTn5STM.2.01.D12 pSymB. 610814 intergenic 16 -0.02 7.4E-01 24 -0.18 6.8E-06 
2011mTn5STM.2.03.E12 SMb20548 hypothetical protein 16 0.24 1.0E-03 40 0.22 8.4E-06 
2011mTn5STM.2.09.F12 SMc03110 hypothetical protein 0 NA NA 16 -0.23 1.9E-02 
2011mTn5STM.2.06.G12 SMc00094 betaine aldehyde dehydrogenase protein BetB 0 NA NA 22 0.01 3.3E-01 
2011mTn5STM.2.06.H12 SMc01711 hypothetical protein 16 0.22 9.8E-07 40 0.37 1.9E-08 
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2011mTn5STM.2.05.A01 S. meliloti 
chromosome, 
2044300 
intergenic 10 1.42 2.2E-04 11 0.38 2.6E-01 
2011mTn5STM.2.07.B01 SMa1182 NosZ N2O reductase 16 0.27 2.5E-06 39 0.24 1.2E-03 
2011mTn5STM.2.11.C01 SMa1677 hypothetical protein 16 0.02 9.8E-01 40 -0.11 1.8E-01 
2011mTn5STM.2.10.D01 SMc01950 high-affinity branched-chain amino acid ABC 
transporter. permease protein LivM 
15 -0.86 4.2E-08 37 -0.81 1.8E-14 
2011mTn5STM.2.12.E01 SMc03249 hypothetical protein 16 -0.28 1.0E-06 40 -0.20 1.9E-08 
2011mTn5STM.2.07.F01 SMa0607 hypothetical protein 13 -1.09 6.4E-03 20 -0.70 1.4E-04 
2011mTn5STM.2.01.G01 pSymA, 854083 intergenic 16 -0.15 2.9E-03 40 -0.02 3.5E-01 
2011mTn5STM.2.12.H01 SMc01219 lipopolysaccharide core biosynthesis 
mannosyltransferase LpsB 
13 -0.91 6.1E-05 25 -0.84 4.8E-11 
2011mTn5STM.2.07.A02 SMc01607 putative permease protein 16 -0.12 7.4E-04 40 -0.03 5.6E-01 
2011mTn5STM.2.05.B02 SMb21144 putative choline uptake ABC transporter 
periplasmic solute-binding protein precursor 
16 0.04 3.6E-01 40 0.01 2.1E-01 
2011mTn5STM.2.05.C02 SMa0876 NolF secretion protein 14 -0.19 1.4E-03 34 -0.23 5.8E-03 
2011mTn5STM.2.09.D02 SMa0322 hypothetical protein 16 -0.87 2.3E-13 40 -0.80 1.2E-23 
2011mTn5STM.2.04.E02 SMb21633 PaaG enoyl-CoA hydratase protein 11 1.00 2.2E-05 36 0.74 1.7E-05 
2011mTn5STM.2.05.F02 S. meliloti 
chromosome, 
1627869 
intergenic 14 0.82 6.6E-06 33 0.65 4.0E-08 
2011mTn5STM.2.02.G02 SMb20273 hypothetical protein 16 -0.47 2.2E-09 40 -0.59 3.3E-12 
2011mTn5STM.2.12.H02 SMb20851 putative transcriptional regulator, SorC family 
protein 
16 -0.29 3.3E-04 37 -0.26 1.3E-04 
2011mTn5STM.2.12.A03 SMb20209 hypothetical protein 16 -0.16 2.8E-04 37 -0.35 8.8E-06 
2011mTn5STM.2.10.B03 S. meliloti 
chromosome, 
3367064 
intergenic 16 0.49 5.7E-06 24 0.45 1.4E-05 
2011mTn5STM.2.02.C03 SMc00556 DNA repair protein RadA 13 -0.52 1.3E-04 36 -0.73 3.9E-07 
2011mTn5STM.2.12.D03 SMa0485 probable ThrC2 threonine synthase 16 -0.30 1.2E-07 24 -0.26 3.7E-06 
2011mTn5STM.2.01.E03 SMb20712 rhizopine uptake ABC transporter periplasmic 
solute-binding protein precursor MocB 
0 NA NA 40 0.10 3.1E-01 
2011mTn5STM.2.07.F03 SMb20168 hypothetical protein 12 -0.03 3.5E-01 26 0.00 9.9E-01 
2011mTn5STM.2.06.G03 SMc03044 chemotaxis protein MotD 15 0.32 2.5E-02 39 0.02 9.7E-01 
2011mTn5STM.2.09.H03 SMa1833 hypothetical protein 0 NA NA 16 -0.13 1.0E-02 
2011mTn5STM.2.11.A04 SMc02270 capsular polysaccharide biosynthesis 
transmembrane protein RkpI 
16 0.05 1.3E-02 40 -0.15 2.5E-01 
2011mTn5STM.2.09.B04 SMb20112 hypothetical protein 16 -0.30 1.3E-06 24 -0.37 6.1E-07 
2011mTn5STM.2.12.C04 SMc02659 GTP pyrophosphokinase protein RelA 0 NA NA 0 NA NA 
2011mTn5STM.2.09.D04 SMb21301 putative membrane-anchored aldehyde 
dehydrogenase protein 
0 NA NA 16 -0.01 5.5E-01 
2011mTn5STM.2.01.E04 SMa0306 putative histidine ammonia-lyase 16 -0.62 5.8E-12 22 -0.72 4.3E-08 
2011mTn5STM.2.01.F04 SMa0431 hypothetical protein 16 0.00 9.3E-02 40 0.11 2.1E-02 
2011mTn5STM.2.11.G04 SMb20472 probable carbamoyltransferase 16 -0.24 1.6E-06 38 -0.01 2.2E-01 
2011mTn5STM.2.10.H04 SMa0110 ABC transporter. ATP-binding protein 16 -0.12 6.1E-02 40 -0.08 3.6E-01 
2011mTn5STM.2.05.A05 SMb21199 oligopeptide uptake ABC transporter ATP-
binding protein OppD 
16 -0.18 2.8E-05 40 -0.04 1.9E-01 
2011mTn5STM.2.10.B05 SMb21367 cytochrome c class I protein CycA 16 0.17 2.7E-04 16 0.85 3.1E-14 
2011mTn5STM.2.11.C05 SMa0250 hypothetical protein 16 0.40 4.7E-04 40 0.16 4.2E-04 
2011mTn5STM.2.08.D05 SMa0849 SyrM transcriptional regulator 16 -0.96 1.4E-18 24 -0.78 1.8E-13 
2011mTn5STM.2.06.E05 SMb21177 phosphate uptake ABC transporter ATP-binding 
protein 
16 -0.40 1.4E-09 40 -0.54 2.2E-13 
2011mTn5STM.2.06.F05 pSymB, 1225168 intergenic 16 -0.12 6.7E-01 19 -0.11 6.5E-01 
2011mTn5STM.2.06.G05 SMa1766 hypothetical protein 15 -0.61 1.4E-06 38 -0.45 1.7E-10 
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2011mTn5STM.2.05.H05 SMc03164 xylulose kinase protein XylB 16 0.78 5.2E-08 24 1.10 4.4E-11 
2011mTn5STM.2.07.A06 SMb20866 hypothetical protein 16 0.01 6.8E-01 40 0.13 5.3E-02 
2011mTn5STM.2.11.B06 SMb20111 putative oligopeptide ABC transporter ATP-
binding protein 
16 -0.29 8.1E-07 40 -0.19 2.1E-02 
2011mTn5STM.2.01.C06 SMa2163 hypothetical protein 16 0.05 9.0E-02 40 0.18 9.2E-05 
2011mTn5STM.2.06.D06 SMc00864 hypothetical protein 16 0.68 1.0E-09 24 0.83 3.4E-09 
2011mTn5STM.2.03.E06 SMb21174 phosphate uptake ABC transporter permease 
protein 
16 0.07 2.8E-02 23 0.33 8.6E-07 
2011mTn5STM.2.10.F06 SMb21000 putative transport protein 14 0.27 2.7E-03 34 0.36 1.0E-09 
2011mTn5STM.2.05.G06 SMb20943 acetyltransferase protein ExoZ 16 -1.12 2.0E-14 31 -1.05 3.1E-22 
2011mTn5STM.2.11.H06 SMb20114 hypothetical protein 16 0.05 4.3E-01 40 0.06 7.9E-01 
2011mTn5STM.2.07.A07 SMc04204 iron transport regulator transmembrane protein 
FecR 
16 -0.03 1.2E-01 32 0.17 5.9E-06 
2011mTn5STM.2.07.B07 SMb21493 putative transcriptional regulator. asnC family 
protein 
16 -0.17 1.6E-03 40 -0.07 9.8E-03 
2011mTn5STM.2.02.C07 SMc01528 dipeptide transport ATP-binding ABC transporter 
protein 
10 0.21 4.7E-02 16 0.66 6.2E-10 
2011mTn5STM.2.01.D07 SMa1957 hypothetical protein 16 -0.43 6.0E-11 40 -0.40 8.5E-06 
2011mTn5STM.2.12.E07 SMc00383 glutatione S-transferase protein  12 0.19 1.9E-02 16 0.10 9.9E-03 
2011mTn5STM.2.06.F07 SMc00774 acetoacetyl-coenzyme A synthetase, additional 16 -0.36 1.4E-07 36 -0.45 2.8E-07 
2011mTn5STM.2.04.G07 SMb20123 putative transcriptional regulator protein 0 NA NA 0 NA NA 
2011mTn5STM.2.09.H07 pSymB.  96435 intergenic 16 1.20 3.0E-11 24 1.69 1.8E-15 
2011mTn5STM.2.04.A08 SMa0039 putative LysR-family transcriptional regulator 16 -0.18 1.3E-05 20 -0.05 3.9E-01 
2011mTn5STM.2.04.B08 S. meliloti 
chromosome, 
3364101 
intergenic 16 -0.20 6.4E-04 40 -0.08 1.9E-01 
2011mTn5STM.2.05.C08 SMa1956 putative LysR-family transcriptional regulator 16 -0.15 2.7E-04 40 0.00 8.8E-01 
2011mTn5STM.2.04.D08 SMc03149 hypothetical protein 0 NA NA 24 0.37 8.3E-10 
2011mTn5STM.2.08.E08 SMb20757 methylmalonyl-CoA mutase protein BhbA 16 -0.84 3.9E-11 32 -0.87 1.4E-26 
2011mTn5STM.2.12.F08 SMa1513 putative ABC transporter permease 16 -0.02 4.8E-01 38 0.08 3.2E-01 
2011mTn5STM.2.11.G08 SMc00527 hypothetical protein 16 0.65 6.5E-11 36 0.55 5.5E-16 
2011mTn5STM.2.10.H08 SMa0394 putative ABC transporter. permease 16 -0.07 1.0E-02 40 -0.03 2.9E-01 
2011mTn5STM.2.11.A09 SMc02899 PheA prephenate dehydratase protein 0 NA NA 0 NA NA 
2011mTn5STM.2.09.B09 SMc00148 hypothetical protein 16 -0.07 9.1E-03 32 -0.12 2.8E-02 
2011mTn5STM.2.09.C09 SMb20959 probable exopolysaccharide biosynthesis protein 
ExoO 
16 -1.05 9.8E-17 40 -1.08 1.8E-31 
2011mTn5STM.2.09.D09 SMc04456 chaperon protein CsaA 16 0.28 3.0E-06 24 0.29 5.3E-06 
2011mTn5STM.2.12.E09 SMc03782 hypothetical protein 16 0.10 2.1E-02 34 -0.31 8.6E-02 
2011mTn5STM.2.07.F09 SMa0260 GabD3 succinate-semialdehyde dehdyrogenase 0 NA NA 34 -0.02 8.5E-01 
2011mTn5STM.2.10.G09 SMa1746 putative iron uptake protein 16 -0.75 1.1E-15 40 -0.65 3.0E-09 
2011mTn5STM.2.03.H09 SMc02045 putative oxidoreductase protein 16 -0.08 2.7E-01 40 -0.26 1.0E-02 
2011mTn5STM.3.08.A10 SMb20860 probable non-heme chloroperoxidase 16 -0.62 1.2E-09 24 -0.90 1.4E-13 
2011mTn5STM.3.07.B10 SMa0316 hypothetical protein 16 -0.10 1.5E-02 40 -0.30 5.5E-04 
2011mTn5STM.3.06.C10 SMa0615 FixO3 cytochrome-c oxidase subunit 16 -0.55 1.3E-11 24 -0.69 2.8E-07 
2011mTn5STM.3.05.D10 SMa1916 hypothetical protein 16 -0.10 5.4E-02 38 -0.35 5.5E-05 
2011mTn5STM.3.09.E10 SMc01000 hypothetical protein 16 -0.64 3.0E-10 38 -0.83 4.3E-19 
2011mTn5STM.3.09.F10 S. meliloti 
chromosome, 
110795 
intergenic 13 0.62 8.2E-06 24 0.69 6.2E-11 
2011mTn5STM.3.11.G10 SMc03025 flagellum-specific ATP synthase protein FliI 14 -0.31 6.4E-01 34 -0.47 1.5E-03 
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2011mTn5STM.3.08.H10 SMb20360 hypothetical protein 16 1.21 2.0E-06 24 1.21 3.0E-09 
2011mTn5STM.3.09.A11 SMc01968 putative transcription regulator protein 16 0.55 1.7E-13 23 -0.16 4.3E-01 
2011mTn5STM.3.12.B11 pSymB. 1003846 intergenic 16 1.53 2.2E-06 40 1.25 6.8E-11 
2011mTn5STM.3.07.C11 pSymA. 291094 intergenic 16 0.32 1.7E-02 35 0.18 5.5E-02 
2011mTn5STM.3.08.D11 SMb20377 putative translation initiation inhibitor protein 16 -0.05 2.0E-01 40 -0.30 4.0E-06 
2011mTn5STM.3.09.E11 SMc04208 putative toxin secretion transmembrane protein 0 NA NA 0 NA NA 
2011mTn5STM.3.12.F11 SMc01946 leucine-specific binding protein precursor 11 0.40 2.2E-05 24 0.39 9.2E-04 
2011mTn5STM.3.11.G11 S. meliloti 
chromosome, 
2065862 
intergenic 0 NA NA 28 0.84 2.2E-09 
2011mTn5STM.3.06.H11 SMc01700 peptidyl-prolyl cis-trans isomerase A 16 -0.67 9.4E-16 24 -0.34 7.0E-07 
2011mTn5STM.3.08.A12 SMc00779 probable FAD-linked oxidoreductase 16 0.08 6.7E-02 40 0.07 1.5E-01 
2011mTn5STM.3.12.B12 SMb20476 putative ABC transporter periplasmic dipeptide-
binding protein 
16 0.83 3.4E-08 34 0.60 3.8E-06 
2011mTn5STM.3.09.C12 SMc00808 ChrA chromate transport protein 16 0.27 7.4E-05 40 0.09 8.6E-02 
2011mTn5STM.3.07.D12 SMc00334 Cmk cytidilate kinase protein 15 1.09 1.7E-04 22 0.80 1.4E-03 
2011mTn5STM.3.09.E12 S. meliloti 
chromosome, 
2288070 
intergenic 10 0.38 7.2E-05 16 0.36 5.3E-04 
2011mTn5STM.3.08.F12 SMa0470 putative ABC transporter. ATP-binding protein 16 -0.40 1.3E-13 24 -0.16 9.1E-05 
2011mTn5STM.3.06.G12 SMc01340 putative aminotransferase protein 16 0.67 1.5E-09 35 0.45 1.3E-08 
2011mTn5STM.3.05.H12 SMc03198 molybdenum transport ATP-binding ABC 
transporter protein ModC 
16 0.65 7.8E-12 39 0.59 1.1E-05 
2011mTn5STM.3.12.A01 SMa0819 FixB electron transfer flavoprotein alpha chain 0 NA NA 40 -0.87 5.0E-20 
2011mTn5STM.3.08.B01 SMc04217 hypothetical protein 16 0.71 6.0E-06 40 0.79 9.0E-15 
2011mTn5STM.3.10.C01 SMc01842 putative methyltransferase transcription regulator 
protein 
14 -0.51 3.0E-03 37 -0.43 1.0E-04 
2011mTn5STM.3.10.D01 SMc00228 ATP-dependent DNA helicase protein RecG 14 0.29 3.4E-01 16 0.00 3.6E-01 
2011mTn5STM.3.10.E01 SMc04386 aspartate aminotransferase B protein 16 0.27 2.1E-02 40 0.14 1.2E-01 
2011mTn5STM.3.08.F01 SMa2333 KdpA potassium-transporting ATPase A chain 16 -0.39 1.0E-02 36 -0.56 9.7E-10 
2011mTn5STM.3.05.G01 SMb20178 hypothetical protein 15 -0.20 2.0E-03 39 -0.37 4.0E-07 
2011mTn5STM.3.11.A02 pSymA, 1215937 intergenic 16 -0.64 2.5E-13 32 -0.54 1.4E-11 
2011mTn5STM.3.08.B02 SMc02691 putative membrane transport protein 16 0.38 1.1E-05 40 0.45 5.8E-06 
2011mTn5STM.3.08.C02 SMb20121 hypothetical protein 14 0.01 7.8E-01 40 0.11 1.0E-02 
2011mTn5STM.3.07.D02 SMc02376 putative heat shock protein 16 -0.62 1.6E-11 40 -0.56 3.6E-22 
2011mTn5STM.3.09.E02 SMa2215 putative GntR-family transcriptional regulator 16 -0.47 8.0E-11 24 -0.69 7.0E-13 
2011mTn5STM.3.10.F02 SMc00420 hypothetical protein 16 0.64 2.0E-04 39 0.47 1.5E-08 
2011mTn5STM.3.08.G02 SMa2075 probable extracellular solute-binding protein 15 -0.06 3.6E-01 39 0.07 1.2E-01 
2011mTn5STM.3.07.H02 SMc02363 cytochrome C-type biogenesis transmembrane 
protein CycK 
0 NA NA 14 -0.19 4.4E-01 
2011mTn5STM.3.09.A03 S. meliloti 
chromosome, 
2823999 
intergenic 16 0.00 3.3E-01 40 0.16 1.2E-03 
2011mTn5STM.3.11.B03 SMb20029 hypothetical protein 16 -0.05 5.9E-01 40 -0.07 1.7E-01 
2011mTn5STM.3.11.C03 SMb20067 hypothetical protein 16 -0.11 6.0E-03 40 -0.23 2.0E-04 
2011mTn5STM.3.09.D03 SMa0929 TraG conjugal transfer protein 16 0.65 6.7E-09 39 0.80 8.4E-16 
2011mTn5STM.3.05.E03 SMc01552 hypothetical protein 16 0.02 9.5E-01 37 -0.19 3.6E-02 
2011mTn5STM.3.08.F03 S. meliloti 
chromosome, 
2178672 
intergenic 16 0.01 8.9E-01 40 0.06 9.9E-01 
2011mTn5STM.3.11.G03 SMa0981 NtrR2 transcription regulator 16 -0.45 5.0E-11 40 -0.37 3.8E-09 
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2011mTn5STM.3.08.H03 SMb20436 probable nitrate transporter 16 -0.12 3.3E-03 40 -0.14 2.2E-01 
2011mTn5STM.3.07.A04 SMc01131 hypothetical protein 16 0.32 8.1E-03 30 -0.19 2.9E-01 
2011mTn5STM.3.11.B04 SMb21431 hypothetical protein 16 -0.02 7.8E-01 38 0.08 2.1E-01 
2011mTn5STM.3.06.C04 SMc01668 hypothetical protein 0 NA NA 16 -0.01 2.0E-01 
2011mTn5STM.3.10.D04 SMb20672 putative sugar ABC transporter 16 0.07 5.8E-02 24 -0.27 5.3E-06 
2011mTn5STM.3.06.E04 SMa1179 NosR Regulatory protein for N2O reductase 16 -0.04 5.9E-01 34 -0.28 2.2E-02 
2011mTn5STM.3.12.F04 SMb20009 putative transcriptional regulator 16 0.10 1.8E-03 39 0.20 1.2E-03 
2011mTn5STM.3.06.G04 SMc00609 anaerobic dimethyl sulfoxide reductase chain A 
protein DmsA 
16 -0.14 2.7E-02 38 -0.27 2.2E-02 
2011mTn5STM.3.05.H04 SMb20152 hypothetical protein 0 NA NA 24 0.06 4.8E-01 
2011mTn5STM.3.11.A05 SMb20037 shikimate 5-dehydrogenase protein AroE2 12 1.20 2.1E-05 31 1.12 5.1E-12 
2011mTn5STM.3.09.B05 SMb20931 putative sugar uptake ABC transporter periplasmic 
solute-binding protein precursor 
16 0.42 3.3E-03 32 0.43 1.4E-09 
2011mTn5STM.3.08.C05 SMa2293 probable beta lactamase transcriptional activator 0 NA NA 16 0.80 9.7E-08 
2011mTn5STM.3.07.D05 SMc01406 putative transcription regulator protein 15 0.80 1.1E-05 29 0.76 9.8E-11 
2011mTn5STM.3.07.E05 SMa0890 hypothetical protein 16 0.14 7.8E-02 38 0.09 1.8E-02 
2011mTn5STM.3.08.F05 SMb21527 putative taurin uptake ABC transporter ATP-
binding protein 
16 0.25 3.5E-06 40 0.37 2.1E-11 
2011mTn5STM.3.10.G05 SMc01717 mercuric reductase protein MerA1 16 0.59 1.4E-07 24 0.57 6.7E-09 
2011mTn5STM.3.07.H05 SMa2000 Putative ABC transporter periplasmic solute-
binding protein 
0 NA NA 40 -0.33 9.2E-06 
2011mTn5STM.3.10.A06 SMc03777 gamma-glutamyl phopsphate reductase protein 
ProA 
0 NA NA 12 -0.02 8.2E-01 
2011mTn5STM.3.10.B06 SMc03899 hypothetical protein 0 NA NA 0 NA NA 
2011mTn5STM.3.10.C06 SMc02070 hypothetical protein 16 -0.20 9.7E-03 30 -0.13 4.1E-01 
2011mTn5STM.3.11.D06 SMc03032 flagellar P-ring precursor transmembrane protein 16 1.23 1.8E-14 40 1.08 3.6E-25 
2011mTn5STM.3.08.E06 SMa0953 AttA1-like ABC transporter. ATP binding protein 0 NA NA 8 0.28 3.1E-03 
2011mTn5STM.3.11.F06 SMa2245 hypothetical protein 16 -0.02 4.1E-01 40 -0.06 1.8E-01 
2011mTn5STM.3.10.G06 SMc02677 pyroline-5-carboxylate reductase protein ProC 16 0.21 2.9E-08 39 0.33 6.9E-05 
2011mTn5STM.3.07.H06 SMa1052 hypothetical protein 16 0.02 8.6E-01 40 -0.15 1.9E-01 
2011mTn5STM.3.09.A07 SMb21079 putative cAMP binding protein 16 -0.17 2.7E-04 40 -0.36 2.0E-04 
2011mTn5STM.3.06.B07 SMc02487 dihydrolipoamide dehydrogenase LpdA2 0 NA NA 10 -0.64 4.6E-05 
2011mTn5STM.3.05.C07 SMb20678 hydroxypyruvate reductase protein TtuD2 15 -0.47 1.2E-09 37 -0.34 5.8E-06 
2011mTn5STM.3.08.D07 SMc01174 cysteine synthase A  protein CysK2 16 -0.31 7.7E-07 40 -0.54 2.0E-09 
2011mTn5STM.3.05.E07 SMc01949 high-affinity branched-chain amino acid ABC 
transporter, ATP-binding ABC transporter protein 
LivG 
16 0.14 5.0E-03 29 0.39 2.8E-09 
2011mTn5STM.3.06.F07 SMc03977 hypothetical protein 16 -0.45 2.2E-07 40 -0.61 2.9E-10 
2011mTn5STM.3.07.G07 SMc01419 RNA polymerase sigma factor protein SigE1 16 0.44 4.6E-13 24 0.46 3.6E-02 
2011mTn5STM.3.08.H07 SMc04258 putative transport system permease ABC 
transporter protein 
0 NA NA 28 -0.01 7.3E-01 
2011mTn5STM.3.06.A08 SMc01198 hypothetical protein 16 0.20 4.1E-05 32 0.07 4.1E-01 
2011mTn5STM.3.08.B08 SMb20888 hypothetical protein 0 NA NA 0 NA NA 
2011mTn5STM.3.10.C08 SMc02050 trigger factor protein Tig 16 -0.06 4.3E-01 24 0.23 1.8E-02 
2011mTn5STM.3.05.D08 SMc01554 hypothetical protein 0 NA NA 0 NA NA 
2011mTn5STM.3.10.E08 SMa2037 Putative oxidoreductase 16 -0.42 1.4E-11 39 -0.50 6.2E-06 
2011mTn5STM.3.05.F08 SMc02857 heat shock protein 70 (HSP70) chaperone 0 NA NA 0 NA NA 
2011mTn5STM.3.08.G08 SMa0583 NrtB. Nitrate transport permease protein 15 0.37 6.8E-05 32 0.79 3.6E-10 
2011mTn5STM.3.09.H08 SMc01965 putative spermidine/putrescine transport ATP-
binding ABC transporter protein 
16 0.94 9.0E-13 39 0.84 6.9E-16 
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2011mTn5STM.3.11.A09 SMa0796 hypothetical protein 16 0.39 2.1E-13 40 0.40 4.3E-13 
2011mTn5STM.3.10.B09 SMb20957 exopolysaccharide biosynthesis protein ExoA 16 -1.15 2.7E-14 40 -1.18 8.5E-33 
2011mTn5STM.3.06.C09 SMb21596 hypothetical protein 16 -0.12 1.0E-02 8 -0.23 3.7E-03 
2011mTn5STM.3.10.D09 SMb20582 putative transcriptional regulator, LysR family 
protein 
16 1.06 5.1E-16 40 1.10 4.7E-26 
2011mTn5STM.3.08.E09 SMb20933 putative two-component sensor histidine kinase 
protein 
0 NA NA 13 -0.34 1.9E-02 
2011mTn5STM.3.12.F09 SMa1087 putative cation transport P-type ATPase 0 NA NA 16 -0.54 4.2E-16 
2011mTn5STM.3.05.G09 SMa1220 FixN1 Heme b / copper cytochrome c oxidase 
subunit 
16 -0.50 2.1E-07 40 -0.35 5.6E-11 
2011mTn5STM.3.07.H09 pSymB, 1322754 intergenic 16 0.13 1.6E-02 34 0.19 1.0E-03 
2011mTn5STM.4.04.A10 pSymA, 248361 intergenic 16 -0.17 5.5E-05 40 -0.28 1.1E-07 
2011mTn5STM.4.11.B10 SMb21300 putative deoxyribose-phosphate aldolase protein 16 0.06 2.0E-02 40 -0.29 9.0E-03 
2011mTn5STM.4.11.C10 SMa0091 hypothetical protein 16 0.13 2.0E-02 39 -0.22 3.9E-03 
2011mTn5STM.4.02.D10 SMa1362 putative inner-membrane permease 16 -0.47 4.6E-10 40 -0.46 1.2E-11 
2011mTn5STM.4.06.E10 SMb20909 hypothetical protein 0 NA NA 10 -0.46 3.1E-03 
2011mTn5STM.4.12.F10 SMc02419 putative peptide transport system permease 
protein 
16 -0.31 6.8E-08 40 -0.22 5.3E-03 
2011mTn5STM.4.06.G10 SMa0769 FixP2 cytochrome c oxidase 16 -0.84 1.9E-12 32 -0.67 7.0E-09 
2011mTn5STM.4.04.H10 SMc02273 RkpA fatty acid synthase protein 16 0.10 7.8E-02 16 -0.32 6.3E-09 
2011mTn5STM.4.01.A11 SMa1397 hypothetical protein 16 0.09 1.5E-02 36 0.01 6.5E-01 
2011mTn5STM.4.05.B11 SMa0583 NrtB. Nitrate transport permease protein 0 NA NA 10 -0.10 1.5E-01 
2011mTn5STM.4.01.C11 SMc02597 superoxide dismutase Cu-Zn precursor protein 
SodC 
12 0.16 1.0E-01 24 0.37 1.9E-06 
2011mTn5STM.4.09.D11 SMc03873 RNA polymerase sigma factor protein SigC 16 1.23 2.1E-10 24 1.15 4.6E-14 
2011mTn5STM.4.04.E11 SMb20942 UDP glucose 4-epimerase protein ExoB 15 -1.14 3.9E-13 38 -1.07 3.8E-22 
2011mTn5STM.4.09.F11 SMa0592 hypothetical protein 16 -0.37 7.2E-11 40 -0.24 2.3E-03 
2011mTn5STM.4.01.G11 SMb20355 hypothetical protein 0 NA NA 28 -0.52 9.3E-06 
2011mTn5STM.4.08.H11 SMc00339 adenylate cyclase 1 protein CyaA 16 0.04 5.3E-02 40 0.22 2.7E-04 
2011mTn5STM.4.04.A12 SMb21165 putative histidine ammonia-lyase histidase protein 
HutH1 
16 -0.64 2.0E-07 39 -0.83 6.0E-17 
2011mTn5STM.4.09.B12 SMc02144 phosphate transport system permease ABC 
transporter protein 
13 -0.76 3.0E-09 32 -0.93 1.1E-11 
2011mTn5STM.4.04.C12 SMc01053 siroheme synthase protein CysG  16 -1.06 9.2E-18 40 -1.06 2.3E-32 
2011mTn5STM.4.07.D12 SMa0070 ABC transporter permease 16 0.75 6.4E-09 40 0.60 8.4E-13 
2011mTn5STM.4.08.E12 SMb21158 putative transcriptional regulator, probably of 
sugar phosphate metabolism protein 
16 -1.13 3.1E-16 16 -0.96 4.5E-17 
2011mTn5STM.4.08.F12 SMb20018 probable sugar transport ATP-binding protein 14 0.34 2.2E-05 34 -0.16 6.6E-01 
2011mTn5STM.4.03.G12 SMc00775 FbpB ABC iron transporter, permease component 8 -0.18 1.0E-01 24 -0.27 5.0E-02 
2011mTn5STM.4.07.H12 SMa0398 probable HisD2 histidinol dehydrogenase 0 NA NA 40 -0.20 4.2E-11 
2011mTn5STM.4.01.A01 SMc00917 ATP phosphoribosyltransferase protein HisG 9 -0.21 5.9E-02 13 -0.23 2.1E-01 
2011mTn5STM.4.10.B01 SMa1141 putative fnr/crp family transcriptional regulator 16 -0.01 8.2E-01 39 0.06 9.9E-02 
2011mTn5STM.4.02.C01 SMc02893 probable transcriptional regulator 15 0.67 2.6E-07 40 0.18 9.2E-03 
2011mTn5STM.4.03.D01 SMc01549 hypothetical protein 0 NA NA 8 1.03 6.1E-06 
2011mTn5STM.4.10.E01 SMa1077 Nex18 Symbiotically induced conserved protein 16 -0.24 1.1E-05 40 -0.04 9.0E-01 
2011mTn5STM.4.07.F01 SMa0166 hypothetical protein 16 -0.14 1.5E-04 40 -0.26 6.4E-04 
2011mTn5STM.4.06.G01 SMb21313 bifunctional glycosyltransferase. forming alpha-
glycosyl and beta-glycosyl linkages protein ExpE2 
15 -0.47 7.8E-08 40 -0.48 9.9E-12 
2011mTn5STM.4.01.H01 SMc03776 glutamate-5-kinase protein ProB1 15 -0.27 7.4E-03 38 -0.66 1.1E-05 
2011mTn5STM.4.04.B02 SMa1131 hypothetical protein 16 0.18 8.1E-07 40 -0.05 7.3E-01 
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2011mTn5STM.4.01.C02 SMa0229 hypothetical protein 15 -0.48 1.1E-05 38 -0.50 8.3E-06 
2011mTn5STM.4.04.D02 SMb21133 putative sulfate uptake ABC transporter 
periplasmic solute-binding protein 
16 -0.65 1.7E-11 38 -0.55 1.1E-10 
2011mTn5STM.4.08.E02 SMc00080 hypothetical protein 16 -0.19 3.1E-04 40 0.02 8.7E-01 
2011mTn5STM.4.07.F02 SMa0695 ArcB catabolic ornithine carbamoyl transferase 16 -0.30 6.4E-04 40 -0.32 6.3E-10 
2011mTn5STM.4.02.G02 SMb20868 putative two-component sensor histidine kinase 
protein 
16 -0.49 1.6E-10 40 -0.54 3.6E-08 
2011mTn5STM.4.08.H02 pSymB. 1408087 intergenic 16 -0.15 7.7E-04 40 0.02 9.6E-01 
2011mTn5STM.4.08.A03 SMb21536 hypothetical protein 16 -0.50 5.2E-08 37 -0.47 3.7E-10 
2011mTn5STM.4.07.B03 S. meliloti 
chromosome, 
2005840 
intergenic 16 0.14 4.5E-03 40 0.21 1.9E-06 
2011mTn5STM.4.09.C03 SMc00606 putative ribonuclease protein 15 0.02 3.4E-01 38 -0.11 2.9E-01 
2011mTn5STM.4.01.D03 SMc00886 hypothetical protein 15 -0.24 6.9E-03 20 -0.20 7.7E-02 
2011mTn5STM.4.09.E03 SMc02117 cystathionine beta-lyase protein MetC 14 -0.25 1.9E-02 36 -0.03 1.5E-01 
2011mTn5STM.4.08.F03 SMa1913 putative transport protein 15 -0.76 1.1E-09 40 -0.86 7.7E-18 
2011mTn5STM.4.02.G03 SMc00828 hypothetical protein 14 -0.87 5.8E-09 38 -0.86 1.2E-15 
2011mTn5STM.4.01.H03 SMb20151 hypothetical protein 16 0.10 7.5E-04 40 0.24 1.0E-07 
2011mTn5STM.4.08.A04 SMc02139 hypothetical protein 16 -0.51 1.4E-09 23 -0.43 9.4E-09 
2011mTn5STM.4.05.B04 SMa1371 probable ABC transporter ATP-binding protein 16 -0.25 2.1E-05 32 0.05 5.4E-01 
2011mTn5STM.4.12.C04 SMa1465 putative ABC transporter permease 16 -0.14 3.2E-06 40 0.02 5.9E-01 
2011mTn5STM.4.04.D04 SMb20481 AsnO asparagine synthase. glutamine-hydrolyzing 16 -1.05 2.1E-18 38 -1.10 4.8E-30 
2011mTn5STM.4.02.E04 pSymA, 1165092 intergenic 0 NA NA 32 -0.02 8.8E-02 
2011mTn5STM.4.09.F04 SMa2115 Gst13 glutathione S-transferase 0 NA NA 0 NA NA 
2011mTn5STM.4.03.G04 SMa0752 FAD/NAD(P)-binding oxidoreductase protein 16 -0.50 2.2E-09 40 -0.43 1.5E-10 
2011mTn5STM.4.10.H04 SMc00428 hypothetical protein 0 NA NA 24 -0.17 7.3E-02 
2011mTn5STM.4.01.A05 pSymB. 376527 intergenic 16 0.70 1.7E-12 35 0.62 1.3E-08 
2011mTn5STM.4.06.B05 SMc00127 choline sulfatase protein BetC 16 -0.06 1.7E-01 32 -0.22 9.8E-02 
2011mTn5STM.4.03.C05 SMc00937 TRK system potassium uptake transmembrane 
protein TrkH 
16 -0.47 2.4E-10 40 -0.33 1.5E-04 
2011mTn5STM.4.05.D05 SMa0222 putative GntR-family transcriptional regulator 16 0.49 1.4E-10 40 0.05 7.9E-01 
2011mTn5STM.4.11.E05 SMb20534 hypothetical protein 0 NA NA 16 -0.16 1.8E-04 
2011mTn5STM.4.11.F05 SMc02149 hypothetical protein 0 NA NA 0 NA NA 
2011mTn5STM.4.05.G05 S. meliloti 
chromosome, 
532543 
intergenic 16 -0.22 3.3E-05 32 -0.35 8.0E-13 
2011mTn5STM.4.02.H05 SMc00523 hypothetical protein 16 0.41 9.6E-09 40 -0.06 6.1E-01 
2011mTn5STM.4.09.A06 SMb20149 hypothetical protein 16 0.17 4.6E-05 40 0.20 2.5E-03 
2011mTn5STM.4.03.B06 SMc00781 methylmalonate-semialdehyde dehydrogenase 
MmsA (IolA) 
16 -1.09 8.9E-16 23 -1.03 2.0E-16 
2011mTn5STM.4.03.C06 SMc01267 hypothetical protein 16 -0.49 6.9E-12 24 -0.44 1.6E-06 
2011mTn5STM.4.04.D06 SMb20227 nutrient deprivation-induced protein A (NdiA1) 16 -0.77 7.0E-15 40 -0.75 1.7E-25 
2011mTn5STM.4.02.E06 SMc02226 hypothetical protein 15 -1.05 2.4E-16 40 -0.97 8.4E-28 
2011mTn5STM.4.05.F06 SMb20820 putative ferredoxin reductase MocF 16 -0.40 1.3E-11 24 0.06 5.6E-01 
2011mTn5STM.4.07.G06 SMc00955 hypothetical protein 16 0.49 9.6E-06 39 0.38 1.4E-07 
2011mTn5STM.4.05.H06 SMa1480 probable LysR-type activator 16 -0.28 1.9E-09 40 -0.35 5.0E-11 
2011mTn5STM.4.11.A07 SMa1734 hypothetical protein 16 -0.50 7.0E-11 40 -0.42 2.0E-07 
2011mTn5STM.4.03.B07 SMa0417 hypothetical protein 16 -0.41 1.0E-08 40 -0.26 2.4E-03 
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2011mTn5STM.4.07.C07 SMb20941 msbA-like saccharide exporting ABC transporter 
protein 
16 -0.52 1.2E-10 39 -0.67 3.9E-12 
2011mTn5STM.4.07.D07 SMb21592 putative sugar uptake ABC transporter ATP-
binding protein 
0 NA NA 0 NA NA 
2011mTn5STM.4.09.E07 SMc00893 hypothetical protein 16 0.51 5.9E-08 40 0.36 2.8E-07 
2011mTn5STM.4.03.F07 S. meliloti 
chromosome, 
2051945 
intergenic 16 0.90 1.2E-11 24 0.86 4.4E-10 
2011mTn5STM.4.09.G07 SMa2279 hypothetical protein 16 -0.25 3.9E-02 24 0.09 2.0E-01 
2011mTn5STM.4.04.H07 S. meliloti 
chromosome, 
81040 
intergenic 16 0.62 1.4E-13 24 0.71 3.6E-10 
2011mTn5STM.4.08.A08 SMc02372 putative transport transmembrane protein 14 0.40 2.7E-04 36 0.48 2.6E-07 
2011mTn5STM.4.12.B08 SMa1355 hypothetical protein 16 -0.05 1.9E-01 40 -0.17 5.6E-02 
2011mTn5STM.4.06.C08 SMa0021 hypothetical protein 14 -0.16 1.2E-02 35 -0.27 7.5E-05 
2011mTn5STM.4.04.D08 SMa1782 putative LysR-family transcriptional regulator 16 0.47 1.3E-16 40 0.66 4.0E-07 
2011mTn5STM.4.01.E08 SMb20925 hypothetical protein 0 NA NA 27 -0.33 7.7E-03 
2011mTn5STM.4.01.F08 SMc01611 ferrichrome-iron receptor precursor protein 16 0.14 6.5E-04 40 0.31 4.7E-05 
2011mTn5STM.4.10.G08 S. meliloti 
chromosome, 
2816977 
intergenic 16 1.10 1.9E-14 40 0.67 2.3E-08 
2011mTn5STM.4.08.H08 SMb20007 KatC catalase protein 16 0.00 6.2E-01 35 -0.30 1.7E-03 
2011mTn5STM.4.03.A09 SMc00825 glutamate-cysteine ligase GshA 0 NA NA 0 NA NA 
2011mTn5STM.4.05.B09 SMa0574 hypothetical protein 16 -0.83 2.4E-12 40 -0.68 1.9E-19 
2011mTn5STM.4.11.C09 S. meliloti 
chromosome, 
3123223 
intergenic 14 0.15 1.2E-01 31 0.27 3.8E-07 
2011mTn5STM.4.08.D09 SMa1084 hypothetical protein 16 -0.42 1.3E-09 40 -0.69 1.8E-12 
2011mTn5STM.4.08.E09 SMa1163 putative cation transport P-type ATPase 16 -0.42 2.4E-07 39 -0.35 1.9E-08 
2011mTn5STM.4.01.F09 SMa0734 hypothetical protein 14 -0.40 1.2E-04 24 -0.18 5.9E-04 
2011mTn5STM.4.07.G09 SMa1582 hypothetical protein 0 NA NA 40 -0.14 1.5E-04 
2011mTn5STM.4.02.H09 SMb20049 putative elongation factor G protein 16 -0.10 5.8E-02 38 -0.14 2.4E-01 
 
a For mutants carrying a transposon insertion in an intergenic region the exact position of insertion in the respective 
replicon is given. 
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TABLE G.4. RESULTS OF IN PLANTA STM EXPERIMENT FOR SET 2 
 
Slide 4, combined DNA Slides 1-3 
mutantID complete aliases function 
n m-value p-value(t) n m-value p-value(t)
2011mTn5STM.1.11.A10 SMb20030 putative ECF-sigma factor protein 8 0.25 2.7E-03 32 -0.02 8.8E-01 
2011mTn5STM.1.05.B10 SMc03248 putative transposase protein 8 0.22 7.3E-03 32 0.24 4.5E-12 
2011mTn5STM.1.02.C10 SMb20097 hypothetical oxidoreductase protein 8 -0.09 2.6E-01 24 -0.68 2.3E-15 
2011mTn5STM.1.01.D10 SMc02642 hypothetical protein 8 0.79 2.6E-07 24 0.40 1.1E-08 
2011mTn5STM.1.03.E10 SMb21630 hypothetical protein 8 1.58 1.9E-09 24 1.70 2.2E-28 
2011mTn5STM.1.06.F10 SMb20443 putative TRAP dicarboxylate transporter 8 -0.41 2.8E-05 32 -0.40 1.7E-14 
2011mTn5STM.1.02.G10 SMc00490 transcription regulator GntR family 8 0.54 9.4E-09 32 0.61 9.6E-13 
2011mTn5STM.1.06.H10 SMc00708 putative hydroxyacylglutathione hydrolase protein 
Glx II 
8 -0.12 8.6E-02 32 -0.21 2.2E-05 
2011mTn5STM.1.12.A11 SMa2089 hypothetical protein 8 -0.37 4.3E-04 32 -0.74 4.6E-09 
2011mTn5STM.1.08.B11 SMb20935 putative transcriptional regulator protein ExsI 0 NA NA 24 0.26 5.1E-05 
2011mTn5STM.1.11.C11 SMc02269 capsule polysaccharide biosynthesis protein RkpJ 8 0.30 4.9E-04 32 -0.40 5.1E-03 
2011mTn5STM.1.03.D11 SMc04346 ketol-acid reductoisomerase protein IlvC 0 NA NA 32 -0.88 1.7E-26 
2011mTn5STM.1.12.E11 SMc02613 glutamine synthetase III protein GlnT 8 0.70 3.3E-06 32 0.53 7.7E-08 
2011mTn5STM.1.09.F11 SMc00033 diguanylate cyclase/phosphodiesterase protein 8 0.28 1.8E-03 32 0.36 1.2E-05 
2011mTn5STM.1.11.G11 SMa1252 hypothetical protein 8 0.11 4.0E-02 32 0.07 7.1E-01 
2011mTn5STM.1.02.H11 SMc03125 putative ABC-transporter ATP-binding protein 8 -0.07 3.4E-02 32 -0.28 4.3E-03 
2011mTn5STM.1.07.A12 SMc00594 beta-etherase protein LigE 8 0.32 1.9E-06 32 0.22 2.0E-04 
2011mTn5STM.1.13.B12 SMb21114 nitrate transport protein NrtA 8 0.15 4.4E-03 32 0.20 9.1E-05 
2011mTn5STM.1.07.C12 SMa1646 putative ABC-transporter ATP-binding protein 8 -0.13 8.1E-02 16 0.10 8.8E-04 
2011mTn5STM.1.07.D12 SMa1660 putative acetyltransferase 8 -0.30 3.4E-05 32 -0.21 2.0E-06 
2011mTn5STM.1.13.E12 SMb20153 hypothetical protein 8 0.12 4.8E-03 32 0.18 6.4E-03 
2011mTn5STM.1.06.F12 SMa1213 FixP1 Di-heme cytochrome c protein 8 0.48 1.9E-06 32 0.46 4.6E-13 
2011mTn5STM.1.12.G12 SMc01909 hypothetical protein 8 0.69 1.9E-08 32 0.60 9.1E-11 
2011mTn5STM.1.09.H12 SMc02767 N-5'-phosphoribosylanthranilate isomerase TrpF 8 -0.95 2.5E-07 32 -0.94 2.5E-27 
2011mTn5STM.1.11.A01 SMc00169 NAD-malic enzyme oxidoreductase protein Dme 8 -0.94 7.0E-07 32 -0.99 5.0E-29 
2011mTn5STM.1.12.B01 SMa1256 hypothetical protein 0 NA NA 32 -0.33 5.6E-06 
2011mTn5STM.1.07.C01 SMb20007 catalase protein CatC 0 NA NA 24 0.23 3.2E-04 
2011mTn5STM.1.06.D01 SMa1084 hypothetical protein 8 -0.50 2.2E-07 8 -0.24 3.0E-04 
2011mTn5STM.1.02.E01 SMc00898 probable glutathione-regulated potassium-efflux 
system transmembrane protein KefB 
8 0.91 2.7E-07 24 1.23 9.9E-11 
2011mTn5STM.1.02.F01 SMc01443 putative glutathione S-transferase protein 8 0.62 7.6E-05 32 0.50 1.6E-13 
2011mTn5STM.1.03.G01 SMb20346 putative efflux transmembrane protein 8 -0.37 3.3E-05 32 -0.52 4.0E-07 
2011mTn5STM.1.10.H01 SMb20551 hypothetical protein 8 -0.14 2.7E-03 32 -0.22 1.8E-04 
2011mTn5STM.1.11.A02 SMc01165 putative sugar kinase protein IolC 0 NA NA 10 0.82 6.6E-07 
2011mTn5STM.1.10.B02 S. meliloti 
chromosome, 
3368649 
intergenic 8 -0.36 3.0E-06 32 -0.26 9.5E-08 
2011mTn5STM.1.11.C02 SMc02851 putative transcriptional regulator 0 NA NA 32 0.79 1.2E-19 
2011mTn5STM.1.11.D02 SMa1272 NorQ protein required for nitric oxide reductase 
activity 
8 0.53 8.0E-05 32 0.48 2.5E-20 
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2011mTn5STM.1.01.E02 SMc04023 probable UTP-glucose-1-phosphate 
uridylyltransferase protein ExoN2 
8 -0.42 2.0E-06 16 -0.55 8.4E-08 
2011mTn5STM.1.06.F02 SMb20216 putative epoxide hydrolase protein 8 -0.09 1.5E-02 16 0.02 1.2E-01 
2011mTn5STM.1.05.H02 SMb21236 hypothetical protein 8 0.24 5.8E-03 32 0.11 7.9E-03 
2011mTn5STM.1.06.A03 SMc00790 probable dipeptide transport ATP-binding ABC 
transporter protein DppF 
8 0.78 5.5E-04 32 0.71 1.5E-08 
2011mTn5STM.1.02.B03 SMb20893 probable sugar uptake ABC transporter permease 
protein 
8 -0.15 1.8E-02 32 -0.23 4.8E-03 
2011mTn5STM.1.12.C03 SMc00830 hypothetical transmembrane protein 8 0.15 6.4E-04 32 0.42 8.6E-05 
2011mTn5STM.1.04.D03 pSymB, 551929 intergenic 8 -0.35 2.3E-04 32 -0.30 1.5E-07 
2011mTn5STM.1.13.E03 SMc04051 putative RNA polymerase sigma-E factor protein 8 1.06 4.8E-05 8 -0.38 2.8E-04 
2011mTn5STM.1.09.F03 SMa2251 hypothetical protein 8 0.36 3.8E-06 32 0.19 1.2E-04 
2011mTn5STM.1.05.G03 SMa0689 hypothetical protein 8 0.53 4.4E-06 32 0.37 9.2E-05 
2011mTn5STM.1.11.H03 SMb20274 hypothetical protein 8 0.32 7.1E-05 16 0.20 5.7E-05 
2011mTn5STM.1.04.A04 SMa0894 hypothetical protein 0 NA NA 16 0.09 1.1E-01 
2011mTn5STM.1.05.B04 pSymA, 1142848 intergenic 8 -0.26 4.8E-03 32 -0.21 7.9E-05 
2011mTn5STM.1.06.C04 SMa1787 hypothetical protein 8 -0.13 1.6E-02 32 -0.08 2.9E-01 
2011mTn5STM.1.06.D04 SMa2119 hypothetical protein 8 -0.35 7.3E-05 32 -0.68 2.0E-10 
2011mTn5STM.1.06.E04 S. meliloti 
chromosome, 
3366182 
intergenic 8 0.06 9.2E-01 24 -0.81 9.3E-11 
2011mTn5STM.1.07.F04 SMa1434 probable ABC transporter ATP-binding protein 8 -0.45 4.5E-08 32 -0.43 4.1E-11 
2011mTn5STM.1.08.G04 SMc00913 GroEL1 60 kD chaperonin A protein 8 0.12 1.2E-01 32 0.22 1.5E-06 
2011mTn5STM.1.10.H04 SMa0873 NifN Nitrogenase Fe-Mo cofactor biosynthesis 
protein 
0 NA NA 32 -0.97 1.4E-26 
2011mTn5STM.1.05.A05 SMb20969 putative sugar ABC transporter permease 8 0.17 2.3E-04 24 -0.01 4.4E-01 
2011mTn5STM.1.08.B05 SMc00289 putative cold shock transcription regulator protein 
CspA5 
8 -0.32 4.5E-06 32 -0.51 1.8E-06 
2011mTn5STM.1.06.C05 SMc01143 probable heat-inducible transcription repressor 
protein HrcA 
8 0.71 5.6E-08 32 0.69 3.5E-23 
2011mTn5STM.1.09.D05 SMb21176 PhoD phosphate uptake ABC transporter 
periplasmic solute-binding protein precursor 
0 NA NA 24 -0.21 1.8E-01 
2011mTn5STM.1.06.E05 SMb20179 hypothetical protein 8 0.42 3.3E-06 32 0.34 1.9E-09 
2011mTn5STM.1.10.F05 SMb21185 putative succinate-semialdehyde dehydrogenase 
(NAD(P)+) protein GabD 
0 NA NA 16 -0.21 1.9E-03 
2011mTn5STM.1.05.G05 SMb20024 ribosomal large subunit pseudouridine synthase B 8 0.39 3.7E-06 32 0.33 6.2E-05 
2011mTn5STM.1.11.H05 SMa1696 hypothetical protein 0 NA NA 8 0.00 6.6E-01 
2011mTn5STM.1.10.A06 SMb20552 putative peptidase 8 -0.46 9.5E-05 32 -0.47 2.2E-16 
2011mTn5STM.1.03.B06 SMb21202 probable dioxygenase 8 -0.28 4.1E-04 32 -0.41 3.9E-05 
2011mTn5STM.1.13.C06 SMc02143 putative phosphate transport system permease 
ABC transporter protein PstA 
8 -0.95 5.0E-08 32 -0.95 4.9E-27 
2011mTn5STM.1.02.D06 SMc00270 putative transketolase alpha subunit protein 0 NA NA 0 NA NA 
2011mTn5STM.1.04.E06 SMa0909 hypothetical protein 8 -0.04 3.7E-01 32 -0.01 7.5E-01 
2011mTn5STM.1.06.F06 SMb21281 putative integral membrane transporter protein. 
xanthineuracil permeases family 
0 NA NA 32 -0.14 1.6E-04 
2011mTn5STM.1.09.G06 SMc02780 probable succinate-semialdehyde dehydrogenase 
(NADP+) protein GabD 
0 NA NA 8 0.34 2.3E-02 
2011mTn5STM.1.10.H06 SMc02361 cytochrome C-type biogenesis transmembrane 
protein CycH 
8 -0.85 2.7E-09 32 -0.90 8.9E-17 
2011mTn5STM.1.10.A07 SMa1643 hypothetical protein 8 -0.25 1.4E-05 32 -0.17 3.7E-02 
2011mTn5STM.1.07.B07 SMc00616 putative permease protein PerM 8 0.15 2.3E-03 32 0.14 2.8E-01 
2011mTn5STM.1.06.C07 SMc00416 probable tetrapyrrole methylase 8 0.32 6.4E-04 24 0.09 1.5E-01 
2011mTn5STM.1.02.D07 SMc01373 putative DNA-damage-inducible protein P (DinP) 0 NA NA 24 0.58 2.7E-07 
2011mTn5STM.1.09.E07 SMc00729 putative electron transfer flavoprotein beta-
subunit EtfB 
8 0.59 6.2E-10 32 0.64 5.4E-23 
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2011mTn5STM.1.08.F07 SMa1442 putative GntR-family transcription factor 8 -0.56 2.3E-06 32 -0.47 5.7E-19 
2011mTn5STM.1.02.G07 SMc01877 probable DNA repair protein RecN 8 -0.77 6.2E-07 32 -0.73 4.0E-14 
2011mTn5STM.1.10.H07 SMb21070 putative tyrosine-protein kinase ExoP2 8 -0.27 2.5E-04 32 -0.15 3.2E-02 
2011mTn5STM.1.09.A08 SMb21076 putative glycosyltransferase 8 0.60 2.3E-07 32 0.74 2.8E-16 
2011mTn5STM.1.09.B08 SMa1153 hypothetical protein 8 0.15 1.7E-02 32 0.14 7.5E-06 
2011mTn5STM.1.13.C08 SMa1229 FixL oxygen regulated histidine kinase 8 -1.08 1.0E-07 24 -0.96 8.2E-19 
2011mTn5STM.1.06.D08 SMa1840 hypothetical protein 8 -0.24 7.5E-04 32 -0.19 7.0E-04 
2011mTn5STM.1.04.E08 SMc03885 putative histidinol-phosphate aminotransferase 
protein HisC 
8 -0.36 2.2E-04 32 -0.19 1.5E-02 
2011mTn5STM.1.10.F08 SMa0626 putative membrane protein 8 -0.50 6.0E-06 32 -0.31 2.3E-03 
2011mTn5STM.1.13.G08 SMb20416 probable ABC transporter periplasmic glycerol-3-
phosphate-binding protein precursor 
8 0.70 1.5E-06 16 -0.14 5.0E-01 
2011mTn5STM.1.11.H08 SMb20457 putative transcriptional regulator 8 -0.30 1.9E-04 32 -0.27 1.5E-05 
2011mTn5STM.1.08.A09 SMa1301 putative transmembrane transport protein 8 -0.57 3.6E-06 32 -0.57 1.9E-07 
2011mTn5STM.1.07.B09 SMb20962 probable phoshomethylpyrimidine kinase protein 
ThiD 
8 -1.13 3.6E-08 32 -1.05 2.0E-31 
2011mTn5STM.1.02.C09 pSymA, 597300 intergenic 8 0.02 8.6E-01 32 -0.15 1.0E-01 
2011mTn5STM.1.10.D09 pSymB, 1120637 intergenic 8 -0.20 6.1E-04 32 -0.08 8.8E-02 
2011mTn5STM.1.13.E09 SMb20110 putative oligopeptide ABC transporter permease 
protein 
8 -0.26 2.8E-04 32 -0.44 2.1E-06 
2011mTn5STM.1.04.F09 SMb21196 putative oligopeptide uptake ABC transporter 
periplasmic solute-binding protein precursor 
OppA 
8 -0.05 2.5E-01 32 -0.13 2.0E-02 
2011mTn5STM.1.12.G09 SMc02285 putative adenylate cyclase transmembrane protein 
CyaE 
8 0.24 7.2E-02 32 0.23 4.6E-03 
2011mTn5STM.1.08.H09 SMc01184 hypothetical transmembrane protein 8 -0.54 1.3E-04 16 0.13 3.6E-02 
2011mTn5STM.2.12.A10 SMc00129 sensor histidine kinase protein FeuQ 8 -0.99 1.6E-07 16 -0.96 5.5E-12 
2011mTn5STM.2.10.B10 SMa2277 hypothetical protein 8 0.65 5.1E-06 32 0.65 7.7E-16 
2011mTn5STM.2.06.C10 SMb21319 putative membrane protein ExpA1 8 0.30 1.4E-06 32 -0.05 7.4E-01 
2011mTn5STM.2.12.D10 SMc02705 hypothetical transmembrane protein 8 -0.79 6.9E-07 32 -0.61 7.3E-20 
2011mTn5STM.2.06.E10 SMb20900 putative diguanylate cyclase/phosphodiesterase 
protein 
8 0.20 6.7E-04 32 0.09 3.4E-01 
2011mTn5STM.2.10.F10 SMa0280 conserved hypothetical protein 8 -0.33 4.4E-05 16 -0.49 5.7E-05 
2011mTn5STM.2.09.G10 SMa0298 putative ABC transporter ATP-binding protein  8 -0.37 2.4E-06 32 -0.23 9.2E-07 
2011mTn5STM.2.07.H10 SMc03133 putative amino-acid transport system permease 
ABC transporter protein 
8 0.43 6.5E-06 16 0.63 2.2E-09 
2011mTn5STM.2.09.A11 SMb20317 putative sugar ABC transporter ATP-binding 
protein 
8 0.64 5.0E-08 32 0.79 1.1E-24 
2011mTn5STM.2.09.B11 SMc00296 poly-beta-hydroxybutyrate polymerase PhbC 8 -0.22 3.3E-03 32 -0.05 9.1E-01 
2011mTn5STM.2.10.C11 SMc01957 hypothetical protein 8 0.55 1.5E-06 32 0.65 1.2E-22 
2011mTn5STM.2.05.D11 SMb20615 putative thiamine biosynthesis protein ThiC 8 -1.06 3.9E-09 8 -0.92 6.2E-08 
2011mTn5STM.2.09.E11 SMa0453 putative plasmid stability protein y4JK 8 0.27 3.3E-03 32 0.25 2.0E-09 
2011mTn5STM.2.07.F11 SMc00012 putative cytochrome C oxidase assembly 
transmembrane protein CtaG 
8 0.07 8.2E-01 32 0.26 1.4E-06 
2011mTn5STM.2.06.G11 SMa1819 hypothetical protein 8 -0.59 1.2E-06 32 -0.37 1.1E-09 
2011mTn5STM.2.04.H11 SMa0160 transcriptional regulator, GntR family 8 -0.25 6.7E-05 32 -0.28 4.1E-06 
2011mTn5STM.2.04.A12 SMc04204 putative iron transport regulator transmembrane 
protein FecR 
8 0.38 9.2E-07 32 0.30 1.6E-04 
2011mTn5STM.2.06.B12 SMb20232 putative suagr ABC transporter permease protein 8 0.36 7.7E-05 8 0.59 8.3E-06 
2011mTn5STM.2.10.C12 SMb20772 probable pyridoxal phosphate biosynthetic 
protein PdxA 
8 0.50 1.6E-04 32 0.52 9.9E-04 
2011mTn5STM.2.12.D12 SMa0013 hypothetical protein 8 -0.31 2.9E-04 8 -0.72 1.0E-06 
2011mTn5STM.2.04.E12 SMa0794 hypothetical protein 8 -0.16 2.6E-02 32 0.14 4.9E-02 
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2011mTn5STM.2.05.F12 SMc03114 probable transposase for insertion sequence 
element ISRM3-like 
8 0.12 3.1E-03 24 0.05 6.3E-02 
2011mTn5STM.2.12.G12 SMb21183 probable chaperonine protein HtpG 8 -0.47 1.7E-07 32 -0.52 6.0E-07 
2011mTn5STM.2.07.H12 SMb20498 probable aldolase 0 NA NA 32 -0.12 3.1E-02 
2011mTn5STM.2.07.A01 SMa1292 hypothetical protein 8 0.14 4.0E-01 31 -0.10 9.6E-02 
2011mTn5STM.2.01.B01 SMa1667 probable ArcD1 arginine/ornithine antiporter 8 -0.52 1.6E-04 32 -0.58 1.7E-11 
2011mTn5STM.2.03.C01 SMc00361 hypothetical protein 8 -0.06 4.4E-02 32 -0.26 5.7E-05 
2011mTn5STM.2.02.D01 SMc02268 KpsF3 involved in KPS assembly. putative 
arabinose 5-phosphate isomerase 
8 -0.33 1.3E-06 32 -0.57 4.1E-14 
2011mTn5STM.2.01.E01 SMb21000 putative transport protein 8 0.03 6.2E-01 32 0.10 1.1E-02 
2011mTn5STM.2.09.F01 pSymA, 280377 intergenic 8 0.00 3.3E-01 32 -0.19 4.8E-02 
2011mTn5STM.2.07.G01 SMc00372 putative oxidoreductase protein 0 NA NA 32 0.34 6.0E-06 
2011mTn5STM.2.02.H01 SMa0224 putative permease of the major facilitator 
superfamily 
8 0.28 2.1E-02 32 0.23 2.1E-05 
2011mTn5STM.2.09.A02 SMc02109 probable ATP-dependent CLP protease ATP-
binding subunit protein 
8 -0.96 4.0E-07 32 -1.03 1.9E-26 
2011mTn5STM.2.02.B02 SMa1966 putative LysR-family transcriptional regulator 8 -0.02 2.1E-01 32 -0.32 2.9E-03 
2011mTn5STM.2.01.C02 SMa0493 putative ABC transporter permease protein 8 0.10 2.9E-01 32 0.05 8.5E-01 
2011mTn5STM.2.06.D02 SMb21351 putative C4-dicarboxylate large membrane 
transport protein DctM 
8 -0.43 5.8E-05 32 -0.58 4.7E-11 
2011mTn5STM.2.07.E02 SMc01166 putative malonic semialdehyde oxidative 
decarboxylase protein IolD 
8 -0.36 9.7E-04 32 -0.48 1.1E-05 
2011mTn5STM.2.03.F02 SMa0352 hypothetical protein 0 NA NA 20 -0.14 5.5E-04 
2011mTn5STM.2.05.G02 SMc02768 hypothetical protein 8 -0.03 5.7E-01 32 0.05 8.7E-01 
2011mTn5STM.2.10.H02 SMa0664 hypothetical protein 8 0.01 7.0E-01 32 -0.35 8.9E-05 
2011mTn5STM.2.01.A03 SMb20881 hypothetical exported protein 8 0.33 6.4E-06 31 0.54 2.5E-09 
2011mTn5STM.2.08.B03 SMb21262 putative mureinpeptideoligopeptide ABC 
transporter permease protein 
8 -0.40 2.3E-04 32 -0.46 6.0E-06 
2011mTn5STM.2.07.C03 SMb21446 probable glycogen operon protein GlgX 8 -0.29 2.4E-05 32 -0.27 3.3E-08 
2011mTn5STM.2.08.D03 SMb20261 putative malate dehydrogenase protein 8 0.29 8.6E-02 32 0.26 4.8E-05 
2011mTn5STM.2.09.E03 SMc01182 hypothetical protein 8 0.26 1.7E-02 24 0.41 6.8E-10 
2011mTn5STM.2.05.F03 SMb20775 hypothetical exported protein. TonB-dependent 
receptor protein 
8 0.45 2.3E-03 32 0.50 2.9E-12 
2011mTn5STM.2.04.G03 SMa2137 probable glycerate 8 -0.05 1.8E-01 32 -0.05 3.4E-01 
2011mTn5STM.2.04.H03 S. meliloti 
chromosome, 
894903 
intergenic 8 0.38 9.0E-04 32 0.27 2.1E-04 
2011mTn5STM.2.01.A04 SMa1250 putative NirK Cu-nitrite reductase 8 0.00 9.6E-01 24 -0.36 6.0E-09 
2011mTn5STM.2.02.B04 SMc02599 probable L-aspartate oxidase protein NadB 0 NA NA 24 0.24 7.8E-05 
2011mTn5STM.2.09.C04 SMc03184 pH adaptation potassium efflux system G 
transmembrane protein PhaG1 
0 NA NA 0 NA NA 
2011mTn5STM.2.01.D04 SMc02165 probable orotate phosphoribosyltransferase 
protein PyrE 
8 -0.96 1.7E-09 32 -0.84 4.9E-24 
2011mTn5STM.2.09.E04 SMa1882 putative transcriptional activator 8 -0.28 4.1E-06 32 -0.29 8.6E-08 
2011mTn5STM.2.07.F04 SMc00196 putative MFS permease 8 0.37 1.0E-06 32 0.38 4.6E-04 
2011mTn5STM.2.09.G04 SMb20879 putative protein required for attachment to host 
cells 
8 0.54 6.2E-06 32 0.62 2.8E-22 
2011mTn5STM.2.05.H04 SMc00380 probable PecS HTH-type transcriptional 
regulator. MarR family 
8 0.41 3.9E-05 32 0.59 1.3E-10 
2011mTn5STM.2.09.A05 SMa1233 NapB periplasmic nitrate reductase 8 -0.67 6.6E-06 8 -0.90 4.6E-08 
2011mTn5STM.2.03.B05 SMb20092 hypothetical protein 8 0.34 4.8E-07 32 0.12 7.1E-02 
2011mTn5STM.2.06.C05 SMc01281 hypothetical protein 8 0.18 2.2E-03 32 0.35 5.5E-05 
2011mTn5STM.2.10.D05 SMa0302 putative ABC transporter. periplasmic solute-
binding protein 
8 0.24 5.5E-03 32 0.09 1.3E-01 
2011mTn5STM.2.04.E05 SMc02176 putative adenylate cyclase transmembrane protein 
CyaD1 
0 NA NA 16 1.03 9.8E-07 
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2011mTn5STM.2.09.F05 SMc01496 probable sorbitol-binding periplasmic protein 
SmoE 
8 0.34 1.0E-04 24 -0.65 1.7E-17 
2011mTn5STM.2.02.G05 SMb20955 endo-beta-1.3-1.4-glycanase protein ExoK 8 -0.47 1.1E-04 32 -0.33 1.4E-10 
2011mTn5STM.2.04.H05 SMa0257 NADH:flavin oxidoreductase 8 -0.49 8.3E-06 32 -0.47 2.1E-06 
2011mTn5STM.2.10.A06 SMc03181 pH adaptation potassium efflux system 
transmembrane protein PhaD1 
8 -1.03 1.4E-10 32 -0.92 6.4E-27 
2011mTn5STM.2.07.B06 SMa0224 putative permease of the major facilitator 
superfamily 
0 NA NA 32 0.04 5.4E-02 
2011mTn5STM.2.04.C06 SMa0059 dehydrogenase related to short chain alcohol 
dehydrogenases 
8 -0.18 8.1E-04 32 -0.25 2.4E-06 
2011mTn5STM.2.10.D06 SMa0557 probable LysR family transcriptional regulator 8 -0.21 1.3E-04 32 -0.29 5.1E-04 
2011mTn5STM.2.07.E06 SMa0829 NifK nitrogenase Fe-Mo beta chain 8 -1.10 7.6E-11 32 -0.96 3.6E-31 
2011mTn5STM.2.04.F06 SMa2404 rhizobactin siderophore biosynthesis protein 8 0.05 8.5E-02 32 -0.02 7.3E-01 
2011mTn5STM.2.10.G06 SMc01228 streptomycin resistance protein StrB 8 0.73 2.4E-08 32 0.55 1.8E-16 
2011mTn5STM.2.12.H06 SMa0101 amidohydrolase 8 0.66 5.6E-08 32 0.72 9.5E-09 
2011mTn5STM.2.09.A07 pSymB, 1668997 intergenic 8 0.16 5.4E-04 24 0.10 5.1E-01 
2011mTn5STM.2.05.B07 SMb20213 hypothetical protein 8 0.39 2.4E-06 32 0.36 1.6E-07 
2011mTn5STM.2.05.C07 SMc00236 probable indole-3-glycerol phosphate synthase 
TrpC 
8 -0.99 1.7E-08 32 -0.82 5.9E-26 
2011mTn5STM.2.06.D07 SMa1223 flavoprotein oxidoreductase FixM 8 -0.60 1.0E-07 24 -0.37 2.0E-03 
2011mTn5STM.2.02.E07 SMc04405 3-isopropylmalate dehydrogenase LeuB 8 -1.12 9.2E-09 32 -0.94 5.5E-31 
2011mTn5STM.2.07.F07 SMb20680 putative hydroxypyruvate isomerase protein 8 0.31 4.4E-06 24 0.18 7.5E-04 
2011mTn5STM.2.08.G07 SMb21263 putative mureinpeptideoligopeptide ABC 
transporter permease protein 
8 -0.12 1.3E-02 16 -0.71 6.1E-10 
2011mTn5STM.2.03.H07 SMc01547 hypothetical protein 8 0.21 1.4E-02 24 -0.18 1.7E-02 
2011mTn5STM.2.08.A08 SMa0179 putative transcriptional activator 8 0.02 1.1E-01 32 0.07 5.8E-01 
2011mTn5STM.2.07.B08 SMa0506 putative ABC transporter. periplasmic solute-
binding protein 
8 0.49 1.4E-05 32 0.46 3.7E-11 
2011mTn5STM.2.02.C08 SMc02365 probable serine protease DegP1 8 0.73 1.7E-07 32 0.56 1.2E-13 
2011mTn5STM.2.03.D08 SMc00399 magnesium and cobalt transport protein corA 0 NA NA 24 0.85 5.3E-11 
2011mTn5STM.2.10.E08 SMa2367 putative ABC transporter. permease 0 NA NA 32 0.38 2.8E-06 
2011mTn5STM.2.03.F08 SMa0554 hypothetical protein 0 NA NA 4 0.31 3.6E-01 
2011mTn5STM.2.07.G08 SMc03766 hypothetical protein 8 0.19 4.9E-04 32 0.27 1.7E-05 
2011mTn5STM.2.05.H08 SMa0036 ABC transporter. ATP-binding protein 8 0.26 7.4E-04 32 -0.13 2.3E-01 
2011mTn5STM.2.10.A09 SMc00819 KatA catalase 8 -0.08 5.2E-02 32 -0.03 7.7E-01 
2011mTn5STM.2.12.B09 SMc01162 putative glutamine amidotransferase 8 0.88 2.0E-06 0 NA NA 
2011mTn5STM.2.06.C09 SMb21343 putative sugar uptake ABC transporter permease 
protein 
8 -0.09 1.9E-02 32 -0.03 3.6E-01 
2011mTn5STM.2.11.D09 pSymA, 1265903 intergenic 8 0.20 7.4E-04 32 0.39 4.6E-04 
2011mTn5STM.2.01.E09 SMc00371 hypothetical protein 0 NA NA 24 0.78 4.8E-18 
2011mTn5STM.2.12.F09 SMb21073 putative OMA family outer membrane saccharide 
export protein. similar to ExoF 
8 -0.18 1.6E-03 32 -0.21 1.4E-03 
2011mTn5STM.2.07.G09 SMb20454 hypothetical protein 0 NA NA 20 -0.11 3.6E-01 
2011mTn5STM.2.06.H09 SMb20612 C4-dicarboxylate transport sensor protein DctB 8 -0.83 9.5E-07 32 -0.76 1.6E-17 
2011mTn5STM.3.09.A10 SMb20264 putative amino acid ABC transporter permease 
protein 
8 0.06 8.2E-02 32 0.22 8.4E-03 
2011mTn5STM.3.09.B10 SMc03106 hypothetical transmembrane protein 8 0.64 2.4E-09 32 0.56 7.3E-14 
2011mTn5STM.3.08.C10 SMb20813 lipid A export ATP-binding/permease protein 
MsbA 
8 -0.49 2.6E-06 32 -0.40 1.9E-06 
2011mTn5STM.3.06.D10 SMa1536 NuoM2 NADH-Ubiquinone/plastoquinone 
(complex I) oxidoreductase 
8 -0.34 3.1E-05 32 -0.21 2.3E-08 
2011mTn5STM.3.06.E10 SMb20707 putative adenylate cyclase protein CyaG2 8 0.20 4.3E-04 32 0.42 1.2E-08 
2011mTn5STM.3.06.F10 SMc02562 phosphoenolpyruvate carboxykinase protein 
PckA 
8 -1.04 3.3E-08 24 -0.85 1.1E-21 
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2011mTn5STM.3.11.H10 SMb20806 hypothetical protein 8 -0.16 5.7E-03 32 -0.16 2.8E-03 
2011mTn5STM.3.05.A11 SMc01551 membrane bound O-acyl transferase 0 NA NA 24 0.16 2.5E-02 
2011mTn5STM.3.10.B11 SMb20607 hypothetical protein 8 0.72 4.6E-06 16 0.88 7.1E-07 
2011mTn5STM.3.10.C11 SMb20976 putative amino acid uptake ABC transporter 
periplasmic solute-binding protein precursor 
8 0.04 6.1E-01 32 0.05 6.4E-01 
2011mTn5STM.3.09.D11 SMb20885 hypothetical membrane protein 8 0.15 7.8E-03 32 0.15 1.3E-04 
2011mTn5STM.3.10.E11 SMc04091 putative protease transmembrane protein HtpX 8 0.05 2.5E-01 8 0.22 1.9E-02 
2011mTn5STM.3.05.F11 SMb20508 probable sugar ABC transporter 8 0.00 8.3E-01 32 -0.06 1.9E-03 
2011mTn5STM.3.09.G11 SMc02337 ABC sugar transporter. fused ATP-binding 
domains 
0 NA NA 8 1.24 7.2E-06 
2011mTn5STM.3.08.H11 SMb20623 hypothetical protein 8 0.64 1.3E-05 32 0.67 1.9E-20 
2011mTn5STM.3.08.B12 SMb20231 putative ABC transporter sugar-binding protein 8 -0.03 3.3E-01 32 -0.08 2.3E-01 
2011mTn5STM.3.12.C12 SMb21530 putative acetolactate synthase isozyme I large 
subunit protein IlvB2 
8 0.11 5.4E-02 32 -0.02 5.7E-01 
2011mTn5STM.3.08.D12 SMa0166 hypothetical protein 0 NA NA 24 -0.43 3.7E-06 
2011mTn5STM.3.07.E12 SMb21039 putative oligopeptidemurein peptide ABC 
transporter permease protein 
8 -0.36 6.9E-05 32 -0.43 1.4E-06 
2011mTn5STM.3.07.F12 pSymA, 465898 intergenic 8 -0.21 4.1E-03 32 -0.31 8.6E-04 
2011mTn5STM.3.08.G12 SMc03849 cytochrome c-type biogenesis protein CcmC 8 -1.06 2.4E-07 16 -0.98 1.1E-14 
2011mTn5STM.3.07.H12 SMc04011 probable nitrogen assimilation regulatory protein 8 0.68 1.5E-07 32 0.70 2.7E-23 
2011mTn5STM.3.07.A01 SMa0447 hypothetical protein 8 -0.37 8.9E-05 32 -0.24 3.2E-02 
2011mTn5STM.3.10.B01 SMc04244 probable high-affinity zinc uptake system ATP-
binding protein znuC 
8 0.34 1.2E-03 32 0.26 8.1E-09 
2011mTn5STM.3.11.C01 SMb20701 hypothetical protein 8 -0.17 1.2E-03 32 -0.06 1.7E-01 
2011mTn5STM.3.08.D01 SMb21512 hypothetical protein 8 -0.22 1.2E-02 32 -0.43 6.1E-09 
2011mTn5STM.3.11.E01 SMc01101 probable polypeptide deformylase protein Def1 8 0.35 1.2E-04 32 0.09 5.2E-01 
2011mTn5STM.3.09.F01 SMb20937 putative ABC transporter protein. fused ATP-
binding and permease components 
8 -0.50 6.4E-05 32 -0.72 6.0E-13 
2011mTn5STM.3.08.G01 SMc01816 alcohol dehydrogenase 8 0.14 1.2E-02 32 -0.43 2.6E-03 
2011mTn5STM.3.10.A02 SMb20211 putative transcriptional regulator protein 8 -0.12 3.5E-01 32 -0.38 4.1E-05 
2011mTn5STM.3.07.B02 SMc00963 biotin ABC transporter. permease component 
BioN 
8 -1.09 2.5E-08 32 -1.07 2.5E-29 
2011mTn5STM.3.09.C02 SMc03099 putative adenylate cyclase protein CyaF1 8 -0.32 1.1E-03 32 -0.45 7.5E-07 
2011mTn5STM.3.11.D02 SMc04169 transcription regulator. AraC family 8 -0.25 4.4E-04 32 -0.32 3.1E-04 
2011mTn5STM.3.08.E02 SMa1306 VirB9 type IV secretion protein 8 -0.11 5.2E-01 32 -0.29 3.0E-06 
2011mTn5STM.3.08.F02 SMc03006 probable CheY chemotaxis regulator protein 8 0.40 9.0E-05 32 0.44 2.9E-07 
2011mTn5STM.3.05.G02 SMc01550 hypothetical protein 8 -0.15 1.2E-01 32 -0.18 4.1E-03 
2011mTn5STM.3.08.H02 SMa1418 putative ABC transporter permease protein 8 -0.06 1.8E-01 32 -0.10 1.1E-01 
2011mTn5STM.3.08.A03 SMc01657 putative ferrichrome-iron receptor precursor 
protein FhuA2 
8 0.25 6.2E-04 32 0.26 1.5E-07 
2011mTn5STM.3.10.B03 SMc01817 putative transcription regulator protein 8 0.69 1.6E-06 24 -0.11 3.2E-01 
2011mTn5STM.3.10.C03 SMc01929 hypothetical protein 8 -0.70 1.1E-07 32 -0.79 1.4E-16 
2011mTn5STM.3.10.D03 SMb21647 periplasmic alpha-galactoside binding protein 
AgpA 
8 0.29 1.9E-03 32 0.37 3.3E-04 
2011mTn5STM.3.07.E03 SMc00109 putative transcription regulator protein 8 -0.32 2.1E-03 32 -0.21 2.6E-02 
2011mTn5STM.3.07.F03 SMb21251 hypothetical membrane protein 8 -0.22 3.3E-03 32 -0.33 1.0E-05 
2011mTn5STM.3.07.G03 pSymA, 127834 intergenic 8 0.09 1.5E-02 32 -0.19 3.8E-03 
2011mTn5STM.3.06.H03 SMb20509 putative transcriptional regulator 8 -0.74 1.8E-04 32 -0.92 2.3E-16 
2011mTn5STM.3.09.A04 SMa1220 FixN1 Heme b / copper cytochrome c oxidase 
subunit 
8 -0.06 7.5E-02 32 -0.10 1.5E-04 
2011mTn5STM.3.12.B04 SMc01579 hypothetical protein 8 0.58 9.6E-07 32 0.44 3.5E-14 
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2011mTn5STM.3.11.C04 SMb20771 hypothetical protein 8 0.15 1.4E-03 32 0.19 7.1E-04 
2011mTn5STM.3.06.D04 SMc02360 high-affinity branched-chain amino acid transport 
system permease protein livH  
8 0.55 6.7E-07 16 0.46 7.0E-04 
2011mTn5STM.3.08.E04 SMc01986 hypothetical transmembrane protein 8 1.00 7.3E-07 8 0.62 2.2E-06 
2011mTn5STM.3.09.F04 SMb20467 putative sensor kinase protein 8 -0.05 9.7E-01 32 -0.05 5.1E-01 
2011mTn5STM.3.08.G04 SMa0911 hypothetical protein 8 -0.04 2.7E-01 32 -0.07 5.4E-01 
2011mTn5STM.3.07.H04 SMc00926 probable glycolate oxidase protein, iron-sulfur 
subunit 
0 NA NA 32 0.13 2.4E-01 
2011mTn5STM.3.05.A05 SMc04045 probable dihydroxy-acid dehydratase protein 
IlvD2 
8 -0.99 2.8E-10 32 -0.85 8.9E-23 
2011mTn5STM.3.11.B05 SMc01203 hypothetical transmembrane protein 8 0.35 2.1E-06 16 0.21 1.4E-02 
2011mTn5STM.3.05.C05 SMa0059 dehydrogenase related to short chain alcohol 
dehydrogenases 
8 0.17 2.6E-04 32 0.08 8.4E-02 
2011mTn5STM.3.05.D05 SMa0900 possible anti-restriction protein 8 -0.33 1.9E-03 32 -0.27 8.8E-04 
2011mTn5STM.3.11.E05 SMb20478 putative dipeptide ABC transporter permease and 
ATP-binding protein 
8 -0.22 6.5E-04 32 -0.12 1.9E-02 
2011mTn5STM.3.10.F05 SMc01431 probable acetolactate synthase isozyme III large 
subunit protein IlvI 
8 -0.99 2.4E-08 32 -0.83 7.9E-23 
2011mTn5STM.3.08.G05 SMb20012 hypothetical protein 8 -0.05 1.3E-01 32 -0.17 7.6E-05 
2011mTn5STM.3.06.H05 SMa0247 hypothetical protein 0 NA NA 32 -0.37 8.7E-07 
2011mTn5STM.3.06.A06 SMb21298 hypothetical protein, possibly exported 0 NA NA 32 0.16 5.1E-03 
2011mTn5STM.3.11.B06 S. meliloti 
chromosome, 
1712504 
intergenic 0 NA NA 0 NA NA 
2011mTn5STM.3.12.C06 SMa2339 putative siderophore biosynthesis protein 8 -0.48 2.1E-06 16 -0.29 1.9E-04 
2011mTn5STM.3.07.D06 SMa1731 putative BetB2 betaine aldehyde dehydrogenase  8 -0.72 1.3E-07 32 -0.59 7.6E-15 
2011mTn5STM.3.06.E06 SMc03254 putative antikinase protein FixT3 8 -0.16 1.3E-01 16 -0.24 6.7E-06 
2011mTn5STM.3.06.G06 SMa0863 NodJ membrane transport protein 8 -1.03 1.5E-07 32 -0.82 1.0E-22 
2011mTn5STM.3.12.H06 SMc02784 hypothetical protein 8 -0.52 9.2E-07 32 -0.65 2.1E-08 
2011mTn5STM.3.12.A07 SMb20105 putative transcriptional regulator protein 8 -0.18 5.0E-03 32 -0.02 8.8E-01 
2011mTn5STM.3.05.B07 SMa1198 possible Copper export protein 0 NA NA 32 1.24 9.5E-32 
2011mTn5STM.3.06.C07 SMb20340 hypothetical protein 8 0.15 1.1E-03 24 0.14 4.3E-03 
2011mTn5STM.3.05.D07 SMb20866 hypothetical protein 8 -0.28 1.6E-05 32 -0.10 5.5E-02 
2011mTn5STM.3.06.E07 pSymB, 1126745 intergenic 8 -0.34 2.0E-06 32 -0.12 5.2E-02 
2011mTn5STM.3.05.F07 SMb20019 putative dihydrolipoamide succinyltransferase 
protein SucB 
8 -0.30 3.0E-07 32 -0.37 8.1E-08 
2011mTn5STM.3.08.G07 SMa1745 putative iron uptake protein 8 -0.19 3.3E-04 32 -0.15 2.3E-07 
2011mTn5STM.3.05.H07 SMa1229 FixL Oxygen regulated histidine kinase 8 -1.09 5.7E-08 32 -0.91 3.4E-22 
2011mTn5STM.3.07.A08 SMc00470 hypothetical transmembrane protein 8 1.32 1.1E-06 16 0.44 9.3E-02 
2011mTn5STM.3.11.B08 SMa2329 probable KdpC potassium-transporting ATPase C 
chain 
8 0.02 1.4E-01 32 0.03 3.6E-01 
2011mTn5STM.3.07.C08 SMb20325 sugar ABC transporter. extracellular solute-
binding protein ThuE 
8 -0.15 2.7E-02 32 -0.13 7.4E-04 
2011mTn5STM.3.12.D08 SMc02041 oxidoreductase. short-chain 
dehydrogenase/reductase family 
0 NA NA 32 0.25 4.0E-02 
2011mTn5STM.3.06.E08 SMc02019 sugar transport system permease protein 8 0.76 3.1E-07 32 0.60 3.5E-09 
2011mTn5STM.3.06.F08 SMc01112 probale hemolysin TlyC 8 -0.19 2.7E-03 16 0.05 5.7E-02 
2011mTn5STM.3.06.G08 pSymA, 600702 intergenic 8 -0.39 9.2E-06 32 -0.25 4.0E-07 
2011mTn5STM.3.10.H08 SMa2414 probable tonB-dependent receptor yncD 
precursor 
8 -0.44 1.6E-06 32 -0.58 2.7E-06 
2011mTn5STM.3.06.A09 SMc01230 putative transglycosylase 8 0.52 6.7E-06 24 0.18 2.7E-02 
2011mTn5STM.3.08.B09 SMa1978 probable haloacid dehalogenase-like hydrolase 8 0.04 7.0E-02 32 0.02 3.0E-01 
2011mTn5STM.3.07.C09 SMc01127 OlsB protein required for ornithine-containing 
lipid biosynthesis 
8 1.17 2.6E-06 16 0.75 1.7E-11 
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2011mTn5STM.3.05.D09 SMb20426 hypothetical transcriptional regulator protein 8 1.06 2.4E-07 16 1.38 1.2E-14 
2011mTn5STM.3.09.E09 SMa1057 hypothetical protein 8 -0.13 4.2E-03 32 -0.07 1.7E-02 
2011mTn5STM.3.07.F09 SMc03762 hypothetical transmembrane protein 0 NA NA 0 NA NA 
2011mTn5STM.3.08.G09 SMc03277 MFS-type transport protein 8 -0.93 1.9E-07 32 -0.88 2.6E-22 
2011mTn5STM.3.06.H09 SMc00378 putative exodeoxyribonuclease protein 8 0.73 2.0E-08 24 0.34 6.3E-04 
2011mTn5STM.4.11.A10 S. meliloti 
chromosome, 
3408566 
intergenic 8 -0.16 6.4E-04 24 0.04 6.1E-01 
2011mTn5STM.4.06.B10 S. meliloti 
chromosome, 
2576040 
intergenic 8 0.13 2.4E-04 32 0.30 1.1E-10 
2011mTn5STM.4.03.C10 SMa0561 hypothetical protein 8 -0.27 7.0E-04 32 -0.12 1.7E-02 
2011mTn5STM.4.09.D10 SMa0118 hypothetical protein 8 -0.25 4.7E-05 32 -0.18 7.8E-10 
2011mTn5STM.4.12.E10 SMb20492 putative short chain oxidoreductase protein 8 -0.12 8.2E-02 32 0.13 2.0E-02 
2011mTn5STM.4.08.F10 SMc02514 probable amino-acid ABC transporter periplasmic 
binding protein precursor. 
8 0.76 3.8E-08 32 0.69 4.4E-20 
2011mTn5STM.4.12.G10 SMb21175 phosphate uptake ABC transporter permease 
protein PhoE 
8 0.27 1.0E-05 32 0.34 2.4E-07 
2011mTn5STM.4.08.H10 SMc04382 NdvB glycosyltransferase involved in the 
production of beta-(1.2)-glucan 
0 NA NA 0 NA NA 
2011mTn5STM.4.02.A11 SMb20358 putative two-component hybrid sensor and 
regulator, adenylate and guanylate cyclase catalytic 
domain 
8 0.09 1.4E-02 32 0.01 8.8E-01 
2011mTn5STM.4.02.B11 SMb20619 probable transcriptional regulator 8 0.23 4.7E-03 16 0.39 1.6E-03 
2011mTn5STM.4.03.C11 SMa1732 hypothetical protein 8 -0.28 3.2E-07 32 -0.33 1.6E-13 
2011mTn5STM.4.02.D11 SMc01139 RNA polymerase sigma-54 factor 8 -1.17 3.0E-08 24 -1.03 2.2E-25 
2011mTn5STM.4.10.E11 SMa0969 putative response regulator of two-component 
system 
8 0.06 1.7E-01 32 -0.04 6.8E-01 
2011mTn5STM.4.06.F11 SMb20725 hypothetical membrane protein 8 -0.25 6.2E-06 32 -0.45 2.6E-06 
2011mTn5STM.4.09.G11 SMa1273 NorB nitric oxide reductase 8 -0.20 4.0E-04 32 -0.07 3.2E-01 
2011mTn5STM.4.02.H11 SMc04054 hypothetical protein 8 0.24 2.8E-04 32 0.13 4.0E-02 
2011mTn5STM.4.05.A12 SMc03112 methionine synthase MetH 8 0.85 9.8E-06 31 0.84 4.5E-19 
2011mTn5STM.4.10.B12 SMa0136 hypothetical protein 8 -0.13 8.3E-02 32 -0.25 2.0E-02 
2011mTn5STM.4.05.C12 SMa1564 hypothetical protein 8 -0.50 5.4E-06 32 -0.58 1.2E-15 
2011mTn5STM.4.10.D12 SMc03195 probable uracil-DNA glycosylase protein 8 -0.01 4.5E-01 32 -0.34 1.7E-02 
2011mTn5STM.4.12.E12 SMa2085 probable ABC transporter. permease protein 8 -0.57 6.3E-07 32 -0.61 7.6E-17 
2011mTn5STM.4.02.F12 SMb21588 probable sugar ABC transporter 8 -0.41 6.2E-07 24 -0.27 2.6E-02 
2011mTn5STM.4.05.G12 SMa1142 FixL-related histidine kinase 8 -0.31 3.7E-04 32 -0.17 2.3E-02 
2011mTn5STM.4.01.H12 SMb20609 putative two-component sensor histidine kinase 
protein 
8 0.13 1.3E-02 24 -0.06 6.5E-02 
2011mTn5STM.4.08.A01 SMc02274 putative capsule polysaccharide export protein 
precursor RkpU 
8 -0.75 6.0E-06 32 -0.74 4.6E-10 
2011mTn5STM.4.12.B01 SMc04207 rhizobiocin secretion protein RspD 8 -0.16 2.3E-02 32 -0.18 5.1E-06 
2011mTn5STM.4.01.C01 SMa1649 putative ABC transporter. permease protein 8 -0.41 5.9E-05 32 -0.56 8.9E-12 
2011mTn5STM.4.09.D01 SMb21240 putative MPA1 family auxiliary surface saccharide 
export protein 
8 -0.55 1.9E-03 24 -0.66 6.2E-11 
2011mTn5STM.4.04.E01 SMb20055 putative transcriptional regulator protein 8 -0.07 3.2E-01 24 -0.27 4.6E-03 
2011mTn5STM.4.03.F01 SMa0172 hypothetical protein 8 -0.57 1.5E-04 32 -0.71 2.0E-09 
2011mTn5STM.4.11.G01 SMb21010 D-beta-hydroxybutyrate dehydrogenase protein 
BdhA 
8 0.24 1.2E-05 32 0.21 3.0E-05 
2011mTn5STM.4.05.H01 SMc01837 urease alpha subunit protein UreC 8 0.61 2.8E-06 32 0.75 2.2E-14 
2011mTn5STM.4.03.B02 SMb21488 putative cytochrome o ubiquinol oxidase chain I 
protein 
8 -0.30 2.5E-04 32 -0.33 1.9E-10 
2011mTn5STM.4.09.C02 SMc00831 probable transcription regulator 8 -0.01 6.7E-01 32 -0.01 7.7E-01 
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2011mTn5STM.4.09.D02 SMc00234 Putative peptidyl-prolyl cis-trans isomerase D  8 -0.40 3.9E-07 32 -0.35 9.1E-13 
2011mTn5STM.4.05.E02 SMc01183 Putative LexA repressor regulator 8 -0.89 1.7E-06 32 -0.86 7.4E-19 
2011mTn5STM.4.08.F02 SMc04403 probable peptidyl-dipeptidase protein 8 -0.13 5.7E-02 32 -0.31 1.4E-05 
2011mTn5STM.4.11.G02 pSymB, 179255 intergenic 8 -0.38 2.0E-04 32 -0.83 9.6E-11 
2011mTn5STM.4.04.H02 SMa2147 hypothetical protein 8 -0.53 8.3E-06 32 -0.72 5.1E-16 
2011mTn5STM.4.02.A03 SMc02172 FrcR transcriptional regulator. ROK family 8 0.51 4.6E-03 32 0.48 7.8E-11 
2011mTn5STM.4.12.B03 SMa1750 hypothetical protein 8 -0.54 6.0E-06 32 -0.55 6.7E-13 
2011mTn5STM.4.02.C03 SMc00644 hypothetical protein 8 -1.13 1.0E-08 32 -1.08 3.5E-29 
2011mTn5STM.4.11.D03 SMa0937 hypothetical protein 0 NA NA 32 0.52 9.8E-09 
2011mTn5STM.4.10.E03 SMa0601 hypothetical protein 8 0.33 1.4E-03 32 0.17 5.5E-03 
2011mTn5STM.4.09.F03 SMc03797 homoserine O-succinyltransferase MetA 8 -1.20 6.7E-08 32 -1.20 1.9E-28 
2011mTn5STM.4.01.G03 SMb20610 putative two-component response regulator 
protein 
8 0.65 3.5E-05 32 0.42 2.0E-10 
2011mTn5STM.4.10.H03 SMc01802 putative agmatinase SpeB 8 0.20 3.6E-03 32 0.15 6.8E-02 
2011mTn5STM.4.06.A04 SMb21021 putative transcriptional regulator protein 8 -0.30 9.0E-04 24 -0.61 3.7E-05 
2011mTn5STM.4.07.B04 SMc04317 solute-binding periplasmic protein precursor 
AfuA 
0 NA NA 20 0.74 6.9E-16 
2011mTn5STM.4.09.C04 SMb20986 putative nitrate reductase. large subunit protein 
NarB 
8 0.04 9.8E-01 24 -0.07 3.7E-01 
2011mTn5STM.4.06.D04 SMc04244 probable high-affinity zinc uptake system ATP-
binding ABC transporter protein ZnuC 
8 -0.46 3.0E-07 32 -0.32 1.8E-03 
2011mTn5STM.4.12.E04 SMc02271 probable ribitol type dehydrogenase RkpH 8 0.03 7.6E-01 32 -0.41 2.6E-04 
2011mTn5STM.4.03.F04 SMa1455 hypothetical protein 8 -0.19 1.2E-02 24 -0.26 9.7E-11 
2011mTn5STM.4.11.G04 SMb21211 putative membrane protein 8 -0.61 3.0E-08 32 -0.58 1.3E-10 
2011mTn5STM.4.04.H04 SMc01265 hypothetical protein 8 -0.27 9.3E-04 32 -0.10 1.4E-01 
2011mTn5STM.4.11.A05 SMc01128 putative sensor histidine kinase transmembrane 
protein 
0 NA NA 16 0.31 1.7E-01 
2011mTn5STM.4.08.B05 SMc03900 beta-glucan export ATP-binding protein NdvA 8 -1.06 1.1E-06 16 -1.02 2.8E-14 
2011mTn5STM.4.04.C05 SMa1247 NirV periplasmic nitrate reductase 8 -0.47 9.4E-07 32 -0.40 2.7E-09 
2011mTn5STM.4.01.D05 pSymA, 12217 intergenic 0 NA NA 0 NA NA 
2011mTn5STM.4.08.E05 SMa2271 hypothetical protein 8 0.53 2.6E-07 16 0.19 3.3E-01 
2011mTn5STM.4.12.F05 SMc02224 putative calcium/proton antiporter 
transmembrane protein ChaA 
0 NA NA 8 0.26 3.7E-03 
2011mTn5STM.4.12.G05 SMa2402 L-2.4-diaminobutyrate decarboxylase 
rhizobactin/siderophore synthesis protein RhbB 
8 -0.38 3.1E-06 32 -0.45 1.1E-10 
2011mTn5STM.4.09.H05 SMa2229 hypothetical protein 8 -0.33 9.3E-06 32 -0.37 1.6E-04 
2011mTn5STM.4.04.A06 SMb20627 hypothetical protein 8 -0.06 1.8E-01 32 -0.32 3.2E-04 
2011mTn5STM.4.11.B06 SMa0647 hypothetical protein 8 -0.13 6.0E-04 32 -0.31 1.7E-05 
2011mTn5STM.4.10.C06 SMc00539 hypothetical transmembrane protein 8 0.02 4.8E-01 16 -0.45 3.3E-10 
2011mTn5STM.4.08.D06 SMc02244 putative transmembrane protein 8 0.32 7.4E-05 32 -0.14 2.8E-01 
2011mTn5STM.4.09.E06 SMa0414 hypothetical protein 0 NA NA 32 -0.80 4.6E-15 
2011mTn5STM.4.07.F06 SMa1471 hypothetical protein 0 NA NA 32 -0.49 1.4E-07 
2011mTn5STM.4.09.G06 SMa0941 hypothetical protein 8 -0.10 3.4E-02 32 -0.45 1.5E-05 
2011mTn5STM.4.09.H06 SMa1896 putative methionine sulfoxide reductase 8 -0.41 3.7E-06 32 -0.36 5.9E-10 
2011mTn5STM.4.10.A07 SMc02123 hypothetical protein 8 -0.81 1.4E-08 24 -0.77 8.4E-18 
2011mTn5STM.4.06.B07 SMa0196 putative gluconolactonase precursor 8 -0.29 9.9E-05 32 -0.13 8.1E-02 
2011mTn5STM.4.08.C07 SMc00114 probable protease II  8 0.01 9.1E-01 32 0.11 6.5E-04 
2011mTn5STM.4.01.D07 SMc03146 type I secretion membrane fusion protein. HlyD 
family 
8 0.23 2.9E-04 32 0.21 8.7E-05 
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2011mTn5STM.4.03.E07 SMa2029 hypothetical protein 0 NA NA 32 -0.52 2.2E-17 
2011mTn5STM.4.05.F07 SMc03015 VisN transcriptional regulator of motility genes 
LuxR family 
0 NA NA 24 0.31 1.0E-02 
2011mTn5STM.4.03.G07 SMb21492 hypothetical protein 8 -0.44 2.8E-06 32 -0.39 1.2E-17 
2011mTn5STM.4.08.H07 SMb20054 putative non-heme chloroperoxidase protein 8 -0.07 7.5E-03 32 0.02 3.4E-01 
2011mTn5STM.4.07.A08 SMa0244 hypothetical protein 8 -0.48 3.9E-06 24 -0.19 5.3E-04 
2011mTn5STM.4.10.B08 SMa1742 putative iron uptake protein 8 -0.72 2.7E-08 20 -0.73 1.0E-14 
2011mTn5STM.4.01.C08 SMb21155 hypothetical protein 8 -0.34 9.0E-05 32 -0.31 1.4E-09 
2011mTn5STM.4.02.D08 SMa1377 Putative amidase 8 -0.52 1.7E-06 32 -0.50 8.4E-09 
2011mTn5STM.4.12.E08 SMb20486 probable sugar ABC transporter 8 0.31 1.0E-06 32 0.36 6.1E-13 
2011mTn5STM.4.09.F08 SMb20362 putative inositol monophosphatase protein 8 0.12 1.9E-02 32 0.27 1.2E-05 
2011mTn5STM.4.11.G08 SMb20420 putative glutathione S-transferase protein 8 -0.17 4.0E-05 32 -0.09 4.6E-01 
2011mTn5STM.4.08.H07 SMc03784 hypothetical transmembrane protein 8 0.75 2.4E-05 32 0.09 5.6E-01 
2011mTn5STM.4.11.A09 SMb21579 putative transcriptional regulator. merR family 
protein 
8 -0.26 8.9E-05 32 -0.55 2.1E-07 
2011mTn5STM.4.11.B09 SMc04344 hypothetical signal peptide protein 8 -0.22 2.9E-05 16 0.11 4.3E-05 
2011mTn5STM.4.12.C09 SMc00726 putative thiol:disulfide interchange redox-active 
center transmembrane protein TlpA 
8 -0.17 1.3E-04 32 -0.40 1.4E-03 
2011mTn5STM.4.06.D09 SMb20614 hypothetical protein 8 -0.38 4.2E-07 32 -0.33 2.7E-07 
2011mTn5STM.4.05.E09 SMc02147 probable phosphate regulon sensor histidine 
kinase transmembrane protein PhoR 
8 0.32 4.7E-05 32 0.13 1.1E-01 
2011mTn5STM.4.06.F09 SMb21222 putative transcriptional regulator 8 -0.78 2.5E-07 32 -0.66 5.5E-19 
2011mTn5STM.4.02.G09 SMc00925 hypothetical protein 8 0.53 6.2E-06 32 0.45 4.7E-14 
2011mTn5STM.4.08.H09 SMc03004 putative methyl-accepting chemotaxis protein 
McpE 
8 0.01 9.4E-01 20 0.32 7.4E-03 
 
a For mutants carrying a transposon insertion in an intergenic region the exact position of insertion in the respective 
replicon is given. 
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G.5 LIST OF ABBREVIATIONS 
 
% (v/v) Volume percent K-iodide Potassium iodide  
% (v/v) Weight percent Km Kanamycin 
°C Degrees Celsius LMW Low molecular weight 
AT Sum of all the bases A and T mg Milligram 
BPB Bromphenol blue min minute 
BSA Bovine serum albumin ml Milliliter 
Cam Chloramphenicol mM Millimolar 
cv Cultivar mRNA Messenger RNA 
Cy3 Cyanine 3 μ Micro 
Cy5 Cyanine 5 μg Microgram 
dATP 2’-deoxyadenosine 5’-triphosphate μl Microliter 
dCTP 2’-deoxycytidine 5’-triphosphate μm Micrometer 
dGTP 2’-deoxyguanosine 5’-triphosphate μM Micromolar 
dTTP 2’-deoxythymidine 5’-triphosphate Nod- Non-nodulating phenotype 
DTT Dithiothreitol Nod+ Nodulating phenotype 
DMSO Dimethyl Sulfoxide Nm Neomicin 
DNA Deoxyribonucleic acid Nx Nalidixic acid 
dNTPs Deoxynucleotide triphosphates o.D. Optical density 
dpi Days post inoculation PEG Polyethylene glycol 
Dr. Doctor  pmol Pikomole 
dsDNA Double-stranded DNA PCR Polymerase chain reaction 
EDTA Ethylenediaminetetraacetic acid pH 
the logarithm of the reciprocal of 
hydrogen-ion concentration in gram 
atoms per liter 
et al.  Et alii (lat.)/and others RNA Ribonucleic acid 
EtOH Ethanol RNase Ribonuklease 
ed/eds Editor/editors rpm Rotations per minute 
Fig. Figure(s) SAP Shrimp alkaline phosphatase 
Fix- Non-nitrogen fixing phenotype sec Seconds 
Fix+ Nitrogen fixing phenotype SDS Sodium dodecyl sulfate 
g Gramm Sm Streptomycin 
× g Times gravity STM Signature tagged mutagenesis 
GC Sum of all the bases G and C U Unit 
Gm Gentamycin UV Ultra-Violet 
h Hour(s) V Volt 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Vol Volume 
HMW High molecular weight X-Gluc 5-Bromo-4-chloro-3-indolyl-ß-D-glucuronide 
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